data_2kmd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kmd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.459 ' HA2' ' HD2' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.672 0 CA-C-O 120.186 -0.23 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.473 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.8 t80 -87.18 -55.14 3.95 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 116.932 0.366 . . . . 0.0 110.402 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.7 m -53.71 -33.35 55.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.209 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.459 ' HD2' ' HA2' ' A' ' 55' ' ' GLY . 90.0 mttt -63.93 -31.8 73.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -86.17 -39.92 16.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 46.5 mt-30 -56.43 -31.67 64.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.302 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -82.98 -33.83 26.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.731 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -69.51 -37.65 77.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.398 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.27 -34.93 10.51 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.33 -0.69 31.08 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.636 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.0 mt -55.88 124.23 56.93 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 122.308 0.243 . . . . 0.0 111.078 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.505 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.1 Cg_endo -73.33 167.22 27.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.556 2.171 . . . . 0.0 112.467 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -76.48 -31.02 57.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.585 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 30.1 t70 -83.99 126.55 69.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.458 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 61.4 Cg_endo -72.62 -24.89 18.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.289 2.659 . . . . 0.0 113.869 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 6.2 mpt_? -69.29 -31.66 70.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.99 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 10.7 pt20 -93.97 36.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 111.084 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.596 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.6 m0 -103.77 166.19 10.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -134.15 179.19 6.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.01 -41.58 47.56 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -63.24 -54.14 42.06 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.274 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.456 ' CD2' HG12 ' A' ' 65' ' ' ILE . 38.0 m170 -58.54 -39.41 80.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.16 -52.24 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.4 ttm105 -69.18 -47.31 65.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.27 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -35.01 69.14 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 26.5 t90 -72.33 -61.67 1.71 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.508 HG13 HD22 ' A' ' 125' ' ' LEU . 48.3 t -40.11 -52.48 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.383 0.427 . . . . 0.0 110.902 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 40.9 ttm -57.2 -47.79 80.39 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.574 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 18.8 t90 -59.96 -39.27 85.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.826 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.7 65.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.455 ' CG2' HG11 ' A' ' 93' ' ' VAL . 77.9 t -76.3 -31.23 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.966 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.4 -31.98 32.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.071 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 11.0 mm-40 -70.15 -41.32 73.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.28 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -107.08 9.91 30.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.873 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.8 m 44.66 54.26 6.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 110.527 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.524 HD13 ' HB ' ' A' ' 121' ' ' VAL . 62.9 mt -82.02 178.21 8.41 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.467 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.18 151.34 15.61 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.553 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.86 -8.69 77.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.57 ' HB ' HG23 ' A' ' 121' ' ' VAL . 12.7 p -83.44 138.7 18.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 117.543 0.672 . . . . 0.0 111.158 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -116.56 152.9 33.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -95.41 -9.85 31.59 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.409 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -63.72 -42.83 97.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 71.0 mmtt -65.99 -32.5 74.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.171 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 117' ' ' ALA . 38.4 m-85 -99.5 33.45 2.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.583 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.7 t -87.69 64.7 8.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.115 0.483 . . . . 0.0 110.271 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.4 ptp -157.17 169.91 23.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.779 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.9 p -76.87 166.53 23.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.322 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.92 -43.65 96.61 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.803 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.42 63.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.689 0.28 . . . . 0.0 110.929 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.72 -46.41 53.77 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.06 -45.67 79.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.182 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.33 -41.39 85.33 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.674 0.273 . . . . 0.0 110.821 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.21 71.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.496 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 61.9 mt -60.72 -39.79 89.94 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.22 172.47 44.65 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.507 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.427 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.1 ttpt -59.06 -55.07 39.75 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.37 -49.9 63.46 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 98.8 m -63.58 -43.61 96.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.509 0.195 . . . . 0.0 111.004 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -62.97 -41.25 99.48 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.675 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.62 -27.43 68.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.721 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -76.31 -23.95 54.34 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.693 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 97.5 mt -79.94 -34.04 39.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . . . -109.33 161.53 23.58 Favored Pre-proline 0 N--CA 1.462 0.137 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.243 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.663 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 68.1 Cg_exo -50.06 165.64 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.878 2.386 . . . . 0.0 113.139 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.84 -15.42 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.644 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -108.21 -61.1 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.992 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.663 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 12.1 m -60.43 -34.33 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.8 -36.14 40.58 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.129 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -65.56 -47.82 74.53 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.519 0.2 . . . . 0.0 111.313 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.26 -54.64 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.328 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.508 HD22 HG13 ' A' ' 81' ' ' VAL . 10.9 mp -53.33 -54.67 33.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.341 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 2.6 t90 -62.04 -29.92 70.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.11 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.07 -59.26 5.71 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.401 ' HA ' HD12 ' A' ' 131' ' ' ILE . 21.8 t-160 -69.54 -36.18 76.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.818 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.507 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.2 tp -61.29 -43.04 99.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.83 -33.33 74.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 128' ' ' HIS . 59.4 mt -59.18 -42.19 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.029 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 95.8 mt -57.98 -38.36 75.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.596 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 . . . . . 0 C--O 1.232 0.155 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.919 179.614 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.53 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 17.7 t80 -94.69 -45.46 7.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 116.701 0.251 . . . . 0.0 110.338 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 95.0 m -58.3 -37.02 74.22 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.978 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -63.15 -30.64 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.298 . . . . 0.0 110.41 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.51 -40.12 23.68 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.045 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 57.1 mt-30 -56.14 -28.7 58.95 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.705 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -88.44 -37.51 15.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.591 0.234 . . . . 0.0 110.992 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -67.25 -39.86 86.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.281 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.79 -29.57 12.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.6 -1.05 49.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -52.45 123.55 29.69 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 122.348 0.259 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 58.1 Cg_endo -71.73 168.94 22.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.494 2.129 . . . . 0.0 112.507 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -97.21 39.74 1.18 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.225 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.496 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 5.5 t70 -144.07 114.22 5.38 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 36.8 Cg_endo -65.7 -24.59 54.86 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.799 2.333 . . . . 0.0 112.775 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 3.4 mpt_? -77.71 -31.24 52.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 11.4 mm-40 -96.77 34.92 1.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.935 0.397 . . . . 0.0 110.487 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 4.1 m0 -107.91 170.35 8.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.69 -177.56 4.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.242 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -50.04 -42.81 50.33 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 m -64.34 -51.69 62.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.537 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -60.15 -42.01 93.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.25 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.26 -53.4 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -68.02 -46.71 70.47 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.696 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -56.49 -41.31 76.43 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.512 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.43 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.8 t90 -64.7 -61.98 1.86 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 85' ' ' VAL . 55.9 t -41.12 -53.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.793 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.418 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 35.4 ttm -58.22 -48.19 81.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.77 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.53 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 15.4 t90 -56.95 -38.43 72.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.836 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.14 83.47 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.505 ' CG2' HG12 ' A' ' 93' ' ' VAL . 81.6 t -53.1 -34.5 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.592 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -79.65 -36.19 38.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.157 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 9.3 mm-40 -68.2 -39.43 82.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.446 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.7 8.55 29.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 46.08 50.79 11.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 110.467 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.489 HD11 ' HB ' ' A' ' 121' ' ' VAL . 67.6 mt -78.75 177.68 8.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.481 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.34 152.82 17.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.26 73.63 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.811 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.505 HG12 ' CG2' ' A' ' 85' ' ' VAL . 14.9 p -74.96 132.04 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 117.58 0.69 . . . . 0.0 110.873 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.467 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 7.9 m-20 -99.12 133.93 42.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.1 -23.78 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.411 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.533 ' HG3' ' HD2' ' A' ' 97' ' ' LYS . 14.1 pt20 -63.22 -33.22 75.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.3 mptp? -67.49 -34.94 78.18 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.999 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -100.62 34.85 2.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.662 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.4 t -87.76 64.62 8.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.138 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.3 ptp -155.7 167.95 28.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.756 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -73.77 159.69 32.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.344 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -55.29 -43.51 84.41 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.961 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.66 -38.6 60.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.665 0.269 . . . . 0.0 111.037 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.02 58.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.1 tp -55.79 -44.72 78.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.079 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.77 -41.76 91.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.777 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.25 72.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.8 mt -61.37 -36.98 81.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.93 176.4 51.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.678 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 52.0 tttp -61.36 -51.3 69.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -50.48 -52.33 39.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.4 m -66.55 -42.67 86.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.434 ' CE1' HD21 ' A' ' 129' ' ' LEU . 59.0 t80 -63.72 -42.14 97.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.99 -29.65 70.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.717 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.67 -21.25 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.664 0.268 . . . . 0.0 110.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.6 mt -85.8 -32.59 21.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.835 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -112.4 150.91 43.32 Favored Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.642 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 85.6 Cg_exo -44.23 167.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.691 2.927 . . . . 0.0 114.079 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.95 -24.05 67.7 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.3 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.06 -49.19 3.24 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.524 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.642 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.2 m -63.11 -34.37 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.168 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.91 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.816 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.34 -45.35 94.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.577 0.227 . . . . 0.0 110.945 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.7 mt -61.98 -56.93 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.268 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.8 mt -55.07 -57.36 12.05 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.3 -36.1 79.14 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.335 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -56.47 -54.87 40.63 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.483 ' HA ' HD11 ' A' ' 131' ' ' ILE . 22.3 t-160 -72.47 -30.3 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.653 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 52.4 tp -59.59 -49.85 76.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.104 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 15.3 mm-40 -67.29 -33.69 75.83 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.222 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 128' ' ' HIS . 69.3 mt -58.64 -40.17 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.315 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.0 mt -62.39 -39.08 92.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.3 mt-30 . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.798 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.408 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.7 t80 -89.01 -47.78 7.88 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.675 0.237 . . . . 0.0 110.779 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.9 m -55.06 -31.75 61.38 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.52 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -62.19 -30.33 71.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.342 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -84.38 -42.18 15.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 31.8 mt-30 -58.33 -31.76 67.86 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.374 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -82.9 -35.73 25.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.517 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -65.86 -35.23 80.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.46 -32.44 9.5 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.85 4.46 39.28 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.627 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.96 127.74 69.49 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.354 0.262 . . . . 0.0 110.929 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.53 174.49 12.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 112.76 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -100.84 45.95 0.96 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -144.48 113.32 5.12 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.495 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 20.3 Cg_endo -61.77 -29.72 83.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.765 2.31 . . . . 0.0 112.823 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 5.5 mpt_? -74.47 -33.45 62.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.558 0.218 . . . . 0.0 110.495 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -95.7 35.03 1.41 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.079 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.507 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.3 m0 -109.73 160.43 16.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.4 t -127.04 -179.32 4.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.345 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.48 -49.63 44.75 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 m -58.16 -45.95 86.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.314 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -64.19 -41.68 96.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.444 HG12 HD21 ' A' ' 105' ' ' LEU . 55.8 t -62.5 -54.54 32.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.117 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -65.75 -45.49 82.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.55 -42.28 92.01 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.573 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 21.9 t90 -63.4 -60.33 3.51 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.553 HG12 HD22 ' A' ' 125' ' ' LEU . 40.3 t -42.19 -53.9 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.365 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 37.7 ttm -56.24 -45.97 79.77 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.705 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.517 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 52.1 t90 -56.77 -36.44 69.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.88 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.35 58.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.156 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 81' ' ' VAL . 89.0 t -78.52 -34.81 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.484 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -83.35 -37.45 23.33 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.138 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 7.3 mm-40 -70.23 -36.07 74.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.309 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.7 8.78 24.91 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t 43.62 62.11 2.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.121 0.486 . . . . 0.0 110.498 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' HB ' ' A' ' 121' ' ' VAL . 59.9 mt -90.43 153.47 20.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.475 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 151.27 49.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.77 -10.62 73.09 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.707 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.473 HG12 ' CG2' ' A' ' 85' ' ' VAL . 13.8 p -79.54 139.75 17.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 117.404 0.602 . . . . 0.0 110.938 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.465 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 10.5 m-20 -117.55 144.17 45.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.212 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.25 -18.66 26.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.977 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.09 -36.44 81.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.041 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.0 mptt -69.24 -34.43 74.79 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.412 ' HZ ' ' HB1' ' A' ' 117' ' ' ALA . 42.8 m-85 -99.96 33.5 2.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.1 t -86.88 64.29 8.41 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.219 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.7 ptp -156.45 169.32 24.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.735 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.2 m -75.81 161.5 28.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.373 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.84 -44.09 92.2 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.014 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.75 59.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.987 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.0 -44.48 63.41 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.444 HD21 HG12 ' A' ' 77' ' ' VAL . 13.9 tp -57.62 -46.64 83.84 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.271 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.92 -38.48 91.26 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 110.604 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.21 67.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.561 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 66.4 mt -64.17 -35.22 80.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.04 175.79 45.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.589 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.28 -66.62 0.37 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.4 m -58.57 -39.53 80.58 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 54.1 t80 -64.17 -45.88 86.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.305 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.1 mt -63.09 -26.37 68.8 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.036 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -75.47 -22.63 57.09 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.603 0.24 . . . . 0.0 110.76 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -83.04 -36.26 25.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.585 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.412 ' HB1' ' HZ ' ' A' ' 98' ' ' PHE . . . -108.39 155.27 40.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.601 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.676 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 76.9 Cg_exo -48.53 169.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.233 2.622 . . . . 0.0 113.775 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.89 -22.97 67.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.983 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -107.81 -57.04 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.364 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.676 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 6.1 m -60.24 -33.29 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.34 -32.99 57.93 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.229 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.17 -48.63 77.58 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.64 0.22 . . . . 0.0 111.422 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.443 ' CD1' HD21 ' A' ' 90' ' ' LEU . 74.0 mt -54.6 -54.48 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.493 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.553 HD22 HG12 ' A' ' 81' ' ' VAL . 10.0 mp -54.28 -59.73 4.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.275 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.76 -30.77 67.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.939 -0.077 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.09 -57.75 11.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -73.77 -39.39 64.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.006 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.573 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.8 tp -54.08 -46.11 71.95 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.36 -35.19 75.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.192 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.48 -42.98 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.473 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.8 mt -52.14 -39.62 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.78 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 . . . . . 0 C--O 1.231 0.131 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.823 179.427 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.54 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.406 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 29.8 t80 -83.25 -50.45 8.4 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 116.453 0.126 . . . . 0.0 110.796 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.687 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 28.8 m -55.72 -40.78 72.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.435 ' HD2' ' NE2' ' A' ' 61' ' ' GLN . 32.0 mmmt -64.95 -25.17 67.76 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 110.851 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.89 -48.17 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.687 ' HG2' ' HA ' ' A' ' 57' ' ' THR . 5.2 pt20 -65.95 -24.96 66.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.043 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.435 ' NE2' ' HD2' ' A' ' 58' ' ' LYS . 9.3 pt20 -79.92 -31.04 40.13 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.697 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -67.65 -30.83 70.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.787 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.13 -30.74 11.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.079 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.82 -1.64 27.35 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.173 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 60' ' ' GLN . 51.5 mt -60.41 128.27 87.73 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.843 0.321 . . . . 0.0 110.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.95 175.06 11.38 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.614 2.21 . . . . 0.0 112.505 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 43.63 1.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 111.154 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 11.1 m-20 -153.57 111.03 2.57 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.536 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 40.9 Cg_exo -57.42 -36.51 98.8 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.988 2.459 . . . . 0.0 112.48 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -55.4 -37.91 68.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.468 0.175 . . . . 0.0 111.105 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.435 ' HG2' ' HB2' ' A' ' 68' ' ' ASP . 12.0 pt20 -99.95 44.31 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.969 0.414 . . . . 0.0 111.156 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.544 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.4 m0 -117.23 169.61 9.33 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.086 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -131.54 -177.84 4.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -51.32 -44.28 61.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.3 m -63.62 -48.59 76.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.628 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.406 ' CD2' HG12 ' A' ' 65' ' ' ILE . 45.3 m170 -60.83 -42.13 97.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.316 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.28 -52.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.21 -47.1 68.79 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.498 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.18 -43.18 82.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.55 0.214 . . . . 0.0 110.54 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 13.7 t90 -63.59 -62.49 1.63 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 85' ' ' VAL . 43.9 t -39.69 -51.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.422 0.451 . . . . 0.0 110.939 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 29.0 ttm -53.39 -49.8 66.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.174 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.477 ' CZ2' ' HG3' ' A' ' 87' ' ' GLU . 76.8 t90 -61.93 -42.8 99.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.92 -20.92 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' CG2' HG13 ' A' ' 93' ' ' VAL . 55.5 t -82.33 -31.7 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.336 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.78 -36.84 42.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.936 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 11.1 mm-40 -71.79 -39.71 69.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.335 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -100.94 5.27 43.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.4 m 44.88 55.2 6.23 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 110.638 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.573 HD12 ' HB ' ' A' ' 121' ' ' VAL . 86.2 mt -75.9 151.32 37.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.908 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -130.64 143.04 50.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 111.623 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.61 -0.44 88.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.512 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.529 HG13 ' CG2' ' A' ' 85' ' ' VAL . 12.6 p -74.55 132.21 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.286 0.543 . . . . 0.0 111.161 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.98 136.78 47.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.058 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.26 -29.56 20.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.397 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.99 -33.69 72.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 47.1 mmtm -66.43 -36.6 83.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.894 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -97.58 34.73 1.78 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.223 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.61 66.12 8.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.388 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.425 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.6 ptp -158.43 169.08 25.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -73.54 156.48 38.09 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.227 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.544 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.07 -41.04 92.34 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.92 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.61 -39.59 65.05 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.726 0.298 . . . . 0.0 110.839 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.49 64.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.7 tp -55.79 -44.29 77.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.002 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 86.1 m -65.62 -42.45 91.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.55 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.1 -30.05 71.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 31.6 mt -62.39 -38.83 91.14 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.882 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.07 170.8 47.37 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.474 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.8 ttpt -59.27 -47.79 84.07 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.67 -51.1 61.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 70.2 m -66.13 -39.64 90.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.477 0.18 . . . . 0.0 111.123 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.403 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 48.2 t80 -63.51 -41.89 98.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.64 -23.13 65.31 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.813 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.72 -22.14 50.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.4 mt -85.86 -36.58 19.89 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.249 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.482 ' HB3' ' CG2' ' A' ' 121' ' ' VAL . . . -110.6 154.75 42.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.184 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.539 ' HG2' ' CG2' ' A' ' 121' ' ' VAL . 10.1 Cg_endo -54.79 172.32 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.749 2.3 . . . . 0.0 113.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.78 -21.99 57.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.33 -53.4 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 113.251 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.573 ' HB ' HD12 ' A' ' 90' ' ' LEU . 2.0 m -59.04 -34.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.49 -36.11 52.94 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.82 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.65 -49.82 56.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.47 0.176 . . . . 0.0 111.09 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.3 mp -57.43 -46.44 85.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.588 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.403 ' HB2' ' HE2' ' A' ' 113' ' ' PHE . 85.0 mt -67.5 -57.16 7.01 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.32 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.496 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -60.73 -33.63 73.19 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.18 -54.63 44.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -71.89 -30.01 64.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.459 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.508 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 43.0 tp -60.27 -50.78 72.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.8 mm-40 -66.13 -33.82 76.65 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 69.4 mt -61.68 -36.58 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.444 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.9 mt -62.96 -40.94 99.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.536 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 69.6 mt-30 . . . . . 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.471 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.558 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.525 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 7.9 t80 -83.91 -50.43 8.05 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.4 m -56.68 -36.85 70.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.55 -30.55 70.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.774 0.321 . . . . 0.0 110.303 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -84.58 -42.79 15.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 8.3 mm100 -56.96 -30.9 64.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -80.31 -36.69 33.94 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.478 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.57 -39.47 84.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.524 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.8 -32.24 14.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.21 -0.53 40.73 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.231 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.04 128.87 66.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 117.011 0.406 . . . . 0.0 110.913 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.87 172.82 14.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.754 2.303 . . . . 0.0 112.85 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.01 48.11 0.9 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.518 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 12.0 m-20 -140.8 105.99 6.32 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.9 Cg_endo -62.65 -37.06 60.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.659 2.24 . . . . 0.0 112.423 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -70.19 -32.67 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 68' ' ' ASP . 2.0 mp0 -97.85 42.21 1.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.55 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -115.68 168.33 10.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 101' ' ' SER . 15.3 t -133.55 -177.03 4.36 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.562 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -49.41 -46.79 47.96 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -63.27 -49.53 73.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.668 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -62.16 -43.06 99.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.688 0.28 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.47 -52.53 60.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.466 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -68.8 -46.07 69.61 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.784 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.39 -38.67 71.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.547 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.493 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 12.8 t90 -66.93 -61.07 2.13 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 85' ' ' VAL . 50.9 t -41.37 -53.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 40.0 ttm -56.57 -46.15 80.92 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.835 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.525 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 54.3 t90 -58.32 -35.94 72.64 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.691 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.35 -21.2 60.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.129 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.527 ' CG2' HG13 ' A' ' 93' ' ' VAL . 84.6 t -77.83 -32.78 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -81.52 -36.66 28.94 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.036 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 10.9 mm-40 -71.27 -40.29 71.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -104.32 6.14 35.05 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.9 m 45.15 56.57 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 110.599 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.475 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 74.5 mt -82.08 169.67 16.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.36 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.1 147.98 27.73 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.358 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -8.52 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.741 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.527 HG13 ' CG2' ' A' ' 85' ' ' VAL . 14.5 p -76.4 135.85 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.418 0.609 . . . . 0.0 110.785 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 12.1 m-20 -109.82 139.16 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.392 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -89.11 -25.08 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.704 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -61.89 -34.48 76.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 2.0 mptm? -67.15 -35.15 79.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.418 ' CZ ' ' HB1' ' A' ' 117' ' ' ALA . 35.9 m-85 -100.49 34.98 2.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.479 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.1 t -89.41 68.42 7.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.069 0.461 . . . . 0.0 110.251 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.4 ptp -160.66 172.97 16.16 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.788 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 72.1 m -73.43 156.59 38.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -57.91 -38.66 89.68 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.601 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.82 -39.58 71.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.283 . . . . 0.0 110.666 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.56 -45.02 66.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.72 -44.6 81.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.031 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.1 m -64.43 -40.35 95.57 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.15 73.67 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.305 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 60.1 mt -61.28 -36.14 79.25 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.895 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.7 176.22 48.92 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.601 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 27.5 ttpp -61.73 -46.82 88.01 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.25 -61.53 2.11 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.473 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 85.5 m -60.6 -39.33 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.438 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -63.36 -43.6 97.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.833 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -66.42 -25.92 66.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -76.63 -21.85 54.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.725 0.297 . . . . 0.0 110.347 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 80.6 mt -86.28 -36.77 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' A' ' 121' ' ' VAL . . . -116.47 151.74 47.33 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.815 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.601 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.8 Cg_exo -43.02 164.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.587 2.858 . . . . 0.0 114.09 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.47 -20.2 62.88 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.053 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -108.07 -52.69 2.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.188 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.601 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.2 m -62.01 -37.12 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.335 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.77 -36.91 88.9 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.669 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.56 -47.39 78.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.406 HD12 HD22 ' A' ' 90' ' ' LEU . 61.0 mt -59.36 -53.73 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.4 mt -55.63 -55.67 29.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.386 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -62.24 -28.91 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.04 -57.27 13.29 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.476 ' HA ' HD12 ' A' ' 131' ' ' ILE . 23.7 t-160 -70.98 -32.42 69.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.311 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 50.0 tp -57.49 -46.29 83.91 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.638 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -68.08 -33.49 74.63 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.233 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 128' ' ' HIS . 85.1 mt -61.12 -43.19 95.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.05 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.499 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.2 mt -58.27 -35.31 71.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.396 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 . . . . . 0 C--N 1.339 0.118 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.443 179.512 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 CA-C-O 120.291 -0.172 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 14.4 t80 -99.47 -50.28 4.14 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.811 0.306 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.8 m -55.67 -31.5 62.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.434 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -61.27 -33.69 73.97 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.674 0.273 . . . . 0.0 110.408 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.14 -38.98 23.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 33.4 mt-30 -58.24 -32.28 68.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.723 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -81.61 -36.89 28.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.796 -0.184 . . . . 0.0 111.48 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -70.76 -39.74 73.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.685 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.3 mt -98.05 -26.36 14.64 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.07 6.24 59.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.533 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 62.8 mt -54.93 122.17 39.69 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 122.305 0.242 . . . . 0.0 111.213 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.21 169.4 9.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.783 2.322 . . . . 0.0 112.558 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -99.24 34.36 2.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -153.78 116.51 2.65 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.3 Cg_endo -61.39 -40.53 47.91 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.145 2.563 . . . . 0.0 112.479 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -54.75 -36.33 64.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.67 0.271 . . . . 0.0 110.456 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -100.15 46.37 0.96 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.762 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.51 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 7.4 m0 -122.07 174.06 7.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.505 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.1 t -132.61 -179.05 5.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.95 -42.93 49.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.3 m -64.19 -50.08 69.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -60.77 -40.6 93.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.544 0.211 . . . . 0.0 111.199 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.409 HG13 HD21 ' A' ' 105' ' ' LEU . 65.6 t -63.2 -55.54 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -64.82 -48.55 74.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.721 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -56.53 -40.1 74.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.576 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.406 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.1 t90 -66.12 -61.11 2.21 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 85' ' ' VAL . 53.6 t -40.74 -55.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 62.1 mtt -55.55 -47.02 77.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.511 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.2 t90 -58.01 -35.95 71.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.938 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.77 -18.41 60.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.556 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 81' ' ' VAL . 96.7 t -81.04 -34.3 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.488 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -83.81 -32.85 25.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.511 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 6.9 mm-40 -75.53 -40.55 56.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -102.21 6.12 40.51 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.946 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 46.08 53.87 8.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 110.746 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.481 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 67.5 mt -81.95 169.23 17.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.118 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -152.54 148.88 27.9 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -7.4 81.33 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.855 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.5 ' HB ' HG22 ' A' ' 121' ' ' VAL . 14.5 p -76.74 134.48 28.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.423 0.612 . . . . 0.0 111.073 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.4 131.78 48.83 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.442 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -85.07 -28.69 25.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.74 -33.33 72.76 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.5 mptm? -67.23 -34.35 77.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.123 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 51.1 m-85 -99.32 35.81 1.87 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.598 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.99 64.43 7.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.045 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.433 ' SD ' HD13 ' A' ' 108' ' ' LEU . 16.8 ptp -155.64 167.34 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.046 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.0 p -70.9 158.12 36.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.51 -42.04 93.75 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.83 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.95 64.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.719 0.295 . . . . 0.0 110.876 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.5 -44.93 63.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.571 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.409 HD21 HG13 ' A' ' 77' ' ' VAL . 18.9 tp -55.15 -44.28 75.01 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.264 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 70.8 m -66.93 -40.61 87.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.713 0.292 . . . . 0.0 110.763 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.16 67.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.642 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.9 mt -68.01 -38.46 82.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.88 176.42 51.49 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.331 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.2 ttpt -61.6 -51.22 69.4 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.76 -51.75 36.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.3 m -66.73 -40.93 88.54 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.445 0.164 . . . . 0.0 111.356 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 125' ' ' LEU . 32.2 t80 -62.31 -43.59 98.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.95 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.8 -25.06 66.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.831 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -76.15 -22.38 55.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 110.216 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 91.4 mt -89.07 -35.63 16.21 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.37 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 121' ' ' VAL . . . -118.32 148.96 44.97 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.934 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.4 Cg_exo -41.89 163.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.752 2.968 . . . . 0.0 114.355 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.5 -21.49 62.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.131 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -108.1 -48.63 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.374 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.58 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 6.2 m -64.15 -37.52 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.48 0.181 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.02 89.59 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.96 -49.35 75.07 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.621 0.248 . . . . 0.0 110.957 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.437 HD13 HD21 ' A' ' 90' ' ' LEU . 47.7 mt -58.09 -57.33 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.0 0.428 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 90.4 mt -52.3 -59.21 4.67 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.057 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.563 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -61.74 -32.97 73.25 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.36 -56.35 21.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.236 0.471 . . . . 0.0 110.159 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.408 ' HA ' HD13 ' A' ' 131' ' ' ILE . 12.8 t-80 -68.13 -36.94 80.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.097 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 32.9 tp -58.71 -46.51 87.18 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.474 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.16 -39.5 86.65 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 128' ' ' HIS . 88.7 mt -60.11 -41.69 87.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.177 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.544 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 85.4 mt -66.52 -37.72 85.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.11 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.53 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.249 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.678 0 N-CA-C 112.792 -0.123 . . . . 0.0 112.792 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.431 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 9.0 t80 -99.43 -46.5 5.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.647 0.223 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.0 m -55.91 -34.9 66.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.626 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -58.37 -39.11 78.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.129 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -41.08 40.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.94 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.8 mt-30 -58.53 -29.19 66.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.677 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.11 -37.6 18.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.211 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -70.18 -30.64 67.81 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.663 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.55 -36.79 6.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.07 -2.91 29.98 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.915 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 69.0 mt -56.29 122.9 52.21 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.784 0.292 . . . . 0.0 111.026 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 70.5 Cg_endo -75.27 174.8 12.18 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.461 2.107 . . . . 0.0 112.249 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -101.22 42.59 1.11 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.028 0.442 . . . . 0.0 110.729 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -132.7 97.76 16.98 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' A' ' 133' ' ' GLN . 27.6 Cg_endo -61.66 -26.94 80.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -79.64 -37.83 35.15 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -95.21 41.7 1.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.23 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.44 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.3 m0 -111.01 172.31 6.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.675 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -131.82 -179.14 5.21 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.99 -43.49 60.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.3 m -63.59 -49.24 74.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.389 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -62.2 -41.16 98.1 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.186 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.454 HG12 HD22 ' A' ' 105' ' ' LEU . 67.1 t -64.06 -52.97 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.489 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.39 -46.16 77.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.594 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.23 -37.04 85.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.776 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.6 t90 -64.9 -65.64 0.65 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 85' ' ' VAL . 7.5 p -42.14 -46.54 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.215 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 43.8 ttm -60.21 -45.93 91.49 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.393 . . . . 0.0 110.432 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.523 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 11.7 t90 -60.65 -37.53 81.83 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.558 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -17.06 62.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.527 ' CG2' HG11 ' A' ' 93' ' ' VAL . 75.4 t -84.28 -32.37 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.164 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -81.55 -35.37 30.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.72 -40.73 55.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.63 7.67 43.84 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t 43.34 59.5 2.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 110.883 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 62.3 mt -89.35 171.63 9.62 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.024 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.99 148.32 23.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.947 0.403 . . . . 0.0 111.547 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.04 -9.1 78.71 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.694 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.6 p -74.23 136.86 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 117.39 0.595 . . . . 0.0 110.837 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.77 132.81 50.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.524 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -86.36 -24.18 25.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.371 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.31 -36.57 84.53 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.624 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.8 mptp? -65.38 -36.18 83.2 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.855 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.4 m-85 -98.54 32.18 2.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.381 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 46.2 t -87.29 67.65 9.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 110.25 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.8 ptp -159.73 171.38 19.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.897 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.4 p -72.33 159.45 34.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.252 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.44 -42.9 94.06 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.636 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.54 -38.74 64.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 110.964 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.77 -47.55 58.99 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.454 HD22 HG12 ' A' ' 77' ' ' VAL . 22.3 tp -55.71 -47.21 77.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.389 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.51 -38.53 91.34 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.681 0.277 . . . . 0.0 110.634 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -32.31 73.97 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.409 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 58.4 mt -59.77 -34.72 73.36 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.88 173.42 45.43 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.471 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.9 ttpt -59.98 -45.92 91.15 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.34 0.126 . . . . 0.0 111.34 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -49.75 -65.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.19 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 93.0 m -58.07 -38.7 76.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.435 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.95 -43.43 98.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.748 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.34 -26.19 67.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 12.5 mm-40 -75.39 -22.62 57.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.77 0.319 . . . . 0.0 110.149 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -87.36 -39.61 15.17 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.46 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -111.54 150.92 42.88 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.619 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.3 Cg_exo -44.04 165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.606 2.871 . . . . 0.0 114.111 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.37 -20.14 62.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.938 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.53 -55.0 2.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.619 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.8 m -59.99 -33.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.73 -32.13 58.47 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.208 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.59 -52.52 30.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.66 0.23 . . . . 0.0 111.305 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.477 HD11 HD23 ' A' ' 90' ' ' LEU . 56.3 mt -56.18 -47.11 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.714 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.12 -60.48 3.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.753 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -62.33 -28.78 69.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.33 -54.75 17.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.062 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -66.71 -32.84 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.17 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.526 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.6 tp -63.73 -41.32 98.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.247 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.443 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 32.6 tt0 -70.26 -23.57 62.91 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.395 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 78.0 mt -77.21 -37.49 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.887 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.95 -47.9 83.44 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.542 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.483 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 6.7 pt20 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.542 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 CA-C-O 120.249 -0.195 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.418 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 16.7 t80 -95.39 -45.77 6.98 Favored 'General case' 0 CA--C 1.526 0.043 0 CA-C-N 116.735 0.267 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.2 m -56.52 -39.17 72.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.954 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -62.03 -36.1 80.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.66 0.267 . . . . 0.0 110.479 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 9.8 tp10 -74.84 -41.13 60.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.4 mt-30 -58.04 -26.69 62.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.331 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -83.31 -31.4 26.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.186 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 89.9 mtt180 -71.76 -43.21 66.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.188 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.5 mt -94.73 -25.79 16.55 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.198 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.56 1.82 61.95 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.595 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 79' ' ' ASP . 67.4 mt -49.81 126.48 18.76 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 122.525 0.33 . . . . 0.0 111.418 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.36 170.09 4.51 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.095 2.53 . . . . 0.0 112.956 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -100.99 38.91 1.46 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -163.96 122.37 1.24 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.571 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 35.3 Cg_exo -60.25 -44.66 27.11 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.601 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 13.5 mtt180 -53.71 -34.24 58.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.611 0.244 . . . . 0.0 110.957 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.85 42.29 1.1 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.483 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 12.9 m0 -120.74 175.94 5.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.636 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 p -137.36 -176.06 4.27 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.029 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -51.77 -37.76 52.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.572 0.225 . . . . 0.0 111.188 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.4 m -67.62 -56.0 11.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.546 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -59.76 -42.72 93.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.607 0.241 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -58.35 -47.69 87.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.412 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 5.4 tmm_? -73.24 -42.4 62.6 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.037 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.4 ' HB3' HD13 ' A' ' 65' ' ' ILE . 1.3 m-20 -58.51 -36.82 74.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.509 0.195 . . . . 0.0 110.617 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.588 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -71.84 -62.24 1.49 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.449 ' O ' HG21 ' A' ' 85' ' ' VAL . 58.1 t -41.53 -51.86 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 56.9 tpp -54.06 -49.06 69.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.7 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -57.27 -38.4 73.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.108 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 88' ' ' PHE . . . -76.18 -18.69 58.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.513 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.508 ' CG2' HG11 ' A' ' 93' ' ' VAL . 78.8 t -85.88 -30.48 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.7 -39.66 15.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.096 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.71 -34.95 62.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.528 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 51.3 m-85 -100.79 4.21 42.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.448 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 46.71 55.97 7.11 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 122.611 0.364 . . . . 0.0 111.506 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.477 HD13 ' HB ' ' A' ' 121' ' ' VAL . 71.8 mt -86.34 167.32 14.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.588 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.64 154.88 38.29 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 111.724 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -8.24 66.58 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.69 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.508 HG11 ' CG2' ' A' ' 85' ' ' VAL . 14.1 p -74.84 130.54 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 117.403 0.601 . . . . 0.0 111.029 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.87 130.68 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.339 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.0 -20.85 29.89 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.43 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -65.49 -33.5 76.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 34.9 mmtp -66.48 -35.76 81.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.697 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 117' ' ' ALA . 28.8 m-85 -100.08 29.75 4.11 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.325 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.5 t -82.4 67.93 8.63 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.2 ptp -160.75 172.2 17.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.697 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.7 p -73.28 158.65 34.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.173 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -60.81 -37.62 93.94 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.804 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.41 72.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.684 0.278 . . . . 0.0 110.694 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.2 63.5 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.387 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.32 -43.76 75.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.113 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 71.2 m -67.31 -42.42 83.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.815 0.341 . . . . 0.0 110.575 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.09 67.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.669 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 64.8 mt -68.53 -31.95 71.55 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.71 174.98 49.0 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.326 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.0 ttpt -63.59 -42.52 98.25 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.571 0.185 . . . . 0.0 111.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.82 -63.37 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.511 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.8 m -59.06 -40.68 85.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.357 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.98 -43.35 99.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.451 HD12 ' HA3' ' A' ' 122' ' ' GLY . 12.0 tp -66.48 -27.15 67.57 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.632 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -75.05 -22.48 58.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.695 0.284 . . . . 0.0 110.653 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.1 mt -84.98 -32.22 23.1 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.451 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . . . -113.04 154.2 45.11 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.619 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.2 Cg_exo -44.32 164.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.502 2.802 . . . . 0.0 113.901 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.1 -19.45 62.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.031 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.409 ' CE2' HG13 ' A' ' 121' ' ' VAL . 13.4 p90 -108.75 -51.72 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.619 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.8 m -62.93 -34.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.451 ' HA3' HD12 ' A' ' 114' ' ' LEU . . . -52.41 -39.74 52.79 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.95 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.54 -47.6 75.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.611 0.244 . . . . 0.0 110.967 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.78 -55.1 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.372 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.85 -57.2 13.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.505 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 5.9 t90 -60.78 -28.27 68.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.04 -57.72 11.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -71.99 -35.24 69.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.459 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.588 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.8 tp -56.78 -49.87 74.0 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.788 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.36 -36.71 84.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 70.2 mt -61.47 -45.71 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.177 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.452 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.8 mt -55.48 -36.84 67.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.052 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.544 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 68.4 mt-30 . . . . . 0 C--O 1.233 0.22 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.557 0 N-CA-C 112.304 -0.318 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.45 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 13.1 t80 -81.03 -49.23 11.17 Favored 'General case' 0 C--N 1.338 0.072 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.7 m -55.54 -34.0 64.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.051 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -63.97 -31.78 73.09 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.831 0.348 . . . . 0.0 110.485 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.18 -41.75 21.89 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.132 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 47.6 mt-30 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.791 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -83.04 -13.61 55.49 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 48.8 mtp180 -85.1 -37.38 20.34 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.66 0.267 . . . . 0.0 111.143 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 mp -105.19 -27.42 11.57 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.69 5.26 42.16 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.129 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 86.9 mt -57.14 125.23 69.85 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.891 0.346 . . . . 0.0 111.027 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 64.4 Cg_endo -74.65 170.45 20.29 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.375 2.05 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -75.84 -36.93 59.45 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.617 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.19 125.22 90.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.59 0.233 . . . . 0.0 111.075 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 63.5 Cg_endo -74.51 -32.98 5.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.015 2.477 . . . . 0.0 113.183 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -29.06 70.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.593 0.235 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -96.56 40.48 1.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.885 0.374 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.614 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 11.0 m0 -112.12 169.56 8.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -128.62 -178.4 4.57 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.76 -39.31 62.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.444 0.164 . . . . 0.0 111.373 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.5 m -66.81 -49.34 66.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.597 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.429 ' CD2' HG12 ' A' ' 65' ' ' ILE . 47.3 m170 -61.45 -42.66 99.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.654 0.264 . . . . 0.0 110.965 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.71 -52.64 59.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.8 ttm105 -66.92 -46.71 73.98 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.708 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.69 -40.72 88.82 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.838 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 14.3 t90 -63.43 -62.69 1.51 Allowed 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 85' ' ' VAL . 73.5 t -41.17 -49.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 55.2 tpp -55.68 -50.73 69.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.832 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -55.19 -39.9 70.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.85 -48.47 53.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.874 0.369 . . . . 0.0 110.27 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.523 ' CG2' HG13 ' A' ' 93' ' ' VAL . 79.4 t -52.85 -30.46 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.38 -46.92 12.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.356 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -66.39 -32.19 73.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.56 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.34 2.5 28.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.4 m 45.02 59.69 3.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.078 0.466 . . . . 0.0 110.63 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.52 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 71.3 mt -86.96 153.08 21.85 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.464 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 155.52 49.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.712 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.83 -7.35 59.28 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.721 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.523 HG13 ' CG2' ' A' ' 85' ' ' VAL . 13.0 p -74.62 132.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 117.315 0.557 . . . . 0.0 111.044 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -105.01 132.26 51.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.375 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.07 -25.52 24.13 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -62.0 -34.05 75.47 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.5 mmtt -66.54 -34.94 79.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.713 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 30.3 m-85 -97.97 32.94 2.24 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.43 65.13 9.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 110.209 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.7 ptp -158.9 169.81 23.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -75.43 161.59 29.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.332 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.614 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.47 -38.37 90.75 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.825 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.01 70.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.773 0.321 . . . . 0.0 110.634 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.48 -44.98 56.72 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.1 tp -56.06 -46.88 78.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.195 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 95.1 m -66.71 -38.75 87.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.813 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.57 69.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.436 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.3 mt -65.72 -32.96 74.81 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 175.39 48.75 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.459 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -62.71 -42.12 99.49 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.36 -63.28 1.2 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.353 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.8 m -60.85 -38.01 84.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.394 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -63.27 -45.26 92.33 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.488 0.185 . . . . 0.0 110.828 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.04 -25.86 68.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.704 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.2 -21.81 58.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.613 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 72.7 mt -87.21 -35.22 18.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.599 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -115.84 151.25 46.17 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.601 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.8 Cg_exo -43.05 163.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.61 2.873 . . . . 0.0 114.065 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.56 -21.3 62.4 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.193 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.81 -52.8 2.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.179 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.601 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 3.8 m -61.26 -37.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.434 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.2 74.74 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.658 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.64 -50.0 72.94 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.468 0.175 . . . . 0.0 110.884 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 90' ' ' LEU . 64.2 mt -56.8 -55.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.431 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.28 -56.36 17.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.274 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 21.4 t90 -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.234 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.66 -54.59 43.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -73.0 -36.05 66.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.312 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.527 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 37.1 tp -59.08 -43.42 91.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.596 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -68.24 -32.84 73.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.192 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.9 mt -65.04 -37.71 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.8 mt -61.55 -53.6 54.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.855 -179.919 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.742 0 N-CA-C 112.669 -0.172 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.448 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 15.3 t80 -98.89 -47.33 5.31 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.598 0.199 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -55.51 -32.81 63.2 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.33 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -60.36 -32.34 71.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.405 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 43.1 tt0 -82.6 -40.08 21.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 11.8 mm100 -58.63 -30.99 67.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.284 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -84.93 -38.45 19.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.238 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.19 -40.22 86.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.678 0.275 . . . . 0.0 111.264 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 mt -96.42 -31.17 12.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.187 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -2.41 55.98 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.685 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.6 mt -53.62 129.26 54.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 122.291 0.236 . . . . 0.0 111.178 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.0 166.69 26.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -97.06 52.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 110.437 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.23 98.82 5.04 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.145 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.565 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 32.0 Cg_exo -58.38 -38.83 88.63 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.857 2.371 . . . . 0.0 112.32 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 12.1 mtt180 -66.44 -35.63 80.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -98.15 43.55 1.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -115.02 174.75 5.82 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.267 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.7 t -133.51 -179.31 5.44 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -50.36 -44.41 54.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -63.39 -49.09 75.17 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.422 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -62.31 -41.9 98.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.234 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.37 -49.91 82.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HA ' ' CG1' ' A' ' 81' ' ' VAL . 70.9 ttt180 -71.43 -41.86 68.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.518 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.27 -35.57 79.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.485 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -69.36 -65.49 0.7 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.468 ' O ' HG22 ' A' ' 85' ' ' VAL . 7.7 p -42.39 -46.88 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.174 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 43.8 ttm -60.82 -47.78 84.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.407 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 17.6 t90 -55.94 -37.95 69.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.87 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.98 60.42 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.596 ' CG2' HG13 ' A' ' 93' ' ' VAL . 88.8 t -49.59 -34.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.244 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -79.47 -42.22 25.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.255 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -68.27 -36.28 79.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.564 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -105.63 6.6 32.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.7 m 44.36 53.36 6.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.948 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 121' ' ' VAL . 68.1 mt -80.32 166.85 20.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.513 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.87 157.83 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.63 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.98 -5.74 69.76 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.677 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.596 HG13 ' CG2' ' A' ' 85' ' ' VAL . 13.6 p -81.92 142.71 13.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.238 0.519 . . . . 0.0 111.338 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.455 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.5 m-20 -116.58 141.96 47.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -90.34 -23.58 21.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.938 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -60.6 -36.25 78.1 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.592 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.9 mptt -67.09 -35.12 79.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.281 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -96.26 32.28 2.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.565 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.2 t -89.84 67.67 7.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.193 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.5 ptp -156.56 166.59 32.96 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -69.68 157.58 36.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.49 74.36 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.634 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.17 61.42 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.669 0.271 . . . . 0.0 111.182 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.58 -48.1 61.36 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.789 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.25 -46.29 83.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.162 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.9 m -64.04 -38.9 92.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.796 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.53 76.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.368 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -58.56 -36.05 73.32 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.51 176.76 49.41 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.473 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.502 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 57.5 tttp -59.67 -47.45 85.58 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 1.0 OUTLIER -50.75 -66.94 0.3 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.4 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.7 m -57.48 -37.58 73.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -62.41 -42.93 99.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.738 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -65.72 -24.49 66.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 10.5 mm-40 -74.55 -22.89 58.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.5 mt -84.11 -40.11 18.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.629 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -105.77 157.43 34.65 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.265 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 12.2 Cg_endo -56.71 174.26 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.685 2.257 . . . . 0.0 112.958 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -63.07 -14.39 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -107.93 -59.79 1.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.755 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.555 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 3.0 m -58.52 -31.25 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.04 -32.43 42.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.115 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.81 -46.35 53.62 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.68 0.24 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.0 mt -62.64 -58.64 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 111.658 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.5 mt -51.19 -58.77 5.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.793 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.502 ' CZ2' ' HD2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.42 -31.59 71.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.288 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.1 -57.09 14.58 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.54 -29.69 66.23 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.63 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.436 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.5 tp -57.83 -49.72 75.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.783 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 13.5 mm-40 -67.78 -34.87 77.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.767 0.318 . . . . 0.0 110.316 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.59 -37.55 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.9 -36.7 82.88 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.521 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.565 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 79.1 mt-30 . . . . . 0 N--CA 1.462 0.139 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.316 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.434 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.669 0 CA-C-O 120.242 -0.199 . . . . 0.0 113.127 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 16.9 t80 -99.16 -47.06 5.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.721 0.26 . . . . 0.0 110.657 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.2 m -57.1 -37.28 71.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.434 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 19.9 pttp -63.21 -36.1 82.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.346 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.49 61.19 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -59.4 -28.09 66.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.408 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -82.87 -40.88 19.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -65.86 -41.85 91.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -89.16 -31.12 18.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.924 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.89 -5.87 51.04 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.617 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 76' ' ' HIS . 85.2 mt -51.43 124.13 23.71 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.61 0.243 . . . . 0.0 110.889 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.62 171.74 16.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.675 2.25 . . . . 0.0 112.714 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -100.3 45.57 0.98 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -140.05 102.76 6.83 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.406 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.474 ' HG2' ' CG ' ' A' ' 133' ' ' GLN . 32.1 Cg_exo -59.06 -31.33 95.42 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.865 2.377 . . . . 0.0 112.555 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.98 -36.03 59.38 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -95.73 38.45 1.17 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.743 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.42 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.0 OUTLIER -108.43 170.78 7.81 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.322 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.5 p -133.24 -179.01 5.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.464 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -52.18 -40.45 61.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -64.25 -50.63 67.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.324 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.434 ' CD2' HG12 ' A' ' 65' ' ' ILE . 25.4 m170 -63.42 -41.3 98.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.81 -54.83 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 111.002 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -63.31 -49.52 73.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.385 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.77 -41.03 76.91 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.42 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.3 t90 -63.88 -61.88 2.0 Allowed 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.477 HG13 HD21 ' A' ' 125' ' ' LEU . 53.5 t -41.08 -55.36 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.775 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.417 ' HE2' ' HB2' ' A' ' 82' ' ' MET . 30.0 ttm -57.68 -45.65 85.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.711 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.515 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 14.4 t90 -56.59 -35.84 68.68 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.933 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.2 -19.72 61.03 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.209 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 81' ' ' VAL . 58.2 t -81.37 -33.47 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.041 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -84.76 -40.26 17.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.61 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.515 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 12.2 mm-40 -72.15 -38.7 69.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -102.62 9.22 39.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t 44.71 52.87 7.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.818 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.582 HD13 HG13 ' A' ' 121' ' ' VAL . 69.4 mt -86.85 176.23 7.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.314 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.82 152.97 16.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.004 0.431 . . . . 0.0 111.745 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.49 -14.21 65.37 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.9 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.404 HG12 ' CG2' ' A' ' 85' ' ' VAL . 13.0 p -75.54 130.55 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.39 0.595 . . . . 0.0 110.879 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.522 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 9.4 m-20 -98.71 134.68 41.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -86.37 -26.99 24.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.473 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 15.8 mm100 -60.52 -37.58 81.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.973 0.415 . . . . 0.0 109.91 177.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 99.5 mttt -66.88 -29.57 69.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.51 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.442 ' HZ ' ' HB1' ' A' ' 117' ' ' ALA . 50.9 m-85 -101.84 33.07 3.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 59.3 m -86.24 65.24 8.98 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.113 0.482 . . . . 0.0 110.32 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.423 ' SD ' HD12 ' A' ' 108' ' ' LEU . 14.7 ptp -153.48 165.46 35.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -74.73 164.68 26.3 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.341 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.13 -42.67 95.3 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.717 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.03 -38.33 62.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.97 55.62 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.71 -47.55 73.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.152 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.7 m -65.85 -38.8 89.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.99 -21.25 66.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.8 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 43.4 mt -71.31 -34.91 71.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.18 179.77 46.87 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.45 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -60.92 -47.81 84.7 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -50.56 -65.15 0.61 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 94.9 m -60.53 -42.27 96.15 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -61.61 -46.35 90.21 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.281 -0.168 . . . . 0.0 111.119 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.3 mt -62.44 -31.35 72.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.598 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.98 -25.65 64.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.748 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.422 HD23 ' HB3' ' A' ' 97' ' ' LYS . 65.2 mt -87.47 -31.23 20.1 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.214 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.495 ' CB ' ' HA2' ' A' ' 122' ' ' GLY . . . -99.13 166.42 13.04 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.82 0.343 . . . . 0.0 111.6 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 21.0 Cg_exo -66.59 173.5 7.75 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.095 2.53 . . . . 0.0 113.225 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.42 -28.21 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.088 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.2 -53.06 2.68 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.475 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.582 HG13 HD13 ' A' ' 90' ' ' LEU . 81.8 t -57.18 -39.55 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.495 ' HA2' ' CB ' ' A' ' 117' ' ' ALA . . . -50.99 -43.48 49.43 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.15 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -63.04 -46.09 89.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.0 mt -57.94 -50.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.631 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.477 HD21 HG13 ' A' ' 81' ' ' VAL . 10.5 mp -63.95 -57.81 8.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.258 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.402 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -61.06 -31.73 71.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.632 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -62.75 -52.45 63.18 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.01 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.551 ' HA ' HD12 ' A' ' 131' ' ' ILE . 18.6 t-160 -71.98 -30.66 65.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.42 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 40.4 tp -62.39 -46.2 89.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.605 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 64.6 mm-40 -67.07 -33.62 75.89 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.9 mt -59.89 -42.89 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.38 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.23 -38.4 89.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.544 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.474 ' CG ' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.158 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 112.36 -0.296 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.436 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 11.7 t80 -77.62 -49.76 13.91 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.0 m -55.31 -32.54 62.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.399 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -59.42 -33.65 71.51 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.809 0.338 . . . . 0.0 110.57 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -83.21 -41.61 18.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 43.6 mt-30 -57.66 -29.45 64.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.736 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -83.25 -32.21 26.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -71.25 -40.16 71.19 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.77 -26.81 13.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.75 11.69 39.85 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.916 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 75.5 mt -56.94 121.22 44.24 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.62 0.248 . . . . 0.0 111.4 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.8 Cg_exo -68.07 170.32 14.68 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.747 2.298 . . . . 0.0 112.241 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -94.05 -4.09 50.07 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.606 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 6.5 t70 -98.5 108.24 46.77 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.715 0.293 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.52 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 33.2 Cg_endo -63.59 -26.96 69.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.001 2.467 . . . . 0.0 112.973 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -76.53 -35.22 58.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -94.7 40.48 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.078 0.466 . . . . 0.0 110.558 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.508 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.2 m0 -108.51 170.35 8.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.375 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.9 p -130.96 179.69 5.84 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -39.49 58.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.0 m -64.24 -53.3 51.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -61.56 -39.38 90.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.18 -52.13 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.136 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -66.01 -48.17 72.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.911 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.81 -32.13 72.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.7 t90 -72.58 -65.86 0.73 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.2 p -40.99 -47.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.506 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.5 ttm -59.3 -48.43 81.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.819 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 87.2 t90 -61.55 -40.22 93.91 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.3 62.76 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.264 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.507 ' CG2' HG12 ' A' ' 93' ' ' VAL . 40.2 t -82.49 -31.4 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.9 -38.43 37.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 11.6 mm-40 -70.27 -36.68 74.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.21 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -104.28 5.67 34.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m 44.64 55.59 5.75 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 110.779 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.474 HD11 ' HB ' ' A' ' 121' ' ' VAL . 83.0 mt -78.2 127.34 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.088 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -108.47 142.34 39.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.464 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 -5.72 84.42 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.756 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.507 HG12 ' CG2' ' A' ' 85' ' ' VAL . 12.5 p -76.34 137.57 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.298 0.549 . . . . 0.0 110.926 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -112.93 138.82 49.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.437 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -89.46 -26.02 21.17 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.598 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -60.61 -34.15 73.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.006 0.431 . . . . 0.0 109.916 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.8 mmmm -68.02 -34.33 76.3 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.847 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 116' ' ' LEU . 40.2 m-85 -99.34 35.45 1.94 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.443 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.91 69.08 10.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.21 169.15 24.75 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.778 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -76.9 165.18 25.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.27 -43.19 95.66 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.103 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.23 66.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.989 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.21 53.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.841 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.7 tp -56.73 -46.59 81.24 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.345 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 80.5 m -66.52 -40.66 89.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.71 0.291 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.57 76.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.215 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.2 mt -58.82 -32.51 69.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.997 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.23 177.18 45.57 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.662 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.498 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -60.66 -45.51 93.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.367 0.136 . . . . 0.0 111.367 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 35.2 tt0 -50.88 -66.73 0.34 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.0 m -57.98 -40.16 79.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.767 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.98 -45.42 93.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.554 0.216 . . . . 0.0 111.018 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.46 -26.19 68.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.745 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 18.5 mm-40 -73.92 -24.03 59.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 110.771 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.1 mt -82.39 -35.47 27.67 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.508 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.69 160.23 28.71 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 120.716 0.293 . . . . 0.0 111.62 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.68 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 50.4 Cg_exo -52.91 171.89 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.116 2.544 . . . . 0.0 113.651 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.73 -22.77 66.05 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.774 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.76 -58.75 1.93 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.68 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.9 m -62.39 -32.83 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.0 -38.51 38.77 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.599 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.49 -46.35 88.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.653 0.264 . . . . 0.0 111.007 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.47 HG13 HD21 ' A' ' 90' ' ' LEU . 50.5 mm -51.29 -51.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.132 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -63.65 -57.09 11.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.418 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.498 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -61.32 -26.95 68.14 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.08 -57.27 12.2 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.451 ' HA ' HD12 ' A' ' 131' ' ' ILE . 20.8 t-160 -73.28 -35.15 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.688 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.526 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 29.7 tp -57.8 -45.63 85.79 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -68.29 -38.93 82.15 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 128' ' ' HIS . 66.5 mt -55.15 -45.24 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.627 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.458 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.2 mt -53.25 -36.31 60.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.318 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.52 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 63.5 mt-30 . . . . . 0 N--CA 1.462 0.171 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.926 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 120.315 -0.158 . . . . 0.0 112.803 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.505 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 9.5 t80 -88.77 -51.08 5.84 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 116.745 0.273 . . . . 0.0 110.628 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.0 m -56.11 -42.24 76.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.112 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.448 ' HE2' ' HA2' ' A' ' 55' ' ' GLY . 56.4 pttt -60.01 -33.85 72.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.734 0.302 . . . . 0.0 110.419 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -77.27 -42.89 35.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.66 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.3 mt-30 -60.66 -27.34 67.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.832 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -80.45 -14.34 58.37 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 78.6 mtt180 -85.01 -34.41 22.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.109 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.79 -24.56 12.89 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.72 9.94 48.25 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.073 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.44 HG12 ' CD2' ' A' ' 76' ' ' HIS . 25.9 mt -56.53 126.01 68.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.742 0.271 . . . . 0.0 111.281 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 63.6 Cg_endo -73.89 175.51 10.71 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.617 2.211 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -98.99 39.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.517 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -148.02 110.48 3.78 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.543 0.211 . . . . 0.0 111.439 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.618 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 34.4 Cg_exo -57.32 -37.96 96.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.181 2.587 . . . . 0.0 112.597 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.668 0.27 . . . . 0.0 110.494 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -96.47 38.7 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.489 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -114.82 169.32 9.16 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.681 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.4 t -132.25 -177.77 4.61 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -49.31 -42.0 40.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.2 m -67.01 -50.08 63.25 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CD2' HG12 ' A' ' 65' ' ' ILE . 37.1 m170 -61.66 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.631 0.253 . . . . 0.0 111.176 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.427 HG11 HD21 ' A' ' 105' ' ' LEU . 54.6 t -59.7 -51.73 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -71.03 -43.37 68.04 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.785 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.03 -39.45 74.82 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.58 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.4 t90 -68.35 -60.57 2.35 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.2 t -41.61 -55.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.647 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 ttm -55.8 -46.15 78.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.69 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.505 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 14.5 t90 -57.2 -37.13 71.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -18.68 62.22 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.273 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.55 ' CG2' HG11 ' A' ' 93' ' ' VAL . 24.4 t -81.9 -35.91 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.853 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -90.9 -30.36 16.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.051 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.67 -38.81 53.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -108.2 11.15 27.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.746 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 45.72 57.11 5.28 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.905 0.383 . . . . 0.0 111.624 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.412 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 70.8 mt -89.16 172.74 8.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.37 153.89 31.16 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 111.643 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.12 -6.23 80.13 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.577 ' HB ' HG23 ' A' ' 121' ' ' VAL . 13.2 p -78.07 133.7 29.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 117.348 0.574 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -104.66 135.98 45.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.74 -28.33 21.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.528 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.15 -34.58 75.25 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.0 mmtt -66.72 -34.98 79.05 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.026 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.62 34.21 2.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.386 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.8 t -86.94 66.51 9.46 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.119 0.485 . . . . 0.0 110.077 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.6 ptp -159.0 170.76 21.37 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.871 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.9 m -74.24 157.11 36.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -60.27 -36.36 90.62 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.925 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.2 -39.46 72.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 110.645 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.28 -43.16 61.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.425 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.427 HD21 HG11 ' A' ' 77' ' ' VAL . 14.4 tp -56.48 -44.89 81.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.074 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.6 -40.22 88.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.723 0.297 . . . . 0.0 110.676 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.08 -24.28 66.68 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.749 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 39.9 mt -68.49 -35.09 77.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.79 172.11 48.56 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.329 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.472 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.8 ttpt -61.47 -48.75 79.7 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.47 -51.81 51.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.8 m -66.69 -39.65 88.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.558 0.218 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -63.0 -43.72 98.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.796 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.27 -25.95 66.31 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.68 -23.53 59.84 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.639 0.257 . . . . 0.0 110.617 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 78.1 mt -85.84 -35.04 20.88 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.302 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.469 ' HB3' ' CG2' ' A' ' 121' ' ' VAL . . . -104.89 161.5 22.59 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 18.9 Cg_endo -59.42 176.12 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.748 2.298 . . . . 0.0 112.888 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.35 -12.91 59.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -108.67 -56.44 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.773 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.589 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 2.6 m -62.98 -31.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.72 -43.96 38.47 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.782 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.29 -49.36 43.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.647 0.26 . . . . 0.0 110.846 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.86 -55.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.459 HD23 HG11 ' A' ' 81' ' ' VAL . 10.3 mp -56.81 -53.08 61.96 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.753 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.472 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 17.4 t90 -61.43 -28.18 69.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -63.95 -54.84 28.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.147 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.443 ' HA ' HD13 ' A' ' 131' ' ' ILE . 22.7 t-160 -72.37 -34.33 67.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.613 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.532 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.7 tp -61.93 -45.29 94.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -67.58 -27.73 67.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 128' ' ' HIS . 62.2 mt -68.28 -37.57 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.44 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.67 -48.52 74.43 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.68 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.618 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 8.4 pt20 . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 120.213 -0.215 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.3 t80 -96.43 -49.67 5.07 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.646 0.223 . . . . 0.0 110.9 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -54.52 -33.23 59.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.248 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 110.115 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.03 -38.89 35.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.952 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 25.0 mt-30 -58.98 -31.72 69.01 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.608 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -85.75 -37.06 19.74 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -71.98 -31.98 66.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 mt -105.54 -32.14 8.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.0 0.49 41.75 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.157 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 48.9 mt -55.83 122.66 47.92 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.762 0.281 . . . . 0.0 110.917 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 74.4 Cg_endo -76.35 171.77 17.47 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.455 2.103 . . . . 0.0 112.648 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -98.75 45.91 1.0 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.927 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -146.17 103.31 4.09 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.068 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.58 ' HG2' ' CG ' ' A' ' 133' ' ' GLN . 51.0 Cg_exo -57.08 -46.88 25.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.921 2.414 . . . . 0.0 112.238 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.469 ' HG2' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -57.71 -33.09 68.05 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.555 0.217 . . . . 0.0 110.805 178.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HG3' ' HG2' ' A' ' 70' ' ' ARG . 46.0 mt-30 -99.98 42.04 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.186 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.594 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.9 m0 -115.33 170.21 8.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.363 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -130.66 -179.46 5.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.23 -43.04 52.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.5 m -62.52 -50.39 71.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.301 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.159 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.49 -52.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.467 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.34 -48.74 69.29 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.482 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.25 -36.22 77.26 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.008 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.543 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 33.5 t90 -69.56 -65.17 0.75 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 85' ' ' VAL . 11.6 p -41.7 -47.53 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.227 0.329 . . . . 0.0 111.378 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 60.4 tpp -59.84 -47.64 84.89 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.101 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.501 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.3 t90 -61.22 -38.17 85.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.988 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.45 61.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.43 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.53 ' CG2' HG11 ' A' ' 93' ' ' VAL . 54.1 t -83.17 -32.84 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.161 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -81.16 -33.84 32.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.501 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.2 mm-40 -73.59 -39.9 64.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.989 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -102.19 7.49 40.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m 44.67 55.22 6.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 110.976 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.546 HD13 ' HB ' ' A' ' 121' ' ' VAL . 53.4 mt -83.12 168.75 16.57 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.36 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -150.99 153.77 35.81 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.733 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.1 -7.61 63.02 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.008 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.3 p -73.81 131.97 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 117.547 0.673 . . . . 0.0 111.167 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.66 131.1 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -86.29 -23.09 26.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.754 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -61.95 -35.7 79.24 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 6.1 mptp? -65.56 -34.27 77.86 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.32 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 36.6 m-85 -101.1 29.95 4.39 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.693 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.3 t -84.86 66.55 9.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.1 0.476 . . . . 0.0 110.241 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.1 ptp -158.43 171.66 19.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.657 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 m -75.92 158.26 32.23 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.594 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.57 -37.95 90.11 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.872 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.42 -39.51 67.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 110.64 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.433 ' O ' ' HG ' ' A' ' 108' ' ' LEU . . . -73.49 -46.76 46.05 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -52.89 -47.5 67.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.323 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.71 -38.52 86.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.785 0.326 . . . . 0.0 110.492 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -18.46 64.16 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.932 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 112' ' ' CYS . 41.9 mt -74.36 -28.49 61.14 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.18 169.8 42.44 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.673 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.58 -44.92 95.67 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.95 -60.79 2.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.734 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 49.8 t -59.61 -44.21 93.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.395 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -59.78 -43.34 94.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.973 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.48 -30.15 70.89 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.723 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.04 -21.85 60.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.733 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 89.0 mt -83.65 -32.21 25.77 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.586 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -112.02 154.62 44.16 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.724 0.297 . . . . 0.0 111.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.657 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.0 Cg_exo -45.77 167.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.398 2.732 . . . . 0.0 113.796 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.21 -21.88 66.74 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.087 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -108.63 -51.51 2.88 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.657 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 9.9 m -61.69 -35.76 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.39 -35.1 49.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.238 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.11 -49.91 72.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.706 0.253 . . . . 0.0 111.202 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 90' ' ' LEU . 74.1 mt -60.16 -53.33 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.565 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -52.62 -58.1 7.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.278 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 1.4 t90 -64.74 -25.45 67.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.427 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.51 -56.69 17.29 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.408 ' HA ' HD11 ' A' ' 131' ' ' ILE . 21.9 t-160 -73.17 -36.63 66.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.523 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.543 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.9 tp -57.23 -45.16 84.14 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.22 -36.42 79.48 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' A' ' 128' ' ' HIS . 64.8 mt -58.31 -41.51 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.698 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 86.7 mt -57.22 -37.37 72.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.683 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.58 ' CG ' ' HG2' ' A' ' 69' ' ' PRO . 45.4 mt-30 . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.164 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.564 0 CA-C-O 120.261 -0.188 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.433 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.1 t80 -96.42 -53.73 3.5 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.697 0.249 . . . . 0.0 110.864 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.6 m -54.7 -33.66 61.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.402 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 14.7 ptmm? -62.15 -31.27 71.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.856 0.36 . . . . 0.0 110.569 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -83.3 -39.3 20.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.087 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 28.4 mt-30 -58.29 -28.32 64.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.455 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 29.1 pt20 -84.78 -37.03 21.3 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.564 0.221 . . . . 0.0 110.962 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -65.06 -42.95 93.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.7 mt -99.14 -29.33 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.29 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.66 6.66 54.51 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.56 119.21 14.8 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 122.31 0.244 . . . . 0.0 111.283 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.14 166.93 13.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.739 2.293 . . . . 0.0 112.386 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -98.92 41.07 1.16 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.725 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -156.28 125.15 3.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 132' ' ' LEU . 38.2 Cg_endo -67.59 -37.73 16.04 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.089 2.526 . . . . 0.0 113.02 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.433 ' HD3' ' HG2' ' A' ' 69' ' ' PRO . 1.5 mpp_? -61.91 -33.06 73.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.519 0.199 . . . . 0.0 110.763 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.37 41.92 1.13 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.932 0.396 . . . . 0.0 110.843 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.551 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 4.9 m0 -119.8 170.05 9.58 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.509 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -133.59 -178.86 5.19 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -49.87 -43.31 49.11 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -63.1 -49.64 73.65 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.335 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -61.67 -41.6 97.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.422 HG11 HD23 ' A' ' 105' ' ' LEU . 64.8 t -62.35 -56.14 19.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.19 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.438 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 7.0 tmm_? -64.08 -46.97 81.94 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.347 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.1 -43.21 99.24 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.724 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.5 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 22.0 t90 -61.13 -62.93 1.49 Allowed 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 85' ' ' VAL . 55.8 t -40.91 -49.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.791 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.404 ' HE1' ' HB2' ' A' ' 82' ' ' MET . 29.9 ttm -58.17 -45.02 88.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.788 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.576 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 17.3 t90 -59.26 -37.82 78.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.68 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.52 -20.28 61.37 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.173 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 81' ' ' VAL . 69.7 t -81.35 -32.07 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.188 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.7 -35.48 24.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.134 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.576 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.1 mm-40 -73.04 -40.13 65.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.84 10.78 36.33 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p 41.83 51.72 4.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.978 0.418 . . . . 0.0 111.183 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.11 171.25 15.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -155.08 160.35 40.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.199 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.06 -7.88 58.85 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.783 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.521 ' HB ' HG23 ' A' ' 121' ' ' VAL . 11.4 p -79.9 131.61 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.497 0.648 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -103.53 139.47 38.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.3 -25.33 21.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -61.59 -30.65 70.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 29.9 mmmt -68.41 -34.59 76.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.872 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -101.52 32.4 3.35 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.189 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.1 t -84.07 67.51 9.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 110.232 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.6 ptp -157.42 168.56 26.98 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.804 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -73.3 161.02 30.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.336 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.37 -44.79 89.78 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.866 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.8 63.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.656 0.265 . . . . 0.0 110.836 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.55 61.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.422 HD23 HG11 ' A' ' 77' ' ' VAL . 16.2 tp -55.95 -47.51 77.45 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.182 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.41 -38.77 85.15 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.799 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.66 67.64 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.794 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.6 mt -67.67 -30.53 70.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.86 173.48 40.82 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.628 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -59.18 -46.81 87.44 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.087 0.155 . . . . 0.0 111.263 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.49 -64.74 0.71 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.894 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.7 m -61.02 -40.78 94.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -60.19 -46.83 88.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.459 0.171 . . . . 0.0 111.23 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.83 -28.51 69.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.28 -20.69 60.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.89 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 69.2 mt -87.24 -35.49 18.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.791 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -111.93 159.52 33.24 Favored Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 10.2 Cg_endo -56.3 172.59 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.673 2.249 . . . . 0.0 113.213 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.04 -19.03 60.89 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -108.66 -50.63 2.99 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.579 ' CG2' ' HB1' ' A' ' 117' ' ' ALA . 3.0 m -63.02 -34.2 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.532 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.36 -39.43 65.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.801 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -68.53 -48.18 65.0 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.628 0.251 . . . . 0.0 110.93 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.33 -55.52 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.408 ' HB3' ' CH2' ' A' ' 80' ' ' TRP . 92.7 mt -57.73 -59.93 4.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.188 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.496 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.47 -28.58 69.39 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.36 -52.54 26.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.298 0.499 . . . . 0.0 110.088 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -67.61 -34.42 76.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.5 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.7 tp -64.28 -39.39 93.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.972 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.437 ' HA ' ' HG2' ' A' ' 133' ' ' GLN . 34.9 tt0 -67.21 -29.12 68.7 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.182 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 51.6 mt -67.86 -35.65 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.571 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.574 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 99.1 mt -68.63 -40.87 80.11 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.563 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.497 ' HB3' ' CG ' ' A' ' 69' ' ' PRO . 9.4 pt20 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.418 ' CA ' ' HE3' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.527 0.793 0 CA-C-O 120.347 -0.141 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.9 t80 -95.21 -45.42 7.19 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m -57.61 -37.27 72.96 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HE3' ' CA ' ' A' ' 55' ' ' GLY . 20.6 pttp -63.35 -32.79 74.3 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.747 0.308 . . . . 0.0 110.625 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -82.84 -38.98 22.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 56.6 mt-30 -57.7 -27.43 62.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.82 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 30.1 pt20 -85.11 -34.64 22.15 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 110.959 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -73.05 -33.67 65.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.3 mt -101.53 -30.84 11.17 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.701 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.18 -1.99 56.38 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.701 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 79' ' ' ASP . 54.7 mt -55.55 122.05 42.43 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.73 0.265 . . . . 0.0 111.203 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.4 Cg_exo -68.13 177.83 4.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.834 2.356 . . . . 0.0 112.252 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -108.47 31.57 5.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.73 98.85 27.27 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.273 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 32.9 Cg_exo -61.35 -27.03 82.42 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.919 2.413 . . . . 0.0 112.907 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -38.38 39.66 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -96.57 39.32 1.17 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.667 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -107.18 175.61 5.44 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.351 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.66 -179.56 5.72 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.55 -43.79 56.28 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -62.43 -53.39 55.55 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -58.49 -40.71 83.52 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.24 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.7 -51.52 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.659 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -64.12 -53.86 42.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.352 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.529 ' HB3' HD11 ' A' ' 65' ' ' ILE . 1.2 m-20 -55.99 -35.21 66.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.375 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.515 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.9 t90 -70.34 -63.24 1.12 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.495 ' O ' HG21 ' A' ' 85' ' ' VAL . 79.3 t -40.51 -54.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.409 ' HG2' ' CE1' ' A' ' 95' ' ' PHE . 63.5 mtt -55.53 -47.41 76.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 7.0 t90 -55.8 -37.83 69.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -18.56 61.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.523 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.552 ' CG2' HG13 ' A' ' 93' ' ' VAL . 47.5 t -79.26 -35.12 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.575 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.54 -31.71 24.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.386 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.551 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.78 -40.66 54.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 111.102 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -103.09 6.22 38.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t 45.67 55.58 6.65 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.452 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.495 HD11 ' HB ' ' A' ' 121' ' ' VAL . 64.4 mt -81.92 174.28 11.43 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.457 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.07 146.92 23.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.457 -179.412 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.07 81.3 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.739 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.552 HG13 ' CG2' ' A' ' 85' ' ' VAL . 14.7 p -71.98 128.19 34.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 117.472 0.636 . . . . 0.0 110.917 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.461 ' CB ' ' HD3' ' A' ' 97' ' ' LYS . 11.1 m-20 -98.8 128.68 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.409 ' CE1' ' HG2' ' A' ' 82' ' ' MET . 39.4 m-85 -86.31 -25.97 25.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.463 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.465 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 30.1 mm-40 -63.9 -34.33 77.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.1 mptt -67.05 -33.5 75.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.189 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -98.28 33.14 2.27 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 37.2 m -88.49 67.19 8.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.041 0.448 . . . . 0.0 110.346 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.431 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.8 ptp -157.08 168.41 27.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.855 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -73.29 158.69 34.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.98 -43.93 87.91 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.743 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.23 62.79 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.98 62.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -55.95 -46.75 78.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.264 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.21 -40.85 94.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.716 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -26.17 67.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.654 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 38.6 mt -65.27 -37.61 87.74 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.09 172.95 49.47 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.331 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.416 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 39.0 ttpt -60.76 -47.2 87.38 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.38 -51.69 61.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.8 m -67.19 -39.51 86.38 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.442 0.163 . . . . 0.0 111.23 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -63.42 -43.1 98.44 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.687 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.93 -24.15 66.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.823 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.87 -23.62 48.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.454 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 95.9 mt -83.62 -36.68 23.69 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.35 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.514 ' HB3' ' CG2' ' A' ' 121' ' ' VAL . . . -108.29 157.79 35.46 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.582 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 12.0 Cg_endo -56.7 176.82 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.787 2.325 . . . . 0.0 112.978 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.51 -15.63 61.18 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.29 -57.47 2.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.706 -0.798 . . . . 0.0 112.949 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.582 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 2.5 m -59.17 -33.69 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.75 -34.51 50.85 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.776 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.07 -50.05 21.35 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.419 0.152 . . . . 0.0 110.987 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -57.12 -57.65 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.1 mt -51.68 -58.97 4.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.905 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -61.33 -31.03 70.89 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.559 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.19 -55.5 27.96 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.056 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -70.89 -32.41 69.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.515 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.1 tp -59.11 -49.59 77.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -65.65 -33.91 76.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.485 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.5 mt -61.69 -39.03 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.4 -35.69 81.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.777 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.524 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 66.7 mt-30 . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.418 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 CA-C-O 120.165 -0.241 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.573 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 8.5 t80 -101.52 -38.11 8.11 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.823 0.312 . . . . 0.0 110.986 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 m -65.25 -24.56 67.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.194 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -74.66 -36.21 62.82 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.003 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.573 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -83.6 -31.68 26.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.667 179.247 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.9 mt-30 -61.32 -29.16 69.71 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.5 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -85.68 -39.5 17.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.521 0.2 . . . . 0.0 111.132 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -71.49 -33.23 69.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.443 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -99.3 -34.7 10.21 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.638 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.67 -5.0 53.97 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.569 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 85.4 mt -50.74 122.92 17.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.522 0.329 . . . . 0.0 111.483 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 22.9 Cg_exo -64.79 172.23 7.33 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.093 2.528 . . . . 0.0 112.719 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.08 -12.17 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.424 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 14.5 t70 -104.12 122.77 43.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.542 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 41.8 Cg_endo -67.51 -24.99 41.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.05 2.5 . . . . 0.0 113.405 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 5.9 mpt_? -70.27 -32.27 70.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.145 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.424 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 27.3 pt20 -93.78 24.7 3.98 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.654 0.264 . . . . 0.0 111.213 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.421 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -97.69 169.96 9.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.211 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.6 p -136.9 -174.55 3.76 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.55 -36.73 62.16 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.473 0.178 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.2 m -68.17 -52.85 29.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.349 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -60.79 -39.72 89.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.678 0.275 . . . . 0.0 111.12 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.95 -52.47 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -67.5 -47.75 69.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.376 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.41 -34.65 75.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.678 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -66.87 -65.16 0.72 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.3 p -42.87 -45.41 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.097 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -58.54 -48.13 81.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -59.18 -38.84 80.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.638 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -20.89 62.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.335 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.525 ' CG2' HG11 ' A' ' 93' ' ' VAL . 62.5 t -82.16 -32.39 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.469 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -82.03 -36.92 27.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.82 -38.45 67.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.262 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.61 6.31 39.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 44.97 56.4 5.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.092 0.472 . . . . 0.0 110.768 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.416 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 77.0 mt -85.19 172.78 10.91 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 153.59 29.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.323 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.26 77.32 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.828 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.573 ' HB ' HG21 ' A' ' 121' ' ' VAL . 11.1 p -77.97 132.58 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 117.416 0.608 . . . . 0.0 111.118 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -102.56 136.53 42.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.737 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.22 -23.45 22.36 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.446 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.75 -31.45 72.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 74.5 mmtt -68.11 -35.46 78.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.876 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -100.17 34.59 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.26 68.9 7.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.7 ptp -157.78 170.9 21.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.239 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 t -72.12 160.5 32.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.278 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.06 -48.5 79.04 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.62 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.76 -37.48 51.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.647 0.261 . . . . 0.0 111.181 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.46 -45.79 65.07 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.72 -44.67 81.84 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 81.3 m -66.48 -39.49 88.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.825 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.9 73.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.479 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -60.46 -37.92 82.54 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.807 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 175.92 50.69 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.662 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 26.2 ttpp -59.85 -53.86 52.95 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.84 -51.87 27.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.1 m -67.51 -41.77 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.415 ' HE1' ' HB2' ' A' ' 125' ' ' LEU . 50.4 t80 -62.53 -44.91 95.18 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.06 -28.95 70.13 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.941 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -73.08 -23.68 60.58 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.638 0.256 . . . . 0.0 110.807 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 76.9 mt -83.29 -34.73 25.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.52 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.496 ' HB3' ' CG2' ' A' ' 121' ' ' VAL . . . -104.99 158.12 32.73 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.471 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 12.5 Cg_endo -57.43 176.88 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.778 2.318 . . . . 0.0 112.927 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.75 -14.77 60.06 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.16 -59.01 1.95 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.913 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.576 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 3.0 m -58.76 -32.33 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.34 -33.48 46.55 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.1 -45.86 46.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.497 0.189 . . . . 0.0 111.27 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.3 mt -63.64 -60.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.539 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.415 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . 71.6 mt -49.74 -56.82 8.8 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.085 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.452 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -63.7 -34.28 77.52 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.16 -55.51 32.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.56 ' HA ' HD12 ' A' ' 131' ' ' ILE . 17.9 t-160 -71.14 -31.35 67.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 34.3 tp -57.93 -46.07 85.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.0 mm-40 -70.32 -32.4 70.12 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.377 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.8 mt -60.96 -39.42 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.473 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 93.7 mt -60.77 -33.62 73.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.477 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 76.3 mt-30 . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.032 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.547 0 CA-C-O 120.221 -0.21 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -97.79 -48.84 5.04 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.694 0.247 . . . . 0.0 111.085 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -59.42 -35.98 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.191 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.01 -31.96 73.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 39.8 tt0 -68.6 -37.62 79.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.061 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -59.77 -24.81 64.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -84.17 -18.19 37.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.764 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 51.7 mtt180 -87.99 -42.67 12.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.601 0.239 . . . . 0.0 111.379 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mp -106.6 -25.56 11.75 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.29 10.59 50.91 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.43 125.21 19.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.667 0.233 . . . . 0.0 111.484 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.69 170.11 6.15 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.876 2.384 . . . . 0.0 112.361 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -98.69 39.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.201 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 12.5 t70 -172.75 126.45 0.51 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 111.453 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.602 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 22.2 Cg_endo -60.4 -40.7 55.65 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.397 2.731 . . . . 0.0 113.01 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -52.85 -36.23 58.58 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.13 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.525 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 29.4 pt20 -99.06 36.73 1.65 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.931 0.396 . . . . 0.0 111.373 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.477 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 17.1 m0 -113.03 174.85 5.7 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.625 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -134.86 -175.42 3.9 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -52.42 -37.9 57.82 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.9 m -68.72 -52.76 27.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.641 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.64 -42.24 96.52 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.668 0.27 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.72 -52.95 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.226 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -69.98 -45.14 67.98 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.599 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.36 -37.45 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.484 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -68.82 -60.69 2.21 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 85' ' ' VAL . 46.9 t -41.26 -55.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.538 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.406 ' HE1' ' HB2' ' A' ' 82' ' ' MET . 36.4 ttm -54.5 -45.66 73.32 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -59.23 -35.62 73.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.998 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.18 -18.85 58.89 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.304 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 81' ' ' VAL . 96.3 t -83.18 -33.39 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.659 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.41 -35.06 17.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -41.15 63.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -100.61 7.68 43.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.817 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.7 m 45.52 56.74 5.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.977 0.418 . . . . 0.0 111.172 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 71.3 mt -85.14 173.11 10.69 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.321 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.31 152.27 32.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.673 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.95 -2.75 87.17 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.699 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.514 HG11 HG23 ' A' ' 85' ' ' VAL . 13.2 p -78.86 135.03 26.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 117.201 0.5 . . . . 0.0 111.318 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.472 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.8 m-20 -112.41 137.69 50.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.98 -24.54 23.51 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.929 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -61.21 -33.69 73.88 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.2 mptt -70.41 -34.01 72.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -98.26 33.33 2.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.5 66.16 8.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.123 0.487 . . . . 0.0 110.32 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.435 ' SD ' HD12 ' A' ' 108' ' ' LEU . 15.5 ptp -157.74 167.01 31.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.791 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 m -72.88 160.57 31.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.45 -42.34 95.76 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.871 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.93 68.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.76 68.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.529 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.08 -43.62 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.085 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.8 m -67.17 -41.74 85.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.842 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -27.98 69.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.556 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 26.3 mt -63.69 -36.19 83.05 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.746 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.7 178.21 50.0 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.725 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -59.96 -53.28 59.69 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -46.66 -52.2 14.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.3 m -70.27 -41.37 73.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 36.6 t80 -61.79 -45.53 93.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.41 0.148 . . . . 0.0 111.232 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.45 -25.73 67.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.884 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.58 -21.6 55.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.669 0.271 . . . . 0.0 110.48 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -86.51 -39.74 15.95 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.467 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -104.2 158.37 32.08 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.21 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 19.2 Cg_endo -58.16 175.11 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.864 2.376 . . . . 0.0 113.17 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.66 -15.94 54.55 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.28 -55.08 2.42 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.631 -0.827 . . . . 0.0 112.902 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.58 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 2.2 m -62.19 -33.64 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.83 -35.87 54.05 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.781 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.59 -43.86 53.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.74 0.305 . . . . 0.0 111.139 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.33 -56.48 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 111.568 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.46 HD23 HG21 ' A' ' 81' ' ' VAL . 11.0 mp -58.44 -58.9 6.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -30.94 70.81 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.49 -53.44 48.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.316 0.507 . . . . 0.0 109.921 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.468 ' HA ' HD13 ' A' ' 131' ' ' ILE . 19.9 t-80 -68.79 -31.56 70.67 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.241 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 29.3 tp -58.3 -45.9 87.14 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.288 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.58 -41.81 99.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.035 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 128' ' ' HIS . 95.8 mt -55.68 -43.3 72.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.284 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.3 mt -63.36 -41.68 98.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.602 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 71.3 mt-30 . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.068 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.691 0 CA-C-O 120.377 -0.124 . . . . 0.0 112.901 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.0 t80 -95.39 -46.72 6.59 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 116.621 0.211 . . . . 0.0 110.473 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -57.05 -35.87 69.82 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.232 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 20.4 pttp -63.32 -32.88 74.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.31 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -41.3 21.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.349 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.3 mt-30 -59.85 -27.08 66.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.719 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -85.85 -38.34 18.22 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.505 0.193 . . . . 0.0 111.106 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -70.25 -33.59 71.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.475 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.9 mt -100.17 -33.79 10.3 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.32 -1.68 50.34 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.705 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.503 HD13 ' HB3' ' A' ' 79' ' ' ASP . 56.3 mt -53.52 125.68 45.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 111.316 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 20.2 Cg_exo -65.23 173.81 5.75 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.828 2.352 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -93.02 -18.67 22.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.485 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -94.1 121.44 63.96 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.73 0.3 . . . . 0.0 111.295 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 38.5 Cg_endo -66.93 -26.99 43.52 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.075 2.517 . . . . 0.0 113.151 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 3.7 mpt_? -72.88 -33.58 66.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.601 0.239 . . . . 0.0 110.399 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.23 40.98 1.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.462 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.7 m0 -113.38 171.47 7.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.661 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.2 p -134.12 -178.38 5.01 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -50.62 -38.99 48.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.489 0.185 . . . . 0.0 111.214 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.5 m -66.61 -55.82 13.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.345 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -58.45 -39.07 78.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.161 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.7 t -61.87 -49.52 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.554 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -74.62 -40.4 61.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.326 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.503 ' HB3' HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -60.14 -36.25 77.11 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.506 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.498 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 15.3 t90 -71.96 -60.99 1.95 Allowed 'General case' 0 C--N 1.339 0.124 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.8 t -40.77 -53.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 123.421 0.451 . . . . 0.0 110.842 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.4 ttm -56.03 -46.33 78.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.428 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 19.1 t90 -60.93 -39.7 90.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.776 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.67 64.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.993 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.476 ' CG2' HG11 ' A' ' 93' ' ' VAL . 77.6 t -80.22 -29.56 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.954 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -82.25 -34.41 28.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.428 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.49 -40.41 70.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -103.27 6.55 38.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.808 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.2 m 43.99 54.58 5.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.617 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.485 HD13 ' HB ' ' A' ' 121' ' ' VAL . 72.8 mt -81.23 174.12 11.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.472 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.4 OUTLIER -156.52 151.52 26.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.501 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 -8.01 78.55 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.901 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 121' ' ' VAL . 12.6 p -76.77 135.35 26.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.53 0.665 . . . . 0.0 110.911 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.79 138.34 41.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.05 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.75 -27.11 20.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.285 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.517 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 14.7 tt0 -60.48 -31.52 70.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.554 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 35.5 mmtp -65.32 -36.88 85.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.867 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 33.3 m-85 -99.82 34.28 2.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.643 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 9.6 m -87.3 69.16 9.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.194 0.521 . . . . 0.0 110.208 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.4 ptp -158.97 171.03 20.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.824 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.9 p -72.18 159.85 33.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.37 -43.5 93.81 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.54 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.39 63.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.48 -46.18 60.56 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.6 -46.18 84.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.146 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 72.6 m -64.18 -38.78 92.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 110.516 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.69 74.44 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 54.3 mt -61.54 -34.97 76.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 177.49 41.19 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.609 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.5 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.5 ttpt -62.89 -40.96 99.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.565 0.221 . . . . 0.0 110.986 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.35 -64.06 0.93 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.301 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.4 m -64.52 -37.54 87.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.06 -46.2 90.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.541 0.21 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.1 -30.29 71.36 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.673 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.4 -22.96 61.04 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.734 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 88.5 mt -85.01 -41.4 15.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.543 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -102.74 157.62 33.36 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.849 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.656 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 74.1 Cg_exo -47.14 166.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.309 2.672 . . . . 0.0 113.662 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.44 -15.01 63.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.719 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -108.25 -60.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.98 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.656 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 11.8 m -59.24 -34.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -52.85 -36.65 50.82 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.934 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.47 -49.22 67.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.447 0.165 . . . . 0.0 111.188 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.0 mt -58.92 -57.34 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.722 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -50.35 -53.94 25.24 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 4.7 t90 -66.18 -28.74 69.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.178 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.31 -51.8 68.29 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -76.45 -37.26 57.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 41.5 tp -54.22 -48.58 70.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.85 -40.73 91.97 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.0 mt -54.72 -46.33 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.641 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.1 mt -51.63 -36.9 47.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.126 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.505 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 64.4 mt-30 . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.393 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -89.31 -48.3 7.45 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.3 m -55.04 -38.86 68.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -57.99 -35.96 71.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.461 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -77.97 -41.38 36.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.847 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -58.58 -29.32 66.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.477 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.84 -19.27 52.43 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 81.6 mtt180 -77.46 -42.9 34.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 111.31 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.34 -24.73 14.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.2 11.03 53.67 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.495 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.5 mt -60.51 129.44 89.33 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.312 0.245 . . . . 0.0 111.249 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.8 Cg_endo -74.29 167.72 26.49 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.394 2.063 . . . . 0.0 112.112 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -93.52 55.61 2.25 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 111.194 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 25.1 t70 -168.14 124.84 0.86 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.558 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 22.8 Cg_exo -65.12 -44.06 10.24 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.523 2.815 . . . . 0.0 113.517 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.47 -37.19 37.2 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.252 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.479 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 10.5 pt20 -100.56 44.36 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.901 0.381 . . . . 0.0 111.377 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.558 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 7.0 m0 -119.88 169.51 10.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -132.53 179.67 5.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.99 -42.6 49.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.6 m -63.47 -49.44 73.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.527 0.203 . . . . 0.0 111.357 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.418 ' CD2' HG12 ' A' ' 65' ' ' ILE . 44.0 m170 -61.2 -41.26 96.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.009 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.75 -53.59 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -65.64 -47.96 73.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.513 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.15 -37.7 72.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 121.149 -0.22 . . . . 0.0 110.776 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 17.4 t90 -69.2 -62.02 1.55 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.438 ' O ' HG21 ' A' ' 85' ' ' VAL . 54.5 t -41.47 -53.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.403 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 28.4 ttm -55.22 -46.73 75.94 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.477 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 16.0 t90 -60.37 -38.1 82.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.91 61.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.571 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 81' ' ' VAL . 78.6 t -83.16 -33.71 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 120.67 0.271 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -82.1 -37.66 26.0 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.5 -39.04 71.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.097 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -100.48 4.81 43.94 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 m 45.38 53.8 7.9 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.563 HD13 HG12 ' A' ' 121' ' ' VAL . 63.3 mt -85.34 166.55 16.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.498 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.37 152.82 33.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.82 -10.97 71.94 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.605 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.467 ' HB ' HG11 ' A' ' 121' ' ' VAL . 14.7 p -79.74 135.86 24.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 117.361 0.581 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.71 138.97 41.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.293 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.18 -27.18 23.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.755 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -61.59 -29.69 70.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 49.6 mmtm -67.02 -33.14 74.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.292 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -100.13 32.25 3.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.709 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.35 65.63 8.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.218 0.532 . . . . 0.0 110.533 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.9 ptp -158.77 167.73 28.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.7 p -74.04 161.7 29.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.558 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -59.45 -40.28 95.96 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.38 76.87 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 110.743 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.95 64.77 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.553 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.98 -42.24 84.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.01 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.56 -42.12 92.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.539 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.65 72.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.0 mt -59.95 -33.57 72.1 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.39 177.72 48.77 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.36 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.72 -47.11 86.74 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 10.0 tp10 -50.1 -67.35 0.27 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.701 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.6 m -55.75 -40.99 73.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.704 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -62.54 -43.78 97.97 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.0 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.88 -30.84 71.85 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.679 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 14.4 mm-40 -70.33 -25.08 63.13 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.4 mt -86.92 -36.74 18.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HB1' ' CA ' ' A' ' 122' ' ' GLY . . . -97.14 167.44 11.97 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.827 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 18.1 Cg_exo -67.65 174.39 7.58 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.054 2.503 . . . . 0.0 113.178 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.78 -29.92 71.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.324 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.4 -49.91 3.11 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.885 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.563 HG12 HD13 ' A' ' 90' ' ' LEU . 98.9 t -59.44 -39.45 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.399 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.435 ' CA ' ' HB1' ' A' ' 117' ' ' ALA . . . -52.5 -38.77 51.89 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.909 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.31 -49.22 70.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 111.054 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mt -56.95 -47.87 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.713 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.7 -59.21 4.87 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.87 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -63.34 -27.16 69.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.18 -54.97 25.2 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.945 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -71.25 -35.55 71.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.177 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.0 tp -61.02 -46.54 90.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.72 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.21 -35.63 81.45 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.126 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.67 -44.33 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.513 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.6 mt -57.22 -35.83 70.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.974 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.558 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 70.1 mt-30 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.605 0.24 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.484 ' HE2' ' HB2' ' A' ' 49' ' ' LEU . 27.1 ttt 72.09 -72.07 0.12 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.471 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -144.58 133.13 22.09 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.641 0.258 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 75.6 m -118.59 105.05 11.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.969 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 55.2 81.41 0.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -133.64 123.47 25.09 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.35 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.63 91.07 37.39 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.432 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.68 105.06 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.963 2.442 . . . . 0.0 112.904 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -150.43 -67.37 0.2 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.495 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 74.4 mt -147.66 51.76 1.05 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.674 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.94 110.27 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.839 2.36 . . . . 0.0 112.173 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.9 p -145.62 151.41 38.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.467 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.509 ' HA ' ' CE ' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -59.42 -38.5 80.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.313 0.102 . . . . 0.0 111.227 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -68.03 -40.66 82.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.512 0.196 . . . . 0.0 110.788 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.509 ' CE ' ' HA ' ' A' ' 41' ' ' SEP . 74.6 mtm -65.62 -37.36 86.36 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.725 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.1 mmm -59.9 -45.32 92.91 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.801 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.5 m -67.94 -39.14 83.5 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.6 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -51.19 -52.73 41.52 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.207 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.15 78.81 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.344 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' HB2' ' HE2' ' A' ' 29' ' ' MET . 22.0 mt -58.73 -43.12 90.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.341 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 8.3 mtpm? -61.59 -41.86 98.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.862 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.35 -30.45 57.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.6 m -67.33 -38.08 84.32 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 22.8 m-85 -45.0 -53.2 8.01 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.8 p -57.88 -33.97 69.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.459 ' HA2' ' HD2' ' A' ' 58' ' ' LYS . . . -79.55 -0.81 85.28 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.038 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.473 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.8 t80 -87.18 -55.14 3.95 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 116.932 0.366 . . . . 0.0 110.402 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.7 m -53.71 -33.35 55.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.209 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' HD2' ' HA2' ' A' ' 55' ' ' GLY . 90.0 mttt -63.93 -31.8 73.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -86.17 -39.92 16.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 46.5 mt-30 -56.43 -31.67 64.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.302 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -82.98 -33.83 26.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.731 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -69.51 -37.65 77.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.398 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.27 -34.93 10.51 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.33 -0.69 31.08 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.636 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.0 mt -55.88 124.23 56.93 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 122.308 0.243 . . . . 0.0 111.078 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.505 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.1 Cg_endo -73.33 167.22 27.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.556 2.171 . . . . 0.0 112.467 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -76.48 -31.02 57.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.585 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 30.1 t70 -83.99 126.55 69.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.458 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 61.4 Cg_endo -72.62 -24.89 18.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.289 2.659 . . . . 0.0 113.869 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 6.2 mpt_? -69.29 -31.66 70.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.99 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 10.7 pt20 -93.97 36.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 111.084 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.596 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.6 m0 -103.77 166.19 10.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -134.15 179.19 6.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.01 -41.58 47.56 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -63.24 -54.14 42.06 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.274 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.456 ' CD2' HG12 ' A' ' 65' ' ' ILE . 38.0 m170 -58.54 -39.41 80.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.16 -52.24 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.4 ttm105 -69.18 -47.31 65.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.27 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -35.01 69.14 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.507 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 26.5 t90 -72.33 -61.67 1.71 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.508 HG13 HD22 ' A' ' 125' ' ' LEU . 48.3 t -40.11 -52.48 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.383 0.427 . . . . 0.0 110.902 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 40.9 ttm -57.2 -47.79 80.39 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.574 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 18.8 t90 -59.96 -39.27 85.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.826 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.7 65.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.455 ' CG2' HG11 ' A' ' 93' ' ' VAL . 77.9 t -76.3 -31.23 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.966 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.4 -31.98 32.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.071 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 11.0 mm-40 -70.15 -41.32 73.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.28 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CZ ' HD22 ' A' ' 49' ' ' LEU . 88.2 m-85 -107.08 9.91 30.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.8 m 44.66 54.26 6.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 110.527 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.524 HD13 ' HB ' ' A' ' 121' ' ' VAL . 62.9 mt -82.02 178.21 8.41 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.467 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.18 151.34 15.61 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.553 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.86 -8.69 77.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.57 ' HB ' HG23 ' A' ' 121' ' ' VAL . 12.7 p -83.44 138.7 18.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 117.543 0.672 . . . . 0.0 111.158 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -116.56 152.9 33.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -95.41 -9.85 31.59 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.409 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -63.72 -42.83 97.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 71.0 mmtt -65.99 -32.5 74.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.171 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 117' ' ' ALA . 38.4 m-85 -99.5 33.45 2.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.583 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.7 t -87.69 64.7 8.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.115 0.483 . . . . 0.0 110.271 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.4 ptp -157.17 169.91 23.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.779 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.9 p -76.87 166.53 23.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.322 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.92 -43.65 96.61 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.803 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.42 63.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.689 0.28 . . . . 0.0 110.929 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.72 -46.41 53.77 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.06 -45.67 79.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.182 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.33 -41.39 85.33 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.674 0.273 . . . . 0.0 110.821 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.21 71.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.496 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 61.9 mt -60.72 -39.79 89.94 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.22 172.47 44.65 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.507 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.427 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.1 ttpt -59.06 -55.07 39.75 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.37 -49.9 63.46 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 98.8 m -63.58 -43.61 96.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.509 0.195 . . . . 0.0 111.004 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -62.97 -41.25 99.48 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.675 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.62 -27.43 68.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.721 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -76.31 -23.95 54.34 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.693 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 97.5 mt -79.94 -34.04 39.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . . . -109.33 161.53 23.58 Favored Pre-proline 0 N--CA 1.462 0.137 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.243 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.663 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 68.1 Cg_exo -50.06 165.64 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.878 2.386 . . . . 0.0 113.139 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.84 -15.42 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.644 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -108.21 -61.1 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.992 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.663 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 12.1 m -60.43 -34.33 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.8 -36.14 40.58 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.129 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -65.56 -47.82 74.53 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.519 0.2 . . . . 0.0 111.313 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.26 -54.64 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.328 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.508 HD22 HG13 ' A' ' 81' ' ' VAL . 10.9 mp -53.33 -54.67 33.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.341 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 2.6 t90 -62.04 -29.92 70.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.11 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.07 -59.26 5.71 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.401 ' HA ' HD12 ' A' ' 131' ' ' ILE . 21.8 t-160 -69.54 -36.18 76.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.818 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.507 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.2 tp -61.29 -43.04 99.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.83 -33.33 74.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 128' ' ' HIS . 59.4 mt -59.18 -42.19 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.029 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 95.8 mt -57.98 -38.36 75.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.596 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -66.01 -53.91 32.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.919 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.46 -45.62 93.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.69 -41.18 98.98 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.959 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -114.33 75.59 0.94 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.323 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.22 124.33 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.25 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.234 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.8 m80 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.572 0.225 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.489 ' HG3' HG12 ' A' ' 131' ' ' ILE . 26.0 mmt 71.77 -67.92 0.24 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.325 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -83.88 153.7 23.84 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.722 0.296 . . . . 0.0 111.015 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -65.5 97.41 0.3 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.977 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.53 -52.57 0.04 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -155.71 46.67 0.49 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.07 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.76 114.37 19.63 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.175 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -86.67 151.69 8.8 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.989 2.459 . . . . 0.0 112.629 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 38' ' ' TPO . 0.4 OUTLIER -72.43 151.24 42.71 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -92.14 89.78 7.06 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.823 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . 0.624 HG22 HD12 ' A' ' 36' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.83 96.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.912 2.408 . . . . 0.0 112.14 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.0 m -152.08 -174.27 4.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.872 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.429 ' HA ' ' HE1' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -66.87 -28.19 68.14 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.383 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -75.18 -24.25 57.84 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.429 ' HE1' ' HA ' ' A' ' 41' ' ' SEP . 57.5 mtm -56.73 -41.45 77.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -62.88 -35.4 79.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.672 0.272 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.421 ' OG ' ' HD3' ' A' ' 50' ' ' LYS . 30.0 t -61.43 -34.8 76.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.268 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -43.82 -52.41 6.73 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.85 -43.81 66.33 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.91 -35.19 26.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HD3' ' OG ' ' A' ' 46' ' ' SER . 12.8 tptt -66.09 -47.55 73.87 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.58 89.67 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.319 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.465 HG21 ' CE2' ' A' ' 88' ' ' PHE . 89.3 m -50.8 -47.92 59.77 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.192 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 27.7 m-85 -46.18 -53.72 10.01 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.351 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.2 m -62.65 -30.92 71.73 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.111 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.72 -0.75 64.57 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.712 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.53 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 17.7 t80 -94.69 -45.46 7.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 116.701 0.251 . . . . 0.0 110.338 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 95.0 m -58.3 -37.02 74.22 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.978 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -63.15 -30.64 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.298 . . . . 0.0 110.41 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.51 -40.12 23.68 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.045 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 57.1 mt-30 -56.14 -28.7 58.95 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.705 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -88.44 -37.51 15.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.591 0.234 . . . . 0.0 110.992 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -67.25 -39.86 86.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.281 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.79 -29.57 12.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.6 -1.05 49.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -52.45 123.55 29.69 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 122.348 0.259 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 58.1 Cg_endo -71.73 168.94 22.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.494 2.129 . . . . 0.0 112.507 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -97.21 39.74 1.18 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.225 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.496 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 5.5 t70 -144.07 114.22 5.38 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 36.8 Cg_endo -65.7 -24.59 54.86 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.799 2.333 . . . . 0.0 112.775 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 3.4 mpt_? -77.71 -31.24 52.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 11.4 mm-40 -96.77 34.92 1.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.935 0.397 . . . . 0.0 110.487 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 4.1 m0 -107.91 170.35 8.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.69 -177.56 4.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.242 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -50.04 -42.81 50.33 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 m -64.34 -51.69 62.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.537 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -60.15 -42.01 93.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.25 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.26 -53.4 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -68.02 -46.71 70.47 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.696 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -56.49 -41.31 76.43 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.512 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.43 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.8 t90 -64.7 -61.98 1.86 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 85' ' ' VAL . 55.9 t -41.12 -53.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.793 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.418 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 35.4 ttm -58.22 -48.19 81.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.77 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.53 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 15.4 t90 -56.95 -38.43 72.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.836 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.14 83.47 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.505 ' CG2' HG12 ' A' ' 93' ' ' VAL . 81.6 t -53.1 -34.5 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.592 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -79.65 -36.19 38.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.157 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 9.3 mm-40 -68.2 -39.43 82.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.446 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.465 ' CE2' HG21 ' A' ' 52' ' ' THR . 97.8 m-85 -107.7 8.55 29.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 46.08 50.79 11.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 110.467 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.489 HD11 ' HB ' ' A' ' 121' ' ' VAL . 67.6 mt -78.75 177.68 8.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.481 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.34 152.82 17.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.26 73.63 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.811 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.505 HG12 ' CG2' ' A' ' 85' ' ' VAL . 14.9 p -74.96 132.04 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 117.58 0.69 . . . . 0.0 110.873 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.467 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 7.9 m-20 -99.12 133.93 42.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.1 -23.78 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.411 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.533 ' HG3' ' HD2' ' A' ' 97' ' ' LYS . 14.1 pt20 -63.22 -33.22 75.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.3 mptp? -67.49 -34.94 78.18 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.999 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -100.62 34.85 2.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.662 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.4 t -87.76 64.62 8.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.138 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.3 ptp -155.7 167.95 28.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.756 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -73.77 159.69 32.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.344 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -55.29 -43.51 84.41 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.961 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.66 -38.6 60.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.665 0.269 . . . . 0.0 111.037 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.02 58.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.1 tp -55.79 -44.72 78.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.079 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.77 -41.76 91.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.777 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.25 72.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.8 mt -61.37 -36.98 81.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.93 176.4 51.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.678 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 52.0 tttp -61.36 -51.3 69.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -50.48 -52.33 39.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.4 m -66.55 -42.67 86.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.434 ' CE1' HD21 ' A' ' 129' ' ' LEU . 59.0 t80 -63.72 -42.14 97.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.99 -29.65 70.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.717 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.67 -21.25 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.664 0.268 . . . . 0.0 110.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.6 mt -85.8 -32.59 21.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.835 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -112.4 150.91 43.32 Favored Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.642 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 85.6 Cg_exo -44.23 167.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.691 2.927 . . . . 0.0 114.079 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.95 -24.05 67.7 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.3 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.06 -49.19 3.24 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.524 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.642 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.2 m -63.11 -34.37 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.168 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.91 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.816 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.34 -45.35 94.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.577 0.227 . . . . 0.0 110.945 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.7 mt -61.98 -56.93 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.268 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.8 mt -55.07 -57.36 12.05 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.3 -36.1 79.14 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.335 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -56.47 -54.87 40.63 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.483 ' HA ' HD11 ' A' ' 131' ' ' ILE . 22.3 t-160 -72.47 -30.3 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.653 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 52.4 tp -59.59 -49.85 76.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.104 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 15.3 mm-40 -67.29 -33.69 75.83 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.222 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.489 HG12 ' HG3' ' A' ' 29' ' ' MET . 69.3 mt -58.64 -40.17 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.315 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.0 mt -62.39 -39.08 92.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.3 mt-30 -62.6 -50.96 69.19 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.798 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.89 -35.14 79.81 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.988 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -60.43 -46.68 89.16 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.809 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -148.23 111.22 4.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.472 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.48 -36.46 20.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.547 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.917 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.677 0.275 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.0 mtt -74.18 -61.06 1.99 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.017 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.92 -42.29 0.27 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.601 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.9 m -86.73 115.05 23.91 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.675 0.274 . . . . 0.0 110.802 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.74 -14.26 59.37 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.829 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.12 65.53 7.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.923 0.392 . . . . 0.0 110.599 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.0 t -140.07 128.76 13.25 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.65 156.43 49.14 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.713 2.275 . . . . 0.0 112.495 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt -122.67 75.02 1.23 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.169 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.3 tp -101.11 74.85 1.61 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.206 0.527 . . . . 0.0 110.568 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -43.9 95.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.169 2.579 . . . . 0.0 112.735 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.5 t -177.37 -165.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.339 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -64.97 -40.24 94.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.56 -35.83 77.94 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.514 0.197 . . . . 0.0 110.485 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.2 ttp -58.09 -32.03 67.68 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.854 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.3 mtp -61.17 -41.71 97.26 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.802 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.8 t -59.8 -46.96 87.58 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.64 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.57 -52.57 17.23 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.614 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.67 -49.75 69.88 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.9 -34.52 75.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.48 -42.91 97.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.595 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.32 -29.93 30.77 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.6 m -55.58 -49.44 72.72 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -101.21 41.57 1.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 47.9 m -71.8 -32.55 67.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.371 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.6 -16.81 79.8 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.804 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.408 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.7 t80 -89.01 -47.78 7.88 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.675 0.237 . . . . 0.0 110.779 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.9 m -55.06 -31.75 61.38 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.52 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 54' ' ' SER . 34.6 mmtp -62.19 -30.33 71.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.342 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -84.38 -42.18 15.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 31.8 mt-30 -58.33 -31.76 67.86 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.374 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -82.9 -35.73 25.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.517 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -65.86 -35.23 80.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.46 -32.44 9.5 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.85 4.46 39.28 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.627 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.96 127.74 69.49 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.354 0.262 . . . . 0.0 110.929 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.53 174.49 12.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 112.76 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -100.84 45.95 0.96 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -144.48 113.32 5.12 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.495 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 20.3 Cg_endo -61.77 -29.72 83.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.765 2.31 . . . . 0.0 112.823 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 5.5 mpt_? -74.47 -33.45 62.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.558 0.218 . . . . 0.0 110.495 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -95.7 35.03 1.41 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.079 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.507 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.3 m0 -109.73 160.43 16.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.4 t -127.04 -179.32 4.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.345 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.48 -49.63 44.75 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 m -58.16 -45.95 86.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.314 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -64.19 -41.68 96.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.444 HG12 HD21 ' A' ' 105' ' ' LEU . 55.8 t -62.5 -54.54 32.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.117 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -65.75 -45.49 82.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.55 -42.28 92.01 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.573 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 21.9 t90 -63.4 -60.33 3.51 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.553 HG12 HD22 ' A' ' 125' ' ' LEU . 40.3 t -42.19 -53.9 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.365 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 37.7 ttm -56.24 -45.97 79.77 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.705 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.517 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 52.1 t90 -56.77 -36.44 69.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.88 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.35 58.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.156 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 81' ' ' VAL . 89.0 t -78.52 -34.81 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.484 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -83.35 -37.45 23.33 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.138 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 7.3 mm-40 -70.23 -36.07 74.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.309 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.7 8.78 24.91 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t 43.62 62.11 2.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.121 0.486 . . . . 0.0 110.498 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' HB ' ' A' ' 121' ' ' VAL . 59.9 mt -90.43 153.47 20.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.475 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 151.27 49.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.77 -10.62 73.09 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.707 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.473 HG12 ' CG2' ' A' ' 85' ' ' VAL . 13.8 p -79.54 139.75 17.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 117.404 0.602 . . . . 0.0 110.938 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.465 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 10.5 m-20 -117.55 144.17 45.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.212 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.25 -18.66 26.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.977 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.09 -36.44 81.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.041 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.0 mptt -69.24 -34.43 74.79 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.412 ' HZ ' ' HB1' ' A' ' 117' ' ' ALA . 42.8 m-85 -99.96 33.5 2.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.1 t -86.88 64.29 8.41 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.219 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.7 ptp -156.45 169.32 24.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.735 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.2 m -75.81 161.5 28.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.373 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.84 -44.09 92.2 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.014 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.75 59.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.987 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.0 -44.48 63.41 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.444 HD21 HG12 ' A' ' 77' ' ' VAL . 13.9 tp -57.62 -46.64 83.84 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.271 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.92 -38.48 91.26 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 110.604 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.21 67.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.561 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 66.4 mt -64.17 -35.22 80.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.04 175.79 45.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.589 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.28 -66.62 0.37 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.4 m -58.57 -39.53 80.58 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 54.1 t80 -64.17 -45.88 86.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.305 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.1 mt -63.09 -26.37 68.8 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.036 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -75.47 -22.63 57.09 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.603 0.24 . . . . 0.0 110.76 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -83.04 -36.26 25.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.585 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.412 ' HB1' ' HZ ' ' A' ' 98' ' ' PHE . . . -108.39 155.27 40.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.601 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.676 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 76.9 Cg_exo -48.53 169.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.233 2.622 . . . . 0.0 113.775 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.89 -22.97 67.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.983 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -107.81 -57.04 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.364 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.676 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 6.1 m -60.24 -33.29 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.34 -32.99 57.93 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.229 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.17 -48.63 77.58 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.64 0.22 . . . . 0.0 111.422 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.443 ' CD1' HD21 ' A' ' 90' ' ' LEU . 74.0 mt -54.6 -54.48 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.493 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.553 HD22 HG12 ' A' ' 81' ' ' VAL . 10.0 mp -54.28 -59.73 4.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.275 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.76 -30.77 67.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.939 -0.077 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.09 -57.75 11.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -73.77 -39.39 64.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.006 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.573 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.8 tp -54.08 -46.11 71.95 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.36 -35.19 75.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.192 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.48 -42.98 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.473 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.8 mt -52.14 -39.62 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.78 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -60.6 -45.81 92.61 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.823 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -69.96 -40.01 75.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.392 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -53.93 -41.31 67.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.674 0.273 . . . . 0.0 111.096 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.71 95.11 2.37 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.335 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.95 92.45 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.14 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.911 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.9 p80 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.583 0.23 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.1 ttt 70.95 137.32 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.501 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -147.28 118.87 7.96 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.774 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.0 t -93.8 -56.73 2.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.309 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.32 -51.44 63.41 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.508 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 11.3 t70 -86.37 145.4 26.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.046 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -92.39 135.27 26.93 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.06 104.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.906 2.404 . . . . 0.0 112.796 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.3 tp -171.82 145.56 1.94 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.558 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.23 89.69 0.47 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.126 0.488 . . . . 0.0 110.683 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -43.24 118.93 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.108 2.539 . . . . 0.0 112.828 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.8 p -166.65 178.39 6.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.989 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HG2' ' HB3' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -72.03 -39.26 69.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.825 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 6.3 tp10 -60.29 -39.17 85.96 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.721 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 58.3 mtm -78.86 -30.48 45.15 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.017 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.8 ttt -56.95 -48.83 77.41 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.088 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.0 m -83.87 -26.84 29.11 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.031 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -55.12 -52.18 64.09 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.71 0.29 . . . . 0.0 110.883 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.28 90.14 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.169 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.517 HD13 HD11 ' A' ' 131' ' ' ILE . 90.6 mt -61.95 -40.24 94.87 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.74 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -70.15 -35.68 74.21 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.451 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.26 -31.21 71.39 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.618 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -58.63 -28.19 65.43 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.334 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -50.27 -28.08 7.15 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -52.74 -41.41 63.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.653 0.206 . . . . 0.0 111.424 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.06 -22.83 56.77 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.654 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.406 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 29.8 t80 -83.25 -50.45 8.4 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 116.453 0.126 . . . . 0.0 110.796 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.687 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 28.8 m -55.72 -40.78 72.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.435 ' HD2' ' NE2' ' A' ' 61' ' ' GLN . 32.0 mmmt -64.95 -25.17 67.76 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 110.851 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.89 -48.17 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.687 ' HG2' ' HA ' ' A' ' 57' ' ' THR . 5.2 pt20 -65.95 -24.96 66.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.043 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.435 ' NE2' ' HD2' ' A' ' 58' ' ' LYS . 9.3 pt20 -79.92 -31.04 40.13 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.697 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -67.65 -30.83 70.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.787 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.13 -30.74 11.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.079 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.82 -1.64 27.35 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.173 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 60' ' ' GLN . 51.5 mt -60.41 128.27 87.73 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.843 0.321 . . . . 0.0 110.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.95 175.06 11.38 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.614 2.21 . . . . 0.0 112.505 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 43.63 1.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 111.154 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 11.1 m-20 -153.57 111.03 2.57 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.536 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 40.9 Cg_exo -57.42 -36.51 98.8 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.988 2.459 . . . . 0.0 112.48 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -55.4 -37.91 68.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.468 0.175 . . . . 0.0 111.105 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.435 ' HG2' ' HB2' ' A' ' 68' ' ' ASP . 12.0 pt20 -99.95 44.31 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.969 0.414 . . . . 0.0 111.156 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.544 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.4 m0 -117.23 169.61 9.33 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.086 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -131.54 -177.84 4.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -51.32 -44.28 61.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.3 m -63.62 -48.59 76.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.628 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.406 ' CD2' HG12 ' A' ' 65' ' ' ILE . 45.3 m170 -60.83 -42.13 97.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.316 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.28 -52.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.21 -47.1 68.79 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.498 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.18 -43.18 82.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.55 0.214 . . . . 0.0 110.54 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 13.7 t90 -63.59 -62.49 1.63 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 85' ' ' VAL . 43.9 t -39.69 -51.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.422 0.451 . . . . 0.0 110.939 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 29.0 ttm -53.39 -49.8 66.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.174 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.477 ' CZ2' ' HG3' ' A' ' 87' ' ' GLU . 76.8 t90 -61.93 -42.8 99.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.92 -20.92 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' CG2' HG13 ' A' ' 93' ' ' VAL . 55.5 t -82.33 -31.7 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.336 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.78 -36.84 42.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.936 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 11.1 mm-40 -71.79 -39.71 69.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.335 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -100.94 5.27 43.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.4 m 44.88 55.2 6.23 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 110.638 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.573 HD12 ' HB ' ' A' ' 121' ' ' VAL . 86.2 mt -75.9 151.32 37.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.908 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -130.64 143.04 50.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 111.623 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.61 -0.44 88.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.512 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.529 HG13 ' CG2' ' A' ' 85' ' ' VAL . 12.6 p -74.55 132.21 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.286 0.543 . . . . 0.0 111.161 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.98 136.78 47.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.058 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.26 -29.56 20.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.397 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.99 -33.69 72.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 47.1 mmtm -66.43 -36.6 83.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.894 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -97.58 34.73 1.78 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.223 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.61 66.12 8.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.388 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.425 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.6 ptp -158.43 169.08 25.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -73.54 156.48 38.09 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.227 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.544 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.07 -41.04 92.34 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.92 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.61 -39.59 65.05 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.726 0.298 . . . . 0.0 110.839 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.49 64.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.7 tp -55.79 -44.29 77.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.002 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 86.1 m -65.62 -42.45 91.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.55 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.1 -30.05 71.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 31.6 mt -62.39 -38.83 91.14 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.882 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.07 170.8 47.37 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.474 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.8 ttpt -59.27 -47.79 84.07 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.67 -51.1 61.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 70.2 m -66.13 -39.64 90.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.477 0.18 . . . . 0.0 111.123 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.403 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 48.2 t80 -63.51 -41.89 98.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.64 -23.13 65.31 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.813 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.72 -22.14 50.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.4 mt -85.86 -36.58 19.89 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.249 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.482 ' HB3' ' CG2' ' A' ' 121' ' ' VAL . . . -110.6 154.75 42.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.184 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.539 ' HG2' ' CG2' ' A' ' 121' ' ' VAL . 10.1 Cg_endo -54.79 172.32 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.749 2.3 . . . . 0.0 113.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.78 -21.99 57.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.33 -53.4 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 113.251 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.573 ' HB ' HD12 ' A' ' 90' ' ' LEU . 2.0 m -59.04 -34.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.49 -36.11 52.94 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.82 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.65 -49.82 56.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.47 0.176 . . . . 0.0 111.09 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.3 mp -57.43 -46.44 85.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.588 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.403 ' HB2' ' HE2' ' A' ' 113' ' ' PHE . 85.0 mt -67.5 -57.16 7.01 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.32 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.496 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -60.73 -33.63 73.19 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.18 -54.63 44.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -71.89 -30.01 64.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.459 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.508 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 43.0 tp -60.27 -50.78 72.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.8 mm-40 -66.13 -33.82 76.65 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.517 HD11 HD13 ' A' ' 49' ' ' LEU . 69.4 mt -61.68 -36.58 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.444 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.9 mt -62.96 -40.94 99.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.536 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 69.6 mt-30 -60.12 -53.1 61.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.471 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 131' ' ' ILE . 21.8 ptmt -65.18 -32.6 74.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.852 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.52 95.45 0.1 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.119 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 60.55 65.32 1.06 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.263 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.2 m -47.41 120.8 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.777 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.736 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.1 p80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.725 0.298 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.0 tpt 57.23 42.68 24.98 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.926 0.393 . . . . 0.0 111.04 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -90.86 -52.76 4.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.444 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HB2' ' HG3' ' A' ' 135' ' ' GLU . 45.0 t -133.09 141.01 47.96 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.86 109.08 20.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.047 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.603 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . 14.4 t70 -154.75 137.45 15.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.16 129.47 21.7 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 138' ' ' LYS . 58.0 Cg_endo -72.73 120.23 6.56 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.71 2.273 . . . . 0.0 112.04 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 tp -149.56 138.76 21.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.42 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.7 mt -90.37 80.9 6.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 97.2 Cg_exo -43.55 100.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.401 2.734 . . . . 0.0 112.689 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 87.7 p -174.2 -173.82 0.83 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.569 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.524 ' HA ' ' HE2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.96 -40.05 79.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.491 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HG3' ' HA ' ' A' ' 39' ' ' PRO . 9.5 mm-40 -62.67 -38.78 91.72 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.167 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.524 ' HE2' ' HA ' ' A' ' 41' ' ' SEP . 4.7 mpp? -79.58 -28.49 41.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.571 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.9 mtp -59.01 -48.05 82.99 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.442 0.163 . . . . 0.0 110.93 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.1 m -79.57 -26.92 41.23 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.671 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -52.03 -52.1 53.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.03 -47.56 74.0 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.745 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.42 -48.34 71.75 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.534 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 96.3 mttt -70.08 -41.03 74.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.566 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.87 -39.26 91.31 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.326 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.454 HG21 ' CH2' ' A' ' 83' ' ' TRP . 26.8 m -65.15 -41.9 94.31 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.174 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 21.6 m-30 -49.93 -36.09 26.38 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -58.93 -35.27 72.83 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.439 0.161 . . . . 0.0 111.052 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.41 -8.59 85.81 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.456 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.525 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 7.9 t80 -83.91 -50.43 8.05 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.4 m -56.68 -36.85 70.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.55 -30.55 70.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.774 0.321 . . . . 0.0 110.303 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -84.58 -42.79 15.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 8.3 mm100 -56.96 -30.9 64.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -80.31 -36.69 33.94 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.478 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.57 -39.47 84.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.524 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.8 -32.24 14.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.21 -0.53 40.73 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.231 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.04 128.87 66.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 117.011 0.406 . . . . 0.0 110.913 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.87 172.82 14.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.754 2.303 . . . . 0.0 112.85 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.01 48.11 0.9 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.518 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 12.0 m-20 -140.8 105.99 6.32 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.9 Cg_endo -62.65 -37.06 60.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.659 2.24 . . . . 0.0 112.423 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -70.19 -32.67 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 68' ' ' ASP . 2.0 mp0 -97.85 42.21 1.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.55 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -115.68 168.33 10.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 101' ' ' SER . 15.3 t -133.55 -177.03 4.36 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.562 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -49.41 -46.79 47.96 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -63.27 -49.53 73.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.668 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -62.16 -43.06 99.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.688 0.28 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.47 -52.53 60.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.466 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -68.8 -46.07 69.61 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.784 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.39 -38.67 71.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.547 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.493 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 12.8 t90 -66.93 -61.07 2.13 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 85' ' ' VAL . 50.9 t -41.37 -53.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 40.0 ttm -56.57 -46.15 80.92 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.835 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.525 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 54.3 t90 -58.32 -35.94 72.64 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.691 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.35 -21.2 60.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.129 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.527 ' CG2' HG13 ' A' ' 93' ' ' VAL . 84.6 t -77.83 -32.78 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -81.52 -36.66 28.94 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.036 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 10.9 mm-40 -71.27 -40.29 71.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -104.32 6.14 35.05 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.9 m 45.15 56.57 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 110.599 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 74.5 mt -82.08 169.67 16.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.36 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.1 147.98 27.73 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.358 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -8.52 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.741 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.527 HG13 ' CG2' ' A' ' 85' ' ' VAL . 14.5 p -76.4 135.85 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.418 0.609 . . . . 0.0 110.785 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 12.1 m-20 -109.82 139.16 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.392 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -89.11 -25.08 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.704 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -61.89 -34.48 76.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 2.0 mptm? -67.15 -35.15 79.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.418 ' CZ ' ' HB1' ' A' ' 117' ' ' ALA . 35.9 m-85 -100.49 34.98 2.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.479 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.1 t -89.41 68.42 7.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.069 0.461 . . . . 0.0 110.251 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.4 ptp -160.66 172.97 16.16 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.788 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 72.1 m -73.43 156.59 38.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -57.91 -38.66 89.68 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.601 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.82 -39.58 71.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.283 . . . . 0.0 110.666 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.56 -45.02 66.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.72 -44.6 81.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.031 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.1 m -64.43 -40.35 95.57 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.15 73.67 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.305 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 60.1 mt -61.28 -36.14 79.25 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.895 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.7 176.22 48.92 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.601 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 27.5 ttpp -61.73 -46.82 88.01 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.25 -61.53 2.11 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.473 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 85.5 m -60.6 -39.33 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.438 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -63.36 -43.6 97.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.833 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -66.42 -25.92 66.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -76.63 -21.85 54.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.725 0.297 . . . . 0.0 110.347 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 80.6 mt -86.28 -36.77 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' A' ' 121' ' ' VAL . . . -116.47 151.74 47.33 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.815 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.601 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.8 Cg_exo -43.02 164.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.587 2.858 . . . . 0.0 114.09 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.47 -20.2 62.88 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.053 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -108.07 -52.69 2.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.188 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.601 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.2 m -62.01 -37.12 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.335 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.77 -36.91 88.9 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.669 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.56 -47.39 78.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.406 HD12 HD22 ' A' ' 90' ' ' LEU . 61.0 mt -59.36 -53.73 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.4 mt -55.63 -55.67 29.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.386 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -62.24 -28.91 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.04 -57.27 13.29 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.476 ' HA ' HD12 ' A' ' 131' ' ' ILE . 23.7 t-160 -70.98 -32.42 69.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.311 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 50.0 tp -57.49 -46.29 83.91 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.638 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -68.08 -33.49 74.63 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.233 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.56 ' HA ' ' CB ' ' A' ' 135' ' ' GLU . 85.1 mt -61.12 -43.19 95.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.05 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.499 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.2 mt -58.27 -35.31 71.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.396 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -68.7 -71.54 0.21 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.443 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -177.78 55.79 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.954 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.56 ' CB ' ' HA ' ' A' ' 131' ' ' ILE . 28.6 tt0 -80.48 132.1 35.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.882 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -86.45 79.87 8.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.908 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.603 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 6.5 m -129.26 120.17 50.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.199 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.45 ' HB2' ' HD3' ' A' ' 35' ' ' PRO . 34.9 mmtp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.834 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.4 p80 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.0 ttp 73.32 -73.35 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.711 0.405 . . . . 0.0 110.926 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.06 33.65 0.14 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.566 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.87 -42.22 5.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.963 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.41 96.99 6.73 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.539 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -128.94 139.59 52.04 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.17 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -80.01 132.77 59.3 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.213 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.3 104.38 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.531 2.154 . . . . 0.0 112.213 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.5 tp -174.71 106.98 0.1 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 tt -164.31 131.85 3.31 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.114 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.1 98.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.398 2.732 . . . . 0.0 113.081 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.7 t -172.66 -80.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.434 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.538 ' HA ' ' HE1' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -73.85 -36.38 64.88 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.13 -40.38 95.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.425 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.538 ' HE1' ' HA ' ' A' ' 41' ' ' SEP . 23.8 ptt? -84.87 -27.14 26.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.549 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 ttt -57.72 -45.45 85.75 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.244 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.7 p -82.36 -27.57 32.05 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.799 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -54.1 -50.66 66.34 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.31 -32.16 58.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.553 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.1 tp -61.99 -44.75 96.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.686 0.279 . . . . 0.0 110.84 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -65.56 -27.85 68.74 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.62 -30.46 65.8 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.6 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.4 p -80.73 -45.43 17.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.506 0.193 . . . . 0.0 111.261 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -48.07 -40.26 22.62 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.9 p -58.87 -35.17 72.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.463 0.173 . . . . 0.0 111.29 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.21 -7.39 88.49 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.837 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 14.4 t80 -99.47 -50.28 4.14 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.811 0.306 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.8 m -55.67 -31.5 62.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.434 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -61.27 -33.69 73.97 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.674 0.273 . . . . 0.0 110.408 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.14 -38.98 23.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 33.4 mt-30 -58.24 -32.28 68.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.723 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -81.61 -36.89 28.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.796 -0.184 . . . . 0.0 111.48 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -70.76 -39.74 73.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.685 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.3 mt -98.05 -26.36 14.64 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.07 6.24 59.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.533 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 62.8 mt -54.93 122.17 39.69 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 122.305 0.242 . . . . 0.0 111.213 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.21 169.4 9.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.783 2.322 . . . . 0.0 112.558 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -99.24 34.36 2.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -153.78 116.51 2.65 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.3 Cg_endo -61.39 -40.53 47.91 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.145 2.563 . . . . 0.0 112.479 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -54.75 -36.33 64.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.67 0.271 . . . . 0.0 110.456 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -100.15 46.37 0.96 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.762 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.51 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 7.4 m0 -122.07 174.06 7.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.505 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.1 t -132.61 -179.05 5.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.95 -42.93 49.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.3 m -64.19 -50.08 69.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -60.77 -40.6 93.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.544 0.211 . . . . 0.0 111.199 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.409 HG13 HD21 ' A' ' 105' ' ' LEU . 65.6 t -63.2 -55.54 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -64.82 -48.55 74.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.721 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -56.53 -40.1 74.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.576 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.406 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.1 t90 -66.12 -61.11 2.21 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 85' ' ' VAL . 53.6 t -40.74 -55.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 62.1 mtt -55.55 -47.02 77.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.511 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.2 t90 -58.01 -35.95 71.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.938 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.77 -18.41 60.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.556 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 81' ' ' VAL . 96.7 t -81.04 -34.3 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.488 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -83.81 -32.85 25.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.511 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 6.9 mm-40 -75.53 -40.55 56.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -102.21 6.12 40.51 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.946 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 46.08 53.87 8.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 110.746 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.481 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 67.5 mt -81.95 169.23 17.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.118 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -152.54 148.88 27.9 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -7.4 81.33 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.855 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.5 ' HB ' HG22 ' A' ' 121' ' ' VAL . 14.5 p -76.74 134.48 28.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.423 0.612 . . . . 0.0 111.073 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.4 131.78 48.83 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.442 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -85.07 -28.69 25.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.74 -33.33 72.76 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.5 mptm? -67.23 -34.35 77.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.123 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 51.1 m-85 -99.32 35.81 1.87 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.598 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.99 64.43 7.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.045 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.433 ' SD ' HD13 ' A' ' 108' ' ' LEU . 16.8 ptp -155.64 167.34 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.046 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.0 p -70.9 158.12 36.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.51 -42.04 93.75 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.83 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.95 64.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.719 0.295 . . . . 0.0 110.876 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.5 -44.93 63.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.571 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.409 HD21 HG13 ' A' ' 77' ' ' VAL . 18.9 tp -55.15 -44.28 75.01 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.264 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 70.8 m -66.93 -40.61 87.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.713 0.292 . . . . 0.0 110.763 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.16 67.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.642 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.9 mt -68.01 -38.46 82.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.88 176.42 51.49 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.331 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.2 ttpt -61.6 -51.22 69.4 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.76 -51.75 36.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.3 m -66.73 -40.93 88.54 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.445 0.164 . . . . 0.0 111.356 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 125' ' ' LEU . 32.2 t80 -62.31 -43.59 98.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.95 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.8 -25.06 66.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.831 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -76.15 -22.38 55.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 110.216 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 91.4 mt -89.07 -35.63 16.21 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.37 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 121' ' ' VAL . . . -118.32 148.96 44.97 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.934 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.4 Cg_exo -41.89 163.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.752 2.968 . . . . 0.0 114.355 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.5 -21.49 62.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.131 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -108.1 -48.63 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.374 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.58 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 6.2 m -64.15 -37.52 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.48 0.181 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.02 89.59 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.96 -49.35 75.07 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.621 0.248 . . . . 0.0 110.957 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.437 HD13 HD21 ' A' ' 90' ' ' LEU . 47.7 mt -58.09 -57.33 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.0 0.428 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 90.4 mt -52.3 -59.21 4.67 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.057 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.563 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -61.74 -32.97 73.25 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.36 -56.35 21.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.236 0.471 . . . . 0.0 110.159 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.408 ' HA ' HD13 ' A' ' 131' ' ' ILE . 12.8 t-80 -68.13 -36.94 80.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.097 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 32.9 tp -58.71 -46.51 87.18 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.474 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.16 -39.5 86.65 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 128' ' ' HIS . 88.7 mt -60.11 -41.69 87.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.177 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.544 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 85.4 mt -66.52 -37.72 85.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.11 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.53 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 -54.52 -41.21 69.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.249 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -57.96 -43.78 86.66 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -84.9 101.9 12.69 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.213 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.68 97.23 7.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.11 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.07 129.86 58.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.916 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.806 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.2 p80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -158.77 -60.41 0.07 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.716 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.57 -55.94 3.45 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.827 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.1 p -149.66 110.86 4.4 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.8 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.33 104.3 0.2 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.343 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -162.21 117.61 1.93 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.764 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.22 89.42 44.96 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.163 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.61 149.93 62.22 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.9 2.4 . . . . 0.0 112.246 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.6 tp -114.09 124.05 51.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.024 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.7 tp -161.18 87.71 0.72 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.599 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.86 147.44 74.8 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.788 2.325 . . . . 0.0 112.39 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.1 t -107.25 166.42 10.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.221 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -66.4 -40.39 89.59 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.003 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -66.43 -40.1 89.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.938 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 44' ' ' MET . 29.7 ttp -74.21 -38.1 63.68 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.342 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 56.3 ttp -60.39 -45.79 92.31 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.678 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.3 m -77.31 -26.42 52.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.254 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -45.21 -49.7 12.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.735 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.01 -44.04 87.05 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.766 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.93 -41.11 91.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.604 0.24 . . . . 0.0 110.896 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -58.51 -34.41 70.93 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.685 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.12 -51.15 25.92 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.7 m -81.25 -43.87 18.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.184 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -46.73 -46.45 20.33 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.4 p -59.43 -40.18 85.95 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.7 -11.5 84.46 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.792 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.431 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 9.0 t80 -99.43 -46.5 5.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.647 0.223 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.0 m -55.91 -34.9 66.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.626 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -58.37 -39.11 78.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.129 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -41.08 40.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.94 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.8 mt-30 -58.53 -29.19 66.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.677 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.11 -37.6 18.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.211 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -70.18 -30.64 67.81 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.663 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.55 -36.79 6.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.07 -2.91 29.98 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.915 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 69.0 mt -56.29 122.9 52.21 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.784 0.292 . . . . 0.0 111.026 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 70.5 Cg_endo -75.27 174.8 12.18 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.461 2.107 . . . . 0.0 112.249 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.433 ' HD2' HG13 ' A' ' 137' ' ' VAL . 30.3 tttp -101.22 42.59 1.11 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.028 0.442 . . . . 0.0 110.729 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -132.7 97.76 16.98 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' A' ' 133' ' ' GLN . 27.6 Cg_endo -61.66 -26.94 80.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -79.64 -37.83 35.15 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -95.21 41.7 1.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.23 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.44 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.3 m0 -111.01 172.31 6.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.675 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -131.82 -179.14 5.21 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.99 -43.49 60.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.3 m -63.59 -49.24 74.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.389 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -62.2 -41.16 98.1 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.186 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.454 HG12 HD22 ' A' ' 105' ' ' LEU . 67.1 t -64.06 -52.97 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.489 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.39 -46.16 77.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.594 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.23 -37.04 85.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.776 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.6 t90 -64.9 -65.64 0.65 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 85' ' ' VAL . 7.5 p -42.14 -46.54 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.215 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 43.8 ttm -60.21 -45.93 91.49 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.393 . . . . 0.0 110.432 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.523 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 11.7 t90 -60.65 -37.53 81.83 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.558 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -17.06 62.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.527 ' CG2' HG11 ' A' ' 93' ' ' VAL . 75.4 t -84.28 -32.37 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.164 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -81.55 -35.37 30.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.72 -40.73 55.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.63 7.67 43.84 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t 43.34 59.5 2.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 110.883 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.478 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 62.3 mt -89.35 171.63 9.62 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.024 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.99 148.32 23.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.947 0.403 . . . . 0.0 111.547 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.04 -9.1 78.71 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.694 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.6 p -74.23 136.86 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 117.39 0.595 . . . . 0.0 110.837 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.77 132.81 50.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.524 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -86.36 -24.18 25.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.371 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.31 -36.57 84.53 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.624 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.8 mptp? -65.38 -36.18 83.2 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.855 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.4 m-85 -98.54 32.18 2.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.381 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 46.2 t -87.29 67.65 9.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 110.25 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.8 ptp -159.73 171.38 19.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.897 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.4 p -72.33 159.45 34.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.252 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.44 -42.9 94.06 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.636 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.54 -38.74 64.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 110.964 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.77 -47.55 58.99 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.454 HD22 HG12 ' A' ' 77' ' ' VAL . 22.3 tp -55.71 -47.21 77.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.389 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.51 -38.53 91.34 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.681 0.277 . . . . 0.0 110.634 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -32.31 73.97 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.409 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 58.4 mt -59.77 -34.72 73.36 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.88 173.42 45.43 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.471 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.9 ttpt -59.98 -45.92 91.15 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.34 0.126 . . . . 0.0 111.34 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -49.75 -65.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.19 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 93.0 m -58.07 -38.7 76.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.435 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.95 -43.43 98.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.748 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.34 -26.19 67.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 12.5 mm-40 -75.39 -22.62 57.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.77 0.319 . . . . 0.0 110.149 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -87.36 -39.61 15.17 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.46 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -111.54 150.92 42.88 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.619 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.3 Cg_exo -44.04 165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.606 2.871 . . . . 0.0 114.111 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.37 -20.14 62.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.938 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.53 -55.0 2.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.619 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.8 m -59.99 -33.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.73 -32.13 58.47 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.208 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.59 -52.52 30.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.66 0.23 . . . . 0.0 111.305 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.477 HD11 HD23 ' A' ' 90' ' ' LEU . 56.3 mt -56.18 -47.11 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.714 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.12 -60.48 3.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.753 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -62.33 -28.78 69.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.33 -54.75 17.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.062 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -66.71 -32.84 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.17 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.526 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.6 tp -63.73 -41.32 98.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.247 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.443 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 32.6 tt0 -70.26 -23.57 62.91 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.395 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 78.0 mt -77.21 -37.49 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.887 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.95 -47.9 83.44 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.542 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.483 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 6.7 pt20 -55.01 -37.76 67.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.542 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -76.62 -55.47 5.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.779 0.323 . . . . 0.0 111.043 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.37 100.35 12.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -118.66 126.97 53.1 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.329 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.433 HG13 ' HD2' ' A' ' 67' ' ' LYS . 10.8 p -103.66 -33.74 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.746 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.565 179.919 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.6 p80 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.488 0.185 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 63.83 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.543 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -111.35 -51.68 2.84 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.998 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 24.4 p -147.12 177.55 9.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.503 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.66 -43.74 72.64 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.752 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -131.26 111.15 11.64 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.59 125.69 68.62 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.67 135.55 12.99 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.754 2.303 . . . . 0.0 112.721 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.77 -49.83 8.71 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.79 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.4 mt -85.04 89.97 7.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.672 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.98 156.66 43.08 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.797 2.331 . . . . 0.0 112.326 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.9 p -75.32 85.85 2.49 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.032 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.406 ' HA ' ' HE3' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -60.7 -38.79 86.21 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.566 0.209 . . . . 0.0 111.566 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -73.76 -40.54 63.41 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.406 ' HE3' ' HA ' ' A' ' 41' ' ' SEP . 4.6 mpp? -73.25 -41.12 64.05 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.506 0.193 . . . . 0.0 111.204 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 ttt -61.07 -39.71 90.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.782 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.561 ' HB3' ' HG2' ' A' ' 134' ' ' LYS . 95.1 p -71.54 -33.25 68.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.702 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -48.45 -44.15 35.18 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.55 94.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.988 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.85 -39.16 80.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.601 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.451 ' HG2' ' CE ' ' A' ' 67' ' ' LYS . 26.5 tptp -68.81 -36.5 78.31 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.217 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.14 -38.38 39.0 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.2 p -58.6 -28.81 65.93 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.64 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -99.36 64.17 1.33 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.724 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 p -67.9 -26.65 66.1 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.415 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.49 -7.38 82.78 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.761 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.418 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 16.7 t80 -95.39 -45.77 6.98 Favored 'General case' 0 CA--C 1.526 0.043 0 CA-C-N 116.735 0.267 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.2 m -56.52 -39.17 72.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.954 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -62.03 -36.1 80.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.66 0.267 . . . . 0.0 110.479 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 9.8 tp10 -74.84 -41.13 60.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.4 mt-30 -58.04 -26.69 62.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.331 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -83.31 -31.4 26.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.186 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 89.9 mtt180 -71.76 -43.21 66.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.188 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.5 mt -94.73 -25.79 16.55 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.198 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.56 1.82 61.95 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.595 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 79' ' ' ASP . 67.4 mt -49.81 126.48 18.76 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 122.525 0.33 . . . . 0.0 111.418 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.36 170.09 4.51 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.095 2.53 . . . . 0.0 112.956 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.582 ' HE2' ' HG2' ' A' ' 135' ' ' GLU . 74.2 tttt -100.99 38.91 1.46 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 136' ' ' ASP . 38.4 t70 -163.96 122.37 1.24 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.571 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 35.3 Cg_exo -60.25 -44.66 27.11 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.601 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 13.5 mtt180 -53.71 -34.24 58.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.611 0.244 . . . . 0.0 110.957 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.85 42.29 1.1 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.483 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 12.9 m0 -120.74 175.94 5.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.636 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 p -137.36 -176.06 4.27 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.029 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -51.77 -37.76 52.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.572 0.225 . . . . 0.0 111.188 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.4 m -67.62 -56.0 11.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.546 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -59.76 -42.72 93.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.607 0.241 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -58.35 -47.69 87.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.412 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 5.4 tmm_? -73.24 -42.4 62.6 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.037 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.4 ' HB3' HD13 ' A' ' 65' ' ' ILE . 1.3 m-20 -58.51 -36.82 74.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.509 0.195 . . . . 0.0 110.617 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.588 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -71.84 -62.24 1.49 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.449 ' O ' HG21 ' A' ' 85' ' ' VAL . 58.1 t -41.53 -51.86 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 56.9 tpp -54.06 -49.06 69.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.7 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -57.27 -38.4 73.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.108 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 88' ' ' PHE . . . -76.18 -18.69 58.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.513 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.508 ' CG2' HG11 ' A' ' 93' ' ' VAL . 78.8 t -85.88 -30.48 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.7 -39.66 15.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.096 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.71 -34.95 62.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.528 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 51.3 m-85 -100.79 4.21 42.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.448 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 46.71 55.97 7.11 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 122.611 0.364 . . . . 0.0 111.506 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.477 HD13 ' HB ' ' A' ' 121' ' ' VAL . 71.8 mt -86.34 167.32 14.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.588 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.64 154.88 38.29 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 111.724 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -8.24 66.58 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.69 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.508 HG11 ' CG2' ' A' ' 85' ' ' VAL . 14.1 p -74.84 130.54 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 117.403 0.601 . . . . 0.0 111.029 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.87 130.68 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.339 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.0 -20.85 29.89 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.43 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -65.49 -33.5 76.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 34.9 mmtp -66.48 -35.76 81.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.697 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 117' ' ' ALA . 28.8 m-85 -100.08 29.75 4.11 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.325 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.5 t -82.4 67.93 8.63 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.2 ptp -160.75 172.2 17.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.697 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.7 p -73.28 158.65 34.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.173 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -60.81 -37.62 93.94 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.804 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.41 72.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.684 0.278 . . . . 0.0 110.694 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.2 63.5 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.387 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.32 -43.76 75.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.113 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 71.2 m -67.31 -42.42 83.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.815 0.341 . . . . 0.0 110.575 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.09 67.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.669 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 64.8 mt -68.53 -31.95 71.55 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.71 174.98 49.0 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.326 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.0 ttpt -63.59 -42.52 98.25 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.571 0.185 . . . . 0.0 111.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.82 -63.37 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.511 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.8 m -59.06 -40.68 85.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.357 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.98 -43.35 99.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.451 HD12 ' HA3' ' A' ' 122' ' ' GLY . 12.0 tp -66.48 -27.15 67.57 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.632 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -75.05 -22.48 58.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.695 0.284 . . . . 0.0 110.653 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.1 mt -84.98 -32.22 23.1 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.451 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 98' ' ' PHE . . . -113.04 154.2 45.11 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.619 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.2 Cg_exo -44.32 164.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.502 2.802 . . . . 0.0 113.901 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.1 -19.45 62.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.031 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.409 ' CE2' HG13 ' A' ' 121' ' ' VAL . 13.4 p90 -108.75 -51.72 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.619 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.8 m -62.93 -34.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.451 ' HA3' HD12 ' A' ' 114' ' ' LEU . . . -52.41 -39.74 52.79 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.95 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.54 -47.6 75.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.611 0.244 . . . . 0.0 110.967 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.78 -55.1 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.372 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.85 -57.2 13.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.505 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 5.9 t90 -60.78 -28.27 68.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.04 -57.72 11.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -71.99 -35.24 69.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.459 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.588 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.8 tp -56.78 -49.87 74.0 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.788 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.36 -36.71 84.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 70.2 mt -61.47 -45.71 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.177 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.452 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.8 mt -55.48 -36.84 67.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.052 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.544 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 68.4 mt-30 -62.9 -42.77 99.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.561 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 71.2 tttt -63.53 -34.72 78.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.716 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.582 ' HG2' ' HE2' ' A' ' 67' ' ' LYS . 0.6 OUTLIER -50.23 -48.83 54.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.724 0.297 . . . . 0.0 111.292 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 68' ' ' ASP . 8.9 m-20 -132.53 83.67 2.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.496 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.67 97.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.122 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.725 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.9 m80 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.733 0.301 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 51.0 tpp 64.19 -80.16 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.177 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.73 -39.14 13.34 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.835 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -69.32 147.9 50.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.703 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.55 66.38 8.12 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -144.17 172.18 13.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.976 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.17 120.7 82.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.613 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.97 106.01 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.757 2.305 . . . . 0.0 112.531 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 tp -155.52 -56.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.697 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.4 tp -96.27 84.97 3.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.768 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.5 -179.81 5.19 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.681 2.254 . . . . 0.0 112.512 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.5 t -54.61 -41.38 69.9 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.905 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.55 ' HA ' ' HE3' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -66.65 -39.84 88.42 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.656 0.265 . . . . 0.0 110.907 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -69.19 -40.39 78.09 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.684 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.55 ' HE3' ' HA ' ' A' ' 41' ' ' SEP . 25.5 ptt? -74.65 -28.92 61.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.464 0.173 . . . . 0.0 111.199 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.63 -39.88 81.78 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.49 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.457 ' HA ' HD11 ' A' ' 49' ' ' LEU . 80.6 p -85.62 -27.86 25.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -51.63 -51.99 51.31 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.727 0.299 . . . . 0.0 111.205 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.28 80.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.768 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 46' ' ' SER . 74.8 mt -59.34 -38.61 80.8 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.563 0.22 . . . . 0.0 111.498 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -68.99 -36.86 78.33 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.16 -31.2 21.94 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.482 HG22 ' CD2' ' A' ' 53' ' ' PHE . 11.8 t -67.63 -29.38 68.68 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' CD2' HG22 ' A' ' 52' ' ' THR . 66.8 m-85 -102.76 55.4 0.77 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.968 0.413 . . . . 0.0 110.808 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -75.66 -24.43 56.35 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.199 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.82 -19.44 77.67 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.304 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.45 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 13.1 t80 -81.03 -49.23 11.17 Favored 'General case' 0 C--N 1.338 0.072 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.7 m -55.54 -34.0 64.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.051 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -63.97 -31.78 73.09 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.831 0.348 . . . . 0.0 110.485 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.18 -41.75 21.89 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.132 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 47.6 mt-30 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.791 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -83.04 -13.61 55.49 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 48.8 mtp180 -85.1 -37.38 20.34 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.66 0.267 . . . . 0.0 111.143 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 mp -105.19 -27.42 11.57 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.69 5.26 42.16 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.129 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 86.9 mt -57.14 125.23 69.85 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.891 0.346 . . . . 0.0 111.027 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 64.4 Cg_endo -74.65 170.45 20.29 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.375 2.05 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -75.84 -36.93 59.45 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.617 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.19 125.22 90.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.59 0.233 . . . . 0.0 111.075 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 63.5 Cg_endo -74.51 -32.98 5.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.015 2.477 . . . . 0.0 113.183 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -29.06 70.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.593 0.235 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -96.56 40.48 1.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.885 0.374 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.614 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 11.0 m0 -112.12 169.56 8.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -128.62 -178.4 4.57 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.76 -39.31 62.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.444 0.164 . . . . 0.0 111.373 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.5 m -66.81 -49.34 66.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.597 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.429 ' CD2' HG12 ' A' ' 65' ' ' ILE . 47.3 m170 -61.45 -42.66 99.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.654 0.264 . . . . 0.0 110.965 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.71 -52.64 59.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.8 ttm105 -66.92 -46.71 73.98 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.708 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.69 -40.72 88.82 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.838 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 14.3 t90 -63.43 -62.69 1.51 Allowed 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 85' ' ' VAL . 73.5 t -41.17 -49.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 55.2 tpp -55.68 -50.73 69.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.832 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -55.19 -39.9 70.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.85 -48.47 53.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.874 0.369 . . . . 0.0 110.27 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.523 ' CG2' HG13 ' A' ' 93' ' ' VAL . 79.4 t -52.85 -30.46 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.38 -46.92 12.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.356 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -66.39 -32.19 73.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.56 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.34 2.5 28.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.4 m 45.02 59.69 3.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.078 0.466 . . . . 0.0 110.63 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.52 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 71.3 mt -86.96 153.08 21.85 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.464 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 155.52 49.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.712 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.83 -7.35 59.28 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.721 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.523 HG13 ' CG2' ' A' ' 85' ' ' VAL . 13.0 p -74.62 132.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 117.315 0.557 . . . . 0.0 111.044 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -105.01 132.26 51.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.375 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.07 -25.52 24.13 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -62.0 -34.05 75.47 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.5 mmtt -66.54 -34.94 79.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.713 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 30.3 m-85 -97.97 32.94 2.24 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.43 65.13 9.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 110.209 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.7 ptp -158.9 169.81 23.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -75.43 161.59 29.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.332 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.614 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.47 -38.37 90.75 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.825 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.01 70.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.773 0.321 . . . . 0.0 110.634 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.48 -44.98 56.72 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.1 tp -56.06 -46.88 78.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.195 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 95.1 m -66.71 -38.75 87.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.813 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.57 69.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.436 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.3 mt -65.72 -32.96 74.81 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 175.39 48.75 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.459 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -62.71 -42.12 99.49 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.36 -63.28 1.2 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.353 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.8 m -60.85 -38.01 84.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.394 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -63.27 -45.26 92.33 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.488 0.185 . . . . 0.0 110.828 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.04 -25.86 68.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.704 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.2 -21.81 58.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.613 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 72.7 mt -87.21 -35.22 18.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.599 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -115.84 151.25 46.17 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.601 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.8 Cg_exo -43.05 163.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.61 2.873 . . . . 0.0 114.065 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.56 -21.3 62.4 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.193 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.81 -52.8 2.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.179 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.601 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 3.8 m -61.26 -37.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.434 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.2 74.74 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.658 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.64 -50.0 72.94 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.468 0.175 . . . . 0.0 110.884 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 90' ' ' LEU . 64.2 mt -56.8 -55.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.431 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.28 -56.36 17.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.274 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 21.4 t90 -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.234 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.66 -54.59 43.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -73.0 -36.05 66.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.312 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.527 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 37.1 tp -59.08 -43.42 91.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.596 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -68.24 -32.84 73.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.192 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 49' ' ' LEU . 52.9 mt -65.04 -37.71 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.8 mt -61.55 -53.6 54.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.11 -38.52 83.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.855 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -72.83 -27.66 62.08 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.645 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -99.15 23.84 8.62 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.671 0.272 . . . . 0.0 111.445 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -154.22 154.84 34.17 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.727 0.298 . . . . 0.0 110.957 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.81 167.47 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.172 -179.89 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.415 ' O ' ' HD2' ' A' ' 35' ' ' PRO . 55.2 m80 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.495 0.188 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.4 mmt 57.58 90.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.235 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -101.71 76.54 1.66 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.957 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.6 m -138.3 -62.21 0.58 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.55 -56.09 1.9 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.708 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.65 144.07 51.03 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.569 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 56.7 t -106.44 90.65 5.05 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.51 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 28' ' ' HIS . 11.8 Cg_endo -55.03 115.78 2.67 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.952 2.435 . . . . 0.0 112.581 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.1 tp -146.77 -54.35 0.24 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.8 tt -143.99 80.78 1.66 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.57 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.91 141.32 94.26 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.884 2.39 . . . . 0.0 112.353 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.3 m -81.93 96.04 7.55 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.116 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.96 -40.13 95.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.866 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -70.96 -38.77 72.8 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.637 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.408 ' HE3' ' HB3' ' A' ' 44' ' ' MET . 35.5 ttp -67.15 -38.2 85.1 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.692 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.7 tpt -62.4 -43.54 98.57 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.123 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.0 p -78.04 -26.34 48.33 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.188 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -48.21 -52.06 22.59 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.438 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.23 89.65 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.1 -44.77 94.6 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.199 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 68.4 mttm -65.01 -34.11 77.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.187 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.9 -38.29 70.01 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.735 0.302 . . . . 0.0 110.876 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.5 m -79.31 -43.93 22.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.899 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 22.9 m-30 -47.74 -45.06 28.56 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.5 p -60.36 -37.8 81.84 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.45 0.166 . . . . 0.0 111.382 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.49 -8.6 85.95 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.669 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.448 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 15.3 t80 -98.89 -47.33 5.31 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.598 0.199 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -55.51 -32.81 63.2 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.33 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -60.36 -32.34 71.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.405 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 43.1 tt0 -82.6 -40.08 21.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 11.8 mm100 -58.63 -30.99 67.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.284 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -84.93 -38.45 19.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.238 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.19 -40.22 86.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.678 0.275 . . . . 0.0 111.264 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 mt -96.42 -31.17 12.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.187 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -2.41 55.98 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.685 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.6 mt -53.62 129.26 54.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 122.291 0.236 . . . . 0.0 111.178 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.0 166.69 26.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 58.7 mttp -97.06 52.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 110.437 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.23 98.82 5.04 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.145 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.565 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 32.0 Cg_exo -58.38 -38.83 88.63 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.857 2.371 . . . . 0.0 112.32 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 12.1 mtt180 -66.44 -35.63 80.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -98.15 43.55 1.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -115.02 174.75 5.82 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.267 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.7 t -133.51 -179.31 5.44 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -50.36 -44.41 54.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -63.39 -49.09 75.17 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.422 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -62.31 -41.9 98.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.234 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.37 -49.91 82.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HA ' ' CG1' ' A' ' 81' ' ' VAL . 70.9 ttt180 -71.43 -41.86 68.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.518 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.27 -35.57 79.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.485 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -69.36 -65.49 0.7 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.468 ' O ' HG22 ' A' ' 85' ' ' VAL . 7.7 p -42.39 -46.88 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.174 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 43.8 ttm -60.82 -47.78 84.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.407 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 17.6 t90 -55.94 -37.95 69.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.87 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.98 60.42 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.596 ' CG2' HG13 ' A' ' 93' ' ' VAL . 88.8 t -49.59 -34.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.244 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -79.47 -42.22 25.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.255 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -68.27 -36.28 79.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.564 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -105.63 6.6 32.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.7 m 44.36 53.36 6.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.948 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 121' ' ' VAL . 68.1 mt -80.32 166.85 20.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.513 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.87 157.83 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.63 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.98 -5.74 69.76 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.677 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.596 HG13 ' CG2' ' A' ' 85' ' ' VAL . 13.6 p -81.92 142.71 13.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.238 0.519 . . . . 0.0 111.338 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.455 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.5 m-20 -116.58 141.96 47.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -90.34 -23.58 21.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.938 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -60.6 -36.25 78.1 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.592 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.9 mptt -67.09 -35.12 79.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.281 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -96.26 32.28 2.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.565 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.2 t -89.84 67.67 7.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.193 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.5 ptp -156.56 166.59 32.96 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -69.68 157.58 36.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.49 74.36 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.634 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.17 61.42 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.669 0.271 . . . . 0.0 111.182 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.58 -48.1 61.36 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.789 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.25 -46.29 83.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.162 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.9 m -64.04 -38.9 92.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.796 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.53 76.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.368 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -58.56 -36.05 73.32 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.51 176.76 49.41 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.473 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.502 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 57.5 tttp -59.67 -47.45 85.58 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 1.0 OUTLIER -50.75 -66.94 0.3 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.4 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.7 m -57.48 -37.58 73.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -62.41 -42.93 99.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.738 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -65.72 -24.49 66.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 10.5 mm-40 -74.55 -22.89 58.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.5 mt -84.11 -40.11 18.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.629 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -105.77 157.43 34.65 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.265 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 12.2 Cg_endo -56.71 174.26 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.685 2.257 . . . . 0.0 112.958 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -63.07 -14.39 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -107.93 -59.79 1.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.755 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.555 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 3.0 m -58.52 -31.25 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.04 -32.43 42.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.115 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.81 -46.35 53.62 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.68 0.24 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.0 mt -62.64 -58.64 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 111.658 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.5 mt -51.19 -58.77 5.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.793 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.502 ' CZ2' ' HD2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.42 -31.59 71.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.288 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.1 -57.09 14.58 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.54 -29.69 66.23 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.63 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.436 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.5 tp -57.83 -49.72 75.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.783 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 13.5 mm-40 -67.78 -34.87 77.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.767 0.318 . . . . 0.0 110.316 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.59 -37.55 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.9 -36.7 82.88 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.521 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.565 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 79.1 mt-30 -60.68 -55.68 30.37 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.316 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -55.48 -36.76 66.99 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.008 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.95 74.34 9.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.201 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -75.03 98.6 3.67 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.326 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 46.5 t -134.96 100.25 2.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.075 -179.73 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.598 0.237 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.6 mtm 61.68 75.72 0.4 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.365 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -68.31 118.96 12.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.7 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.93 67.96 2.29 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.984 0.421 . . . . 0.0 110.599 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.53 -54.85 0.1 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.398 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -124.71 -65.64 1.02 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 15.7 m -147.66 136.63 11.59 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.088 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 32.1 Cg_exo -58.96 140.15 94.05 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.803 2.335 . . . . 0.0 112.474 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt -138.0 104.34 5.22 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.856 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mp -100.22 133.74 44.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.755 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.553 ' HD2' ' HD3' ' A' ' 42' ' ' LYS . 32.8 Cg_endo -64.8 179.9 1.21 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.776 2.318 . . . . 0.0 112.173 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.4 m -50.4 -48.82 55.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.525 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.577 ' HA ' ' HE1' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.553 ' HD3' ' HD2' ' A' ' 39' ' ' PRO . 37.0 mtpt -69.03 -31.48 70.31 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.368 -0.133 . . . . 0.0 111.274 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.81 -28.53 69.53 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.39 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.577 ' HE1' ' HA ' ' A' ' 41' ' ' SEP . 63.8 mtm -66.38 -30.08 70.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.027 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -57.44 -45.2 84.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.916 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.4 m -66.25 -40.35 90.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.51 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -51.95 -52.93 46.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.66 70.49 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.549 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 131' ' ' ILE . 42.3 tp -56.29 -47.54 78.43 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.867 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -63.51 -40.06 96.07 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.994 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.07 -30.21 64.9 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 m -59.32 -29.03 67.33 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -97.18 37.63 1.31 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.7 t -71.11 -23.5 62.11 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.214 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.434 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . -77.28 -0.96 73.23 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.127 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 16.9 t80 -99.16 -47.06 5.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.721 0.26 . . . . 0.0 110.657 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.2 m -57.1 -37.28 71.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.434 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 19.9 pttp -63.21 -36.1 82.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.346 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.49 61.19 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -59.4 -28.09 66.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.408 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -82.87 -40.88 19.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -65.86 -41.85 91.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -89.16 -31.12 18.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.924 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.89 -5.87 51.04 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.617 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 76' ' ' HIS . 85.2 mt -51.43 124.13 23.71 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.61 0.243 . . . . 0.0 110.889 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.62 171.74 16.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.675 2.25 . . . . 0.0 112.714 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -100.3 45.57 0.98 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -140.05 102.76 6.83 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.406 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.474 ' HG2' ' CG ' ' A' ' 133' ' ' GLN . 32.1 Cg_exo -59.06 -31.33 95.42 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.865 2.377 . . . . 0.0 112.555 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.98 -36.03 59.38 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -95.73 38.45 1.17 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.743 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.42 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.0 OUTLIER -108.43 170.78 7.81 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.322 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.5 p -133.24 -179.01 5.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.464 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -52.18 -40.45 61.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -64.25 -50.63 67.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.324 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.434 ' CD2' HG12 ' A' ' 65' ' ' ILE . 25.4 m170 -63.42 -41.3 98.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.81 -54.83 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 111.002 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -63.31 -49.52 73.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.385 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.77 -41.03 76.91 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.42 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.3 t90 -63.88 -61.88 2.0 Allowed 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.477 HG13 HD21 ' A' ' 125' ' ' LEU . 53.5 t -41.08 -55.36 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.775 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.417 ' HE2' ' HB2' ' A' ' 82' ' ' MET . 30.0 ttm -57.68 -45.65 85.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.711 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.515 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 14.4 t90 -56.59 -35.84 68.68 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.933 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.2 -19.72 61.03 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.209 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 81' ' ' VAL . 58.2 t -81.37 -33.47 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.041 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -84.76 -40.26 17.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.61 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.515 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 12.2 mm-40 -72.15 -38.7 69.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -102.62 9.22 39.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t 44.71 52.87 7.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.818 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.582 HD13 HG13 ' A' ' 121' ' ' VAL . 69.4 mt -86.85 176.23 7.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.314 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.82 152.97 16.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.004 0.431 . . . . 0.0 111.745 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.49 -14.21 65.37 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.9 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.404 HG12 ' CG2' ' A' ' 85' ' ' VAL . 13.0 p -75.54 130.55 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.39 0.595 . . . . 0.0 110.879 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.522 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 9.4 m-20 -98.71 134.68 41.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -86.37 -26.99 24.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.473 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 15.8 mm100 -60.52 -37.58 81.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.973 0.415 . . . . 0.0 109.91 177.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 99.5 mttt -66.88 -29.57 69.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.51 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.442 ' HZ ' ' HB1' ' A' ' 117' ' ' ALA . 50.9 m-85 -101.84 33.07 3.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 59.3 m -86.24 65.24 8.98 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.113 0.482 . . . . 0.0 110.32 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.423 ' SD ' HD12 ' A' ' 108' ' ' LEU . 14.7 ptp -153.48 165.46 35.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -74.73 164.68 26.3 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.341 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.42 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.13 -42.67 95.3 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.717 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.03 -38.33 62.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.97 55.62 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.71 -47.55 73.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.152 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.7 m -65.85 -38.8 89.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.99 -21.25 66.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.8 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 43.4 mt -71.31 -34.91 71.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.18 179.77 46.87 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.45 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -60.92 -47.81 84.7 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -50.56 -65.15 0.61 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 94.9 m -60.53 -42.27 96.15 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -61.61 -46.35 90.21 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.281 -0.168 . . . . 0.0 111.119 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.3 mt -62.44 -31.35 72.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.598 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.98 -25.65 64.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.748 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.422 HD23 ' HB3' ' A' ' 97' ' ' LYS . 65.2 mt -87.47 -31.23 20.1 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.214 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.495 ' CB ' ' HA2' ' A' ' 122' ' ' GLY . . . -99.13 166.42 13.04 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.82 0.343 . . . . 0.0 111.6 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 21.0 Cg_exo -66.59 173.5 7.75 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.095 2.53 . . . . 0.0 113.225 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.42 -28.21 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.088 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.2 -53.06 2.68 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.475 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.582 HG13 HD13 ' A' ' 90' ' ' LEU . 81.8 t -57.18 -39.55 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.495 ' HA2' ' CB ' ' A' ' 117' ' ' ALA . . . -50.99 -43.48 49.43 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.15 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -63.04 -46.09 89.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.0 mt -57.94 -50.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.631 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.477 HD21 HG13 ' A' ' 81' ' ' VAL . 10.5 mp -63.95 -57.81 8.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.258 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.402 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -61.06 -31.73 71.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.632 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -62.75 -52.45 63.18 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.01 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.551 ' HA ' HD12 ' A' ' 131' ' ' ILE . 18.6 t-160 -71.98 -30.66 65.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.42 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 40.4 tp -62.39 -46.2 89.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.605 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 64.6 mm-40 -67.07 -33.62 75.89 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.9 mt -59.89 -42.89 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.38 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.23 -38.4 89.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.544 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.474 ' CG ' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 -65.89 -49.35 68.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.158 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -66.63 -47.46 72.53 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.05 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.85 -39.77 82.28 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -126.92 77.46 1.73 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.367 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.2 m -72.69 80.3 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.246 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 mttp . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.404 -0.808 . . . . 0.0 110.724 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 48.9 t60 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.304 0.097 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.7 mmt 62.71 84.91 0.14 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.933 0.396 . . . . 0.0 110.652 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -74.84 -41.0 60.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.209 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.8 m -67.56 -41.36 84.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.036 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.0 -45.41 74.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.082 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -137.31 131.26 31.97 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.909 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.08 91.91 17.0 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.06 -174.94 2.4 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.577 2.185 . . . . 0.0 112.454 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.4 tp -52.3 -47.09 66.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.92 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 pp -98.52 168.81 9.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.065 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.44 168.23 18.41 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.97 2.447 . . . . 0.0 112.806 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.6 m -96.31 98.55 10.37 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.747 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.472 ' HA ' ' CE ' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -69.55 -39.98 77.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.678 0.275 . . . . 0.0 110.967 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -69.86 -40.91 75.49 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.155 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.472 ' CE ' ' HA ' ' A' ' 41' ' ' SEP . 70.9 mtm -66.87 -40.76 87.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.434 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 84.1 mmm -60.06 -41.85 93.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.676 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -81.79 -29.22 32.81 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.226 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -53.56 -52.04 61.01 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.156 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.5 81.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.479 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.5 mt -58.77 -43.87 90.5 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.404 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -77.07 -42.3 38.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.597 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.47 -44.69 90.26 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 m -71.46 -50.13 34.7 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -55.25 -39.34 69.64 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 74.3 m -58.12 -44.57 87.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 121.304 -0.158 . . . . 0.0 111.079 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.22 -20.74 74.82 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.36 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.436 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 11.7 t80 -77.62 -49.76 13.91 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.0 m -55.31 -32.54 62.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.399 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 54' ' ' SER . 34.7 mmtp -59.42 -33.65 71.51 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.809 0.338 . . . . 0.0 110.57 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -83.21 -41.61 18.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 43.6 mt-30 -57.66 -29.45 64.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.736 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -83.25 -32.21 26.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -71.25 -40.16 71.19 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.77 -26.81 13.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.75 11.69 39.85 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.916 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 75.5 mt -56.94 121.22 44.24 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.62 0.248 . . . . 0.0 111.4 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.8 Cg_exo -68.07 170.32 14.68 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.747 2.298 . . . . 0.0 112.241 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -94.05 -4.09 50.07 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.606 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 6.5 t70 -98.5 108.24 46.77 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.715 0.293 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.52 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 33.2 Cg_endo -63.59 -26.96 69.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.001 2.467 . . . . 0.0 112.973 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -76.53 -35.22 58.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -94.7 40.48 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.078 0.466 . . . . 0.0 110.558 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.508 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.2 m0 -108.51 170.35 8.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.375 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.9 p -130.96 179.69 5.84 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -39.49 58.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.0 m -64.24 -53.3 51.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -61.56 -39.38 90.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.18 -52.13 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.136 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -66.01 -48.17 72.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.911 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.81 -32.13 72.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.7 t90 -72.58 -65.86 0.73 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.2 p -40.99 -47.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.506 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.5 ttm -59.3 -48.43 81.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.819 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 87.2 t90 -61.55 -40.22 93.91 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.3 62.76 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.264 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.507 ' CG2' HG12 ' A' ' 93' ' ' VAL . 40.2 t -82.49 -31.4 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.9 -38.43 37.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 11.6 mm-40 -70.27 -36.68 74.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.21 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -104.28 5.67 34.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m 44.64 55.59 5.75 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 110.779 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.474 HD11 ' HB ' ' A' ' 121' ' ' VAL . 83.0 mt -78.2 127.34 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.088 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -108.47 142.34 39.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.464 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 -5.72 84.42 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.756 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.507 HG12 ' CG2' ' A' ' 85' ' ' VAL . 12.5 p -76.34 137.57 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.298 0.549 . . . . 0.0 110.926 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -112.93 138.82 49.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.437 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -89.46 -26.02 21.17 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.598 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -60.61 -34.15 73.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.006 0.431 . . . . 0.0 109.916 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.8 mmmm -68.02 -34.33 76.3 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.847 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 116' ' ' LEU . 40.2 m-85 -99.34 35.45 1.94 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.443 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.91 69.08 10.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.21 169.15 24.75 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.778 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -76.9 165.18 25.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.27 -43.19 95.66 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.103 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.23 66.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.989 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.21 53.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.841 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.7 tp -56.73 -46.59 81.24 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.345 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 80.5 m -66.52 -40.66 89.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.71 0.291 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.57 76.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.215 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.2 mt -58.82 -32.51 69.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.997 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.23 177.18 45.57 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.662 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.498 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -60.66 -45.51 93.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.367 0.136 . . . . 0.0 111.367 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 35.2 tt0 -50.88 -66.73 0.34 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.0 m -57.98 -40.16 79.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.767 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.98 -45.42 93.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.554 0.216 . . . . 0.0 111.018 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.46 -26.19 68.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.745 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 18.5 mm-40 -73.92 -24.03 59.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 110.771 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.1 mt -82.39 -35.47 27.67 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.508 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.69 160.23 28.71 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 120.716 0.293 . . . . 0.0 111.62 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.68 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 50.4 Cg_exo -52.91 171.89 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.116 2.544 . . . . 0.0 113.651 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.73 -22.77 66.05 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.774 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.76 -58.75 1.93 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.68 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.9 m -62.39 -32.83 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.0 -38.51 38.77 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.599 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.49 -46.35 88.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.653 0.264 . . . . 0.0 111.007 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.47 HG13 HD21 ' A' ' 90' ' ' LEU . 50.5 mm -51.29 -51.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.132 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -63.65 -57.09 11.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.418 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.498 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -61.32 -26.95 68.14 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.08 -57.27 12.2 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.451 ' HA ' HD12 ' A' ' 131' ' ' ILE . 20.8 t-160 -73.28 -35.15 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.688 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.526 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 29.7 tp -57.8 -45.63 85.79 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -68.29 -38.93 82.15 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 128' ' ' HIS . 66.5 mt -55.15 -45.24 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.627 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.458 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.2 mt -53.25 -36.31 60.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.318 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.52 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 63.5 mt-30 -61.94 -48.17 81.63 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.926 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -66.14 -35.67 81.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.563 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 131' ' ' ILE . 20.2 mm-40 -52.27 -37.33 55.18 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.622 0.248 . . . . 0.0 111.33 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.09 76.86 1.53 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.038 0.447 . . . . 0.0 110.909 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.8 m -75.8 168.03 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.352 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.865 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 111.414 0.154 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 90.4 mtp 58.9 66.66 1.02 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.035 0.445 . . . . 0.0 110.711 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.44 -45.36 13.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.957 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.9 p -112.52 124.8 53.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.624 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.07 -57.44 2.22 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.575 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -103.89 -56.91 2.12 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.268 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.43 124.43 28.55 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.203 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.32 154.68 56.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.622 2.214 . . . . 0.0 112.039 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.416 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 28.4 tp -144.76 141.73 29.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.23 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.506 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 6.5 mp -95.54 159.84 14.8 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.852 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . 0.441 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 37' ' ' LEU . 43.8 Cg_endo -67.88 177.82 3.93 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.554 2.17 . . . . 0.0 112.446 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.2 p -50.84 -64.48 0.8 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.41 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.417 ' HA ' ' CE ' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 38' ' ' TPO . 21.2 tptm -65.4 -25.73 67.68 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -38.08 74.66 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.429 0.104 . . . . 0.0 111.131 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.417 ' CE ' ' HA ' ' A' ' 41' ' ' SEP . 2.9 mpp? -56.66 -41.49 77.33 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.673 0.273 . . . . 0.0 110.552 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.7 mtp -67.76 -42.67 81.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.406 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.4 m -60.77 -34.4 74.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.696 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -49.41 -52.71 26.86 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.071 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.75 -49.86 76.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.572 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -59.44 -44.85 92.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.525 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.17 -39.65 75.75 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.897 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.63 -30.31 29.5 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.3 m -70.06 -33.57 72.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.439 0.162 . . . . 0.0 111.267 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -93.06 41.01 1.07 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.861 0.363 . . . . 0.0 111.389 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.3 p -76.09 -16.53 59.9 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.237 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 58' ' ' LYS . . . -78.23 -14.11 82.58 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.803 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.505 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 9.5 t80 -88.77 -51.08 5.84 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 116.745 0.273 . . . . 0.0 110.628 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.0 m -56.11 -42.24 76.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.112 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.448 ' HE2' ' HA2' ' A' ' 55' ' ' GLY . 56.4 pttt -60.01 -33.85 72.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.734 0.302 . . . . 0.0 110.419 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -77.27 -42.89 35.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.66 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.3 mt-30 -60.66 -27.34 67.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.832 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -80.45 -14.34 58.37 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 78.6 mtt180 -85.01 -34.41 22.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.109 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.79 -24.56 12.89 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.72 9.94 48.25 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.073 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.44 HG12 ' CD2' ' A' ' 76' ' ' HIS . 25.9 mt -56.53 126.01 68.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.742 0.271 . . . . 0.0 111.281 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 63.6 Cg_endo -73.89 175.51 10.71 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.617 2.211 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -98.99 39.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.517 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -148.02 110.48 3.78 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.543 0.211 . . . . 0.0 111.439 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.618 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 34.4 Cg_exo -57.32 -37.96 96.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.181 2.587 . . . . 0.0 112.597 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.668 0.27 . . . . 0.0 110.494 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -96.47 38.7 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.489 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -114.82 169.32 9.16 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.681 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.4 t -132.25 -177.77 4.61 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -49.31 -42.0 40.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.2 m -67.01 -50.08 63.25 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CD2' HG12 ' A' ' 65' ' ' ILE . 37.1 m170 -61.66 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.631 0.253 . . . . 0.0 111.176 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.427 HG11 HD21 ' A' ' 105' ' ' LEU . 54.6 t -59.7 -51.73 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -71.03 -43.37 68.04 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.785 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.03 -39.45 74.82 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.58 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.4 t90 -68.35 -60.57 2.35 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.2 t -41.61 -55.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.647 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 ttm -55.8 -46.15 78.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.69 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.505 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 14.5 t90 -57.2 -37.13 71.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -18.68 62.22 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.273 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.55 ' CG2' HG11 ' A' ' 93' ' ' VAL . 24.4 t -81.9 -35.91 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.853 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -90.9 -30.36 16.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.051 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.67 -38.81 53.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -108.2 11.15 27.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.746 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 45.72 57.11 5.28 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.905 0.383 . . . . 0.0 111.624 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.412 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 70.8 mt -89.16 172.74 8.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.37 153.89 31.16 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 111.643 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.12 -6.23 80.13 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.577 ' HB ' HG23 ' A' ' 121' ' ' VAL . 13.2 p -78.07 133.7 29.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 117.348 0.574 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -104.66 135.98 45.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.74 -28.33 21.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.528 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.15 -34.58 75.25 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.0 mmtt -66.72 -34.98 79.05 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.026 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.62 34.21 2.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.386 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.8 t -86.94 66.51 9.46 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.119 0.485 . . . . 0.0 110.077 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.6 ptp -159.0 170.76 21.37 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.871 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.9 m -74.24 157.11 36.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -60.27 -36.36 90.62 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.925 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.2 -39.46 72.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 110.645 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.28 -43.16 61.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.425 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.427 HD21 HG11 ' A' ' 77' ' ' VAL . 14.4 tp -56.48 -44.89 81.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.074 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.6 -40.22 88.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.723 0.297 . . . . 0.0 110.676 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.08 -24.28 66.68 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.749 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 39.9 mt -68.49 -35.09 77.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.79 172.11 48.56 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.329 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.472 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.8 ttpt -61.47 -48.75 79.7 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.47 -51.81 51.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.8 m -66.69 -39.65 88.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.558 0.218 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -63.0 -43.72 98.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.796 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.27 -25.95 66.31 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.68 -23.53 59.84 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.639 0.257 . . . . 0.0 110.617 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 78.1 mt -85.84 -35.04 20.88 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.302 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.469 ' HB3' ' CG2' ' A' ' 121' ' ' VAL . . . -104.89 161.5 22.59 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 18.9 Cg_endo -59.42 176.12 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.748 2.298 . . . . 0.0 112.888 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.35 -12.91 59.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -108.67 -56.44 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.773 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.589 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 2.6 m -62.98 -31.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.72 -43.96 38.47 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.782 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.29 -49.36 43.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.647 0.26 . . . . 0.0 110.846 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.86 -55.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.459 HD23 HG11 ' A' ' 81' ' ' VAL . 10.3 mp -56.81 -53.08 61.96 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.753 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.472 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 17.4 t90 -61.43 -28.18 69.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -63.95 -54.84 28.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.147 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.443 ' HA ' HD13 ' A' ' 131' ' ' ILE . 22.7 t-160 -72.37 -34.33 67.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.613 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.532 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.7 tp -61.93 -45.29 94.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.604 ' HG2' ' HE2' ' A' ' 134' ' ' LYS . 31.9 tt0 -67.58 -27.73 67.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.48 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 128' ' ' HIS . 62.2 mt -68.28 -37.57 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.44 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.67 -48.52 74.43 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.68 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.618 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 8.4 pt20 -57.13 -38.18 73.09 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.604 ' HE2' ' HG2' ' A' ' 130' ' ' GLU . 64.5 mttm -68.67 -38.46 80.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.914 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.64 130.28 36.64 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.86 90.58 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.881 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.9 m -122.02 147.15 26.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.16 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.698 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.0 m80 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 51.7 ttm -157.79 -59.7 0.08 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.749 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -139.29 96.57 3.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.57 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.5 m 59.18 44.26 16.0 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.145 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.25 100.96 5.19 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -128.36 140.81 51.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.033 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.2 m -93.36 135.15 25.79 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 23.4 Cg_exo -64.67 146.4 88.65 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.943 2.429 . . . . 0.0 112.497 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.91 100.86 1.01 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.4 mt -127.57 156.95 41.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.397 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . 0.43 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.84 -178.97 3.81 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.811 2.341 . . . . 0.0 112.388 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -49.97 -47.79 52.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.948 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.409 ' HA ' ' CE ' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 38' ' ' TPO . 59.4 tptt -69.94 -40.02 75.75 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.784 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.86 -39.23 93.71 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.948 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.409 ' CE ' ' HA ' ' A' ' 41' ' ' SEP . 66.3 mtm -74.27 -26.71 60.37 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.142 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.4 ttt -56.71 -38.09 71.82 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.339 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 136' ' ' ASP . 24.8 t -69.37 -36.76 77.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.905 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -47.46 -52.23 17.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.565 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.34 -45.93 71.56 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.64 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.86 -45.76 82.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.776 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -74.6 -30.52 61.71 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.629 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.94 73.34 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.4 p -56.63 -33.41 66.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.378 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -96.74 68.13 2.39 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 110.73 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -72.68 -26.42 61.61 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.442 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.8 -17.14 80.22 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.698 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.3 t80 -96.43 -49.67 5.07 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.646 0.223 . . . . 0.0 110.9 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -54.52 -33.23 59.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.248 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 110.115 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.03 -38.89 35.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.952 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 25.0 mt-30 -58.98 -31.72 69.01 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.608 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -85.75 -37.06 19.74 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -71.98 -31.98 66.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 mt -105.54 -32.14 8.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.0 0.49 41.75 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.157 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 48.9 mt -55.83 122.66 47.92 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.762 0.281 . . . . 0.0 110.917 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 74.4 Cg_endo -76.35 171.77 17.47 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.455 2.103 . . . . 0.0 112.648 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HE3' ' HG2' ' A' ' 135' ' ' GLU . 30.9 mtpp -98.75 45.91 1.0 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.927 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -146.17 103.31 4.09 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.068 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.58 ' HG2' ' CG ' ' A' ' 133' ' ' GLN . 51.0 Cg_exo -57.08 -46.88 25.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.921 2.414 . . . . 0.0 112.238 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.469 ' HG2' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -57.71 -33.09 68.05 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.555 0.217 . . . . 0.0 110.805 178.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HG3' ' HG2' ' A' ' 70' ' ' ARG . 46.0 mt-30 -99.98 42.04 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.186 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.594 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.9 m0 -115.33 170.21 8.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.363 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -130.66 -179.46 5.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.23 -43.04 52.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.5 m -62.52 -50.39 71.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.301 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.159 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.49 -52.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.467 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.34 -48.74 69.29 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.482 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.25 -36.22 77.26 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.008 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.543 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 33.5 t90 -69.56 -65.17 0.75 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 85' ' ' VAL . 11.6 p -41.7 -47.53 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.227 0.329 . . . . 0.0 111.378 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 60.4 tpp -59.84 -47.64 84.89 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.101 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.501 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.3 t90 -61.22 -38.17 85.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.988 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.45 61.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.43 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.53 ' CG2' HG11 ' A' ' 93' ' ' VAL . 54.1 t -83.17 -32.84 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.161 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -81.16 -33.84 32.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.501 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.2 mm-40 -73.59 -39.9 64.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.989 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -102.19 7.49 40.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m 44.67 55.22 6.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 110.976 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.546 HD13 ' HB ' ' A' ' 121' ' ' VAL . 53.4 mt -83.12 168.75 16.57 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.36 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -150.99 153.77 35.81 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.733 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.1 -7.61 63.02 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.008 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.3 p -73.81 131.97 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 117.547 0.673 . . . . 0.0 111.167 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.66 131.1 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -86.29 -23.09 26.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.754 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -61.95 -35.7 79.24 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 6.1 mptp? -65.56 -34.27 77.86 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.32 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 36.6 m-85 -101.1 29.95 4.39 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.693 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.3 t -84.86 66.55 9.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.1 0.476 . . . . 0.0 110.241 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.1 ptp -158.43 171.66 19.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.657 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 m -75.92 158.26 32.23 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.594 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.57 -37.95 90.11 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.872 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.42 -39.51 67.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 110.64 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.433 ' O ' ' HG ' ' A' ' 108' ' ' LEU . . . -73.49 -46.76 46.05 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -52.89 -47.5 67.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.323 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.71 -38.52 86.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.785 0.326 . . . . 0.0 110.492 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -18.46 64.16 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.932 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 112' ' ' CYS . 41.9 mt -74.36 -28.49 61.14 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.18 169.8 42.44 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.673 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.58 -44.92 95.67 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.95 -60.79 2.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.734 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 49.8 t -59.61 -44.21 93.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.395 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -59.78 -43.34 94.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.973 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.48 -30.15 70.89 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.723 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.04 -21.85 60.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.733 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 89.0 mt -83.65 -32.21 25.77 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.586 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -112.02 154.62 44.16 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.724 0.297 . . . . 0.0 111.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.657 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.0 Cg_exo -45.77 167.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.398 2.732 . . . . 0.0 113.796 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.21 -21.88 66.74 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.087 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -108.63 -51.51 2.88 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.657 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 9.9 m -61.69 -35.76 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.39 -35.1 49.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.238 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.11 -49.91 72.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.706 0.253 . . . . 0.0 111.202 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 90' ' ' LEU . 74.1 mt -60.16 -53.33 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.565 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -52.62 -58.1 7.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.278 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 1.4 t90 -64.74 -25.45 67.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.427 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.51 -56.69 17.29 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.408 ' HA ' HD11 ' A' ' 131' ' ' ILE . 21.9 t-160 -73.17 -36.63 66.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.523 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.543 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.9 tp -57.23 -45.16 84.14 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.22 -36.42 79.48 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' A' ' 128' ' ' HIS . 64.8 mt -58.31 -41.51 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.698 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 86.7 mt -57.22 -37.37 72.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.683 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.58 ' CG ' ' HG2' ' A' ' 69' ' ' PRO . 45.4 mt-30 -68.31 -46.84 69.19 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.164 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -90.04 31.54 0.97 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.732 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.451 ' HG2' ' HE3' ' A' ' 67' ' ' LYS . 19.0 tp10 -63.54 -56.97 11.83 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.519 0.199 . . . . 0.0 111.002 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 3.7 t70 -176.84 111.54 0.09 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.8 m -131.53 150.88 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.387 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.6 tttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.161 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.4 p80 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.721 0.296 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.403 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 53.9 ttm -93.04 -63.02 1.27 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.091 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HG3' ' HG2' ' A' ' 29' ' ' MET . 41.6 mt-10 -121.7 -57.43 1.81 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.234 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.2 t -105.94 128.57 53.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.006 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.97 -49.85 6.01 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.152 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.17 139.69 39.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 26.9 m -85.83 133.69 40.98 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.152 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 24.5 Cg_exo -63.57 139.18 68.69 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.852 2.368 . . . . 0.0 112.33 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.0 mt -139.41 142.73 37.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.186 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.8 tp -91.34 125.22 36.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.592 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.97 166.97 26.07 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.785 2.323 . . . . 0.0 112.237 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.8 p -66.72 129.39 39.7 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.164 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.563 ' HA ' ' HE3' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -80.26 -21.16 43.02 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.629 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 31.9 mt-10 -75.31 -32.72 61.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.434 0.159 . . . . 0.0 110.952 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.563 ' HE3' ' HA ' ' A' ' 41' ' ' SEP . 73.1 mtm -64.62 -26.77 68.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.54 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 69.5 mtm -56.22 -32.1 64.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 49' ' ' LEU . 66.5 m -52.24 -37.79 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.574 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -51.35 -52.31 46.67 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.463 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.57 -28.84 41.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.444 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.488 HD13 ' CG2' ' A' ' 131' ' ' ILE . 62.4 mt -61.67 -32.44 72.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.565 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -64.54 -27.44 68.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.613 0.244 . . . . 0.0 111.094 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.33 -30.65 16.45 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.474 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.1 p -71.14 -32.04 68.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.396 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -88.9 74.41 8.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.019 0.438 . . . . 0.0 110.775 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -72.77 -24.17 60.91 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.116 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.69 -16.61 72.67 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.735 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.433 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.1 t80 -96.42 -53.73 3.5 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.697 0.249 . . . . 0.0 110.864 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.6 m -54.7 -33.66 61.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.402 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 14.7 ptmm? -62.15 -31.27 71.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.856 0.36 . . . . 0.0 110.569 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -83.3 -39.3 20.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.087 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 28.4 mt-30 -58.29 -28.32 64.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.455 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 29.1 pt20 -84.78 -37.03 21.3 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.564 0.221 . . . . 0.0 110.962 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -65.06 -42.95 93.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.7 mt -99.14 -29.33 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.29 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.66 6.66 54.51 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.56 119.21 14.8 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 122.31 0.244 . . . . 0.0 111.283 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.14 166.93 13.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.739 2.293 . . . . 0.0 112.386 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -98.92 41.07 1.16 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.725 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -156.28 125.15 3.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 132' ' ' LEU . 38.2 Cg_endo -67.59 -37.73 16.04 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.089 2.526 . . . . 0.0 113.02 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.433 ' HD3' ' HG2' ' A' ' 69' ' ' PRO . 1.5 mpp_? -61.91 -33.06 73.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.519 0.199 . . . . 0.0 110.763 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.37 41.92 1.13 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.932 0.396 . . . . 0.0 110.843 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.551 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 4.9 m0 -119.8 170.05 9.58 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.509 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -133.59 -178.86 5.19 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -49.87 -43.31 49.11 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -63.1 -49.64 73.65 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.335 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -61.67 -41.6 97.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.422 HG11 HD23 ' A' ' 105' ' ' LEU . 64.8 t -62.35 -56.14 19.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.19 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.438 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 7.0 tmm_? -64.08 -46.97 81.94 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.347 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.1 -43.21 99.24 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.724 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.5 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 22.0 t90 -61.13 -62.93 1.49 Allowed 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 85' ' ' VAL . 55.8 t -40.91 -49.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.791 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.404 ' HE1' ' HB2' ' A' ' 82' ' ' MET . 29.9 ttm -58.17 -45.02 88.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.788 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.576 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 17.3 t90 -59.26 -37.82 78.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.68 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.52 -20.28 61.37 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.173 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 81' ' ' VAL . 69.7 t -81.35 -32.07 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.188 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.7 -35.48 24.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.134 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.576 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.1 mm-40 -73.04 -40.13 65.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.84 10.78 36.33 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p 41.83 51.72 4.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.978 0.418 . . . . 0.0 111.183 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.11 171.25 15.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -155.08 160.35 40.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.199 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.06 -7.88 58.85 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.783 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.521 ' HB ' HG23 ' A' ' 121' ' ' VAL . 11.4 p -79.9 131.61 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.497 0.648 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -103.53 139.47 38.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.3 -25.33 21.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -61.59 -30.65 70.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 29.9 mmmt -68.41 -34.59 76.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.872 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -101.52 32.4 3.35 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.189 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.1 t -84.07 67.51 9.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 110.232 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.6 ptp -157.42 168.56 26.98 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.804 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -73.3 161.02 30.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.336 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.37 -44.79 89.78 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.866 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.8 63.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.656 0.265 . . . . 0.0 110.836 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.55 61.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.422 HD23 HG11 ' A' ' 77' ' ' VAL . 16.2 tp -55.95 -47.51 77.45 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.182 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.41 -38.77 85.15 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.799 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.66 67.64 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.794 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.6 mt -67.67 -30.53 70.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.86 173.48 40.82 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.628 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -59.18 -46.81 87.44 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.087 0.155 . . . . 0.0 111.263 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.49 -64.74 0.71 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.894 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.7 m -61.02 -40.78 94.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -60.19 -46.83 88.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.459 0.171 . . . . 0.0 111.23 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.83 -28.51 69.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.28 -20.69 60.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.89 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 69.2 mt -87.24 -35.49 18.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.791 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.579 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -111.93 159.52 33.24 Favored Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 10.2 Cg_endo -56.3 172.59 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.673 2.249 . . . . 0.0 113.213 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.04 -19.03 60.89 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -108.66 -50.63 2.99 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.579 ' CG2' ' HB1' ' A' ' 117' ' ' ALA . 3.0 m -63.02 -34.2 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.532 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.36 -39.43 65.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.801 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -68.53 -48.18 65.0 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.628 0.251 . . . . 0.0 110.93 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.33 -55.52 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.408 ' HB3' ' CH2' ' A' ' 80' ' ' TRP . 92.7 mt -57.73 -59.93 4.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.188 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.496 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.47 -28.58 69.39 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.36 -52.54 26.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.298 0.499 . . . . 0.0 110.088 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -67.61 -34.42 76.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.5 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.7 tp -64.28 -39.39 93.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.972 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.437 ' HA ' ' HG2' ' A' ' 133' ' ' GLN . 34.9 tt0 -67.21 -29.12 68.7 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.182 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.488 ' CG2' HD13 ' A' ' 49' ' ' LEU . 51.6 mt -67.86 -35.65 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.571 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.574 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 99.1 mt -68.63 -40.87 80.11 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.563 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.497 ' HB3' ' CG ' ' A' ' 69' ' ' PRO . 9.4 pt20 -68.5 -47.44 67.0 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.44 ' HB2' ' HG2' ' A' ' 43' ' ' GLU . 19.8 ptpt -58.58 -21.7 53.79 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.75 -42.09 67.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.622 0.249 . . . . 0.0 111.317 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -133.23 -171.41 2.68 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.082 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.33 -55.82 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.292 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.947 -179.658 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.6 p80 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mpp? 67.69 -80.6 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.756 0.422 . . . . 0.0 111.184 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -115.57 -57.6 2.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.642 0.258 . . . . 0.0 110.55 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 77.0 m -94.39 132.71 38.73 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.509 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.73 145.31 24.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.532 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.88 111.75 2.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.9 t -70.39 113.47 18.43 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.212 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -91.42 135.67 1.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.054 2.503 . . . . 0.0 112.565 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.492 HD23 ' HD3' ' A' ' 134' ' ' LYS . 21.8 tp -158.49 -67.78 0.09 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.924 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.9 tp -161.88 81.72 0.57 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.716 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 71.2 Cg_endo -73.59 -178.64 3.86 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.915 2.41 . . . . 0.0 112.699 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.9 t -98.12 -75.48 0.55 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.768 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.422 ' HB2' ' CB ' ' A' ' 39' ' ' PRO . 59.4 mtpt -76.36 -17.86 59.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.746 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 4.9 tp10 -57.44 -22.85 46.04 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -30.55 62.57 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -72.91 -39.91 65.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.951 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.4 t -69.8 -26.63 64.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.281 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -45.25 -52.3 9.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.786 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.68 -45.22 85.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.429 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.07 -40.46 94.71 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.96 -40.47 97.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.066 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.39 -36.14 66.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.69 0.281 . . . . 0.0 111.268 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.6 m -62.83 -34.1 76.62 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.341 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -83.67 11.92 6.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.6 m -66.69 -19.85 65.85 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.372 0.129 . . . . 0.0 111.006 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.418 ' CA ' ' HE3' ' A' ' 58' ' ' LYS . . . -76.08 -0.71 66.2 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.814 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.9 t80 -95.21 -45.42 7.19 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m -57.61 -37.27 72.96 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HE3' ' CA ' ' A' ' 55' ' ' GLY . 20.6 pttp -63.35 -32.79 74.3 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.747 0.308 . . . . 0.0 110.625 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -82.84 -38.98 22.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 56.6 mt-30 -57.7 -27.43 62.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.82 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 30.1 pt20 -85.11 -34.64 22.15 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 110.959 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -73.05 -33.67 65.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.3 mt -101.53 -30.84 11.17 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.701 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.18 -1.99 56.38 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.701 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 79' ' ' ASP . 54.7 mt -55.55 122.05 42.43 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.73 0.265 . . . . 0.0 111.203 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.4 Cg_exo -68.13 177.83 4.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.834 2.356 . . . . 0.0 112.252 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -108.47 31.57 5.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.73 98.85 27.27 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.273 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 32.9 Cg_exo -61.35 -27.03 82.42 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.919 2.413 . . . . 0.0 112.907 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -38.38 39.66 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -96.57 39.32 1.17 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.667 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -107.18 175.61 5.44 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.351 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.66 -179.56 5.72 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.55 -43.79 56.28 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -62.43 -53.39 55.55 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -58.49 -40.71 83.52 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.24 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.7 -51.52 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.659 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -64.12 -53.86 42.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.352 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.529 ' HB3' HD11 ' A' ' 65' ' ' ILE . 1.2 m-20 -55.99 -35.21 66.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.375 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.515 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.9 t90 -70.34 -63.24 1.12 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.495 ' O ' HG21 ' A' ' 85' ' ' VAL . 79.3 t -40.51 -54.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.409 ' HG2' ' CE1' ' A' ' 95' ' ' PHE . 63.5 mtt -55.53 -47.41 76.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 7.0 t90 -55.8 -37.83 69.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -18.56 61.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.523 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.552 ' CG2' HG13 ' A' ' 93' ' ' VAL . 47.5 t -79.26 -35.12 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.575 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.54 -31.71 24.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.386 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.551 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.78 -40.66 54.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 111.102 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -103.09 6.22 38.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t 45.67 55.58 6.65 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.452 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.495 HD11 ' HB ' ' A' ' 121' ' ' VAL . 64.4 mt -81.92 174.28 11.43 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.457 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.07 146.92 23.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.457 -179.412 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.07 81.3 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.739 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.552 HG13 ' CG2' ' A' ' 85' ' ' VAL . 14.7 p -71.98 128.19 34.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 117.472 0.636 . . . . 0.0 110.917 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.461 ' CB ' ' HD3' ' A' ' 97' ' ' LYS . 11.1 m-20 -98.8 128.68 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.409 ' CE1' ' HG2' ' A' ' 82' ' ' MET . 39.4 m-85 -86.31 -25.97 25.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.463 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.465 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 30.1 mm-40 -63.9 -34.33 77.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.1 mptt -67.05 -33.5 75.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.189 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -98.28 33.14 2.27 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 37.2 m -88.49 67.19 8.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.041 0.448 . . . . 0.0 110.346 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.431 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.8 ptp -157.08 168.41 27.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.855 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -73.29 158.69 34.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.98 -43.93 87.91 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.743 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.23 62.79 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.98 62.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -55.95 -46.75 78.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.264 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.21 -40.85 94.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.716 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -26.17 67.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.654 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 38.6 mt -65.27 -37.61 87.74 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.09 172.95 49.47 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.331 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.416 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 39.0 ttpt -60.76 -47.2 87.38 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.38 -51.69 61.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.8 m -67.19 -39.51 86.38 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.442 0.163 . . . . 0.0 111.23 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -63.42 -43.1 98.44 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.687 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.93 -24.15 66.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.823 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.87 -23.62 48.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.454 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 95.9 mt -83.62 -36.68 23.69 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.35 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.514 ' HB3' ' CG2' ' A' ' 121' ' ' VAL . . . -108.29 157.79 35.46 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.582 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 12.0 Cg_endo -56.7 176.82 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.787 2.325 . . . . 0.0 112.978 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.51 -15.63 61.18 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.29 -57.47 2.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.706 -0.798 . . . . 0.0 112.949 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.582 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 2.5 m -59.17 -33.69 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.75 -34.51 50.85 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.776 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.07 -50.05 21.35 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.419 0.152 . . . . 0.0 110.987 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -57.12 -57.65 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.1 mt -51.68 -58.97 4.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.905 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -61.33 -31.03 70.89 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.559 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.19 -55.5 27.96 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.056 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -70.89 -32.41 69.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.515 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.1 tp -59.11 -49.59 77.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.48 ' HG3' HD21 ' A' ' 36' ' ' LEU . 12.6 tp10 -65.65 -33.91 76.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.485 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.509 ' HA ' ' HE2' ' A' ' 134' ' ' LYS . 67.5 mt -61.69 -39.03 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.4 -35.69 81.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.777 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.524 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 66.7 mt-30 -64.82 -54.38 32.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.418 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' A' ' 131' ' ' ILE . 55.6 pttt -57.94 -38.19 75.51 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.435 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.14 -52.91 56.8 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.459 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -82.76 113.06 20.16 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.91 0.386 . . . . 0.0 111.066 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.8 m -120.68 39.92 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.119 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 138' ' ' LYS . 2.7 mptp? . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.177 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' A' ' 29' ' ' MET . 66.8 t60 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.338 0.113 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 28' ' ' HIS . 28.1 ttt 73.34 -68.8 0.21 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.487 0.492 . . . . 0.0 111.095 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.46 165.17 31.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.5 t -84.65 63.23 7.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.113 0.483 . . . . 0.0 110.45 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.47 -49.26 0.02 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.848 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -139.89 140.11 36.38 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.021 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.418 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 34.5 m -78.83 156.15 77.56 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.956 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 34' ' ' VAL . 23.8 Cg_endo -61.56 103.94 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.566 2.177 . . . . 0.0 112.092 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.4 tp 177.81 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.603 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.87 178.2 8.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.81 147.92 22.03 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.533 2.155 . . . . 0.0 112.225 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.9 m -103.52 68.77 0.96 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 111.285 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -62.01 -40.07 94.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.863 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -73.26 -37.43 66.31 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.08 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.442 ' HE2' ' HB3' ' A' ' 44' ' ' MET . 31.2 ttp -67.48 -44.24 79.04 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.112 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 92.3 mtp -61.02 -43.89 98.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.373 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.3 p -75.89 -26.92 57.46 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -47.86 -49.41 29.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.339 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.34 -44.62 95.37 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.486 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.6 mp -61.58 -44.0 97.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.971 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -62.75 -41.48 99.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.41 80.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.416 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.8 m -67.12 -44.19 80.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.421 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -45.95 -61.33 1.79 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.9 t -60.38 -39.72 88.29 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.05 -9.85 76.91 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.222 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.573 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 8.5 t80 -101.52 -38.11 8.11 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.823 0.312 . . . . 0.0 110.986 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 m -65.25 -24.56 67.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.194 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -74.66 -36.21 62.82 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.003 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.573 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -83.6 -31.68 26.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.667 179.247 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.9 mt-30 -61.32 -29.16 69.71 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.5 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -85.68 -39.5 17.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.521 0.2 . . . . 0.0 111.132 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -71.49 -33.23 69.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.443 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 mt -99.3 -34.7 10.21 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.638 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.67 -5.0 53.97 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.569 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 85.4 mt -50.74 122.92 17.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.522 0.329 . . . . 0.0 111.483 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 22.9 Cg_exo -64.79 172.23 7.33 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.093 2.528 . . . . 0.0 112.719 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.46 ' HD3' ' HG2' ' A' ' 135' ' ' GLU . 40.0 ttmt -93.08 -12.17 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.424 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 14.5 t70 -104.12 122.77 43.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.542 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 41.8 Cg_endo -67.51 -24.99 41.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.05 2.5 . . . . 0.0 113.405 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 5.9 mpt_? -70.27 -32.27 70.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.145 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 27.3 pt20 -93.78 24.7 3.98 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.654 0.264 . . . . 0.0 111.213 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.421 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -97.69 169.96 9.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.211 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.6 p -136.9 -174.55 3.76 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.55 -36.73 62.16 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.473 0.178 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.2 m -68.17 -52.85 29.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.349 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -60.79 -39.72 89.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.678 0.275 . . . . 0.0 111.12 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.95 -52.47 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -67.5 -47.75 69.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.376 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.41 -34.65 75.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.678 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -66.87 -65.16 0.72 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.3 p -42.87 -45.41 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.097 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -58.54 -48.13 81.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -59.18 -38.84 80.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.638 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -20.89 62.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.335 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.525 ' CG2' HG11 ' A' ' 93' ' ' VAL . 62.5 t -82.16 -32.39 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.469 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -82.03 -36.92 27.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.82 -38.45 67.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.262 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.61 6.31 39.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 44.97 56.4 5.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.092 0.472 . . . . 0.0 110.768 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.416 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 77.0 mt -85.19 172.78 10.91 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 153.59 29.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.323 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.26 77.32 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.828 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.573 ' HB ' HG21 ' A' ' 121' ' ' VAL . 11.1 p -77.97 132.58 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 117.416 0.608 . . . . 0.0 111.118 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -102.56 136.53 42.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.737 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.22 -23.45 22.36 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.446 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.75 -31.45 72.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 74.5 mmtt -68.11 -35.46 78.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.876 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -100.17 34.59 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.26 68.9 7.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.7 ptp -157.78 170.9 21.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.239 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 t -72.12 160.5 32.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.278 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.06 -48.5 79.04 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.62 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.76 -37.48 51.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.647 0.261 . . . . 0.0 111.181 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.46 -45.79 65.07 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.72 -44.67 81.84 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 81.3 m -66.48 -39.49 88.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.825 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.9 73.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.479 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -60.46 -37.92 82.54 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.807 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 175.92 50.69 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.662 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 26.2 ttpp -59.85 -53.86 52.95 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.84 -51.87 27.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.1 m -67.51 -41.77 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.415 ' HE1' ' HB2' ' A' ' 125' ' ' LEU . 50.4 t80 -62.53 -44.91 95.18 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.06 -28.95 70.13 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.941 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -73.08 -23.68 60.58 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.638 0.256 . . . . 0.0 110.807 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 76.9 mt -83.29 -34.73 25.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.52 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.496 ' HB3' ' CG2' ' A' ' 121' ' ' VAL . . . -104.99 158.12 32.73 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.471 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 12.5 Cg_endo -57.43 176.88 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.778 2.318 . . . . 0.0 112.927 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.75 -14.77 60.06 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.16 -59.01 1.95 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.913 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.576 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 3.0 m -58.76 -32.33 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.34 -33.48 46.55 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.1 -45.86 46.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.497 0.189 . . . . 0.0 111.27 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.3 mt -63.64 -60.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.539 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.415 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . 71.6 mt -49.74 -56.82 8.8 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.085 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.452 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -63.7 -34.28 77.52 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.16 -55.51 32.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.56 ' HA ' HD12 ' A' ' 131' ' ' ILE . 17.9 t-160 -71.14 -31.35 67.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 34.3 tp -57.93 -46.07 85.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.0 mm-40 -70.32 -32.4 70.12 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.377 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.8 mt -60.96 -39.42 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.473 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 93.7 mt -60.77 -33.62 73.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.477 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 76.3 mt-30 -65.98 -57.43 7.83 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.032 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.444 ' HD3' ' N ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -65.06 -32.69 74.53 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.681 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 42.8 tt0 -71.63 -38.0 70.8 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.397 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -151.77 112.53 4.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.793 0.33 . . . . 0.0 110.704 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.39 -27.61 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.772 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.042 -179.752 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.446 ' HA ' ' HB1' ' A' ' 32' ' ' ALA . 40.9 t60 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.46 0.172 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.5 mmt 64.59 -82.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.37 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -145.5 110.02 5.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.641 0.257 . . . . 0.0 111.098 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.3 m 58.14 88.97 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.697 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 28' ' ' HIS . . . -107.33 87.48 2.51 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.77 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -152.25 151.94 31.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.319 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.02 93.56 22.68 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.96 126.17 18.19 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.742 2.294 . . . . 0.0 112.13 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.1 mt -144.24 144.3 31.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.281 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 38' ' ' TPO . 6.4 tt -80.64 125.79 30.46 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.425 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . 0.4 ' N ' HD22 ' A' ' 37' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.08 162.44 32.78 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.786 2.324 . . . . 0.0 112.282 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.0 m -138.88 163.13 33.09 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.411 ' HA ' ' HE1' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' HD3' ' C ' ' A' ' 42' ' ' LYS . 1.1 tmtp? -70.15 -40.51 74.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.502 0.191 . . . . 0.0 110.87 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -60.3 -38.85 84.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.051 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.411 ' HE1' ' HA ' ' A' ' 41' ' ' SEP . 39.6 mtm -85.88 -26.42 25.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.546 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 46.5 ttm -55.91 -39.13 71.18 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.8 m -71.26 -38.49 71.88 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -52.88 -49.75 65.24 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.749 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.69 -38.09 62.47 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.681 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.01 -44.66 94.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.658 0.266 . . . . 0.0 111.079 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HE3' ' HD3' ' A' ' 67' ' ' LYS . 4.6 mptp? -73.3 -30.01 63.1 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.102 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.72 -32.91 64.12 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.93 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.0 p -78.73 -37.7 40.75 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.521 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -98.43 65.63 1.66 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.088 0.47 . . . . 0.0 109.999 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -68.17 -25.31 65.19 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.666 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.56 -18.2 77.98 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.602 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -97.79 -48.84 5.04 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.694 0.247 . . . . 0.0 111.085 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -59.42 -35.98 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.191 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.01 -31.96 73.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 39.8 tt0 -68.6 -37.62 79.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.061 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -59.77 -24.81 64.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -84.17 -18.19 37.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.764 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 51.7 mtt180 -87.99 -42.67 12.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.601 0.239 . . . . 0.0 111.379 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mp -106.6 -25.56 11.75 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.29 10.59 50.91 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -50.43 125.21 19.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.667 0.233 . . . . 0.0 111.484 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.69 170.11 6.15 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.876 2.384 . . . . 0.0 112.361 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HD3' ' HE3' ' A' ' 50' ' ' LYS . 57.6 mttp -98.69 39.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.563 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . 12.5 t70 -172.75 126.45 0.51 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 111.453 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.602 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 22.2 Cg_endo -60.4 -40.7 55.65 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.397 2.731 . . . . 0.0 113.01 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -52.85 -36.23 58.58 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.13 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.525 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 29.4 pt20 -99.06 36.73 1.65 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.931 0.396 . . . . 0.0 111.373 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.477 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 17.1 m0 -113.03 174.85 5.7 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.625 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -134.86 -175.42 3.9 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -52.42 -37.9 57.82 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.9 m -68.72 -52.76 27.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.641 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.64 -42.24 96.52 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.668 0.27 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.72 -52.95 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.226 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -69.98 -45.14 67.98 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.599 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.36 -37.45 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.484 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -68.82 -60.69 2.21 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 85' ' ' VAL . 46.9 t -41.26 -55.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.538 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.406 ' HE1' ' HB2' ' A' ' 82' ' ' MET . 36.4 ttm -54.5 -45.66 73.32 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -59.23 -35.62 73.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.998 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.18 -18.85 58.89 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.304 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 81' ' ' VAL . 96.3 t -83.18 -33.39 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.659 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.41 -35.06 17.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -41.15 63.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -100.61 7.68 43.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.817 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.7 m 45.52 56.74 5.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.977 0.418 . . . . 0.0 111.172 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB3' ' CG1' ' A' ' 121' ' ' VAL . 71.3 mt -85.14 173.11 10.69 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.321 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.31 152.27 32.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.673 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.95 -2.75 87.17 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.699 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.514 HG11 HG23 ' A' ' 85' ' ' VAL . 13.2 p -78.86 135.03 26.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 117.201 0.5 . . . . 0.0 111.318 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.472 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.8 m-20 -112.41 137.69 50.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.98 -24.54 23.51 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.929 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -61.21 -33.69 73.88 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.2 mptt -70.41 -34.01 72.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -98.26 33.33 2.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.5 66.16 8.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.123 0.487 . . . . 0.0 110.32 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.435 ' SD ' HD12 ' A' ' 108' ' ' LEU . 15.5 ptp -157.74 167.01 31.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.791 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 m -72.88 160.57 31.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.45 -42.34 95.76 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.871 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.93 68.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.76 68.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.529 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.08 -43.62 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.085 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.8 m -67.17 -41.74 85.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.842 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -27.98 69.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.556 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 26.3 mt -63.69 -36.19 83.05 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.746 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.7 178.21 50.0 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.725 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -59.96 -53.28 59.69 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -46.66 -52.2 14.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.3 m -70.27 -41.37 73.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 36.6 t80 -61.79 -45.53 93.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.41 0.148 . . . . 0.0 111.232 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.45 -25.73 67.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.884 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.58 -21.6 55.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.669 0.271 . . . . 0.0 110.48 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -86.51 -39.74 15.95 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.467 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -104.2 158.37 32.08 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.21 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 19.2 Cg_endo -58.16 175.11 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.864 2.376 . . . . 0.0 113.17 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.66 -15.94 54.55 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.28 -55.08 2.42 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.631 -0.827 . . . . 0.0 112.902 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.58 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 2.2 m -62.19 -33.64 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.83 -35.87 54.05 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.781 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.59 -43.86 53.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.74 0.305 . . . . 0.0 111.139 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.33 -56.48 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 111.568 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.46 HD23 HG21 ' A' ' 81' ' ' VAL . 11.0 mp -58.44 -58.9 6.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -30.94 70.81 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.49 -53.44 48.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.316 0.507 . . . . 0.0 109.921 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.468 ' HA ' HD13 ' A' ' 131' ' ' ILE . 19.9 t-80 -68.79 -31.56 70.67 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.241 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 29.3 tp -58.3 -45.9 87.14 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.288 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.58 -41.81 99.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.035 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 128' ' ' HIS . 95.8 mt -55.68 -43.3 72.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.284 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.3 mt -63.36 -41.68 98.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.602 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 71.3 mt-30 -56.14 -45.32 79.64 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.068 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -60.74 -40.37 92.14 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.455 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -102.66 82.89 2.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.417 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.563 ' HA ' ' HB2' ' A' ' 68' ' ' ASP . 12.3 t70 -75.84 -48.02 23.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.235 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.72 -179.37 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.538 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 mptt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.85 179.865 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.2 p80 . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.632 0.254 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt 54.33 67.46 1.01 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.962 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -95.28 139.71 31.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.186 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.1 t -148.0 -67.33 0.24 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.68 102.87 13.09 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.835 0.35 . . . . 0.0 111.109 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -137.43 80.95 1.84 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.528 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.47 126.87 27.05 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.159 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.94 170.99 18.77 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.908 2.406 . . . . 0.0 112.487 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.15 84.88 5.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.821 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.579 ' HG ' ' HD3' ' A' ' 39' ' ' PRO . 14.8 tp -167.99 139.44 2.9 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HG2' ' HD3' ' A' ' 42' ' ' LYS . 74.4 Cg_endo -74.39 -179.83 5.16 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.539 2.16 . . . . 0.0 112.072 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.2 t -55.92 -50.54 70.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.411 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . 0.578 ' HA ' ' HE1' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.583 ' HD3' ' HG2' ' A' ' 39' ' ' PRO . 12.8 mptt -73.4 -39.45 65.07 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.535 0.207 . . . . 0.0 111.25 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -61.53 -40.08 93.37 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.235 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.578 ' HE1' ' HA ' ' A' ' 41' ' ' SEP . 26.0 ptt? -81.5 -28.87 33.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.315 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.571 ' HA ' ' HE3' ' A' ' 45' ' ' MET . 4.2 tpt -59.89 -48.85 80.03 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.23 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.6 m -79.1 -26.79 42.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.051 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -49.05 -49.88 39.2 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.117 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.28 -44.13 84.44 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.666 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 128' ' ' HIS . 4.6 mm? -60.86 -42.09 97.18 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.619 0.247 . . . . 0.0 111.289 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -64.56 -29.26 70.28 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.145 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.58 -30.55 59.67 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.85 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.8 p -54.57 -28.54 46.64 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -43.58 -57.09 3.32 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 m -60.26 -39.95 88.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.432 0.158 . . . . 0.0 111.414 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . -76.58 -8.83 86.23 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.901 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.0 t80 -95.39 -46.72 6.59 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 116.621 0.211 . . . . 0.0 110.473 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -57.05 -35.87 69.82 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.232 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 20.4 pttp -63.32 -32.88 74.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.31 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -41.3 21.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.349 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.3 mt-30 -59.85 -27.08 66.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.719 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -85.85 -38.34 18.22 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.505 0.193 . . . . 0.0 111.106 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -70.25 -33.59 71.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.475 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.9 mt -100.17 -33.79 10.3 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.32 -1.68 50.34 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.705 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.503 HD13 ' HB3' ' A' ' 79' ' ' ASP . 56.3 mt -53.52 125.68 45.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 111.316 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 20.2 Cg_exo -65.23 173.81 5.75 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.828 2.352 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -93.02 -18.67 22.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.485 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.442 ' HB2' ' N ' ' A' ' 138' ' ' LYS . 38.7 t70 -94.1 121.44 63.96 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.73 0.3 . . . . 0.0 111.295 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 38.5 Cg_endo -66.93 -26.99 43.52 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.075 2.517 . . . . 0.0 113.151 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 3.7 mpt_? -72.88 -33.58 66.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.601 0.239 . . . . 0.0 110.399 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.23 40.98 1.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.462 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.7 m0 -113.38 171.47 7.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.661 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.2 p -134.12 -178.38 5.01 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -50.62 -38.99 48.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.489 0.185 . . . . 0.0 111.214 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.5 m -66.61 -55.82 13.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.345 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -58.45 -39.07 78.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.161 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.7 t -61.87 -49.52 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.554 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -74.62 -40.4 61.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.326 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.503 ' HB3' HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -60.14 -36.25 77.11 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.506 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.498 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 15.3 t90 -71.96 -60.99 1.95 Allowed 'General case' 0 C--N 1.339 0.124 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.8 t -40.77 -53.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 123.421 0.451 . . . . 0.0 110.842 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.4 ttm -56.03 -46.33 78.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.428 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 19.1 t90 -60.93 -39.7 90.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.776 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.67 64.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.993 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.476 ' CG2' HG11 ' A' ' 93' ' ' VAL . 77.6 t -80.22 -29.56 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.954 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -82.25 -34.41 28.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.428 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.49 -40.41 70.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -103.27 6.55 38.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.808 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.2 m 43.99 54.58 5.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.617 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.485 HD13 ' HB ' ' A' ' 121' ' ' VAL . 72.8 mt -81.23 174.12 11.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.472 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.4 OUTLIER -156.52 151.52 26.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.501 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 -8.01 78.55 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.901 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 121' ' ' VAL . 12.6 p -76.77 135.35 26.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.53 0.665 . . . . 0.0 110.911 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.79 138.34 41.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.05 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.75 -27.11 20.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.285 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.517 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 14.7 tt0 -60.48 -31.52 70.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.554 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 35.5 mmtp -65.32 -36.88 85.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.867 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 33.3 m-85 -99.82 34.28 2.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.643 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 9.6 m -87.3 69.16 9.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.194 0.521 . . . . 0.0 110.208 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.4 ptp -158.97 171.03 20.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.824 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.9 p -72.18 159.85 33.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.37 -43.5 93.81 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.54 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.39 63.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.48 -46.18 60.56 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.6 -46.18 84.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.146 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 72.6 m -64.18 -38.78 92.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 110.516 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.69 74.44 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 54.3 mt -61.54 -34.97 76.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 177.49 41.19 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.609 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.5 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.5 ttpt -62.89 -40.96 99.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.565 0.221 . . . . 0.0 110.986 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.35 -64.06 0.93 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.301 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.4 m -64.52 -37.54 87.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.06 -46.2 90.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.541 0.21 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.1 -30.29 71.36 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.673 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.4 -22.96 61.04 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.734 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 88.5 mt -85.01 -41.4 15.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.543 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -102.74 157.62 33.36 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.849 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.656 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 74.1 Cg_exo -47.14 166.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.309 2.672 . . . . 0.0 113.662 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.44 -15.01 63.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.719 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -108.25 -60.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.98 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.656 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 11.8 m -59.24 -34.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -52.85 -36.65 50.82 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.934 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.47 -49.22 67.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.447 0.165 . . . . 0.0 111.188 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.0 mt -58.92 -57.34 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.722 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -50.35 -53.94 25.24 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 4.7 t90 -66.18 -28.74 69.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.178 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.31 -51.8 68.29 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.565 ' HB2' HD11 ' A' ' 49' ' ' LEU . 20.6 t-160 -76.45 -37.26 57.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 41.5 tp -54.22 -48.58 70.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.85 -40.73 91.97 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.592 ' HA ' ' HE2' ' A' ' 134' ' ' LYS . 64.0 mt -54.72 -46.33 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.641 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.1 mt -51.63 -36.9 47.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.126 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.505 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 64.4 mt-30 -63.0 -56.48 16.69 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.393 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 131' ' ' ILE . 60.6 pttt -69.58 -30.59 68.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.449 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 131' ' ' ILE . 40.1 mm-40 -62.42 -69.39 0.26 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -143.79 160.61 40.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.084 0.469 . . . . 0.0 111.685 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.432 ' HA ' ' HB2' ' A' ' 68' ' ' ASP . 17.3 m -121.86 52.19 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.652 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.442 ' N ' ' HB2' ' A' ' 68' ' ' ASP . 90.6 mttt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.999 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.5 p80 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.54 ' HA ' ' HE1' ' A' ' 29' ' ' MET . 25.5 mmt 73.1 -73.1 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.773 0.429 . . . . 0.0 111.177 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -174.45 -49.66 0.01 OUTLIER 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.578 0.228 . . . . 0.0 111.041 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.2 t -93.11 -42.73 9.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.33 97.89 0.59 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.808 0.337 . . . . 0.0 111.215 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -143.73 121.9 12.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.69 103.8 48.09 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.44 ' HG2' ' HB ' ' A' ' 38' ' ' TPO . 82.0 Cg_endo -77.42 -177.37 3.79 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.791 2.327 . . . . 0.0 112.685 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.0 mt -61.07 -53.83 52.24 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.175 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.3 mt -108.62 103.1 12.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TPO . . . . . 0.44 ' HB ' ' HG2' ' A' ' 35' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.93 153.68 72.21 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.721 2.281 . . . . 0.0 112.417 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.3 t -71.21 107.83 4.41 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.933 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -60.57 -41.08 93.9 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.692 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -79.47 -38.88 33.5 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.608 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.2 ttm -54.91 -46.38 74.86 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.16 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.6 mtp -58.88 -33.78 70.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.722 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -85.56 -28.4 24.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 121.291 -0.163 . . . . 0.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -54.97 -52.24 63.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.725 0.297 . . . . 0.0 110.954 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.99 -34.76 50.67 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.563 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 131' ' ' ILE . 40.6 tp -61.45 -45.74 93.02 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.535 0.207 . . . . 0.0 111.113 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -70.29 -34.85 73.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.432 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.96 -35.31 80.75 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.729 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 m -67.48 -46.57 72.59 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -48.46 -44.17 35.34 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.311 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.445 ' O ' ' HD3' ' A' ' 58' ' ' LYS . 42.9 m -58.83 -44.43 90.91 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.814 -0.175 . . . . 0.0 111.129 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.57 -14.57 79.55 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.546 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -89.31 -48.3 7.45 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.3 m -55.04 -38.86 68.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 54' ' ' SER . 6.1 mptp? -57.99 -35.96 71.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.461 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -77.97 -41.38 36.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.847 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -58.58 -29.32 66.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.477 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.84 -19.27 52.43 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 81.6 mtt180 -77.46 -42.9 34.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 111.31 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.34 -24.73 14.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.2 11.03 53.67 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.495 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.5 mt -60.51 129.44 89.33 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.312 0.245 . . . . 0.0 111.249 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.8 Cg_endo -74.29 167.72 26.49 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.394 2.063 . . . . 0.0 112.112 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -93.52 55.61 2.25 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 111.194 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 25.1 t70 -168.14 124.84 0.86 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.558 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 22.8 Cg_exo -65.12 -44.06 10.24 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.523 2.815 . . . . 0.0 113.517 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.47 -37.19 37.2 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.252 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.479 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 10.5 pt20 -100.56 44.36 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.901 0.381 . . . . 0.0 111.377 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.558 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 7.0 m0 -119.88 169.51 10.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -132.53 179.67 5.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.99 -42.6 49.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.6 m -63.47 -49.44 73.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.527 0.203 . . . . 0.0 111.357 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.418 ' CD2' HG12 ' A' ' 65' ' ' ILE . 44.0 m170 -61.2 -41.26 96.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.009 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.75 -53.59 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -65.64 -47.96 73.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.513 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.15 -37.7 72.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 121.149 -0.22 . . . . 0.0 110.776 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 17.4 t90 -69.2 -62.02 1.55 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.438 ' O ' HG21 ' A' ' 85' ' ' VAL . 54.5 t -41.47 -53.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.403 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 28.4 ttm -55.22 -46.73 75.94 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.477 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 16.0 t90 -60.37 -38.1 82.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.91 61.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.571 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 81' ' ' VAL . 78.6 t -83.16 -33.71 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 120.67 0.271 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -82.1 -37.66 26.0 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.5 -39.04 71.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.097 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -100.48 4.81 43.94 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 m 45.38 53.8 7.9 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.563 HD13 HG12 ' A' ' 121' ' ' VAL . 63.3 mt -85.34 166.55 16.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.498 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.37 152.82 33.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.82 -10.97 71.94 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.605 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.467 ' HB ' HG11 ' A' ' 121' ' ' VAL . 14.7 p -79.74 135.86 24.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 117.361 0.581 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.71 138.97 41.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.293 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.18 -27.18 23.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.755 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -61.59 -29.69 70.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 49.6 mmtm -67.02 -33.14 74.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.292 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -100.13 32.25 3.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.709 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.35 65.63 8.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.218 0.532 . . . . 0.0 110.533 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.9 ptp -158.77 167.73 28.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.7 p -74.04 161.7 29.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.558 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -59.45 -40.28 95.96 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.38 76.87 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 110.743 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.95 64.77 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.553 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.98 -42.24 84.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.01 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.56 -42.12 92.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.539 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.65 72.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.0 mt -59.95 -33.57 72.1 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.39 177.72 48.77 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.36 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.72 -47.11 86.74 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 10.0 tp10 -50.1 -67.35 0.27 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.701 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.6 m -55.75 -40.99 73.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.704 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -62.54 -43.78 97.97 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.0 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.88 -30.84 71.85 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.679 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 14.4 mm-40 -70.33 -25.08 63.13 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.4 mt -86.92 -36.74 18.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HB1' ' CA ' ' A' ' 122' ' ' GLY . . . -97.14 167.44 11.97 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.827 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 18.1 Cg_exo -67.65 174.39 7.58 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.054 2.503 . . . . 0.0 113.178 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.78 -29.92 71.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.324 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.4 -49.91 3.11 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.885 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.563 HG12 HD13 ' A' ' 90' ' ' LEU . 98.9 t -59.44 -39.45 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.399 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.435 ' CA ' ' HB1' ' A' ' 117' ' ' ALA . . . -52.5 -38.77 51.89 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.909 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.31 -49.22 70.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 111.054 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mt -56.95 -47.87 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.713 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.7 -59.21 4.87 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.87 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -63.34 -27.16 69.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.18 -54.97 25.2 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.945 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -71.25 -35.55 71.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.177 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.0 tp -61.02 -46.54 90.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.72 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.21 -35.63 81.45 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.126 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.559 ' HA ' ' HE2' ' A' ' 134' ' ' LYS . 70.4 mt -62.67 -44.33 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.513 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.6 mt -57.22 -35.83 70.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.974 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.558 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 70.1 mt-30 -60.48 -53.44 57.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 131' ' ' ILE . 53.5 mtmt -51.99 -43.23 63.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.255 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.94 81.17 6.93 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.935 0.398 . . . . 0.0 110.402 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -81.06 84.98 6.37 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.593 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.68 128.04 41.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.986 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.835 179.843 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.465 ' HA2' ' HD2' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.672 0 CA-C-O 120.186 -0.23 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.485 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.8 t80 -87.18 -55.14 3.95 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 116.932 0.366 . . . . 0.0 110.402 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.7 m -53.71 -33.35 55.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.209 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.465 ' HD2' ' HA2' ' A' ' 55' ' ' GLY . 90.0 mttt -63.93 -31.8 73.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -86.17 -39.92 16.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 46.5 mt-30 -56.43 -31.67 64.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.302 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -82.98 -33.83 26.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.731 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -69.51 -37.65 77.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.398 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.27 -34.93 10.51 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.33 -0.69 31.08 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.636 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.0 mt -55.88 124.23 56.93 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 122.308 0.243 . . . . 0.0 111.078 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.1 Cg_endo -73.33 167.22 27.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.556 2.171 . . . . 0.0 112.467 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -76.48 -31.02 57.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.585 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.455 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 30.1 t70 -83.99 126.55 69.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.47 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 61.4 Cg_endo -72.62 -24.89 18.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.289 2.659 . . . . 0.0 113.869 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 6.2 mpt_? -69.29 -31.66 70.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.99 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 20.8 pt20 -93.97 36.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 111.084 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.639 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.6 m0 -103.77 166.19 10.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -134.15 179.19 6.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.01 -41.58 47.56 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -63.24 -54.14 42.06 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.274 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.482 ' CD2' HG12 ' A' ' 65' ' ' ILE . 38.0 m170 -58.54 -39.41 80.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 81' ' ' VAL . 54.4 t -62.16 -52.24 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.4 ttm105 -69.18 -47.31 65.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.27 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -35.01 69.14 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 26.5 t90 -72.33 -61.67 1.71 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.525 HG13 HD21 ' A' ' 125' ' ' LEU . 48.3 t -40.11 -52.48 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.383 0.427 . . . . 0.0 110.902 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.411 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 40.9 ttm -57.2 -47.79 80.39 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.574 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.423 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 18.8 t90 -59.96 -39.27 85.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.826 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.7 65.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 81' ' ' VAL . 77.9 t -76.3 -31.23 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.966 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.4 -31.98 32.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.071 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 11.0 mm-40 -70.15 -41.32 73.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.28 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -107.08 9.91 30.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.873 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.8 m 44.66 54.26 6.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 110.527 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 121' ' ' VAL . 62.9 mt -82.02 178.21 8.41 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.467 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.18 151.34 15.61 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.553 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.86 -8.69 77.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.716 ' HB ' HG21 ' A' ' 121' ' ' VAL . 12.7 p -83.44 138.7 18.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 117.543 0.672 . . . . 0.0 111.158 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -116.56 152.9 33.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -95.41 -9.85 31.59 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.409 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -63.72 -42.83 97.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 71.0 mmtt -65.99 -32.5 74.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.171 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 38.4 m-85 -99.5 33.45 2.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.583 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.7 t -87.69 64.7 8.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.115 0.483 . . . . 0.0 110.271 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.4 ptp -157.17 169.91 23.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.779 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.9 p -76.87 166.53 23.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.322 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.92 -43.65 96.61 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.803 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.42 63.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.689 0.28 . . . . 0.0 110.929 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.72 -46.41 53.77 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.06 -45.67 79.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.182 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.33 -41.39 85.33 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.674 0.273 . . . . 0.0 110.821 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.21 71.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.496 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.494 HD13 HD11 ' A' ' 116' ' ' LEU . 61.9 mt -60.72 -39.79 89.94 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.22 172.47 44.65 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.507 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.1 ttpt -59.06 -55.07 39.75 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.37 -49.9 63.46 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 98.8 m -63.58 -43.61 96.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.509 0.195 . . . . 0.0 111.004 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -62.97 -41.25 99.48 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.675 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.62 -27.43 68.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.721 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -76.31 -23.95 54.34 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.693 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 97.5 mt -79.94 -34.04 39.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -109.33 161.53 23.58 Favored Pre-proline 0 N--CA 1.462 0.137 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.243 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.651 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 68.1 Cg_exo -50.06 165.64 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.878 2.386 . . . . 0.0 113.139 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.84 -15.42 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.644 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -108.21 -61.1 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.992 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.716 HG21 ' HB ' ' A' ' 93' ' ' VAL . 12.1 m -60.43 -34.33 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.8 -36.14 40.58 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.129 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -65.56 -47.82 74.53 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.519 0.2 . . . . 0.0 111.313 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.26 -54.64 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.328 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.525 HD21 HG13 ' A' ' 81' ' ' VAL . 10.9 mp -53.33 -54.67 33.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.341 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.451 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 2.6 t90 -62.04 -29.92 70.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.11 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.07 -59.26 5.71 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.424 ' HA ' HD12 ' A' ' 131' ' ' ILE . 2.7 t60 -69.54 -36.18 76.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.818 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.514 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.2 tp -61.29 -43.04 99.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.83 -33.33 74.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 128' ' ' HIS . 59.4 mt -59.18 -42.19 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.029 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.42 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 95.8 mt -57.98 -38.36 75.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.596 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 . . . . . 0 C--O 1.232 0.155 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.919 179.614 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.529 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 17.7 t80 -94.69 -45.46 7.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 116.701 0.251 . . . . 0.0 110.338 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 95.0 m -58.3 -37.02 74.22 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.978 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 4.7 ptpp? -63.15 -30.64 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.298 . . . . 0.0 110.41 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.51 -40.12 23.68 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.045 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 57.1 mt-30 -56.14 -28.7 58.95 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.705 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 3.4 pt20 -88.44 -37.51 15.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.591 0.234 . . . . 0.0 110.992 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -67.25 -39.86 86.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.281 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.79 -29.57 12.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.6 -1.05 49.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -52.45 123.55 29.69 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 122.348 0.259 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 58.1 Cg_endo -71.73 168.94 22.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.494 2.129 . . . . 0.0 112.507 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -97.21 39.74 1.18 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.225 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 5.5 t70 -144.07 114.22 5.38 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 36.8 Cg_endo -65.7 -24.59 54.86 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.799 2.333 . . . . 0.0 112.775 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.512 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 3.4 mpt_? -77.71 -31.24 52.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 11.4 mm-40 -96.77 34.92 1.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.935 0.397 . . . . 0.0 110.487 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.512 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 4.1 m0 -107.91 170.35 8.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.69 -177.56 4.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.242 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HG2' ' CA ' ' A' ' 100' ' ' MET . 46.0 mt-10 -50.04 -42.81 50.33 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 m -64.34 -51.69 62.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.537 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -60.15 -42.01 93.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.25 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.425 HG13 HD22 ' A' ' 105' ' ' LEU . 56.0 t -60.26 -53.4 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -68.02 -46.71 70.47 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.696 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -56.49 -41.31 76.43 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.512 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.433 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.8 t90 -64.7 -61.98 1.86 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . 55.9 t -41.12 -53.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.793 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.4 ttm -58.22 -48.19 81.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.77 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 15.4 t90 -56.95 -38.43 72.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.836 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.14 83.47 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.515 ' CG2' HG11 ' A' ' 93' ' ' VAL . 81.6 t -53.1 -34.5 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.592 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -79.65 -36.19 38.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.157 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 9.3 mm-40 -68.2 -39.43 82.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.446 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.7 8.55 29.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 46.08 50.79 11.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 110.467 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 121' ' ' VAL . 67.6 mt -78.75 177.68 8.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.481 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.457 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.34 152.82 17.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.26 73.63 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.811 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.597 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.9 p -74.96 132.04 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 117.58 0.69 . . . . 0.0 110.873 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 7.9 m-20 -99.12 133.93 42.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.1 -23.78 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.411 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.574 ' HG3' ' HD2' ' A' ' 97' ' ' LYS . 14.1 pt20 -63.22 -33.22 75.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.626 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.3 mptp? -67.49 -34.94 78.18 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.999 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 38.7 m-85 -100.62 34.85 2.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.662 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.4 t -87.76 64.62 8.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.138 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.46 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.3 ptp -155.7 167.95 28.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.756 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -73.77 159.69 32.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.344 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -55.29 -43.51 84.41 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.961 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.66 -38.6 60.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.665 0.269 . . . . 0.0 111.037 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.02 58.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 77' ' ' VAL . 14.1 tp -55.79 -44.72 78.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.079 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.77 -41.76 91.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.777 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.25 72.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.8 mt -61.37 -36.98 81.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.93 176.4 51.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.678 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 52.0 tttp -61.36 -51.3 69.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -50.48 -52.33 39.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.4 m -66.55 -42.67 86.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 126' ' ' TRP . 59.0 t80 -63.72 -42.14 97.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.99 -29.65 70.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.717 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.67 -21.25 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.664 0.268 . . . . 0.0 110.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.6 mt -85.8 -32.59 21.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.835 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -112.4 150.91 43.32 Favored Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.626 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 85.6 Cg_exo -44.23 167.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.691 2.927 . . . . 0.0 114.079 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.95 -24.05 67.7 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.3 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.06 -49.19 3.24 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.524 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.626 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.2 m -63.11 -34.37 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.168 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.91 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.816 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 16.3 t70 -61.34 -45.35 94.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.577 0.227 . . . . 0.0 110.945 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.463 ' CD1' HD21 ' A' ' 90' ' ' LEU . 73.7 mt -61.98 -56.93 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.268 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.8 mt -55.07 -57.36 12.05 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.3 -36.1 79.14 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.335 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 123' ' ' ASP . 30.9 tt0 -56.47 -54.87 40.63 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.49 ' HA ' HD12 ' A' ' 131' ' ' ILE . 22.3 t-160 -72.47 -30.3 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.653 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 52.4 tp -59.59 -49.85 76.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.104 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 15.3 mm-40 -67.29 -33.69 75.83 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.222 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 128' ' ' HIS . 69.3 mt -58.64 -40.17 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.315 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.517 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.0 mt -62.39 -39.08 92.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.456 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.3 mt-30 . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.798 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.7 t80 -89.01 -47.78 7.88 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.675 0.237 . . . . 0.0 110.779 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.9 m -55.06 -31.75 61.38 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.52 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -62.19 -30.33 71.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.342 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -84.38 -42.18 15.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 31.8 mt-30 -58.33 -31.76 67.86 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.374 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.9 -35.73 25.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.517 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -65.86 -35.23 80.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.46 -32.44 9.5 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.85 4.46 39.28 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.627 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.96 127.74 69.49 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.354 0.262 . . . . 0.0 110.929 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.53 174.49 12.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 112.76 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -100.84 45.95 0.96 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 5.8 m-20 -144.48 113.32 5.12 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.504 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 20.3 Cg_endo -61.77 -29.72 83.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.765 2.31 . . . . 0.0 112.823 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.504 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 5.5 mpt_? -74.47 -33.45 62.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.558 0.218 . . . . 0.0 110.495 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -95.7 35.03 1.41 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.079 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.546 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.3 m0 -109.73 160.43 16.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.4 t -127.04 -179.32 4.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.345 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.48 -49.63 44.75 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 m -58.16 -45.95 86.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.314 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -64.19 -41.68 96.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.528 HG13 HD22 ' A' ' 105' ' ' LEU . 55.8 t -62.5 -54.54 32.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.117 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -65.75 -45.49 82.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.55 -42.28 92.01 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.581 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 21.9 t90 -63.4 -60.33 3.51 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.624 HG13 HD21 ' A' ' 125' ' ' LEU . 40.3 t -42.19 -53.9 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.365 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.433 ' HB2' ' HE3' ' A' ' 82' ' ' MET . 37.7 ttm -56.24 -45.97 79.77 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.705 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.532 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 52.1 t90 -56.77 -36.44 69.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.88 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.35 58.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.156 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.519 HG22 HG11 ' A' ' 93' ' ' VAL . 89.0 t -78.52 -34.81 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.484 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.35 -37.45 23.33 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.138 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 7.3 mm-40 -70.23 -36.07 74.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.309 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.7 8.78 24.91 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t 43.62 62.11 2.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.121 0.486 . . . . 0.0 110.498 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.58 HD13 ' HB ' ' A' ' 121' ' ' VAL . 59.9 mt -90.43 153.47 20.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.475 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 151.27 49.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.77 -10.62 73.09 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.707 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.583 ' HB ' HG21 ' A' ' 121' ' ' VAL . 13.8 p -79.54 139.75 17.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 117.404 0.602 . . . . 0.0 110.938 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 10.5 m-20 -117.55 144.17 45.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.212 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.25 -18.66 26.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.977 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.09 -36.44 81.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.041 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.0 mptt -69.24 -34.43 74.79 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.527 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 42.8 m-85 -99.96 33.5 2.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.1 t -86.88 64.29 8.41 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.219 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.449 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.7 ptp -156.45 169.32 24.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.735 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.2 m -75.81 161.5 28.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.373 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.84 -44.09 92.2 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.014 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.75 59.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.987 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.0 -44.48 63.41 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.528 HD22 HG13 ' A' ' 77' ' ' VAL . 13.9 tp -57.62 -46.64 83.84 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.271 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.92 -38.48 91.26 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 110.604 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.21 67.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.561 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 66.4 mt -64.17 -35.22 80.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.04 175.79 45.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.589 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.28 -66.62 0.37 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.4 m -58.57 -39.53 80.58 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 54.1 t80 -64.17 -45.88 86.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.305 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.1 mt -63.09 -26.37 68.8 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.036 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -75.47 -22.63 57.09 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.603 0.24 . . . . 0.0 110.76 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -83.04 -36.26 25.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.585 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.527 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -108.39 155.27 40.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.601 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.665 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 76.9 Cg_exo -48.53 169.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.233 2.622 . . . . 0.0 113.775 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.89 -22.97 67.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.983 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -107.81 -57.04 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.364 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.665 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 6.1 m -60.24 -33.29 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.34 -32.99 57.93 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.229 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.17 -48.63 77.58 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.64 0.22 . . . . 0.0 111.422 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.547 ' CD1' HD21 ' A' ' 90' ' ' LEU . 74.0 mt -54.6 -54.48 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.493 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.624 HD21 HG13 ' A' ' 81' ' ' VAL . 10.0 mp -54.28 -59.73 4.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.275 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.76 -30.77 67.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.939 -0.077 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.09 -57.75 11.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -73.77 -39.39 64.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.006 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.581 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.8 tp -54.08 -46.11 71.95 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.36 -35.19 75.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.192 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.48 -42.98 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.473 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.8 mt -52.14 -39.62 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.78 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 . . . . . 0 C--O 1.231 0.131 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.823 179.427 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.54 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 29.8 t80 -83.25 -50.45 8.4 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 116.453 0.126 . . . . 0.0 110.796 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.71 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 28.8 m -55.72 -40.78 72.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -64.95 -25.17 67.76 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 110.851 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.89 -48.17 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.71 ' HG2' ' HA ' ' A' ' 57' ' ' THR . 5.2 pt20 -65.95 -24.96 66.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.043 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.92 -31.04 40.13 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.697 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -67.65 -30.83 70.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.787 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.13 -30.74 11.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.079 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.82 -1.64 27.35 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.173 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 60' ' ' GLN . 51.5 mt -60.41 128.27 87.73 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.843 0.321 . . . . 0.0 110.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 77.0 Cg_endo -78.95 175.06 11.38 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.614 2.21 . . . . 0.0 112.505 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 43.63 1.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 111.154 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 11.1 m-20 -153.57 111.03 2.57 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.57 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 40.9 Cg_exo -57.42 -36.51 98.8 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.988 2.459 . . . . 0.0 112.48 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -55.4 -37.91 68.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.468 0.175 . . . . 0.0 111.105 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 68' ' ' ASP . 20.8 pt20 -99.95 44.31 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.969 0.414 . . . . 0.0 111.156 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.583 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.4 m0 -117.23 169.61 9.33 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.086 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -131.54 -177.84 4.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -51.32 -44.28 61.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.3 m -63.62 -48.59 76.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.628 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CD2' HG12 ' A' ' 65' ' ' ILE . 45.3 m170 -60.83 -42.13 97.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.316 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 81' ' ' VAL . 60.5 t -61.28 -52.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.21 -47.1 68.79 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.498 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.18 -43.18 82.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.55 0.214 . . . . 0.0 110.54 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.513 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 13.7 t90 -63.59 -62.49 1.63 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 85' ' ' VAL . 43.9 t -39.69 -51.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.422 0.451 . . . . 0.0 110.939 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 29.0 ttm -53.39 -49.8 66.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.174 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.489 ' CZ2' ' HG3' ' A' ' 87' ' ' GLU . 76.8 t90 -61.93 -42.8 99.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.92 -20.92 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.652 HG21 HG11 ' A' ' 93' ' ' VAL . 55.5 t -82.33 -31.7 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.336 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.78 -36.84 42.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.936 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 11.1 mm-40 -71.79 -39.71 69.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.335 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -100.94 5.27 43.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.4 m 44.88 55.2 6.23 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 110.638 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.613 HD13 ' HB ' ' A' ' 121' ' ' VAL . 86.2 mt -75.9 151.32 37.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.908 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -130.64 143.04 50.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 111.623 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.4 ' C ' ' HG3' ' A' ' 118' ' ' PRO . . . 85.61 -0.44 88.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.512 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.652 HG11 HG21 ' A' ' 85' ' ' VAL . 12.6 p -74.55 132.21 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.286 0.543 . . . . 0.0 111.161 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.98 136.78 47.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.058 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.26 -29.56 20.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.397 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.99 -33.69 72.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 47.1 mmtm -66.43 -36.6 83.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.894 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.537 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 35.5 m-85 -97.58 34.73 1.78 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.223 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.61 66.12 8.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.388 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.461 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.6 ptp -158.43 169.08 25.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -73.54 156.48 38.09 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.227 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.583 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.07 -41.04 92.34 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.92 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.61 -39.59 65.05 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.726 0.298 . . . . 0.0 110.839 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.49 64.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.7 tp -55.79 -44.29 77.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.002 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 86.1 m -65.62 -42.45 91.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.55 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.1 -30.05 71.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 31.6 mt -62.39 -38.83 91.14 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.882 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.07 170.8 47.37 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.474 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.8 ttpt -59.27 -47.79 84.07 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.67 -51.1 61.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 70.2 m -66.13 -39.64 90.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.477 0.18 . . . . 0.0 111.123 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.419 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 48.2 t80 -63.51 -41.89 98.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.64 -23.13 65.31 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.813 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.72 -22.14 50.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.4 mt -85.86 -36.58 19.89 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.249 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.541 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -110.6 154.75 42.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.184 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.719 ' HG2' HG22 ' A' ' 121' ' ' VAL . 10.1 Cg_endo -54.79 172.32 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.749 2.3 . . . . 0.0 113.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.78 -21.99 57.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.33 -53.4 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 113.251 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.719 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.0 m -59.04 -34.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.49 -36.11 52.94 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.82 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.65 -49.82 56.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.47 0.176 . . . . 0.0 111.09 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 124' ' ' ILE . 3.3 mp -57.43 -46.44 85.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.588 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 113' ' ' PHE . 85.0 mt -67.5 -57.16 7.01 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.32 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.52 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -60.73 -33.63 73.19 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.18 -54.63 44.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -71.89 -30.01 64.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.459 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.513 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 43.0 tp -60.27 -50.78 72.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.8 mm-40 -66.13 -33.82 76.65 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 69.4 mt -61.68 -36.58 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.444 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.458 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.9 mt -62.96 -40.94 99.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 69.6 mt-30 . . . . . 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.471 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.558 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.526 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 7.9 t80 -83.91 -50.43 8.05 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.4 m -56.68 -36.85 70.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.55 -30.55 70.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.774 0.321 . . . . 0.0 110.303 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -84.58 -42.79 15.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 8.3 mm100 -56.96 -30.9 64.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -80.31 -36.69 33.94 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.478 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.57 -39.47 84.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.524 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 63' ' ' LEU . 7.4 mp -93.8 -32.24 14.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.21 -0.53 40.73 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.231 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.04 128.87 66.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 117.011 0.406 . . . . 0.0 110.913 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.87 172.82 14.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.754 2.303 . . . . 0.0 112.85 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.01 48.11 0.9 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.518 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 12.0 m-20 -140.8 105.99 6.32 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.9 Cg_endo -62.65 -37.06 60.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.659 2.24 . . . . 0.0 112.423 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -70.19 -32.67 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 68' ' ' ASP . 2.0 mp0 -97.85 42.21 1.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.55 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -115.68 168.33 10.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 101' ' ' SER . 15.3 t -133.55 -177.03 4.36 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.562 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HG3' ' CA ' ' A' ' 100' ' ' MET . 2.6 mp0 -49.41 -46.79 47.96 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -63.27 -49.53 73.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.668 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -62.16 -43.06 99.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.688 0.28 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 105' ' ' LEU . 54.3 t -61.47 -52.53 60.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.466 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -68.8 -46.07 69.61 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.784 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.39 -38.67 71.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.547 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 12.8 t90 -66.93 -61.07 2.13 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 85' ' ' VAL . 50.9 t -41.37 -53.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.419 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 40.0 ttm -56.57 -46.15 80.92 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.835 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 54.3 t90 -58.32 -35.94 72.64 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.691 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.35 -21.2 60.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.129 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.543 ' CG2' HG11 ' A' ' 93' ' ' VAL . 84.6 t -77.83 -32.78 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -81.52 -36.66 28.94 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.036 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 10.9 mm-40 -71.27 -40.29 71.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -104.32 6.14 35.05 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.9 m 45.15 56.57 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 110.599 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HB3' HG12 ' A' ' 121' ' ' VAL . 74.5 mt -82.08 169.67 16.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.36 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.1 147.98 27.73 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.358 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -8.52 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.741 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.599 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.5 p -76.4 135.85 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.418 0.609 . . . . 0.0 110.785 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.454 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 12.1 m-20 -109.82 139.16 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.392 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -89.11 -25.08 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.704 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -61.89 -34.48 76.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.649 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 2.0 mptm? -67.15 -35.15 79.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 35.9 m-85 -100.49 34.98 2.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.479 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.1 t -89.41 68.42 7.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.069 0.461 . . . . 0.0 110.251 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.414 ' CA ' ' HG3' ' A' ' 74' ' ' GLU . 14.4 ptp -160.66 172.97 16.16 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.788 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 72.1 m -73.43 156.59 38.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -57.91 -38.66 89.68 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.601 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.82 -39.58 71.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.283 . . . . 0.0 110.666 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.56 -45.02 66.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.424 HD22 HG13 ' A' ' 77' ' ' VAL . 15.7 tp -56.72 -44.6 81.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.031 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.1 m -64.43 -40.35 95.57 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.15 73.67 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.305 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 60.1 mt -61.28 -36.14 79.25 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.895 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.7 176.22 48.92 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.601 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 27.5 ttpp -61.73 -46.82 88.01 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.25 -61.53 2.11 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.473 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 85.5 m -60.6 -39.33 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.438 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HE1' ' HB2' ' A' ' 125' ' ' LEU . 45.3 t80 -63.36 -43.6 97.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.833 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -66.42 -25.92 66.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -76.63 -21.85 54.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.725 0.297 . . . . 0.0 110.347 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.649 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 80.6 mt -86.28 -36.77 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -116.47 151.74 47.33 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.815 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.8 Cg_exo -43.02 164.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.587 2.858 . . . . 0.0 114.09 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.47 -20.2 62.88 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.053 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -108.07 -52.69 2.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.188 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' A' ' 93' ' ' VAL . 5.2 m -62.01 -37.12 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.335 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.77 -36.91 88.9 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.669 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.56 -47.39 78.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.456 HD12 HD21 ' A' ' 90' ' ' LEU . 61.0 mt -59.36 -53.73 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . 84.4 mt -55.63 -55.67 29.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.386 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.506 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -62.24 -28.91 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.04 -57.27 13.29 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.499 ' HA ' HD12 ' A' ' 131' ' ' ILE . 23.7 t-160 -70.98 -32.42 69.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.311 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.506 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 50.0 tp -57.49 -46.29 83.91 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.638 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -68.08 -33.49 74.63 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.233 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 128' ' ' HIS . 85.1 mt -61.12 -43.19 95.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.05 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.2 mt -58.27 -35.31 71.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.396 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.422 ' N ' ' HG3' ' A' ' 69' ' ' PRO . 59.1 mt-30 . . . . . 0 C--N 1.339 0.118 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.443 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 CA-C-O 120.291 -0.172 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.484 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 14.4 t80 -99.47 -50.28 4.14 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.811 0.306 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.8 m -55.67 -31.5 62.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.434 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -61.27 -33.69 73.97 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.674 0.273 . . . . 0.0 110.408 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.14 -38.98 23.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 33.4 mt-30 -58.24 -32.28 68.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.723 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -81.61 -36.89 28.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.796 -0.184 . . . . 0.0 111.48 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -70.76 -39.74 73.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.685 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.3 mt -98.05 -26.36 14.64 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.07 6.24 59.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.533 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 62.8 mt -54.93 122.17 39.69 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 122.305 0.242 . . . . 0.0 111.213 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 23.9 Cg_exo -63.21 169.4 9.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.783 2.322 . . . . 0.0 112.558 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -99.24 34.36 2.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 38.4 t70 -153.78 116.51 2.65 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.3 Cg_endo -61.39 -40.53 47.91 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.145 2.563 . . . . 0.0 112.479 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -54.75 -36.33 64.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.67 0.271 . . . . 0.0 110.456 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -100.15 46.37 0.96 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.762 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.538 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 7.4 m0 -122.07 174.06 7.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.505 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.1 t -132.61 -179.05 5.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.95 -42.93 49.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.3 m -64.19 -50.08 69.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -60.77 -40.6 93.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.544 0.211 . . . . 0.0 111.199 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 HD22 ' A' ' 105' ' ' LEU . 65.6 t -63.2 -55.54 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -64.82 -48.55 74.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.721 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -56.53 -40.1 74.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.576 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.1 t90 -66.12 -61.11 2.21 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 85' ' ' VAL . 53.6 t -40.74 -55.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.422 ' HG2' ' CE1' ' A' ' 95' ' ' PHE . 62.1 mtt -55.55 -47.02 77.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.527 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.2 t90 -58.01 -35.95 71.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.938 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.77 -18.41 60.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.556 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 81' ' ' VAL . 96.7 t -81.04 -34.3 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.488 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -83.81 -32.85 25.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 6.9 mm-40 -75.53 -40.55 56.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -102.21 6.12 40.51 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.946 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 46.08 53.87 8.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 110.746 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.546 HD13 ' HB ' ' A' ' 121' ' ' VAL . 67.5 mt -81.95 169.23 17.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.118 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -152.54 148.88 27.9 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -7.4 81.33 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.855 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.623 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.5 p -76.74 134.48 28.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.423 0.612 . . . . 0.0 111.073 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.4 131.78 48.83 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.442 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 82' ' ' MET . 40.0 m-85 -85.07 -28.69 25.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.74 -33.33 72.76 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.5 mptm? -67.23 -34.35 77.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.123 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 51.1 m-85 -99.32 35.81 1.87 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.598 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.99 64.43 7.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.045 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.48 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.8 ptp -155.64 167.34 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.046 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.0 p -70.9 158.12 36.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.538 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.51 -42.04 93.75 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.83 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.95 64.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.719 0.295 . . . . 0.0 110.876 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.5 -44.93 63.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.571 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.448 HD22 HG13 ' A' ' 77' ' ' VAL . 18.9 tp -55.15 -44.28 75.01 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.264 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 70.8 m -66.93 -40.61 87.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.713 0.292 . . . . 0.0 110.763 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.16 67.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.642 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.9 mt -68.01 -38.46 82.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.88 176.42 51.49 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.331 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.2 ttpt -61.6 -51.22 69.4 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.76 -51.75 36.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.3 m -66.73 -40.93 88.54 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.445 0.164 . . . . 0.0 111.356 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 125' ' ' LEU . 32.2 t80 -62.31 -43.59 98.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.95 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.8 -25.06 66.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.831 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -76.15 -22.38 55.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 110.216 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 91.4 mt -89.07 -35.63 16.21 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.37 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.523 ' HB1' HG23 ' A' ' 121' ' ' VAL . . . -118.32 148.96 44.97 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.934 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.4 Cg_exo -41.89 163.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.752 2.968 . . . . 0.0 114.355 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.5 -21.49 62.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.131 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 121' ' ' VAL . 11.3 p90 -108.1 -48.63 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.374 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.623 HG21 ' HB ' ' A' ' 93' ' ' VAL . 6.2 m -64.15 -37.52 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.48 0.181 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.02 89.59 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.96 -49.35 75.07 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.621 0.248 . . . . 0.0 110.957 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.483 HD12 HD21 ' A' ' 90' ' ' LEU . 47.7 mt -58.09 -57.33 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.0 0.428 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 90.4 mt -52.3 -59.21 4.67 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.057 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.583 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -61.74 -32.97 73.25 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.36 -56.35 21.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.236 0.471 . . . . 0.0 110.159 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.43 ' HA ' HD12 ' A' ' 131' ' ' ILE . 38.1 t60 -68.13 -36.94 80.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.097 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 69' ' ' PRO . 32.9 tp -58.71 -46.51 87.18 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.474 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.16 -39.5 86.65 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 128' ' ' HIS . 88.7 mt -60.11 -41.69 87.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.177 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.6 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 85.4 mt -66.52 -37.72 85.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.11 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.583 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.249 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.678 0 N-CA-C 112.792 -0.123 . . . . 0.0 112.792 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.428 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 9.0 t80 -99.43 -46.5 5.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.647 0.223 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.0 m -55.91 -34.9 66.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.626 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 55' ' ' GLY . 56.9 pttt -58.37 -39.11 78.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.129 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -41.08 40.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.94 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.8 mt-30 -58.53 -29.19 66.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.677 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.11 -37.6 18.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.211 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -70.18 -30.64 67.81 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.663 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.55 -36.79 6.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.07 -2.91 29.98 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.915 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 69.0 mt -56.29 122.9 52.21 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.784 0.292 . . . . 0.0 111.026 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 70.5 Cg_endo -75.27 174.8 12.18 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.461 2.107 . . . . 0.0 112.249 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -101.22 42.59 1.11 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.028 0.442 . . . . 0.0 110.729 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -132.7 97.76 16.98 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HG2' ' HB3' ' A' ' 133' ' ' GLN . 27.6 Cg_endo -61.66 -26.94 80.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -79.64 -37.83 35.15 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -95.21 41.7 1.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.23 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.484 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.3 m0 -111.01 172.31 6.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.675 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -131.82 -179.14 5.21 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.99 -43.49 60.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.3 m -63.59 -49.24 74.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.389 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -62.2 -41.16 98.1 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.186 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.527 HG13 HD22 ' A' ' 105' ' ' LEU . 67.1 t -64.06 -52.97 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.39 -46.16 77.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.594 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.23 -37.04 85.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.776 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.6 t90 -64.9 -65.64 0.65 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.5 p -42.14 -46.54 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.215 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.402 ' N ' HG13 ' A' ' 81' ' ' VAL . 43.8 ttm -60.21 -45.93 91.49 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.393 . . . . 0.0 110.432 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 11.7 t90 -60.65 -37.53 81.83 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.558 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -17.06 62.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 81' ' ' VAL . 75.4 t -84.28 -32.37 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.164 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -81.55 -35.37 30.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.541 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.72 -40.73 55.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.63 7.67 43.84 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t 43.34 59.5 2.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 110.883 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.566 HD21 HD12 ' A' ' 124' ' ' ILE . 62.3 mt -89.35 171.63 9.62 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.024 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.99 148.32 23.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.947 0.403 . . . . 0.0 111.547 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.04 -9.1 78.71 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.694 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.6 p -74.23 136.86 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 117.39 0.595 . . . . 0.0 110.837 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.77 132.81 50.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.524 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -86.36 -24.18 25.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.371 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.31 -36.57 84.53 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.8 mptp? -65.38 -36.18 83.2 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.855 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.4 m-85 -98.54 32.18 2.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.381 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 46.2 t -87.29 67.65 9.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 110.25 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.8 ptp -159.73 171.38 19.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.897 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.4 p -72.33 159.45 34.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.252 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.44 -42.9 94.06 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.636 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.54 -38.74 64.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 110.964 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.77 -47.55 58.99 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.527 HD22 HG13 ' A' ' 77' ' ' VAL . 22.3 tp -55.71 -47.21 77.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.389 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.51 -38.53 91.34 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.681 0.277 . . . . 0.0 110.634 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -32.31 73.97 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.409 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 58.4 mt -59.77 -34.72 73.36 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.88 173.42 45.43 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.471 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.536 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.9 ttpt -59.98 -45.92 91.15 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.34 0.126 . . . . 0.0 111.34 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -49.75 -65.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.19 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 93.0 m -58.07 -38.7 76.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.435 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.95 -43.43 98.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.748 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.34 -26.19 67.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 12.5 mm-40 -75.39 -22.62 57.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.77 0.319 . . . . 0.0 110.149 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -87.36 -39.61 15.17 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.46 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -111.54 150.92 42.88 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.606 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.3 Cg_exo -44.04 165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.606 2.871 . . . . 0.0 114.111 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.37 -20.14 62.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.938 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.53 -55.0 2.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.606 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.8 m -59.99 -33.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.73 -32.13 58.47 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.208 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.59 -52.52 30.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.66 0.23 . . . . 0.0 111.305 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 90' ' ' LEU . 56.3 mt -56.18 -47.11 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.714 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.12 -60.48 3.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.753 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -62.33 -28.78 69.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.33 -54.75 17.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.062 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.404 ' HA ' HD12 ' A' ' 131' ' ' ILE . 12.7 t-160 -66.71 -32.84 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.17 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.6 tp -63.73 -41.32 98.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.247 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 32.6 tt0 -70.26 -23.57 62.91 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.395 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 128' ' ' HIS . 78.0 mt -77.21 -37.49 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.887 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 95.4 mt -58.95 -47.9 83.44 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.542 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.524 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 6.7 pt20 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.542 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 CA-C-O 120.249 -0.195 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.421 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 16.7 t80 -95.39 -45.77 6.98 Favored 'General case' 0 CA--C 1.526 0.043 0 CA-C-N 116.735 0.267 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.2 m -56.52 -39.17 72.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.954 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -62.03 -36.1 80.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.66 0.267 . . . . 0.0 110.479 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.84 -41.13 60.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.4 mt-30 -58.04 -26.69 62.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.331 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -83.31 -31.4 26.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.186 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -71.76 -43.21 66.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.188 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HB2' HG13 ' A' ' 65' ' ' ILE . 36.5 mt -94.73 -25.79 16.55 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.198 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.56 1.82 61.95 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.595 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 79' ' ' ASP . 67.4 mt -49.81 126.48 18.76 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 122.525 0.33 . . . . 0.0 111.418 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 37.1 Cg_exo -60.36 170.09 4.51 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.095 2.53 . . . . 0.0 112.956 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -100.99 38.91 1.46 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -163.96 122.37 1.24 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.587 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 35.3 Cg_exo -60.25 -44.66 27.11 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.601 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 13.5 mtt180 -53.71 -34.24 58.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.611 0.244 . . . . 0.0 110.957 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.85 42.29 1.1 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 12.9 m0 -120.74 175.94 5.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.636 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 p -137.36 -176.06 4.27 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.029 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' CA ' ' A' ' 100' ' ' MET . 46.2 mt-10 -51.77 -37.76 52.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.572 0.225 . . . . 0.0 111.188 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.4 m -67.62 -56.0 11.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.546 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -59.76 -42.72 93.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.607 0.241 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 81' ' ' VAL . 47.2 t -58.35 -47.69 87.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 5.4 tmm_? -73.24 -42.4 62.6 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.037 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 65' ' ' ILE . 1.3 m-20 -58.51 -36.82 74.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.509 0.195 . . . . 0.0 110.617 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.593 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -71.84 -62.24 1.49 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 85' ' ' VAL . 58.1 t -41.53 -51.86 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 56.9 tpp -54.06 -49.06 69.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.7 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -57.27 -38.4 73.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.108 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' PHE . . . -76.18 -18.69 58.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.513 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 81' ' ' VAL . 78.8 t -85.88 -30.48 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.7 -39.66 15.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.096 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.71 -34.95 62.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.528 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 51.3 m-85 -100.79 4.21 42.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.448 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 46.71 55.97 7.11 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 122.611 0.364 . . . . 0.0 111.506 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD13 ' HB ' ' A' ' 121' ' ' VAL . 71.8 mt -86.34 167.32 14.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.588 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.64 154.88 38.29 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 111.724 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -8.24 66.58 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.69 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.574 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.1 p -74.84 130.54 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 117.403 0.601 . . . . 0.0 111.029 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.87 130.68 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.339 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.0 -20.85 29.89 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.43 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -65.49 -33.5 76.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 34.9 mmtp -66.48 -35.76 81.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.697 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 28.8 m-85 -100.08 29.75 4.11 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.325 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.5 t -82.4 67.93 8.63 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.406 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.2 ptp -160.75 172.2 17.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.697 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.7 p -73.28 158.65 34.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.173 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -60.81 -37.62 93.94 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.804 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.41 72.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.684 0.278 . . . . 0.0 110.694 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.2 63.5 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.387 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.32 -43.76 75.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.113 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 71.2 m -67.31 -42.42 83.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.815 0.341 . . . . 0.0 110.575 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.09 67.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.669 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 64.8 mt -68.53 -31.95 71.55 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.71 174.98 49.0 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.326 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.487 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.0 ttpt -63.59 -42.52 98.25 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.571 0.185 . . . . 0.0 111.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.82 -63.37 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.511 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.8 m -59.06 -40.68 85.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.357 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.98 -43.35 99.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.49 HD12 ' HA3' ' A' ' 122' ' ' GLY . 12.0 tp -66.48 -27.15 67.57 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.632 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -75.05 -22.48 58.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.695 0.284 . . . . 0.0 110.653 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.1 mt -84.98 -32.22 23.1 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.451 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -113.04 154.2 45.11 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.608 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.2 Cg_exo -44.32 164.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.502 2.802 . . . . 0.0 113.901 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.1 -19.45 62.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.031 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.458 ' CE2' HG13 ' A' ' 121' ' ' VAL . 13.4 p90 -108.75 -51.72 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.608 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.8 m -62.93 -34.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.49 ' HA3' HD12 ' A' ' 114' ' ' LEU . . . -52.41 -39.74 52.79 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.95 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.54 -47.6 75.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.611 0.244 . . . . 0.0 110.967 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.78 -55.1 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.372 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.85 -57.2 13.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.505 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 5.9 t90 -60.78 -28.27 68.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.04 -57.72 11.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -71.99 -35.24 69.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.459 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.593 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.8 tp -56.78 -49.87 74.0 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.788 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.36 -36.71 84.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 70.2 mt -61.47 -45.71 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.177 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.8 mt -55.48 -36.84 67.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.052 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 68.4 mt-30 . . . . . 0 C--O 1.233 0.22 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.557 0 N-CA-C 112.304 -0.318 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 13.1 t80 -81.03 -49.23 11.17 Favored 'General case' 0 C--N 1.338 0.072 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.7 m -55.54 -34.0 64.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.051 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -63.97 -31.78 73.09 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.831 0.348 . . . . 0.0 110.485 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.18 -41.75 21.89 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.132 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 47.6 mt-30 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.791 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -83.04 -13.61 55.49 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 48.8 mtp180 -85.1 -37.38 20.34 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.66 0.267 . . . . 0.0 111.143 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 mp -105.19 -27.42 11.57 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.69 5.26 42.16 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.129 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 86.9 mt -57.14 125.23 69.85 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.891 0.346 . . . . 0.0 111.027 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 64.4 Cg_endo -74.65 170.45 20.29 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.375 2.05 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -75.84 -36.93 59.45 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.617 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.19 125.22 90.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.59 0.233 . . . . 0.0 111.075 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 63.5 Cg_endo -74.51 -32.98 5.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.015 2.477 . . . . 0.0 113.183 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -29.06 70.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.593 0.235 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -96.56 40.48 1.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.885 0.374 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.648 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 11.0 m0 -112.12 169.56 8.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -128.62 -178.4 4.57 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.76 -39.31 62.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.444 0.164 . . . . 0.0 111.373 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.5 m -66.81 -49.34 66.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.597 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CD2' HG12 ' A' ' 65' ' ' ILE . 47.3 m170 -61.45 -42.66 99.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.654 0.264 . . . . 0.0 110.965 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 81' ' ' VAL . 54.0 t -60.71 -52.64 59.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.8 ttm105 -66.92 -46.71 73.98 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.708 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.69 -40.72 88.82 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.838 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 14.3 t90 -63.43 -62.69 1.51 Allowed 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 85' ' ' VAL . 73.5 t -41.17 -49.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 55.2 tpp -55.68 -50.73 69.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.832 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -55.19 -39.9 70.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.85 -48.47 53.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.874 0.369 . . . . 0.0 110.27 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.568 ' CG2' HG11 ' A' ' 93' ' ' VAL . 79.4 t -52.85 -30.46 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.38 -46.92 12.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.356 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -66.39 -32.19 73.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.56 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.34 2.5 28.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.4 m 45.02 59.69 3.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.078 0.466 . . . . 0.0 110.63 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 121' ' ' VAL . 71.3 mt -86.96 153.08 21.85 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.464 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 155.52 49.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.712 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.83 -7.35 59.28 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.721 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.579 ' HB ' HG21 ' A' ' 121' ' ' VAL . 13.0 p -74.62 132.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 117.315 0.557 . . . . 0.0 111.044 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -105.01 132.26 51.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.375 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.07 -25.52 24.13 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -62.0 -34.05 75.47 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.5 mmtt -66.54 -34.94 79.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.713 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 30.3 m-85 -97.97 32.94 2.24 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.43 65.13 9.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 110.209 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.7 ptp -158.9 169.81 23.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -75.43 161.59 29.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.332 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.648 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.47 -38.37 90.75 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.825 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.01 70.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.773 0.321 . . . . 0.0 110.634 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.48 -44.98 56.72 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.421 HD22 HG13 ' A' ' 77' ' ' VAL . 15.1 tp -56.06 -46.88 78.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.195 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 95.1 m -66.71 -38.75 87.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.813 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.57 69.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.436 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.3 mt -65.72 -32.96 74.81 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 175.39 48.75 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.459 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -62.71 -42.12 99.49 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.36 -63.28 1.2 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.353 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.8 m -60.85 -38.01 84.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.394 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -63.27 -45.26 92.33 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.488 0.185 . . . . 0.0 110.828 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.04 -25.86 68.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.704 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.2 -21.81 58.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.613 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 72.7 mt -87.21 -35.22 18.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.599 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -115.84 151.25 46.17 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.8 Cg_exo -43.05 163.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.61 2.873 . . . . 0.0 114.065 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.56 -21.3 62.4 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.193 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.81 -52.8 2.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.179 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.605 ' HB ' HD13 ' A' ' 90' ' ' LEU . 3.8 m -61.26 -37.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.434 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.2 74.74 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.658 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.64 -50.0 72.94 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.468 0.175 . . . . 0.0 110.884 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.547 HD12 HD21 ' A' ' 90' ' ' LEU . 64.2 mt -56.8 -55.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.431 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.28 -56.36 17.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.274 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 21.4 t90 -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.234 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.66 -54.59 43.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -73.0 -36.05 66.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.312 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.532 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.1 tp -59.08 -43.42 91.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.596 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -68.24 -32.84 73.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.192 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.9 mt -65.04 -37.71 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.502 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.8 mt -61.55 -53.6 54.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.407 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 8.8 pt20 . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.855 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.742 0 N-CA-C 112.669 -0.172 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 15.3 t80 -98.89 -47.33 5.31 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.598 0.199 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -55.51 -32.81 63.2 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.33 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -60.36 -32.34 71.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.415 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 43.1 tt0 -82.6 -40.08 21.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 11.8 mm100 -58.63 -30.99 67.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.284 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -84.93 -38.45 19.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.238 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.19 -40.22 86.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.678 0.275 . . . . 0.0 111.264 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 mt -96.42 -31.17 12.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.187 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -2.41 55.98 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.685 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.6 mt -53.62 129.26 54.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 122.291 0.236 . . . . 0.0 111.178 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.0 166.69 26.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -97.06 52.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 110.437 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.23 98.82 5.04 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.145 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.585 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 32.0 Cg_exo -58.38 -38.83 88.63 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.857 2.371 . . . . 0.0 112.32 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 12.1 mtt180 -66.44 -35.63 80.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -98.15 43.55 1.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 2.0 m0 -115.02 174.75 5.82 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.267 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.7 t -133.51 -179.31 5.44 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -50.36 -44.41 54.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -63.39 -49.09 75.17 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.422 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -62.31 -41.9 98.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.234 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.508 HG13 HD22 ' A' ' 105' ' ' LEU . 56.1 t -60.37 -49.91 82.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HA ' HG12 ' A' ' 81' ' ' VAL . 70.9 ttt180 -71.43 -41.86 68.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.518 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.27 -35.57 79.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.485 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -69.36 -65.49 0.7 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.7 p -42.39 -46.88 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.174 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.415 ' N ' HG13 ' A' ' 81' ' ' VAL . 43.8 ttm -60.82 -47.78 84.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.407 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 17.6 t90 -55.94 -37.95 69.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.87 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.98 60.42 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.627 ' CG2' HG11 ' A' ' 93' ' ' VAL . 88.8 t -49.59 -34.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.244 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -79.47 -42.22 25.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.255 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 7.2 mm-40 -68.27 -36.28 79.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.564 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -105.63 6.6 32.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.7 m 44.36 53.36 6.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.948 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.522 ' HB3' HG12 ' A' ' 121' ' ' VAL . 68.1 mt -80.32 166.85 20.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.513 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.87 157.83 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.63 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.98 -5.74 69.76 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.677 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' A' ' 85' ' ' VAL . 13.6 p -81.92 142.71 13.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.238 0.519 . . . . 0.0 111.338 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.5 m-20 -116.58 141.96 47.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -90.34 -23.58 21.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.938 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -60.6 -36.25 78.1 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.9 mptt -67.09 -35.12 79.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.281 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.634 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 43.1 m-85 -96.26 32.28 2.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.565 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.2 t -89.84 67.67 7.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.193 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.5 ptp -156.56 166.59 32.96 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -69.68 157.58 36.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.49 74.36 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.634 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.17 61.42 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.669 0.271 . . . . 0.0 111.182 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.58 -48.1 61.36 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.789 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.508 HD22 HG13 ' A' ' 77' ' ' VAL . 18.8 tp -57.25 -46.29 83.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.162 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.9 m -64.04 -38.9 92.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.796 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.53 76.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.368 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -58.56 -36.05 73.32 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.51 176.76 49.41 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.473 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 57.5 tttp -59.67 -47.45 85.58 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 1.0 OUTLIER -50.75 -66.94 0.3 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.4 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.7 m -57.48 -37.58 73.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -62.41 -42.93 99.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.738 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -65.72 -24.49 66.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 10.5 mm-40 -74.55 -22.89 58.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.5 mt -84.11 -40.11 18.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.629 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -105.77 157.43 34.65 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.265 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.752 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.2 Cg_endo -56.71 174.26 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.685 2.257 . . . . 0.0 112.958 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -63.07 -14.39 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -107.93 -59.79 1.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.755 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.752 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -58.52 -31.25 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.04 -32.43 42.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.115 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.81 -46.35 53.62 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.68 0.24 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.424 HD12 HD21 ' A' ' 90' ' ' LEU . 57.0 mt -62.64 -58.64 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 111.658 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.403 HD13 HG23 ' A' ' 81' ' ' VAL . 66.5 mt -51.19 -58.77 5.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.793 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.517 ' CZ2' ' HD2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.42 -31.59 71.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.288 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.1 -57.09 14.58 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.54 -29.69 66.23 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.63 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.5 tp -57.83 -49.72 75.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.783 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 13.5 mm-40 -67.78 -34.87 77.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.767 0.318 . . . . 0.0 110.316 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.59 -37.55 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.9 -36.7 82.88 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.521 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.585 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 79.1 mt-30 . . . . . 0 N--CA 1.462 0.139 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.316 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.669 0 CA-C-O 120.242 -0.199 . . . . 0.0 113.127 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.465 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 16.9 t80 -99.16 -47.06 5.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.721 0.26 . . . . 0.0 110.657 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.2 m -57.1 -37.28 71.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 19.9 pttp -63.21 -36.1 82.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.346 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.49 61.19 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 55.3 mt-30 -59.4 -28.09 66.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.408 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -82.87 -40.88 19.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -65.86 -41.85 91.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -89.16 -31.12 18.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.924 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.89 -5.87 51.04 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.617 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' A' ' 76' ' ' HIS . 85.2 mt -51.43 124.13 23.71 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.61 0.243 . . . . 0.0 110.889 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.62 171.74 16.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.675 2.25 . . . . 0.0 112.714 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -100.3 45.57 0.98 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -140.05 102.76 6.83 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.406 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 32.1 Cg_exo -59.06 -31.33 95.42 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.865 2.377 . . . . 0.0 112.555 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.98 -36.03 59.38 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -95.73 38.45 1.17 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.743 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.465 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.0 OUTLIER -108.43 170.78 7.81 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.322 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.5 p -133.24 -179.01 5.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.464 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -52.18 -40.45 61.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -64.25 -50.63 67.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.324 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CD2' HG12 ' A' ' 65' ' ' ILE . 25.4 m170 -63.42 -41.3 98.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.81 -54.83 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 111.002 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -63.31 -49.52 73.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.385 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.77 -41.03 76.91 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.3 t90 -63.88 -61.88 2.0 Allowed 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.491 HG13 HD21 ' A' ' 125' ' ' LEU . 53.5 t -41.08 -55.36 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.775 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 30.0 ttm -57.68 -45.65 85.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.711 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.535 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 14.4 t90 -56.59 -35.84 68.68 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.933 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.2 -19.72 61.03 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.209 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 81' ' ' VAL . 58.2 t -81.37 -33.47 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.041 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -84.76 -40.26 17.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.61 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 12.2 mm-40 -72.15 -38.7 69.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -102.62 9.22 39.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t 44.71 52.87 7.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.818 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.833 HD13 HG13 ' A' ' 121' ' ' VAL . 69.4 mt -86.85 176.23 7.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.314 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.438 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.82 152.97 16.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.004 0.431 . . . . 0.0 111.745 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.49 -14.21 65.37 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.9 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.499 ' HB ' HG11 ' A' ' 121' ' ' VAL . 13.0 p -75.54 130.55 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.39 0.595 . . . . 0.0 110.879 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 9.4 m-20 -98.71 134.68 41.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -86.37 -26.99 24.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.474 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 15.8 mm100 -60.52 -37.58 81.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.973 0.415 . . . . 0.0 109.91 177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 99.5 mttt -66.88 -29.57 69.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.51 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.465 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 50.9 m-85 -101.84 33.07 3.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 59.3 m -86.24 65.24 8.98 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.113 0.482 . . . . 0.0 110.32 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.518 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.7 ptp -153.48 165.46 35.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -74.73 164.68 26.3 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.341 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.13 -42.67 95.3 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.717 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.03 -38.33 62.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.97 55.62 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.71 -47.55 73.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.152 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.7 m -65.85 -38.8 89.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.99 -21.25 66.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.8 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 43.4 mt -71.31 -34.91 71.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.18 179.77 46.87 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.45 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.416 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.1 ttpt -60.92 -47.81 84.7 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -50.56 -65.15 0.61 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 94.9 m -60.53 -42.27 96.15 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 52.8 t80 -61.61 -46.35 90.21 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.281 -0.168 . . . . 0.0 111.119 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.3 mt -62.44 -31.35 72.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.598 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.98 -25.65 64.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.748 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 97' ' ' LYS . 65.2 mt -87.47 -31.23 20.1 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.214 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.514 ' CB ' ' HA2' ' A' ' 122' ' ' GLY . . . -99.13 166.42 13.04 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.82 0.343 . . . . 0.0 111.6 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 21.0 Cg_exo -66.59 173.5 7.75 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.095 2.53 . . . . 0.0 113.225 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.42 -28.21 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.088 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.2 -53.06 2.68 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.475 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.833 HG13 HD13 ' A' ' 90' ' ' LEU . 81.8 t -57.18 -39.55 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 117' ' ' ALA . . . -50.99 -43.48 49.43 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.15 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 12.6 m-20 -63.04 -46.09 89.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.0 mt -57.94 -50.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.631 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.491 HD21 HG13 ' A' ' 81' ' ' VAL . 10.5 mp -63.95 -57.81 8.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.258 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.416 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.06 -31.73 71.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.632 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 123' ' ' ASP . 8.2 tp10 -62.75 -52.45 63.18 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.01 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.568 ' HA ' HD12 ' A' ' 131' ' ' ILE . 18.6 t-160 -71.98 -30.66 65.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.424 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 40.4 tp -62.39 -46.2 89.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.605 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 64.6 mm-40 -67.07 -33.62 75.89 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.9 mt -59.89 -42.89 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.38 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.23 -38.4 89.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.544 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.478 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.158 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 112.36 -0.296 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.446 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 11.7 t80 -77.62 -49.76 13.91 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.0 m -55.31 -32.54 62.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.399 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 34.7 mmtp -59.42 -33.65 71.51 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.809 0.338 . . . . 0.0 110.57 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -83.21 -41.61 18.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 43.6 mt-30 -57.66 -29.45 64.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.736 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 3.1 pt20 -83.25 -32.21 26.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -71.25 -40.16 71.19 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.77 -26.81 13.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.75 11.69 39.85 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.916 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 75.5 mt -56.94 121.22 44.24 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.62 0.248 . . . . 0.0 111.4 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.8 Cg_exo -68.07 170.32 14.68 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.747 2.298 . . . . 0.0 112.241 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -94.05 -4.09 50.07 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.606 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 6.5 t70 -98.5 108.24 46.77 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.715 0.293 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.571 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 33.2 Cg_endo -63.59 -26.96 69.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.001 2.467 . . . . 0.0 112.973 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -76.53 -35.22 58.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -94.7 40.48 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.078 0.466 . . . . 0.0 110.558 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.55 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.2 m0 -108.51 170.35 8.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.375 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.9 p -130.96 179.69 5.84 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -39.49 58.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.0 m -64.24 -53.3 51.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -61.56 -39.38 90.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 81' ' ' VAL . 50.5 t -64.18 -52.13 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.136 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -66.01 -48.17 72.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.911 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.81 -32.13 72.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.7 t90 -72.58 -65.86 0.73 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.2 p -40.99 -47.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.506 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.429 ' N ' HG13 ' A' ' 81' ' ' VAL . 38.5 ttm -59.3 -48.43 81.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.819 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.423 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 87.2 t90 -61.55 -40.22 93.91 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.3 62.76 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.264 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.61 ' CG2' HG11 ' A' ' 93' ' ' VAL . 40.2 t -82.49 -31.4 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.9 -38.43 37.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 11.6 mm-40 -70.27 -36.68 74.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.21 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -104.28 5.67 34.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m 44.64 55.59 5.75 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 110.779 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.557 HD21 HG13 ' A' ' 124' ' ' ILE . 83.0 mt -78.2 127.34 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.088 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -108.47 142.34 39.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.464 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 -5.72 84.42 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.756 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.61 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.5 p -76.34 137.57 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.298 0.549 . . . . 0.0 110.926 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -112.93 138.82 49.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.437 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -89.46 -26.02 21.17 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.598 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -60.61 -34.15 73.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.006 0.431 . . . . 0.0 109.916 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.8 mmmm -68.02 -34.33 76.3 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.847 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.2 m-85 -99.34 35.45 1.94 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.443 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.91 69.08 10.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.21 169.15 24.75 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.778 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -76.9 165.18 25.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.55 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.27 -43.19 95.66 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.103 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.23 66.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.989 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.21 53.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.841 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.427 HD22 HG13 ' A' ' 77' ' ' VAL . 14.7 tp -56.73 -46.59 81.24 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.345 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 80.5 m -66.52 -40.66 89.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.71 0.291 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.57 76.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.215 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.2 mt -58.82 -32.51 69.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.997 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.23 177.18 45.57 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.662 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.521 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -60.66 -45.51 93.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.367 0.136 . . . . 0.0 111.367 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 35.2 tt0 -50.88 -66.73 0.34 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.0 m -57.98 -40.16 79.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.767 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.98 -45.42 93.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.554 0.216 . . . . 0.0 111.018 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.46 -26.19 68.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.745 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 18.5 mm-40 -73.92 -24.03 59.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 110.771 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.1 mt -82.39 -35.47 27.67 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.508 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -109.69 160.23 28.71 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 120.716 0.293 . . . . 0.0 111.62 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.674 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 50.4 Cg_exo -52.91 171.89 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.116 2.544 . . . . 0.0 113.651 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.73 -22.77 66.05 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.774 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.76 -58.75 1.93 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.674 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.9 m -62.39 -32.83 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.0 -38.51 38.77 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.599 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.49 -46.35 88.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.653 0.264 . . . . 0.0 111.007 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.557 HG13 HD21 ' A' ' 90' ' ' LEU . 50.5 mm -51.29 -51.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.132 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -63.65 -57.09 11.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.418 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.521 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -61.32 -26.95 68.14 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.08 -57.27 12.2 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.473 ' HA ' HD12 ' A' ' 131' ' ' ILE . 20.8 t-160 -73.28 -35.15 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.688 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.533 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 29.7 tp -57.8 -45.63 85.79 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 1.7 tm-20 -68.29 -38.93 82.15 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 128' ' ' HIS . 66.5 mt -55.15 -45.24 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.627 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.479 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.2 mt -53.25 -36.31 60.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.318 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.571 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 63.5 mt-30 . . . . . 0 N--CA 1.462 0.171 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.926 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' HA2' ' HE2' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 120.315 -0.158 . . . . 0.0 112.803 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 9.5 t80 -88.77 -51.08 5.84 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 116.745 0.273 . . . . 0.0 110.628 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 91.0 m -56.11 -42.24 76.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.112 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HE2' ' HA2' ' A' ' 55' ' ' GLY . 56.4 pttt -60.01 -33.85 72.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.734 0.302 . . . . 0.0 110.419 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -77.27 -42.89 35.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.66 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.3 mt-30 -60.66 -27.34 67.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.832 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 57' ' ' THR . 87.1 mm-40 -80.45 -14.34 58.37 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 78.6 mtt180 -85.01 -34.41 22.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.109 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.79 -24.56 12.89 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.72 9.94 48.25 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.073 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.451 HG12 ' CD2' ' A' ' 76' ' ' HIS . 25.9 mt -56.53 126.01 68.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.742 0.271 . . . . 0.0 111.281 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 63.6 Cg_endo -73.89 175.51 10.71 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.617 2.211 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -98.99 39.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.517 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -148.02 110.48 3.78 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.543 0.211 . . . . 0.0 111.439 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 34.4 Cg_exo -57.32 -37.96 96.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.181 2.587 . . . . 0.0 112.597 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -63.34 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.668 0.27 . . . . 0.0 110.494 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -96.47 38.7 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.526 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -114.82 169.32 9.16 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.681 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.4 t -132.25 -177.77 4.61 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -49.31 -42.0 40.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.2 m -67.01 -50.08 63.25 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.451 ' CD2' HG12 ' A' ' 65' ' ' ILE . 37.1 m170 -61.66 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.631 0.253 . . . . 0.0 111.176 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.473 HG13 HD22 ' A' ' 105' ' ' LEU . 54.6 t -59.7 -51.73 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -71.03 -43.37 68.04 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.785 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.03 -39.45 74.82 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.58 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.541 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.4 t90 -68.35 -60.57 2.35 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.2 t -41.61 -55.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.647 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 ttm -55.8 -46.15 78.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.69 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 14.5 t90 -57.2 -37.13 71.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -18.68 62.22 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.273 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 HG11 ' A' ' 93' ' ' VAL . 24.4 t -81.9 -35.91 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.853 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -90.9 -30.36 16.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.051 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.67 -38.81 53.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -108.2 11.15 27.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.746 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 45.72 57.11 5.28 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.905 0.383 . . . . 0.0 111.624 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HB3' HG12 ' A' ' 121' ' ' VAL . 70.8 mt -89.16 172.74 8.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -155.37 153.89 31.16 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 111.643 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.12 -6.23 80.13 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG22 ' A' ' 85' ' ' VAL . 13.2 p -78.07 133.7 29.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 117.348 0.574 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -104.66 135.98 45.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.74 -28.33 21.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.528 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.15 -34.58 75.25 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.0 mmtt -66.72 -34.98 79.05 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.026 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.605 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 42.3 m-85 -100.62 34.21 2.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.386 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.8 t -86.94 66.51 9.46 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.119 0.485 . . . . 0.0 110.077 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.6 ptp -159.0 170.76 21.37 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.871 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.9 m -74.24 157.11 36.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -60.27 -36.36 90.62 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.925 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.2 -39.46 72.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 110.645 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.28 -43.16 61.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.425 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 77' ' ' VAL . 14.4 tp -56.48 -44.89 81.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.074 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.6 -40.22 88.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.723 0.297 . . . . 0.0 110.676 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.08 -24.28 66.68 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.749 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 39.9 mt -68.49 -35.09 77.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.79 172.11 48.56 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.329 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.491 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.8 ttpt -61.47 -48.75 79.7 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.47 -51.81 51.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.8 m -66.69 -39.65 88.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.558 0.218 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 64.1 t80 -63.0 -43.72 98.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.796 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.27 -25.95 66.31 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.68 -23.53 59.84 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.639 0.257 . . . . 0.0 110.617 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 78.1 mt -85.84 -35.04 20.88 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.302 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -104.89 161.5 22.59 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.795 ' HG2' HG22 ' A' ' 121' ' ' VAL . 18.9 Cg_endo -59.42 176.12 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.748 2.298 . . . . 0.0 112.888 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.35 -12.91 59.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -108.67 -56.44 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.773 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.795 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.6 m -62.98 -31.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.72 -43.96 38.47 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.782 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.29 -49.36 43.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.647 0.26 . . . . 0.0 110.846 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.86 -55.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.517 HD21 HG13 ' A' ' 81' ' ' VAL . 10.3 mp -56.81 -53.08 61.96 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.753 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.491 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 17.4 t90 -61.43 -28.18 69.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -63.95 -54.84 28.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.147 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.451 ' HA ' HD12 ' A' ' 131' ' ' ILE . 2.0 t60 -72.37 -34.33 67.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.613 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.541 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.7 tp -61.93 -45.29 94.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -67.58 -27.73 67.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 128' ' ' HIS . 62.2 mt -68.28 -37.57 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.44 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.414 ' HB2' ' HG3' ' A' ' 69' ' ' PRO . 96.2 mt -64.67 -48.52 74.43 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.68 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.65 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 12.0 pt20 . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 120.213 -0.215 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.496 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.3 t80 -96.43 -49.67 5.07 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.646 0.223 . . . . 0.0 110.9 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -54.52 -33.23 59.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.248 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 110.115 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.03 -38.89 35.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.952 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 25.0 mt-30 -58.98 -31.72 69.01 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.608 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -85.75 -37.06 19.74 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -71.98 -31.98 66.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 mt -105.54 -32.14 8.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.0 0.49 41.75 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.157 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 48.9 mt -55.83 122.66 47.92 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.762 0.281 . . . . 0.0 110.917 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 74.4 Cg_endo -76.35 171.77 17.47 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.455 2.103 . . . . 0.0 112.648 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -98.75 45.91 1.0 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.927 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -146.17 103.31 4.09 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.068 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.6 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 51.0 Cg_exo -57.08 -46.88 25.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.921 2.414 . . . . 0.0 112.238 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -57.71 -33.09 68.05 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.555 0.217 . . . . 0.0 110.805 178.434 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG3' ' HG2' ' A' ' 70' ' ' ARG . 46.0 mt-30 -99.98 42.04 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.186 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.635 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.9 m0 -115.33 170.21 8.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.363 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -130.66 -179.46 5.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.23 -43.04 52.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.5 m -62.52 -50.39 71.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.301 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.159 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.49 -52.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.34 -48.74 69.29 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.482 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.25 -36.22 77.26 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.008 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 33.5 t90 -69.56 -65.17 0.75 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 85' ' ' VAL . 11.6 p -41.7 -47.53 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.227 0.329 . . . . 0.0 111.378 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.427 ' N ' HG13 ' A' ' 81' ' ' VAL . 60.4 tpp -59.84 -47.64 84.89 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.101 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.516 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.3 t90 -61.22 -38.17 85.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.988 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.45 61.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.43 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 81' ' ' VAL . 54.1 t -83.17 -32.84 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.161 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -81.16 -33.84 32.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.2 mm-40 -73.59 -39.9 64.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.989 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -102.19 7.49 40.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m 44.67 55.22 6.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 110.976 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.626 HD13 ' HB ' ' A' ' 121' ' ' VAL . 53.4 mt -83.12 168.75 16.57 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.36 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -150.99 153.77 35.81 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.733 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.1 -7.61 63.02 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.008 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 85' ' ' VAL . 12.3 p -73.81 131.97 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 117.547 0.673 . . . . 0.0 111.167 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.66 131.1 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -86.29 -23.09 26.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.754 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -61.95 -35.7 79.24 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 6.1 mptp? -65.56 -34.27 77.86 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.32 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 36.6 m-85 -101.1 29.95 4.39 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.693 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.3 t -84.86 66.55 9.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.1 0.476 . . . . 0.0 110.241 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.1 ptp -158.43 171.66 19.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.657 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 m -75.92 158.26 32.23 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.635 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.57 -37.95 90.11 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.872 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.42 -39.51 67.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 110.64 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 108' ' ' LEU . . . -73.49 -46.76 46.05 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -52.89 -47.5 67.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.323 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.71 -38.52 86.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.785 0.326 . . . . 0.0 110.492 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -18.46 64.16 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.932 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 112' ' ' CYS . 41.9 mt -74.36 -28.49 61.14 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.18 169.8 42.44 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.673 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.58 -44.92 95.67 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.95 -60.79 2.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.734 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 49.8 t -59.61 -44.21 93.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.395 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -59.78 -43.34 94.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.973 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.48 -30.15 70.89 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.723 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.04 -21.85 60.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.733 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 89.0 mt -83.65 -32.21 25.77 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.586 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -112.02 154.62 44.16 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.724 0.297 . . . . 0.0 111.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.639 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.0 Cg_exo -45.77 167.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.398 2.732 . . . . 0.0 113.796 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.21 -21.88 66.74 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.087 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.422 ' CE2' HG13 ' A' ' 121' ' ' VAL . 18.9 p90 -108.63 -51.51 2.88 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.639 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 9.9 m -61.69 -35.76 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.39 -35.1 49.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.238 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.11 -49.91 72.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.706 0.253 . . . . 0.0 111.202 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.535 HD12 HD21 ' A' ' 90' ' ' LEU . 74.1 mt -60.16 -53.33 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.565 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -52.62 -58.1 7.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.278 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 1.4 t90 -64.74 -25.45 67.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.427 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.51 -56.69 17.29 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.423 ' HA ' HD12 ' A' ' 131' ' ' ILE . 2.5 t60 -73.17 -36.63 66.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.523 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.55 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.9 tp -57.23 -45.16 84.14 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.22 -36.42 79.48 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 128' ' ' HIS . 64.8 mt -58.31 -41.51 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.698 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.507 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 86.7 mt -57.22 -37.37 72.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.683 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.6 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 45.4 mt-30 . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.164 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.564 0 CA-C-O 120.261 -0.188 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.1 t80 -96.42 -53.73 3.5 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.697 0.249 . . . . 0.0 110.864 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.6 m -54.7 -33.66 61.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.402 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 14.7 ptmm? -62.15 -31.27 71.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.856 0.36 . . . . 0.0 110.569 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -83.3 -39.3 20.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.087 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 28.4 mt-30 -58.29 -28.32 64.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.455 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 29.1 pt20 -84.78 -37.03 21.3 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.564 0.221 . . . . 0.0 110.962 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -65.06 -42.95 93.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.7 mt -99.14 -29.33 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.29 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.66 6.66 54.51 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.56 119.21 14.8 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 122.31 0.244 . . . . 0.0 111.283 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.14 166.93 13.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.739 2.293 . . . . 0.0 112.386 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -98.92 41.07 1.16 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.725 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -156.28 125.15 3.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 132' ' ' LEU . 38.2 Cg_endo -67.59 -37.73 16.04 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.089 2.526 . . . . 0.0 113.02 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.442 ' HD3' ' HG2' ' A' ' 69' ' ' PRO . 1.5 mpp_? -61.91 -33.06 73.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.519 0.199 . . . . 0.0 110.763 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -99.37 41.92 1.13 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.932 0.396 . . . . 0.0 110.843 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.595 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 4.9 m0 -119.8 170.05 9.58 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.509 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -133.59 -178.86 5.19 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -49.87 -43.31 49.11 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -63.1 -49.64 73.65 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.335 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -61.67 -41.6 97.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.605 HG13 HD22 ' A' ' 105' ' ' LEU . 64.8 t -62.35 -56.14 19.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.19 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.432 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 7.0 tmm_? -64.08 -46.97 81.94 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.347 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.1 -43.21 99.24 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.724 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 22.0 t90 -61.13 -62.93 1.49 Allowed 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 85' ' ' VAL . 55.8 t -40.91 -49.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.791 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.403 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 29.9 ttm -58.17 -45.02 88.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.788 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.595 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 17.3 t90 -59.26 -37.82 78.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.68 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.52 -20.28 61.37 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.173 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 81' ' ' VAL . 69.7 t -81.35 -32.07 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.188 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.7 -35.48 24.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.134 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.595 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.1 mm-40 -73.04 -40.13 65.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.84 10.78 36.33 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p 41.83 51.72 4.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.978 0.418 . . . . 0.0 111.183 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.432 ' HB3' HG12 ' A' ' 121' ' ' VAL . 79.5 mt -80.11 171.25 15.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -155.08 160.35 40.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.199 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.06 -7.88 58.85 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.783 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.549 ' HB ' HG21 ' A' ' 121' ' ' VAL . 11.4 p -79.9 131.61 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.497 0.648 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -103.53 139.47 38.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.3 -25.33 21.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -61.59 -30.65 70.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 29.9 mmmt -68.41 -34.59 76.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.872 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.6 m-85 -101.52 32.4 3.35 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.189 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.1 t -84.07 67.51 9.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 110.232 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.428 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.6 ptp -157.42 168.56 26.98 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.804 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -73.3 161.02 30.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.336 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.37 -44.79 89.78 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.866 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.8 63.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.656 0.265 . . . . 0.0 110.836 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.55 61.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.605 HD22 HG13 ' A' ' 77' ' ' VAL . 16.2 tp -55.95 -47.51 77.45 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.182 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.41 -38.77 85.15 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.799 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.66 67.64 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.794 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.6 mt -67.67 -30.53 70.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.86 173.48 40.82 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.628 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -59.18 -46.81 87.44 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.087 0.155 . . . . 0.0 111.263 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.49 -64.74 0.71 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.894 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.7 m -61.02 -40.78 94.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -60.19 -46.83 88.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.459 0.171 . . . . 0.0 111.23 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.83 -28.51 69.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.28 -20.69 60.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.89 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 69.2 mt -87.24 -35.49 18.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.791 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.604 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -111.93 159.52 33.24 Favored Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.741 ' HG2' HG22 ' A' ' 121' ' ' VAL . 10.2 Cg_endo -56.3 172.59 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.673 2.249 . . . . 0.0 113.213 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.04 -19.03 60.89 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -108.66 -50.63 2.99 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.741 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -63.02 -34.2 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.532 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.36 -39.43 65.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.801 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -68.53 -48.18 65.0 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.628 0.251 . . . . 0.0 110.93 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.33 -55.52 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.41 ' HB3' ' CH2' ' A' ' 80' ' ' TRP . 92.7 mt -57.73 -59.93 4.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.188 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.47 -28.58 69.39 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.36 -52.54 26.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.298 0.499 . . . . 0.0 110.088 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.404 ' HA ' HD12 ' A' ' 131' ' ' ILE . 3.9 t60 -67.61 -34.42 76.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.508 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.7 tp -64.28 -39.39 93.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.972 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' A' ' 133' ' ' GLN . 34.9 tt0 -67.21 -29.12 68.7 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.182 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 128' ' ' HIS . 51.6 mt -67.86 -35.65 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.571 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.593 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 99.1 mt -68.63 -40.87 80.11 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.563 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.503 ' HB3' ' CG ' ' A' ' 69' ' ' PRO . 15.8 pt20 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.423 ' CA ' ' HE3' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.527 0.793 0 CA-C-O 120.347 -0.141 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.9 t80 -95.21 -45.42 7.19 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m -57.61 -37.27 72.96 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 20.6 pttp -63.35 -32.79 74.3 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.747 0.308 . . . . 0.0 110.625 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -82.84 -38.98 22.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 56.6 mt-30 -57.7 -27.43 62.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.82 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 30.1 pt20 -85.11 -34.64 22.15 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 110.959 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -73.05 -33.67 65.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.3 mt -101.53 -30.84 11.17 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.701 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.18 -1.99 56.38 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.701 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.645 HD11 ' HB3' ' A' ' 79' ' ' ASP . 54.7 mt -55.55 122.05 42.43 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.73 0.265 . . . . 0.0 111.203 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.4 Cg_exo -68.13 177.83 4.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.834 2.356 . . . . 0.0 112.252 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -108.47 31.57 5.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.73 98.85 27.27 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.273 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.55 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 32.9 Cg_exo -61.35 -27.03 82.42 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.919 2.413 . . . . 0.0 112.907 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -78.65 -38.38 39.66 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -96.57 39.32 1.17 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.667 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -107.18 175.61 5.44 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.351 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.66 -179.56 5.72 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.55 -43.79 56.28 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -62.43 -53.39 55.55 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -58.49 -40.71 83.52 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.24 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 81' ' ' VAL . 60.3 t -62.7 -51.52 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.659 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -64.12 -53.86 42.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.352 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.645 ' HB3' HD11 ' A' ' 65' ' ' ILE . 1.2 m-20 -55.99 -35.21 66.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.375 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.9 t90 -70.34 -63.24 1.12 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 85' ' ' VAL . 79.3 t -40.51 -54.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.435 ' HG2' ' CE1' ' A' ' 95' ' ' PHE . 63.5 mtt -55.53 -47.41 76.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.564 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 7.0 t90 -55.8 -37.83 69.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -18.56 61.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.523 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 HG11 ' A' ' 93' ' ' VAL . 47.5 t -79.26 -35.12 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.575 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.54 -31.71 24.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.386 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.564 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.78 -40.66 54.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 111.102 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -103.09 6.22 38.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t 45.67 55.58 6.65 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.452 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.578 ' HB3' HG12 ' A' ' 121' ' ' VAL . 64.4 mt -81.92 174.28 11.43 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.457 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.07 146.92 23.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.457 -179.412 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.07 81.3 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.739 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG22 ' A' ' 85' ' ' VAL . 14.7 p -71.98 128.19 34.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 117.472 0.636 . . . . 0.0 110.917 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.463 ' CB ' ' HD3' ' A' ' 97' ' ' LYS . 11.1 m-20 -98.8 128.68 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' ' HG2' ' A' ' 82' ' ' MET . 39.4 m-85 -86.31 -25.97 25.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.463 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.466 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 30.1 mm-40 -63.9 -34.33 77.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.1 mptt -67.05 -33.5 75.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.189 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 48.6 m-85 -98.28 33.14 2.27 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 37.2 m -88.49 67.19 8.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.041 0.448 . . . . 0.0 110.346 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.524 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.8 ptp -157.08 168.41 27.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.855 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -73.29 158.69 34.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.98 -43.93 87.91 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.743 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.23 62.79 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.98 62.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -55.95 -46.75 78.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.264 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.21 -40.85 94.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.716 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -26.17 67.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.654 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 38.6 mt -65.27 -37.61 87.74 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.09 172.95 49.47 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.331 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.0 ttpt -60.76 -47.2 87.38 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.38 -51.69 61.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.8 m -67.19 -39.51 86.38 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.442 0.163 . . . . 0.0 111.23 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -63.42 -43.1 98.44 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.687 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.93 -24.15 66.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.823 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.87 -23.62 48.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.454 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 95.9 mt -83.62 -36.68 23.69 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.35 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.607 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -108.29 157.79 35.46 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.782 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.0 Cg_endo -56.7 176.82 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.787 2.325 . . . . 0.0 112.978 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.51 -15.63 61.18 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.29 -57.47 2.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.706 -0.798 . . . . 0.0 112.949 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.782 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.5 m -59.17 -33.69 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.75 -34.51 50.85 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.776 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.07 -50.05 21.35 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.419 0.152 . . . . 0.0 110.987 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -57.12 -57.65 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.1 mt -51.68 -58.97 4.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.905 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -61.33 -31.03 70.89 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.559 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.19 -55.5 27.96 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.056 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -70.89 -32.41 69.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.519 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.1 tp -59.11 -49.59 77.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -65.65 -33.91 76.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.485 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.5 mt -61.69 -39.03 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.425 ' HB2' ' HG3' ' A' ' 69' ' ' PRO . 86.2 mt -64.4 -35.69 81.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.777 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.55 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 66.7 mt-30 . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.418 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 CA-C-O 120.165 -0.241 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.589 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 8.5 t80 -101.52 -38.11 8.11 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.823 0.312 . . . . 0.0 110.986 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 m -65.25 -24.56 67.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.194 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -74.66 -36.21 62.82 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.003 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -83.6 -31.68 26.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.667 179.247 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.9 mt-30 -61.32 -29.16 69.71 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.5 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 3.9 pt20 -85.68 -39.5 17.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.521 0.2 . . . . 0.0 111.132 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -71.49 -33.23 69.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.443 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.441 HD13 ' OD1' ' A' ' 79' ' ' ASP . 12.5 mt -99.3 -34.7 10.21 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.638 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.67 -5.0 53.97 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.569 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 85.4 mt -50.74 122.92 17.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.522 0.329 . . . . 0.0 111.483 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 22.9 Cg_exo -64.79 172.23 7.33 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.093 2.528 . . . . 0.0 112.719 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.08 -12.17 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 14.5 t70 -104.12 122.77 43.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.547 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 41.8 Cg_endo -67.51 -24.99 41.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.05 2.5 . . . . 0.0 113.405 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 5.9 mpt_? -70.27 -32.27 70.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.145 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 2.7 pt20 -93.78 24.7 3.98 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.654 0.264 . . . . 0.0 111.213 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.466 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -97.69 169.96 9.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.211 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.6 p -136.9 -174.55 3.76 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.55 -36.73 62.16 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.473 0.178 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.2 m -68.17 -52.85 29.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.349 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -60.79 -39.72 89.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.678 0.275 . . . . 0.0 111.12 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.95 -52.47 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -67.5 -47.75 69.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.376 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD1' HD13 ' A' ' 63' ' ' LEU . 10.1 t70 -61.41 -34.65 75.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.678 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -66.87 -65.16 0.72 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.3 p -42.87 -45.41 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.097 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -58.54 -48.13 81.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -59.18 -38.84 80.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.638 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -20.89 62.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.335 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 81' ' ' VAL . 62.5 t -82.16 -32.39 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.469 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -82.03 -36.92 27.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.82 -38.45 67.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.262 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.61 6.31 39.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 44.97 56.4 5.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.092 0.472 . . . . 0.0 110.768 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.544 ' HB3' HG12 ' A' ' 121' ' ' VAL . 77.0 mt -85.19 172.78 10.91 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 153.59 29.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.323 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.26 77.32 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.828 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.619 ' HB ' HG21 ' A' ' 121' ' ' VAL . 11.1 p -77.97 132.58 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 117.416 0.608 . . . . 0.0 111.118 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 97' ' ' LYS . 29.0 t70 -102.56 136.53 42.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.737 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.22 -23.45 22.36 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.446 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.75 -31.45 72.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 74.5 mmtt -68.11 -35.46 78.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.876 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.543 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 33.7 m-85 -100.17 34.59 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.26 68.9 7.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.466 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.7 ptp -157.78 170.9 21.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.239 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 t -72.12 160.5 32.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.278 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.06 -48.5 79.04 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.62 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.76 -37.48 51.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.647 0.261 . . . . 0.0 111.181 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.46 -45.79 65.07 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.72 -44.67 81.84 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 81.3 m -66.48 -39.49 88.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.825 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.9 73.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.479 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -60.46 -37.92 82.54 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.807 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 175.92 50.69 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.662 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 26.2 ttpp -59.85 -53.86 52.95 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 10.6 pt-20 -48.84 -51.87 27.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.1 m -67.51 -41.77 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.436 ' HE1' ' HB2' ' A' ' 125' ' ' LEU . 50.4 t80 -62.53 -44.91 95.18 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.06 -28.95 70.13 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.941 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 19.3 mm-40 -73.08 -23.68 60.58 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.638 0.256 . . . . 0.0 110.807 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 76.9 mt -83.29 -34.73 25.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.52 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.598 ' HB1' HG23 ' A' ' 121' ' ' VAL . . . -104.99 158.12 32.73 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.471 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.798 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.5 Cg_endo -57.43 176.88 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.778 2.318 . . . . 0.0 112.927 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.75 -14.77 60.06 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.16 -59.01 1.95 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.913 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -58.76 -32.33 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.34 -33.48 46.55 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.1 -45.86 46.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.497 0.189 . . . . 0.0 111.27 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.401 HD12 HD21 ' A' ' 90' ' ' LEU . 50.3 mt -63.64 -60.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.539 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.436 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . 71.6 mt -49.74 -56.82 8.8 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.085 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.474 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -63.7 -34.28 77.52 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.16 -55.51 32.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.579 ' HA ' HD12 ' A' ' 131' ' ' ILE . 17.9 t-160 -71.14 -31.35 67.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 34.3 tp -57.93 -46.07 85.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.0 mm-40 -70.32 -32.4 70.12 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.377 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.8 mt -60.96 -39.42 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 93.7 mt -60.77 -33.62 73.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.534 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 76.3 mt-30 . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.032 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.547 0 CA-C-O 120.221 -0.21 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -97.79 -48.84 5.04 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.694 0.247 . . . . 0.0 111.085 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -59.42 -35.98 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.191 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.01 -31.96 73.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 39.8 tt0 -68.6 -37.62 79.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.061 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -59.77 -24.81 64.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -84.17 -18.19 37.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.764 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 51.7 mtt180 -87.99 -42.67 12.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.601 0.239 . . . . 0.0 111.379 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mp -106.6 -25.56 11.75 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.29 10.59 50.91 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 81.4 mt -50.43 125.21 19.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.667 0.233 . . . . 0.0 111.484 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 27.0 Cg_exo -61.69 170.11 6.15 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.876 2.384 . . . . 0.0 112.361 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -98.69 39.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.201 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.529 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 12.5 t70 -172.75 126.45 0.51 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 111.453 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.663 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 22.2 Cg_endo -60.4 -40.7 55.65 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.397 2.731 . . . . 0.0 113.01 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -52.85 -36.23 58.58 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.13 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 29.4 pt20 -99.06 36.73 1.65 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.931 0.396 . . . . 0.0 111.373 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.517 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 17.1 m0 -113.03 174.85 5.7 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.625 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -134.86 -175.42 3.9 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' MET . 42.0 mt-10 -52.42 -37.9 57.82 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.9 m -68.72 -52.76 27.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.641 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.64 -42.24 96.52 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.668 0.27 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.558 HG13 HD22 ' A' ' 105' ' ' LEU . 42.6 t -59.72 -52.95 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.226 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -69.98 -45.14 67.98 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.599 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.36 -37.45 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.484 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -68.82 -60.69 2.21 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.9 t -41.26 -55.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.538 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.4 ttm -54.5 -45.66 73.32 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -59.23 -35.62 73.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.998 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.18 -18.85 58.89 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.304 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.811 ' CG2' HG11 ' A' ' 93' ' ' VAL . 96.3 t -83.18 -33.39 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.659 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.41 -35.06 17.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -41.15 63.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -100.61 7.68 43.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.817 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.7 m 45.52 56.74 5.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.977 0.418 . . . . 0.0 111.172 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.656 ' HB3' HG12 ' A' ' 121' ' ' VAL . 71.3 mt -85.14 173.11 10.69 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.321 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.31 152.27 32.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.673 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.95 -2.75 87.17 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.699 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.811 HG11 ' CG2' ' A' ' 85' ' ' VAL . 13.2 p -78.86 135.03 26.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 117.201 0.5 . . . . 0.0 111.318 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.8 m-20 -112.41 137.69 50.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.98 -24.54 23.51 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.929 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -61.21 -33.69 73.88 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.2 mptt -70.41 -34.01 72.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.721 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 47.9 m-85 -98.26 33.33 2.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.5 66.16 8.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.123 0.487 . . . . 0.0 110.32 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.5 ptp -157.74 167.01 31.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.791 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 m -72.88 160.57 31.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.45 -42.34 95.76 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.871 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.93 68.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.76 68.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.529 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.558 HD22 HG13 ' A' ' 77' ' ' VAL . 15.4 tp -56.08 -43.62 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.085 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.8 m -67.17 -41.74 85.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.842 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -27.98 69.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.556 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 26.3 mt -63.69 -36.19 83.05 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.746 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.7 178.21 50.0 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.725 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -59.96 -53.28 59.69 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -46.66 -52.2 14.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.3 m -70.27 -41.37 73.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.443 ' HE2' HD21 ' A' ' 105' ' ' LEU . 36.6 t80 -61.79 -45.53 93.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.41 0.148 . . . . 0.0 111.232 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.45 -25.73 67.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.884 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.58 -21.6 55.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.669 0.271 . . . . 0.0 110.48 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -86.51 -39.74 15.95 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.721 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -104.2 158.37 32.08 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.21 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.677 ' HG2' HG22 ' A' ' 121' ' ' VAL . 19.2 Cg_endo -58.16 175.11 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.864 2.376 . . . . 0.0 113.17 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.66 -15.94 54.55 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.28 -55.08 2.42 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.631 -0.827 . . . . 0.0 112.902 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.705 ' CG2' ' HB1' ' A' ' 117' ' ' ALA . 2.2 m -62.19 -33.64 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.83 -35.87 54.05 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.781 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.59 -43.86 53.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.74 0.305 . . . . 0.0 111.139 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.33 -56.48 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 111.568 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.523 HD23 HG22 ' A' ' 81' ' ' VAL . 11.0 mp -58.44 -58.9 6.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -30.94 70.81 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.49 -53.44 48.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.316 0.507 . . . . 0.0 109.921 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.488 ' HA ' HD12 ' A' ' 131' ' ' ILE . 19.9 t-80 -68.79 -31.56 70.67 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.241 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.456 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 29.3 tp -58.3 -45.9 87.14 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.288 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.58 -41.81 99.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.035 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 128' ' ' HIS . 95.8 mt -55.68 -43.3 72.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.284 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.581 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.3 mt -63.36 -41.68 98.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.663 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 25.4 mt-30 . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.068 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.484 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.691 0 CA-C-O 120.377 -0.124 . . . . 0.0 112.901 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.441 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.0 t80 -95.39 -46.72 6.59 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 116.621 0.211 . . . . 0.0 110.473 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -57.05 -35.87 69.82 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.232 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 20.4 pttp -63.32 -32.88 74.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.31 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -41.3 21.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.349 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.3 mt-30 -59.85 -27.08 66.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.719 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -85.85 -38.34 18.22 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.505 0.193 . . . . 0.0 111.106 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -70.25 -33.59 71.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.475 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.9 mt -100.17 -33.79 10.3 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.32 -1.68 50.34 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.705 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 79' ' ' ASP . 56.3 mt -53.52 125.68 45.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 111.316 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 20.2 Cg_exo -65.23 173.81 5.75 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.828 2.352 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -93.02 -18.67 22.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.485 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -94.1 121.44 63.96 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.73 0.3 . . . . 0.0 111.295 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.561 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 38.5 Cg_endo -66.93 -26.99 43.52 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.075 2.517 . . . . 0.0 113.151 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 3.7 mpt_? -72.88 -33.58 66.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.601 0.239 . . . . 0.0 110.399 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.23 40.98 1.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.505 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.7 m0 -113.38 171.47 7.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.661 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.2 p -134.12 -178.38 5.01 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -50.62 -38.99 48.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.489 0.185 . . . . 0.0 111.214 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.5 m -66.61 -55.82 13.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.345 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -58.45 -39.07 78.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.161 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 81' ' ' VAL . 44.7 t -61.87 -49.52 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.554 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -74.62 -40.4 61.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.326 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -60.14 -36.25 77.11 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.506 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.505 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 15.3 t90 -71.96 -60.99 1.95 Allowed 'General case' 0 C--N 1.339 0.124 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.8 t -40.77 -53.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 123.421 0.451 . . . . 0.0 110.842 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.4 ttm -56.03 -46.33 78.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.445 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 19.1 t90 -60.93 -39.7 90.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.776 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.67 64.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.993 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 81' ' ' VAL . 77.6 t -80.22 -29.56 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.954 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -82.25 -34.41 28.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.445 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.49 -40.41 70.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -103.27 6.55 38.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.808 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.2 m 43.99 54.58 5.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.617 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.522 HD13 ' HB ' ' A' ' 121' ' ' VAL . 72.8 mt -81.23 174.12 11.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.472 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.427 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.4 OUTLIER -156.52 151.52 26.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.501 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 -8.01 78.55 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.901 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 121' ' ' VAL . 12.6 p -76.77 135.35 26.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.53 0.665 . . . . 0.0 110.911 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.79 138.34 41.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.05 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.75 -27.11 20.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.285 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.518 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 14.7 tt0 -60.48 -31.52 70.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 35.5 mmtp -65.32 -36.88 85.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.867 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 33.3 m-85 -99.82 34.28 2.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.643 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 9.6 m -87.3 69.16 9.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.194 0.521 . . . . 0.0 110.208 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.433 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.4 ptp -158.97 171.03 20.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.824 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.9 p -72.18 159.85 33.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.37 -43.5 93.81 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.54 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.39 63.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.48 -46.18 60.56 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.6 -46.18 84.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.146 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 72.6 m -64.18 -38.78 92.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 110.516 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.69 74.44 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 54.3 mt -61.54 -34.97 76.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 177.49 41.19 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.609 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.506 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.5 ttpt -62.89 -40.96 99.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.565 0.221 . . . . 0.0 110.986 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.35 -64.06 0.93 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.301 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.4 m -64.52 -37.54 87.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.06 -46.2 90.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.541 0.21 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.1 -30.29 71.36 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.673 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.4 -22.96 61.04 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.734 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 88.5 mt -85.01 -41.4 15.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.543 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.478 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -102.74 157.62 33.36 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.849 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.639 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 74.1 Cg_exo -47.14 166.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.309 2.672 . . . . 0.0 113.662 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.44 -15.01 63.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.719 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -108.25 -60.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.98 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.639 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 11.8 m -59.24 -34.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -52.85 -36.65 50.82 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.934 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.47 -49.22 67.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.447 0.165 . . . . 0.0 111.188 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.0 mt -58.92 -57.34 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.722 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -50.35 -53.94 25.24 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 4.7 t90 -66.18 -28.74 69.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.178 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.31 -51.8 68.29 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -76.45 -37.26 57.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 41.5 tp -54.22 -48.58 70.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.85 -40.73 91.97 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.0 mt -54.72 -46.33 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.641 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.1 mt -51.63 -36.9 47.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.126 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.561 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 64.4 mt-30 . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.393 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -89.31 -48.3 7.45 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.3 m -55.04 -38.86 68.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -57.99 -35.96 71.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.461 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -77.97 -41.38 36.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.847 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -58.58 -29.32 66.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.477 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.84 -19.27 52.43 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.416 ' HB2' HD12 ' A' ' 63' ' ' LEU . 81.6 mtt180 -77.46 -42.9 34.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 111.31 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 62' ' ' ARG . 5.7 mp -101.34 -24.73 14.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.2 11.03 53.67 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.495 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.43 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.5 mt -60.51 129.44 89.33 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.312 0.245 . . . . 0.0 111.249 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.8 Cg_endo -74.29 167.72 26.49 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.394 2.063 . . . . 0.0 112.112 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -93.52 55.61 2.25 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 111.194 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 25.1 t70 -168.14 124.84 0.86 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.602 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 22.8 Cg_exo -65.12 -44.06 10.24 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.523 2.815 . . . . 0.0 113.517 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.47 -37.19 37.2 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.252 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.471 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 10.5 pt20 -100.56 44.36 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.901 0.381 . . . . 0.0 111.377 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.595 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 7.0 m0 -119.88 169.51 10.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -132.53 179.67 5.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.99 -42.6 49.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.6 m -63.47 -49.44 73.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.527 0.203 . . . . 0.0 111.357 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.43 ' CD2' HG12 ' A' ' 65' ' ' ILE . 44.0 m170 -61.2 -41.26 96.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.009 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.75 -53.59 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -65.64 -47.96 73.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.513 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.15 -37.7 72.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 121.149 -0.22 . . . . 0.0 110.776 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.544 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 17.4 t90 -69.2 -62.02 1.55 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 85' ' ' VAL . 54.5 t -41.47 -53.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.4 ttm -55.22 -46.73 75.94 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.493 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 16.0 t90 -60.37 -38.1 82.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.91 61.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.571 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 81' ' ' VAL . 78.6 t -83.16 -33.71 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 120.67 0.271 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -82.1 -37.66 26.0 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.5 -39.04 71.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.097 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -100.48 4.81 43.94 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 m 45.38 53.8 7.9 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 121' ' ' VAL . 63.3 mt -85.34 166.55 16.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.498 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.37 152.82 33.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.82 -10.97 71.94 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.605 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.644 ' HB ' HG11 ' A' ' 121' ' ' VAL . 14.7 p -79.74 135.86 24.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 117.361 0.581 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.71 138.97 41.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.293 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.18 -27.18 23.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.755 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -61.59 -29.69 70.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 49.6 mmtm -67.02 -33.14 74.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.292 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.62 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 28.3 m-85 -100.13 32.25 3.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.709 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.35 65.63 8.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.218 0.532 . . . . 0.0 110.533 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.448 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.9 ptp -158.77 167.73 28.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.7 p -74.04 161.7 29.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -59.45 -40.28 95.96 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.38 76.87 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 110.743 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.95 64.77 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.553 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.98 -42.24 84.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.01 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.56 -42.12 92.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.539 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.65 72.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.0 mt -59.95 -33.57 72.1 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.39 177.72 48.77 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.36 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.72 -47.11 86.74 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 10.0 tp10 -50.1 -67.35 0.27 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.701 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.574 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.6 m -55.75 -40.99 73.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.704 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -62.54 -43.78 97.97 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.0 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.88 -30.84 71.85 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.679 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 14.4 mm-40 -70.33 -25.08 63.13 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.4 mt -86.92 -36.74 18.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.62 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -97.14 167.44 11.97 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.827 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 18.1 Cg_exo -67.65 174.39 7.58 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.054 2.503 . . . . 0.0 113.178 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.78 -29.92 71.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.324 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.4 -49.91 3.11 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.885 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 90' ' ' LEU . 98.9 t -59.44 -39.45 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.399 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 117' ' ' ALA . . . -52.5 -38.77 51.89 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.909 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.31 -49.22 70.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 111.054 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mt -56.95 -47.87 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.713 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.7 -59.21 4.87 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.87 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -63.34 -27.16 69.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.18 -54.97 25.2 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.945 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -71.25 -35.55 71.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.177 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.544 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.0 tp -61.02 -46.54 90.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.72 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.21 -35.63 81.45 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.126 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.67 -44.33 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.6 mt -57.22 -35.83 70.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.974 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.602 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 70.1 mt-30 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.605 0.24 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.1 ttt 72.09 -72.07 0.12 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.471 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -144.58 133.13 22.09 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.641 0.258 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 75.6 m -118.59 105.05 11.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.969 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 55.2 81.41 0.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -133.64 123.47 25.09 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.35 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.63 91.07 37.39 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.432 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.68 105.06 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.963 2.442 . . . . 0.0 112.904 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -150.43 -67.37 0.2 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.495 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 74.4 mt -147.66 51.76 1.05 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.674 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.94 110.27 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.839 2.36 . . . . 0.0 112.173 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.9 p -145.62 151.41 38.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.467 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SEP . . . . . 0.573 ' HA ' ' HE2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -59.42 -38.5 80.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.313 0.102 . . . . 0.0 111.227 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -68.03 -40.66 82.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.512 0.196 . . . . 0.0 110.788 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.573 ' HE2' ' HA ' ' A' ' 41' ' ' SEP . 74.6 mtm -65.62 -37.36 86.36 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.725 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.1 mmm -59.9 -45.32 92.91 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.801 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.5 m -67.94 -39.14 83.5 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.6 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -51.19 -52.73 41.52 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.207 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.15 78.81 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.344 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.444 HD23 ' CZ ' ' A' ' 88' ' ' PHE . 22.0 mt -58.73 -43.12 90.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.341 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 8.3 mtpm? -61.59 -41.86 98.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.862 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.35 -30.45 57.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.418 HG22 ' CH2' ' A' ' 83' ' ' TRP . 82.6 m -67.33 -38.08 84.32 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 22.8 m-85 -45.0 -53.2 8.01 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.8 p -57.88 -33.97 69.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' HA2' ' HD2' ' A' ' 58' ' ' LYS . . . -79.55 -0.81 85.28 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.038 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.485 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.8 t80 -87.18 -55.14 3.95 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 116.932 0.366 . . . . 0.0 110.402 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.7 m -53.71 -33.35 55.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.209 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.465 ' HD2' ' HA2' ' A' ' 55' ' ' GLY . 90.0 mttt -63.93 -31.8 73.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -86.17 -39.92 16.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 46.5 mt-30 -56.43 -31.67 64.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.302 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -82.98 -33.83 26.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.731 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -69.51 -37.65 77.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.398 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.27 -34.93 10.51 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.33 -0.69 31.08 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.636 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.0 mt -55.88 124.23 56.93 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 122.308 0.243 . . . . 0.0 111.078 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.1 Cg_endo -73.33 167.22 27.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.556 2.171 . . . . 0.0 112.467 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -76.48 -31.02 57.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.585 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.455 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 30.1 t70 -83.99 126.55 69.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.47 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 61.4 Cg_endo -72.62 -24.89 18.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.289 2.659 . . . . 0.0 113.869 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 6.2 mpt_? -69.29 -31.66 70.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.99 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 20.8 pt20 -93.97 36.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 111.084 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.639 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.6 m0 -103.77 166.19 10.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -134.15 179.19 6.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.01 -41.58 47.56 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -63.24 -54.14 42.06 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.274 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.482 ' CD2' HG12 ' A' ' 65' ' ' ILE . 38.0 m170 -58.54 -39.41 80.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 81' ' ' VAL . 54.4 t -62.16 -52.24 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.4 ttm105 -69.18 -47.31 65.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.27 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -35.01 69.14 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 26.5 t90 -72.33 -61.67 1.71 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.525 HG13 HD21 ' A' ' 125' ' ' LEU . 48.3 t -40.11 -52.48 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.383 0.427 . . . . 0.0 110.902 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.411 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 40.9 ttm -57.2 -47.79 80.39 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.574 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.423 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 18.8 t90 -59.96 -39.27 85.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.826 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.7 65.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 81' ' ' VAL . 77.9 t -76.3 -31.23 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.966 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.4 -31.98 32.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.071 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 11.0 mm-40 -70.15 -41.32 73.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.28 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.444 ' CZ ' HD23 ' A' ' 49' ' ' LEU . 88.2 m-85 -107.08 9.91 30.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.8 m 44.66 54.26 6.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 110.527 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 121' ' ' VAL . 62.9 mt -82.02 178.21 8.41 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.467 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.18 151.34 15.61 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.553 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.86 -8.69 77.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.716 ' HB ' HG21 ' A' ' 121' ' ' VAL . 12.7 p -83.44 138.7 18.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 117.543 0.672 . . . . 0.0 111.158 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -116.56 152.9 33.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -95.41 -9.85 31.59 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.409 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -63.72 -42.83 97.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 71.0 mmtt -65.99 -32.5 74.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.171 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 38.4 m-85 -99.5 33.45 2.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.583 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.7 t -87.69 64.7 8.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.115 0.483 . . . . 0.0 110.271 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.4 ptp -157.17 169.91 23.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.779 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.9 p -76.87 166.53 23.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.322 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.92 -43.65 96.61 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.803 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.42 63.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.689 0.28 . . . . 0.0 110.929 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.72 -46.41 53.77 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.06 -45.67 79.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.182 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.33 -41.39 85.33 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.674 0.273 . . . . 0.0 110.821 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.21 71.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.496 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.494 HD13 HD11 ' A' ' 116' ' ' LEU . 61.9 mt -60.72 -39.79 89.94 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.22 172.47 44.65 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.507 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.1 ttpt -59.06 -55.07 39.75 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.37 -49.9 63.46 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 98.8 m -63.58 -43.61 96.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.509 0.195 . . . . 0.0 111.004 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -62.97 -41.25 99.48 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.675 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.62 -27.43 68.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.721 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -76.31 -23.95 54.34 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.693 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 97.5 mt -79.94 -34.04 39.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -109.33 161.53 23.58 Favored Pre-proline 0 N--CA 1.462 0.137 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.243 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.651 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 68.1 Cg_exo -50.06 165.64 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.878 2.386 . . . . 0.0 113.139 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.84 -15.42 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.644 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -108.21 -61.1 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.992 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.716 HG21 ' HB ' ' A' ' 93' ' ' VAL . 12.1 m -60.43 -34.33 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.8 -36.14 40.58 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.129 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -65.56 -47.82 74.53 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.519 0.2 . . . . 0.0 111.313 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.26 -54.64 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.328 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.525 HD21 HG13 ' A' ' 81' ' ' VAL . 10.9 mp -53.33 -54.67 33.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.341 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.451 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 2.6 t90 -62.04 -29.92 70.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.11 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.07 -59.26 5.71 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.424 ' HA ' HD12 ' A' ' 131' ' ' ILE . 2.7 t60 -69.54 -36.18 76.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.818 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.514 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.2 tp -61.29 -43.04 99.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.83 -33.33 74.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 128' ' ' HIS . 59.4 mt -59.18 -42.19 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.029 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.42 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 95.8 mt -57.98 -38.36 75.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.596 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -66.01 -53.91 32.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.919 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.46 -45.62 93.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.69 -41.18 98.98 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.959 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -114.33 75.59 0.94 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.323 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.22 124.33 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.25 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.234 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.472 ' ND1' HD22 ' A' ' 49' ' ' LEU . 39.8 m80 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.572 0.225 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.477 ' HG3' HG12 ' A' ' 131' ' ' ILE . 26.0 mmt 71.77 -67.92 0.24 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.325 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -83.88 153.7 23.84 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.722 0.296 . . . . 0.0 111.015 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -65.5 97.41 0.3 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.977 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.53 -52.57 0.04 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -155.71 46.67 0.49 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.07 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.76 114.37 19.63 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.175 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -86.67 151.69 8.8 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.989 2.459 . . . . 0.0 112.629 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.527 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -72.43 151.24 42.71 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 37' ' ' LEU . 1.5 tm? -92.14 89.78 7.06 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.823 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.473 HG23 HD13 ' A' ' 36' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.83 96.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.912 2.408 . . . . 0.0 112.14 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.0 m -152.08 -174.27 4.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.872 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HB3' HD11 ' A' ' 36' ' ' LEU . 57.7 tptt -66.87 -28.19 68.14 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.383 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -75.18 -24.25 57.84 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.5 mtm -56.73 -41.45 77.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -62.88 -35.4 79.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.672 0.272 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.429 ' OG ' ' HD3' ' A' ' 50' ' ' LYS . 30.0 t -61.43 -34.8 76.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.268 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -43.82 -52.41 6.73 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.85 -43.81 66.33 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.472 HD22 ' ND1' ' A' ' 28' ' ' HIS . 7.3 mp -82.91 -35.19 26.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HD3' ' OG ' ' A' ' 46' ' ' SER . 12.8 tptt -66.09 -47.55 73.87 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.58 89.67 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.319 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.443 HG21 ' CE2' ' A' ' 88' ' ' PHE . 89.3 m -50.8 -47.92 59.77 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.192 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 27.7 m-85 -46.18 -53.72 10.01 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.351 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.2 m -62.65 -30.92 71.73 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.111 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.72 -0.75 64.57 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.712 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.529 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 17.7 t80 -94.69 -45.46 7.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 116.701 0.251 . . . . 0.0 110.338 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 95.0 m -58.3 -37.02 74.22 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.978 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 4.7 ptpp? -63.15 -30.64 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.298 . . . . 0.0 110.41 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.51 -40.12 23.68 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.045 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 57.1 mt-30 -56.14 -28.7 58.95 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.705 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 3.4 pt20 -88.44 -37.51 15.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.591 0.234 . . . . 0.0 110.992 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -67.25 -39.86 86.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.281 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.79 -29.57 12.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.6 -1.05 49.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -52.45 123.55 29.69 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 122.348 0.259 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 58.1 Cg_endo -71.73 168.94 22.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.494 2.129 . . . . 0.0 112.507 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -97.21 39.74 1.18 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.225 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 5.5 t70 -144.07 114.22 5.38 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 36.8 Cg_endo -65.7 -24.59 54.86 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.799 2.333 . . . . 0.0 112.775 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.512 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 3.4 mpt_? -77.71 -31.24 52.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 11.4 mm-40 -96.77 34.92 1.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.935 0.397 . . . . 0.0 110.487 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.512 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 4.1 m0 -107.91 170.35 8.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.69 -177.56 4.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.242 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HG2' ' CA ' ' A' ' 100' ' ' MET . 46.0 mt-10 -50.04 -42.81 50.33 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 m -64.34 -51.69 62.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.537 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -60.15 -42.01 93.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.25 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.425 HG13 HD22 ' A' ' 105' ' ' LEU . 56.0 t -60.26 -53.4 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -68.02 -46.71 70.47 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.696 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -56.49 -41.31 76.43 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.512 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.433 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.8 t90 -64.7 -61.98 1.86 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . 55.9 t -41.12 -53.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.793 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.4 ttm -58.22 -48.19 81.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.77 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 15.4 t90 -56.95 -38.43 72.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.836 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.14 83.47 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.515 ' CG2' HG11 ' A' ' 93' ' ' VAL . 81.6 t -53.1 -34.5 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.592 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -79.65 -36.19 38.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.157 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 9.3 mm-40 -68.2 -39.43 82.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.446 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 52' ' ' THR . 97.8 m-85 -107.7 8.55 29.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 46.08 50.79 11.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 110.467 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 121' ' ' VAL . 67.6 mt -78.75 177.68 8.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.481 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.457 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.34 152.82 17.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.26 73.63 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.811 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.597 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.9 p -74.96 132.04 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 117.58 0.69 . . . . 0.0 110.873 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 7.9 m-20 -99.12 133.93 42.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.1 -23.78 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.411 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.574 ' HG3' ' HD2' ' A' ' 97' ' ' LYS . 14.1 pt20 -63.22 -33.22 75.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.626 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.3 mptp? -67.49 -34.94 78.18 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.999 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 38.7 m-85 -100.62 34.85 2.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.662 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.4 t -87.76 64.62 8.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.138 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.46 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.3 ptp -155.7 167.95 28.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.756 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -73.77 159.69 32.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.344 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -55.29 -43.51 84.41 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.961 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.66 -38.6 60.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.665 0.269 . . . . 0.0 111.037 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.02 58.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 77' ' ' VAL . 14.1 tp -55.79 -44.72 78.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.079 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.77 -41.76 91.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.777 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.25 72.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.8 mt -61.37 -36.98 81.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.93 176.4 51.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.678 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 52.0 tttp -61.36 -51.3 69.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -50.48 -52.33 39.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.4 m -66.55 -42.67 86.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 126' ' ' TRP . 59.0 t80 -63.72 -42.14 97.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.99 -29.65 70.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.717 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.67 -21.25 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.664 0.268 . . . . 0.0 110.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.6 mt -85.8 -32.59 21.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.835 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -112.4 150.91 43.32 Favored Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.626 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 85.6 Cg_exo -44.23 167.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.691 2.927 . . . . 0.0 114.079 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.95 -24.05 67.7 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.3 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.06 -49.19 3.24 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.524 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.626 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.2 m -63.11 -34.37 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.168 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.91 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.816 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 16.3 t70 -61.34 -45.35 94.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.577 0.227 . . . . 0.0 110.945 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.463 ' CD1' HD21 ' A' ' 90' ' ' LEU . 73.7 mt -61.98 -56.93 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.268 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.8 mt -55.07 -57.36 12.05 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.3 -36.1 79.14 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.335 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 123' ' ' ASP . 30.9 tt0 -56.47 -54.87 40.63 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.49 ' HA ' HD12 ' A' ' 131' ' ' ILE . 22.3 t-160 -72.47 -30.3 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.653 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 52.4 tp -59.59 -49.85 76.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.104 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 15.3 mm-40 -67.29 -33.69 75.83 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.222 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 128' ' ' HIS . 69.3 mt -58.64 -40.17 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.315 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.517 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.0 mt -62.39 -39.08 92.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.456 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.3 mt-30 -62.6 -50.96 69.19 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.798 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HE3' ' HA ' ' A' ' 131' ' ' ILE . 48.2 mtmt -65.89 -35.14 79.81 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.988 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -60.43 -46.68 89.16 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.809 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -148.23 111.22 4.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.472 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.48 -36.46 20.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.547 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.917 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.9 p80 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.677 0.275 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.0 mtt -74.18 -61.06 1.99 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.017 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.92 -42.29 0.27 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.601 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.9 m -86.73 115.05 23.91 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.675 0.274 . . . . 0.0 110.802 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.436 ' HB3' HG23 ' A' ' 137' ' ' VAL . . . -78.74 -14.26 59.37 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.829 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.12 65.53 7.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.923 0.392 . . . . 0.0 110.599 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.0 t -140.07 128.76 13.25 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.65 156.43 49.14 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.713 2.275 . . . . 0.0 112.495 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt -122.67 75.02 1.23 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.169 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.3 tp -101.11 74.85 1.61 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.206 0.527 . . . . 0.0 110.568 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -43.9 95.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.169 2.579 . . . . 0.0 112.735 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.5 t -177.37 -165.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.339 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -64.97 -40.24 94.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.56 -35.83 77.94 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.514 0.197 . . . . 0.0 110.485 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.2 ttp -58.09 -32.03 67.68 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.854 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.3 mtp -61.17 -41.71 97.26 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.802 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.8 t -59.8 -46.96 87.58 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.64 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.57 -52.57 17.23 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.614 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.67 -49.75 69.88 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.9 -34.52 75.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.48 -42.91 97.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.595 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.32 -29.93 30.77 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.6 m -55.58 -49.44 72.72 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -101.21 41.57 1.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 47.9 m -71.8 -32.55 67.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.371 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.6 -16.81 79.8 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.804 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.7 t80 -89.01 -47.78 7.88 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.675 0.237 . . . . 0.0 110.779 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.9 m -55.06 -31.75 61.38 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.52 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 54' ' ' SER . 34.6 mmtp -62.19 -30.33 71.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.342 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -84.38 -42.18 15.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 31.8 mt-30 -58.33 -31.76 67.86 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.374 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.9 -35.73 25.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.517 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -65.86 -35.23 80.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.46 -32.44 9.5 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.85 4.46 39.28 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.627 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.96 127.74 69.49 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.354 0.262 . . . . 0.0 110.929 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.53 174.49 12.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 112.76 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -100.84 45.95 0.96 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 5.8 m-20 -144.48 113.32 5.12 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.504 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 20.3 Cg_endo -61.77 -29.72 83.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.765 2.31 . . . . 0.0 112.823 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.504 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 5.5 mpt_? -74.47 -33.45 62.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.558 0.218 . . . . 0.0 110.495 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -95.7 35.03 1.41 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.079 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.546 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.3 m0 -109.73 160.43 16.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.4 t -127.04 -179.32 4.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.345 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.48 -49.63 44.75 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 m -58.16 -45.95 86.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.314 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -64.19 -41.68 96.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.528 HG13 HD22 ' A' ' 105' ' ' LEU . 55.8 t -62.5 -54.54 32.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.117 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -65.75 -45.49 82.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.55 -42.28 92.01 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.581 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 21.9 t90 -63.4 -60.33 3.51 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.624 HG13 HD21 ' A' ' 125' ' ' LEU . 40.3 t -42.19 -53.9 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.365 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.433 ' HB2' ' HE3' ' A' ' 82' ' ' MET . 37.7 ttm -56.24 -45.97 79.77 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.705 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.532 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 52.1 t90 -56.77 -36.44 69.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.88 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.35 58.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.156 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.519 HG22 HG11 ' A' ' 93' ' ' VAL . 89.0 t -78.52 -34.81 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.484 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.35 -37.45 23.33 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.138 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 7.3 mm-40 -70.23 -36.07 74.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.309 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.7 8.78 24.91 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t 43.62 62.11 2.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.121 0.486 . . . . 0.0 110.498 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.58 HD13 ' HB ' ' A' ' 121' ' ' VAL . 59.9 mt -90.43 153.47 20.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.475 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 151.27 49.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.77 -10.62 73.09 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.707 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.583 ' HB ' HG21 ' A' ' 121' ' ' VAL . 13.8 p -79.54 139.75 17.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 117.404 0.602 . . . . 0.0 110.938 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 10.5 m-20 -117.55 144.17 45.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.212 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.25 -18.66 26.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.977 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.09 -36.44 81.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.041 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.0 mptt -69.24 -34.43 74.79 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.527 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 42.8 m-85 -99.96 33.5 2.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.1 t -86.88 64.29 8.41 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.219 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.449 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.7 ptp -156.45 169.32 24.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.735 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.2 m -75.81 161.5 28.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.373 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.84 -44.09 92.2 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.014 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.75 59.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.987 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.0 -44.48 63.41 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.528 HD22 HG13 ' A' ' 77' ' ' VAL . 13.9 tp -57.62 -46.64 83.84 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.271 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.92 -38.48 91.26 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 110.604 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.21 67.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.561 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 66.4 mt -64.17 -35.22 80.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.04 175.79 45.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.589 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.28 -66.62 0.37 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.4 m -58.57 -39.53 80.58 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 54.1 t80 -64.17 -45.88 86.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.305 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.1 mt -63.09 -26.37 68.8 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.036 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -75.47 -22.63 57.09 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.603 0.24 . . . . 0.0 110.76 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -83.04 -36.26 25.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.585 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.527 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -108.39 155.27 40.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.601 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.665 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 76.9 Cg_exo -48.53 169.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.233 2.622 . . . . 0.0 113.775 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.89 -22.97 67.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.983 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -107.81 -57.04 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.364 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.665 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 6.1 m -60.24 -33.29 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.34 -32.99 57.93 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.229 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.17 -48.63 77.58 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.64 0.22 . . . . 0.0 111.422 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.547 ' CD1' HD21 ' A' ' 90' ' ' LEU . 74.0 mt -54.6 -54.48 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.493 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.624 HD21 HG13 ' A' ' 81' ' ' VAL . 10.0 mp -54.28 -59.73 4.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.275 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.76 -30.77 67.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.939 -0.077 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.09 -57.75 11.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -73.77 -39.39 64.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.006 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.581 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.8 tp -54.08 -46.11 71.95 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.36 -35.19 75.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.192 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.48 -42.98 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.473 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.8 mt -52.14 -39.62 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.78 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -60.6 -45.81 92.61 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.823 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -69.96 -40.01 75.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.392 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -53.93 -41.31 67.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.674 0.273 . . . . 0.0 111.096 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.71 95.11 2.37 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.335 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 32' ' ' ALA . 47.6 t -75.95 92.45 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.14 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.911 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.9 p80 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.583 0.23 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.1 ttt 70.95 137.32 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.501 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -147.28 118.87 7.96 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.774 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.0 t -93.8 -56.73 2.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.309 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.32 -51.44 63.41 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.508 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.524 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 11.3 t70 -86.37 145.4 26.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.046 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -92.39 135.27 26.93 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.06 104.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.906 2.404 . . . . 0.0 112.796 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.3 tp -171.82 145.56 1.94 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.558 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.23 89.69 0.47 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.126 0.488 . . . . 0.0 110.683 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -43.24 118.93 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.108 2.539 . . . . 0.0 112.828 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.8 p -166.65 178.39 6.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.989 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -72.03 -39.26 69.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.825 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 6.3 tp10 -60.29 -39.17 85.96 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.721 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 58.3 mtm -78.86 -30.48 45.15 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.017 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.8 ttt -56.95 -48.83 77.41 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.088 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.0 m -83.87 -26.84 29.11 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.031 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -55.12 -52.18 64.09 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.71 0.29 . . . . 0.0 110.883 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.28 90.14 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.169 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 131' ' ' ILE . 90.6 mt -61.95 -40.24 94.87 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.74 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -70.15 -35.68 74.21 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.451 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.26 -31.21 71.39 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.618 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -58.63 -28.19 65.43 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.334 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -50.27 -28.08 7.15 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 77.7 p -52.74 -41.41 63.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.653 0.206 . . . . 0.0 111.424 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.06 -22.83 56.77 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.654 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 29.8 t80 -83.25 -50.45 8.4 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 116.453 0.126 . . . . 0.0 110.796 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.71 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 28.8 m -55.72 -40.78 72.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 54' ' ' SER . 32.0 mmmt -64.95 -25.17 67.76 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 110.851 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.89 -48.17 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.71 ' HG2' ' HA ' ' A' ' 57' ' ' THR . 5.2 pt20 -65.95 -24.96 66.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.043 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.92 -31.04 40.13 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.697 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -67.65 -30.83 70.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.787 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.13 -30.74 11.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.079 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.82 -1.64 27.35 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.173 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 60' ' ' GLN . 51.5 mt -60.41 128.27 87.73 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.843 0.321 . . . . 0.0 110.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 77.0 Cg_endo -78.95 175.06 11.38 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.614 2.21 . . . . 0.0 112.505 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 43.63 1.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 111.154 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 11.1 m-20 -153.57 111.03 2.57 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.57 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 40.9 Cg_exo -57.42 -36.51 98.8 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.988 2.459 . . . . 0.0 112.48 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -55.4 -37.91 68.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.468 0.175 . . . . 0.0 111.105 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 68' ' ' ASP . 12.0 pt20 -99.95 44.31 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.969 0.414 . . . . 0.0 111.156 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.583 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.4 m0 -117.23 169.61 9.33 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.086 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -131.54 -177.84 4.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -51.32 -44.28 61.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.3 m -63.62 -48.59 76.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.628 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CD2' HG12 ' A' ' 65' ' ' ILE . 45.3 m170 -60.83 -42.13 97.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.316 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 81' ' ' VAL . 60.5 t -61.28 -52.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.21 -47.1 68.79 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.498 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.18 -43.18 82.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.55 0.214 . . . . 0.0 110.54 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.513 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 13.7 t90 -63.59 -62.49 1.63 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 85' ' ' VAL . 43.9 t -39.69 -51.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.422 0.451 . . . . 0.0 110.939 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 29.0 ttm -53.39 -49.8 66.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.174 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.489 ' CZ2' ' HG3' ' A' ' 87' ' ' GLU . 76.8 t90 -61.93 -42.8 99.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.92 -20.92 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.652 HG21 HG11 ' A' ' 93' ' ' VAL . 55.5 t -82.33 -31.7 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.336 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.78 -36.84 42.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.936 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 11.1 mm-40 -71.79 -39.71 69.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.335 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -100.94 5.27 43.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.4 m 44.88 55.2 6.23 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 110.638 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.613 HD13 ' HB ' ' A' ' 121' ' ' VAL . 86.2 mt -75.9 151.32 37.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.908 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -130.64 143.04 50.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 111.623 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.4 ' C ' ' HG3' ' A' ' 118' ' ' PRO . . . 85.61 -0.44 88.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.512 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.652 HG11 HG21 ' A' ' 85' ' ' VAL . 12.6 p -74.55 132.21 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.286 0.543 . . . . 0.0 111.161 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.98 136.78 47.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.058 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.26 -29.56 20.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.397 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.99 -33.69 72.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 47.1 mmtm -66.43 -36.6 83.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.894 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.537 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 35.5 m-85 -97.58 34.73 1.78 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.223 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.61 66.12 8.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.388 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.461 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.6 ptp -158.43 169.08 25.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -73.54 156.48 38.09 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.227 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.583 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.07 -41.04 92.34 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.92 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.61 -39.59 65.05 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.726 0.298 . . . . 0.0 110.839 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.49 64.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.7 tp -55.79 -44.29 77.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.002 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 86.1 m -65.62 -42.45 91.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.55 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.1 -30.05 71.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 31.6 mt -62.39 -38.83 91.14 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.882 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.07 170.8 47.37 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.474 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.8 ttpt -59.27 -47.79 84.07 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.67 -51.1 61.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 70.2 m -66.13 -39.64 90.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.477 0.18 . . . . 0.0 111.123 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.419 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 48.2 t80 -63.51 -41.89 98.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.64 -23.13 65.31 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.813 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.72 -22.14 50.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.4 mt -85.86 -36.58 19.89 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.249 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.541 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -110.6 154.75 42.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.184 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.719 ' HG2' HG22 ' A' ' 121' ' ' VAL . 10.1 Cg_endo -54.79 172.32 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.749 2.3 . . . . 0.0 113.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.78 -21.99 57.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.33 -53.4 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 113.251 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.719 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.0 m -59.04 -34.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.49 -36.11 52.94 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.82 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.65 -49.82 56.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.47 0.176 . . . . 0.0 111.09 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 124' ' ' ILE . 3.3 mp -57.43 -46.44 85.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.588 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 113' ' ' PHE . 85.0 mt -67.5 -57.16 7.01 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.32 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.52 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -60.73 -33.63 73.19 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.18 -54.63 44.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -71.89 -30.01 64.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.459 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.513 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 43.0 tp -60.27 -50.78 72.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.8 mm-40 -66.13 -33.82 76.65 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.623 HD11 HD13 ' A' ' 49' ' ' LEU . 69.4 mt -61.68 -36.58 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.444 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.458 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.9 mt -62.96 -40.94 99.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 69.6 mt-30 -60.12 -53.1 61.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.471 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 131' ' ' ILE . 21.8 ptmt -65.18 -32.6 74.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.852 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.52 95.45 0.1 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.119 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 60.55 65.32 1.06 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.263 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.2 m -47.41 120.8 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.777 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.736 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.1 p80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.725 0.298 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.0 tpt 57.23 42.68 24.98 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.926 0.393 . . . . 0.0 111.04 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -90.86 -52.76 4.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.444 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 135' ' ' GLU . 45.0 t -133.09 141.01 47.96 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.86 109.08 20.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.047 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.621 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . 14.4 t70 -154.75 137.45 15.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.16 129.47 21.7 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 138' ' ' LYS . 58.0 Cg_endo -72.73 120.23 6.56 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.71 2.273 . . . . 0.0 112.04 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 tp -149.56 138.76 21.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.42 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.7 mt -90.37 80.9 6.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.479 HG22 ' O ' ' A' ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.467 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 97.2 Cg_exo -43.55 100.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.401 2.734 . . . . 0.0 112.689 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 87.7 p -174.2 -173.82 0.83 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.569 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SEP . . . . . 0.569 ' HA ' ' HE2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.96 -40.05 79.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.491 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 39' ' ' PRO . 9.5 mm-40 -62.67 -38.78 91.72 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.167 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.569 ' HE2' ' HA ' ' A' ' 41' ' ' SEP . 4.7 mpp? -79.58 -28.49 41.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.571 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.9 mtp -59.01 -48.05 82.99 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.442 0.163 . . . . 0.0 110.93 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.1 m -79.57 -26.92 41.23 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.671 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -52.03 -52.1 53.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.03 -47.56 74.0 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.745 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.42 -48.34 71.75 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.534 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 96.3 mttt -70.08 -41.03 74.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.566 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.87 -39.26 91.31 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.326 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.462 HG22 ' CH2' ' A' ' 83' ' ' TRP . 26.8 m -65.15 -41.9 94.31 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.174 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 21.6 m-30 -49.93 -36.09 26.38 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -58.93 -35.27 72.83 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.439 0.161 . . . . 0.0 111.052 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.41 -8.59 85.81 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.456 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.526 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 7.9 t80 -83.91 -50.43 8.05 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.4 m -56.68 -36.85 70.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.55 -30.55 70.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.774 0.321 . . . . 0.0 110.303 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -84.58 -42.79 15.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 8.3 mm100 -56.96 -30.9 64.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -80.31 -36.69 33.94 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.478 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.57 -39.47 84.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.524 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 63' ' ' LEU . 7.4 mp -93.8 -32.24 14.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.21 -0.53 40.73 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.231 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.04 128.87 66.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 117.011 0.406 . . . . 0.0 110.913 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.87 172.82 14.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.754 2.303 . . . . 0.0 112.85 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.01 48.11 0.9 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.518 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 12.0 m-20 -140.8 105.99 6.32 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.9 Cg_endo -62.65 -37.06 60.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.659 2.24 . . . . 0.0 112.423 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -70.19 -32.67 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 68' ' ' ASP . 2.0 mp0 -97.85 42.21 1.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.55 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -115.68 168.33 10.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 101' ' ' SER . 15.3 t -133.55 -177.03 4.36 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.562 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HG3' ' CA ' ' A' ' 100' ' ' MET . 2.6 mp0 -49.41 -46.79 47.96 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -63.27 -49.53 73.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.668 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -62.16 -43.06 99.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.688 0.28 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 105' ' ' LEU . 54.3 t -61.47 -52.53 60.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.466 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -68.8 -46.07 69.61 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.784 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.39 -38.67 71.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.547 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 12.8 t90 -66.93 -61.07 2.13 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 85' ' ' VAL . 50.9 t -41.37 -53.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.419 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 40.0 ttm -56.57 -46.15 80.92 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.835 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 54.3 t90 -58.32 -35.94 72.64 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.691 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.35 -21.2 60.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.129 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.543 ' CG2' HG11 ' A' ' 93' ' ' VAL . 84.6 t -77.83 -32.78 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -81.52 -36.66 28.94 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.036 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 10.9 mm-40 -71.27 -40.29 71.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -104.32 6.14 35.05 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.9 m 45.15 56.57 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 110.599 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HB3' HG12 ' A' ' 121' ' ' VAL . 74.5 mt -82.08 169.67 16.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.36 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.1 147.98 27.73 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.358 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -8.52 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.741 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.599 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.5 p -76.4 135.85 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.418 0.609 . . . . 0.0 110.785 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.454 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 12.1 m-20 -109.82 139.16 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.392 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -89.11 -25.08 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.704 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -61.89 -34.48 76.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.649 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 2.0 mptm? -67.15 -35.15 79.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 35.9 m-85 -100.49 34.98 2.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.479 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.1 t -89.41 68.42 7.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.069 0.461 . . . . 0.0 110.251 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.414 ' CA ' ' HG3' ' A' ' 74' ' ' GLU . 14.4 ptp -160.66 172.97 16.16 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.788 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 72.1 m -73.43 156.59 38.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -57.91 -38.66 89.68 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.601 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.82 -39.58 71.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.283 . . . . 0.0 110.666 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.56 -45.02 66.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.424 HD22 HG13 ' A' ' 77' ' ' VAL . 15.7 tp -56.72 -44.6 81.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.031 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.1 m -64.43 -40.35 95.57 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.15 73.67 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.305 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 60.1 mt -61.28 -36.14 79.25 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.895 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.7 176.22 48.92 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.601 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 27.5 ttpp -61.73 -46.82 88.01 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.25 -61.53 2.11 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.473 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 85.5 m -60.6 -39.33 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.438 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HE1' ' HB2' ' A' ' 125' ' ' LEU . 45.3 t80 -63.36 -43.6 97.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.833 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -66.42 -25.92 66.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -76.63 -21.85 54.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.725 0.297 . . . . 0.0 110.347 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.649 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 80.6 mt -86.28 -36.77 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -116.47 151.74 47.33 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.815 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.8 Cg_exo -43.02 164.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.587 2.858 . . . . 0.0 114.09 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.47 -20.2 62.88 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.053 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -108.07 -52.69 2.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.188 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' A' ' 93' ' ' VAL . 5.2 m -62.01 -37.12 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.335 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.77 -36.91 88.9 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.669 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.56 -47.39 78.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.456 HD12 HD21 ' A' ' 90' ' ' LEU . 61.0 mt -59.36 -53.73 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . 84.4 mt -55.63 -55.67 29.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.386 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.506 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -62.24 -28.91 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.04 -57.27 13.29 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.499 ' HA ' HD12 ' A' ' 131' ' ' ILE . 23.7 t-160 -70.98 -32.42 69.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.311 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.506 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 50.0 tp -57.49 -46.29 83.91 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.638 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -68.08 -33.49 74.63 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.233 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.572 ' HA ' ' CB ' ' A' ' 135' ' ' GLU . 85.1 mt -61.12 -43.19 95.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.05 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.2 mt -58.27 -35.31 71.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.396 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.422 ' N ' ' HG3' ' A' ' 69' ' ' PRO . 59.1 mt-30 -68.7 -71.54 0.21 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.443 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -177.78 55.79 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.954 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.572 ' CB ' ' HA ' ' A' ' 131' ' ' ILE . 28.6 tt0 -80.48 132.1 35.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.882 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -86.45 79.87 8.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.908 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.621 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 6.5 m -129.26 120.17 50.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.199 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HB2' ' HD3' ' A' ' 35' ' ' PRO . 34.9 mmtp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.834 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.4 p80 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.0 ttp 73.32 -73.35 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.711 0.405 . . . . 0.0 110.926 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.06 33.65 0.14 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.566 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.87 -42.22 5.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.963 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.41 96.99 6.73 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.539 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -128.94 139.59 52.04 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.17 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -80.01 132.77 59.3 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.213 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.3 104.38 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.531 2.154 . . . . 0.0 112.213 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.5 tp -174.71 106.98 0.1 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 38' ' ' TPO . 1.2 tt -164.31 131.85 3.31 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.114 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.42 ' N ' HD23 ' A' ' 37' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.1 98.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.398 2.732 . . . . 0.0 113.081 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.7 t -172.66 -80.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.434 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -73.85 -36.38 64.88 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.13 -40.38 95.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.425 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -84.87 -27.14 26.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.549 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 ttt -57.72 -45.45 85.75 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.244 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.7 p -82.36 -27.57 32.05 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.799 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -54.1 -50.66 66.34 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.31 -32.16 58.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.553 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.1 tp -61.99 -44.75 96.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.686 0.279 . . . . 0.0 110.84 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -65.56 -27.85 68.74 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.62 -30.46 65.8 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.6 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.4 p -80.73 -45.43 17.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.506 0.193 . . . . 0.0 111.261 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -48.07 -40.26 22.62 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.9 p -58.87 -35.17 72.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.463 0.173 . . . . 0.0 111.29 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.21 -7.39 88.49 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.837 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.484 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 14.4 t80 -99.47 -50.28 4.14 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.811 0.306 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.8 m -55.67 -31.5 62.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.434 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -61.27 -33.69 73.97 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.674 0.273 . . . . 0.0 110.408 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.14 -38.98 23.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 33.4 mt-30 -58.24 -32.28 68.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.723 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -81.61 -36.89 28.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.796 -0.184 . . . . 0.0 111.48 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -70.76 -39.74 73.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.685 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.3 mt -98.05 -26.36 14.64 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.07 6.24 59.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.533 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 62.8 mt -54.93 122.17 39.69 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 122.305 0.242 . . . . 0.0 111.213 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 23.9 Cg_exo -63.21 169.4 9.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.783 2.322 . . . . 0.0 112.558 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -99.24 34.36 2.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 38.4 t70 -153.78 116.51 2.65 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.3 Cg_endo -61.39 -40.53 47.91 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.145 2.563 . . . . 0.0 112.479 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -54.75 -36.33 64.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.67 0.271 . . . . 0.0 110.456 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -100.15 46.37 0.96 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.762 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.538 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 7.4 m0 -122.07 174.06 7.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.505 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.1 t -132.61 -179.05 5.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.95 -42.93 49.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.3 m -64.19 -50.08 69.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -60.77 -40.6 93.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.544 0.211 . . . . 0.0 111.199 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 HD22 ' A' ' 105' ' ' LEU . 65.6 t -63.2 -55.54 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -64.82 -48.55 74.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.721 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -56.53 -40.1 74.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.576 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.1 t90 -66.12 -61.11 2.21 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 85' ' ' VAL . 53.6 t -40.74 -55.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.422 ' HG2' ' CE1' ' A' ' 95' ' ' PHE . 62.1 mtt -55.55 -47.02 77.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.527 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.2 t90 -58.01 -35.95 71.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.938 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.77 -18.41 60.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.556 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 81' ' ' VAL . 96.7 t -81.04 -34.3 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.488 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -83.81 -32.85 25.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 6.9 mm-40 -75.53 -40.55 56.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -102.21 6.12 40.51 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.946 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 46.08 53.87 8.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 110.746 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.546 HD13 ' HB ' ' A' ' 121' ' ' VAL . 67.5 mt -81.95 169.23 17.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.118 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -152.54 148.88 27.9 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -7.4 81.33 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.855 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.623 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.5 p -76.74 134.48 28.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.423 0.612 . . . . 0.0 111.073 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.4 131.78 48.83 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.442 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 82' ' ' MET . 40.0 m-85 -85.07 -28.69 25.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.74 -33.33 72.76 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.5 mptm? -67.23 -34.35 77.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.123 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 51.1 m-85 -99.32 35.81 1.87 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.598 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.99 64.43 7.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.045 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.48 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.8 ptp -155.64 167.34 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.046 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.0 p -70.9 158.12 36.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.538 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.51 -42.04 93.75 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.83 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.95 64.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.719 0.295 . . . . 0.0 110.876 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.5 -44.93 63.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.571 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.448 HD22 HG13 ' A' ' 77' ' ' VAL . 18.9 tp -55.15 -44.28 75.01 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.264 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 70.8 m -66.93 -40.61 87.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.713 0.292 . . . . 0.0 110.763 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.16 67.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.642 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.9 mt -68.01 -38.46 82.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.88 176.42 51.49 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.331 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.2 ttpt -61.6 -51.22 69.4 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.76 -51.75 36.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.3 m -66.73 -40.93 88.54 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.445 0.164 . . . . 0.0 111.356 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 125' ' ' LEU . 32.2 t80 -62.31 -43.59 98.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.95 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.8 -25.06 66.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.831 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -76.15 -22.38 55.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 110.216 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 91.4 mt -89.07 -35.63 16.21 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.37 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' HB1' HG23 ' A' ' 121' ' ' VAL . . . -118.32 148.96 44.97 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.934 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.4 Cg_exo -41.89 163.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.752 2.968 . . . . 0.0 114.355 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.5 -21.49 62.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.131 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 121' ' ' VAL . 11.3 p90 -108.1 -48.63 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.374 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.623 HG21 ' HB ' ' A' ' 93' ' ' VAL . 6.2 m -64.15 -37.52 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.48 0.181 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.02 89.59 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.96 -49.35 75.07 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.621 0.248 . . . . 0.0 110.957 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.483 HD12 HD21 ' A' ' 90' ' ' LEU . 47.7 mt -58.09 -57.33 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.0 0.428 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 90.4 mt -52.3 -59.21 4.67 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.057 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.583 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -61.74 -32.97 73.25 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.36 -56.35 21.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.236 0.471 . . . . 0.0 110.159 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.43 ' HA ' HD12 ' A' ' 131' ' ' ILE . 38.1 t60 -68.13 -36.94 80.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.097 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 69' ' ' PRO . 32.9 tp -58.71 -46.51 87.18 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.474 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.16 -39.5 86.65 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 128' ' ' HIS . 88.7 mt -60.11 -41.69 87.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.177 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.6 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 85.4 mt -66.52 -37.72 85.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.11 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.583 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 -54.52 -41.21 69.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.249 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -57.96 -43.78 86.66 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -84.9 101.9 12.69 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.213 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.68 97.23 7.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.11 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.07 129.86 58.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.916 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.806 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.2 p80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -158.77 -60.41 0.07 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.716 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.57 -55.94 3.45 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.827 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.1 p -149.66 110.86 4.4 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.8 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.33 104.3 0.2 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.343 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -162.21 117.61 1.93 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.764 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.22 89.42 44.96 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.163 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.61 149.93 62.22 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.9 2.4 . . . . 0.0 112.246 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.6 tp -114.09 124.05 51.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.024 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.7 tp -161.18 87.71 0.72 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.599 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.86 147.44 74.8 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.788 2.325 . . . . 0.0 112.39 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.1 t -107.25 166.42 10.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.221 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -66.4 -40.39 89.59 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.003 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -66.43 -40.1 89.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.938 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 29.7 ttp -74.21 -38.1 63.68 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.342 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 56.3 ttp -60.39 -45.79 92.31 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.678 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.3 m -77.31 -26.42 52.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.254 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -45.21 -49.7 12.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.735 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.01 -44.04 87.05 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.766 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.93 -41.11 91.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.604 0.24 . . . . 0.0 110.896 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -58.51 -34.41 70.93 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.685 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.12 -51.15 25.92 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.7 m -81.25 -43.87 18.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.184 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -46.73 -46.45 20.33 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.4 p -59.43 -40.18 85.95 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -75.7 -11.5 84.46 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.792 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.428 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 9.0 t80 -99.43 -46.5 5.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.647 0.223 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.0 m -55.91 -34.9 66.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.626 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 55' ' ' GLY . 56.9 pttt -58.37 -39.11 78.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.129 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -41.08 40.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.94 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.8 mt-30 -58.53 -29.19 66.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.677 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.11 -37.6 18.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.211 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -70.18 -30.64 67.81 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.663 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.55 -36.79 6.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.07 -2.91 29.98 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.915 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 69.0 mt -56.29 122.9 52.21 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.784 0.292 . . . . 0.0 111.026 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 70.5 Cg_endo -75.27 174.8 12.18 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.461 2.107 . . . . 0.0 112.249 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.502 ' HD2' HG12 ' A' ' 137' ' ' VAL . 30.3 tttp -101.22 42.59 1.11 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.028 0.442 . . . . 0.0 110.729 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -132.7 97.76 16.98 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HG2' ' HB3' ' A' ' 133' ' ' GLN . 27.6 Cg_endo -61.66 -26.94 80.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -79.64 -37.83 35.15 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -95.21 41.7 1.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.23 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.484 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.3 m0 -111.01 172.31 6.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.675 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -131.82 -179.14 5.21 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.99 -43.49 60.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.3 m -63.59 -49.24 74.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.389 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -62.2 -41.16 98.1 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.186 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.527 HG13 HD22 ' A' ' 105' ' ' LEU . 67.1 t -64.06 -52.97 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.39 -46.16 77.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.594 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.23 -37.04 85.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.776 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.6 t90 -64.9 -65.64 0.65 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.5 p -42.14 -46.54 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.215 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.402 ' N ' HG13 ' A' ' 81' ' ' VAL . 43.8 ttm -60.21 -45.93 91.49 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.393 . . . . 0.0 110.432 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 11.7 t90 -60.65 -37.53 81.83 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.558 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -17.06 62.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 81' ' ' VAL . 75.4 t -84.28 -32.37 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.164 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -81.55 -35.37 30.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.541 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.72 -40.73 55.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.63 7.67 43.84 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t 43.34 59.5 2.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 110.883 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.566 HD21 HD12 ' A' ' 124' ' ' ILE . 62.3 mt -89.35 171.63 9.62 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.024 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.99 148.32 23.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.947 0.403 . . . . 0.0 111.547 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.04 -9.1 78.71 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.694 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.6 p -74.23 136.86 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 117.39 0.595 . . . . 0.0 110.837 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.77 132.81 50.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.524 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -86.36 -24.18 25.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.371 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.31 -36.57 84.53 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.8 mptp? -65.38 -36.18 83.2 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.855 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.4 m-85 -98.54 32.18 2.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.381 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 46.2 t -87.29 67.65 9.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 110.25 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.8 ptp -159.73 171.38 19.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.897 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.4 p -72.33 159.45 34.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.252 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.44 -42.9 94.06 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.636 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.54 -38.74 64.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 110.964 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.77 -47.55 58.99 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.527 HD22 HG13 ' A' ' 77' ' ' VAL . 22.3 tp -55.71 -47.21 77.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.389 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.51 -38.53 91.34 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.681 0.277 . . . . 0.0 110.634 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -32.31 73.97 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.409 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 58.4 mt -59.77 -34.72 73.36 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.88 173.42 45.43 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.471 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.536 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.9 ttpt -59.98 -45.92 91.15 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.34 0.126 . . . . 0.0 111.34 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -49.75 -65.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.19 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 93.0 m -58.07 -38.7 76.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.435 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.95 -43.43 98.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.748 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.34 -26.19 67.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 12.5 mm-40 -75.39 -22.62 57.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.77 0.319 . . . . 0.0 110.149 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -87.36 -39.61 15.17 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.46 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -111.54 150.92 42.88 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.606 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.3 Cg_exo -44.04 165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.606 2.871 . . . . 0.0 114.111 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.37 -20.14 62.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.938 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.53 -55.0 2.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.606 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.8 m -59.99 -33.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.73 -32.13 58.47 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.208 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.59 -52.52 30.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.66 0.23 . . . . 0.0 111.305 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 90' ' ' LEU . 56.3 mt -56.18 -47.11 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.714 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.12 -60.48 3.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.753 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -62.33 -28.78 69.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.33 -54.75 17.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.062 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.404 ' HA ' HD12 ' A' ' 131' ' ' ILE . 12.7 t-160 -66.71 -32.84 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.17 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.6 tp -63.73 -41.32 98.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.247 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 32.6 tt0 -70.26 -23.57 62.91 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.395 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 128' ' ' HIS . 78.0 mt -77.21 -37.49 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.887 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 95.4 mt -58.95 -47.9 83.44 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.542 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.524 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 6.7 pt20 -55.01 -37.76 67.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.542 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -76.62 -55.47 5.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.779 0.323 . . . . 0.0 111.043 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.37 100.35 12.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -118.66 126.97 53.1 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.329 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.502 HG12 ' HD2' ' A' ' 67' ' ' LYS . 10.8 p -103.66 -33.74 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.746 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.565 179.919 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.6 p80 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.488 0.185 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 63.83 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.543 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -111.35 -51.68 2.84 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.998 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 24.4 p -147.12 177.55 9.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.503 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.66 -43.74 72.64 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.752 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -131.26 111.15 11.64 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.59 125.69 68.62 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.67 135.55 12.99 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.754 2.303 . . . . 0.0 112.721 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 36' ' ' LEU . 7.8 mp -83.77 -49.83 8.71 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.79 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.4 mt -85.04 89.97 7.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.672 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.438 HG22 ' O ' ' A' ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.98 156.66 43.08 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.797 2.331 . . . . 0.0 112.326 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.9 p -75.32 85.85 2.49 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.032 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SEP . . . . . 0.426 ' HA ' ' HE2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -60.7 -38.79 86.21 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.566 0.209 . . . . 0.0 111.566 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -73.76 -40.54 63.41 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.426 ' HE2' ' HA ' ' A' ' 41' ' ' SEP . 4.6 mpp? -73.25 -41.12 64.05 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.506 0.193 . . . . 0.0 111.204 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 ttt -61.07 -39.71 90.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.782 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.563 ' HB3' ' HG2' ' A' ' 134' ' ' LYS . 95.1 p -71.54 -33.25 68.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.702 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -48.45 -44.15 35.18 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.55 94.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.988 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.85 -39.16 80.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.601 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HG2' ' HE3' ' A' ' 67' ' ' LYS . 26.5 tptp -68.81 -36.5 78.31 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.217 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.14 -38.38 39.0 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.2 p -58.6 -28.81 65.93 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.64 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -99.36 64.17 1.33 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.724 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 p -67.9 -26.65 66.1 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.415 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.49 -7.38 82.78 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.761 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.421 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 16.7 t80 -95.39 -45.77 6.98 Favored 'General case' 0 CA--C 1.526 0.043 0 CA-C-N 116.735 0.267 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.2 m -56.52 -39.17 72.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.954 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -62.03 -36.1 80.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.66 0.267 . . . . 0.0 110.479 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.84 -41.13 60.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.4 mt-30 -58.04 -26.69 62.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.331 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -83.31 -31.4 26.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.186 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -71.76 -43.21 66.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.188 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HB2' HG13 ' A' ' 65' ' ' ILE . 36.5 mt -94.73 -25.79 16.55 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.198 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.56 1.82 61.95 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.595 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 79' ' ' ASP . 67.4 mt -49.81 126.48 18.76 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 122.525 0.33 . . . . 0.0 111.418 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 37.1 Cg_exo -60.36 170.09 4.51 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.095 2.53 . . . . 0.0 112.956 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.623 ' HE2' ' HG2' ' A' ' 135' ' ' GLU . 74.2 tttt -100.99 38.91 1.46 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 136' ' ' ASP . 38.4 t70 -163.96 122.37 1.24 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.587 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 35.3 Cg_exo -60.25 -44.66 27.11 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.601 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 13.5 mtt180 -53.71 -34.24 58.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.611 0.244 . . . . 0.0 110.957 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.85 42.29 1.1 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 12.9 m0 -120.74 175.94 5.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.636 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 p -137.36 -176.06 4.27 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.029 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' CA ' ' A' ' 100' ' ' MET . 46.2 mt-10 -51.77 -37.76 52.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.572 0.225 . . . . 0.0 111.188 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.4 m -67.62 -56.0 11.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.546 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -59.76 -42.72 93.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.607 0.241 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 81' ' ' VAL . 47.2 t -58.35 -47.69 87.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 5.4 tmm_? -73.24 -42.4 62.6 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.037 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 65' ' ' ILE . 1.3 m-20 -58.51 -36.82 74.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.509 0.195 . . . . 0.0 110.617 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.593 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -71.84 -62.24 1.49 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 85' ' ' VAL . 58.1 t -41.53 -51.86 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 56.9 tpp -54.06 -49.06 69.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.7 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -57.27 -38.4 73.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.108 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' PHE . . . -76.18 -18.69 58.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.513 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 81' ' ' VAL . 78.8 t -85.88 -30.48 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.7 -39.66 15.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.096 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.71 -34.95 62.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.528 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 51.3 m-85 -100.79 4.21 42.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.448 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 46.71 55.97 7.11 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 122.611 0.364 . . . . 0.0 111.506 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD13 ' HB ' ' A' ' 121' ' ' VAL . 71.8 mt -86.34 167.32 14.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.588 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.64 154.88 38.29 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 111.724 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -8.24 66.58 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.69 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.574 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.1 p -74.84 130.54 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 117.403 0.601 . . . . 0.0 111.029 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.87 130.68 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.339 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.0 -20.85 29.89 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.43 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -65.49 -33.5 76.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 34.9 mmtp -66.48 -35.76 81.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.697 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 28.8 m-85 -100.08 29.75 4.11 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.325 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.5 t -82.4 67.93 8.63 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.406 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.2 ptp -160.75 172.2 17.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.697 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.7 p -73.28 158.65 34.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.173 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -60.81 -37.62 93.94 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.804 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.41 72.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.684 0.278 . . . . 0.0 110.694 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.2 63.5 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.387 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.32 -43.76 75.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.113 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 71.2 m -67.31 -42.42 83.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.815 0.341 . . . . 0.0 110.575 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.09 67.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.669 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 64.8 mt -68.53 -31.95 71.55 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.71 174.98 49.0 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.326 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.0 ttpt -63.59 -42.52 98.25 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.571 0.185 . . . . 0.0 111.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.82 -63.37 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.511 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.8 m -59.06 -40.68 85.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.357 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.98 -43.35 99.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.49 HD12 ' HA3' ' A' ' 122' ' ' GLY . 12.0 tp -66.48 -27.15 67.57 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.632 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -75.05 -22.48 58.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.695 0.284 . . . . 0.0 110.653 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.1 mt -84.98 -32.22 23.1 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.451 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -113.04 154.2 45.11 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.608 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.2 Cg_exo -44.32 164.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.502 2.802 . . . . 0.0 113.901 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.1 -19.45 62.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.031 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.458 ' CE2' HG13 ' A' ' 121' ' ' VAL . 13.4 p90 -108.75 -51.72 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.608 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.8 m -62.93 -34.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.49 ' HA3' HD12 ' A' ' 114' ' ' LEU . . . -52.41 -39.74 52.79 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.95 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.54 -47.6 75.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.611 0.244 . . . . 0.0 110.967 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.78 -55.1 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.372 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.85 -57.2 13.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.505 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 5.9 t90 -60.78 -28.27 68.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.04 -57.72 11.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -71.99 -35.24 69.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.459 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.593 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.8 tp -56.78 -49.87 74.0 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.788 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.36 -36.71 84.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 70.2 mt -61.47 -45.71 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.177 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.8 mt -55.48 -36.84 67.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.052 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 68.4 mt-30 -62.9 -42.77 99.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.563 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 71.2 tttt -63.53 -34.72 78.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.716 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.623 ' HG2' ' HE2' ' A' ' 67' ' ' LYS . 0.6 OUTLIER -50.23 -48.83 54.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.724 0.297 . . . . 0.0 111.292 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 68' ' ' ASP . 8.9 m-20 -132.53 83.67 2.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.496 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.67 97.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.122 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.725 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.9 m80 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.733 0.301 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 51.0 tpp 64.19 -80.16 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.177 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.73 -39.14 13.34 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.835 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -69.32 147.9 50.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.703 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.55 66.38 8.12 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -144.17 172.18 13.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.976 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.17 120.7 82.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.613 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.97 106.01 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.757 2.305 . . . . 0.0 112.531 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 tp -155.52 -56.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.697 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.4 tp -96.27 84.97 3.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.768 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.5 -179.81 5.19 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.681 2.254 . . . . 0.0 112.512 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.5 t -54.61 -41.38 69.9 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.905 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SEP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -66.65 -39.84 88.42 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.656 0.265 . . . . 0.0 110.907 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -69.19 -40.39 78.09 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.684 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 41' ' ' SEP . 25.5 ptt? -74.65 -28.92 61.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.464 0.173 . . . . 0.0 111.199 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.63 -39.88 81.78 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.49 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.494 ' HA ' HD12 ' A' ' 49' ' ' LEU . 80.6 p -85.62 -27.86 25.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -51.63 -51.99 51.31 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.727 0.299 . . . . 0.0 111.205 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.28 80.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.768 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 46' ' ' SER . 74.8 mt -59.34 -38.61 80.8 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.563 0.22 . . . . 0.0 111.498 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -68.99 -36.86 78.33 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.16 -31.2 21.94 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.5 HG23 ' CD2' ' A' ' 53' ' ' PHE . 11.8 t -67.63 -29.38 68.68 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.5 ' CD2' HG23 ' A' ' 52' ' ' THR . 66.8 m-85 -102.76 55.4 0.77 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.968 0.413 . . . . 0.0 110.808 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -75.66 -24.43 56.35 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.199 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.82 -19.44 77.67 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.304 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 13.1 t80 -81.03 -49.23 11.17 Favored 'General case' 0 C--N 1.338 0.072 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.7 m -55.54 -34.0 64.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.051 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -63.97 -31.78 73.09 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.831 0.348 . . . . 0.0 110.485 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.18 -41.75 21.89 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.132 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 47.6 mt-30 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.791 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -83.04 -13.61 55.49 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 48.8 mtp180 -85.1 -37.38 20.34 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.66 0.267 . . . . 0.0 111.143 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 mp -105.19 -27.42 11.57 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.69 5.26 42.16 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.129 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 86.9 mt -57.14 125.23 69.85 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.891 0.346 . . . . 0.0 111.027 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 64.4 Cg_endo -74.65 170.45 20.29 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.375 2.05 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -75.84 -36.93 59.45 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.617 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.19 125.22 90.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.59 0.233 . . . . 0.0 111.075 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 63.5 Cg_endo -74.51 -32.98 5.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.015 2.477 . . . . 0.0 113.183 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -29.06 70.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.593 0.235 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -96.56 40.48 1.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.885 0.374 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.648 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 11.0 m0 -112.12 169.56 8.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -128.62 -178.4 4.57 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.76 -39.31 62.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.444 0.164 . . . . 0.0 111.373 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.5 m -66.81 -49.34 66.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.597 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CD2' HG12 ' A' ' 65' ' ' ILE . 47.3 m170 -61.45 -42.66 99.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.654 0.264 . . . . 0.0 110.965 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 81' ' ' VAL . 54.0 t -60.71 -52.64 59.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.8 ttm105 -66.92 -46.71 73.98 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.708 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.69 -40.72 88.82 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.838 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 14.3 t90 -63.43 -62.69 1.51 Allowed 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 85' ' ' VAL . 73.5 t -41.17 -49.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 55.2 tpp -55.68 -50.73 69.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.832 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -55.19 -39.9 70.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.85 -48.47 53.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.874 0.369 . . . . 0.0 110.27 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.568 ' CG2' HG11 ' A' ' 93' ' ' VAL . 79.4 t -52.85 -30.46 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.38 -46.92 12.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.356 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -66.39 -32.19 73.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.56 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.34 2.5 28.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.4 m 45.02 59.69 3.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.078 0.466 . . . . 0.0 110.63 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 121' ' ' VAL . 71.3 mt -86.96 153.08 21.85 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.464 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 155.52 49.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.712 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.83 -7.35 59.28 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.721 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.579 ' HB ' HG21 ' A' ' 121' ' ' VAL . 13.0 p -74.62 132.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 117.315 0.557 . . . . 0.0 111.044 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -105.01 132.26 51.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.375 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.07 -25.52 24.13 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -62.0 -34.05 75.47 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.5 mmtt -66.54 -34.94 79.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.713 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 30.3 m-85 -97.97 32.94 2.24 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.43 65.13 9.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 110.209 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.7 ptp -158.9 169.81 23.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -75.43 161.59 29.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.332 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.648 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.47 -38.37 90.75 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.825 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.01 70.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.773 0.321 . . . . 0.0 110.634 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.48 -44.98 56.72 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.421 HD22 HG13 ' A' ' 77' ' ' VAL . 15.1 tp -56.06 -46.88 78.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.195 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 95.1 m -66.71 -38.75 87.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.813 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.57 69.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.436 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.3 mt -65.72 -32.96 74.81 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 175.39 48.75 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.459 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -62.71 -42.12 99.49 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.36 -63.28 1.2 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.353 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.8 m -60.85 -38.01 84.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.394 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -63.27 -45.26 92.33 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.488 0.185 . . . . 0.0 110.828 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.04 -25.86 68.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.704 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.2 -21.81 58.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.613 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 72.7 mt -87.21 -35.22 18.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.599 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -115.84 151.25 46.17 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.8 Cg_exo -43.05 163.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.61 2.873 . . . . 0.0 114.065 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.56 -21.3 62.4 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.193 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.81 -52.8 2.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.179 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.605 ' HB ' HD13 ' A' ' 90' ' ' LEU . 3.8 m -61.26 -37.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.434 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.2 74.74 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.658 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.64 -50.0 72.94 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.468 0.175 . . . . 0.0 110.884 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.547 HD12 HD21 ' A' ' 90' ' ' LEU . 64.2 mt -56.8 -55.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.431 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.28 -56.36 17.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.274 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 21.4 t90 -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.234 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.66 -54.59 43.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -73.0 -36.05 66.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.312 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.532 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.1 tp -59.08 -43.42 91.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.596 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -68.24 -32.84 73.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.192 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.493 HG23 HD13 ' A' ' 49' ' ' LEU . 52.9 mt -65.04 -37.71 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.502 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.8 mt -61.55 -53.6 54.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.407 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 8.8 pt20 -60.11 -38.52 83.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.855 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -72.83 -27.66 62.08 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.645 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -99.15 23.84 8.62 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.671 0.272 . . . . 0.0 111.445 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -154.22 154.84 34.17 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.727 0.298 . . . . 0.0 110.957 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 27.1 m -112.81 167.47 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 86.0 tttt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.172 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.41 ' O ' ' HD2' ' A' ' 35' ' ' PRO . 55.2 m80 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.495 0.188 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.4 mmt 57.58 90.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.235 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -101.71 76.54 1.66 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.957 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.6 m -138.3 -62.21 0.58 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.55 -56.09 1.9 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.708 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.65 144.07 51.03 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.569 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 56.7 t -106.44 90.65 5.05 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.51 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 34' ' ' VAL . 11.8 Cg_endo -55.03 115.78 2.67 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.952 2.435 . . . . 0.0 112.581 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.1 tp -146.77 -54.35 0.24 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.8 tt -143.99 80.78 1.66 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.57 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.91 141.32 94.26 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.884 2.39 . . . . 0.0 112.353 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.3 m -81.93 96.04 7.55 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.116 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.96 -40.13 95.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.866 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -70.96 -38.77 72.8 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.637 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 35.5 ttp -67.15 -38.2 85.1 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.692 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.7 tpt -62.4 -43.54 98.57 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.123 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.0 p -78.04 -26.34 48.33 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.188 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -48.21 -52.06 22.59 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.438 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.23 89.65 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.403 HD22 HD13 ' A' ' 131' ' ' ILE . 95.1 mt -60.1 -44.77 94.6 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.199 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.515 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 68.4 mttm -65.01 -34.11 77.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.187 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.9 -38.29 70.01 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.735 0.302 . . . . 0.0 110.876 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.5 m -79.31 -43.93 22.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.899 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 22.9 m-30 -47.74 -45.06 28.56 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.5 p -60.36 -37.8 81.84 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.45 0.166 . . . . 0.0 111.382 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.49 -8.6 85.95 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.669 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 15.3 t80 -98.89 -47.33 5.31 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.598 0.199 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -55.51 -32.81 63.2 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.33 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -60.36 -32.34 71.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 43.1 tt0 -82.6 -40.08 21.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 11.8 mm100 -58.63 -30.99 67.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.284 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -84.93 -38.45 19.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.238 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.19 -40.22 86.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.678 0.275 . . . . 0.0 111.264 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 mt -96.42 -31.17 12.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.187 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -2.41 55.98 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.685 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.6 mt -53.62 129.26 54.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 122.291 0.236 . . . . 0.0 111.178 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.0 166.69 26.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 58.7 mttp -97.06 52.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 110.437 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.23 98.82 5.04 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.145 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.585 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 32.0 Cg_exo -58.38 -38.83 88.63 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.857 2.371 . . . . 0.0 112.32 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 12.1 mtt180 -66.44 -35.63 80.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -98.15 43.55 1.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 2.0 m0 -115.02 174.75 5.82 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.267 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.7 t -133.51 -179.31 5.44 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -50.36 -44.41 54.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -63.39 -49.09 75.17 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.422 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -62.31 -41.9 98.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.234 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.508 HG13 HD22 ' A' ' 105' ' ' LEU . 56.1 t -60.37 -49.91 82.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HA ' HG12 ' A' ' 81' ' ' VAL . 70.9 ttt180 -71.43 -41.86 68.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.518 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.27 -35.57 79.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.485 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -69.36 -65.49 0.7 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.7 p -42.39 -46.88 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.174 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.415 ' N ' HG13 ' A' ' 81' ' ' VAL . 43.8 ttm -60.82 -47.78 84.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.407 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 17.6 t90 -55.94 -37.95 69.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.87 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.98 60.42 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.627 ' CG2' HG11 ' A' ' 93' ' ' VAL . 88.8 t -49.59 -34.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.244 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -79.47 -42.22 25.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.255 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 7.2 mm-40 -68.27 -36.28 79.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.564 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -105.63 6.6 32.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.7 m 44.36 53.36 6.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.948 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.522 ' HB3' HG12 ' A' ' 121' ' ' VAL . 68.1 mt -80.32 166.85 20.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.513 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.87 157.83 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.63 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.98 -5.74 69.76 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.677 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' A' ' 85' ' ' VAL . 13.6 p -81.92 142.71 13.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.238 0.519 . . . . 0.0 111.338 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.5 m-20 -116.58 141.96 47.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -90.34 -23.58 21.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.938 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -60.6 -36.25 78.1 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.9 mptt -67.09 -35.12 79.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.281 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.634 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 43.1 m-85 -96.26 32.28 2.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.565 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.2 t -89.84 67.67 7.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.193 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.5 ptp -156.56 166.59 32.96 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -69.68 157.58 36.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.49 74.36 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.634 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.17 61.42 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.669 0.271 . . . . 0.0 111.182 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.58 -48.1 61.36 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.789 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.508 HD22 HG13 ' A' ' 77' ' ' VAL . 18.8 tp -57.25 -46.29 83.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.162 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.9 m -64.04 -38.9 92.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.796 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.53 76.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.368 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -58.56 -36.05 73.32 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.51 176.76 49.41 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.473 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 57.5 tttp -59.67 -47.45 85.58 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 1.0 OUTLIER -50.75 -66.94 0.3 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.4 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.7 m -57.48 -37.58 73.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -62.41 -42.93 99.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.738 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -65.72 -24.49 66.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 10.5 mm-40 -74.55 -22.89 58.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.5 mt -84.11 -40.11 18.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.629 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -105.77 157.43 34.65 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.265 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.752 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.2 Cg_endo -56.71 174.26 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.685 2.257 . . . . 0.0 112.958 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -63.07 -14.39 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -107.93 -59.79 1.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.755 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.752 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -58.52 -31.25 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.04 -32.43 42.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.115 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.81 -46.35 53.62 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.68 0.24 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.424 HD12 HD21 ' A' ' 90' ' ' LEU . 57.0 mt -62.64 -58.64 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 111.658 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.403 HD13 HG23 ' A' ' 81' ' ' VAL . 66.5 mt -51.19 -58.77 5.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.793 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.517 ' CZ2' ' HD2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.42 -31.59 71.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.288 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.1 -57.09 14.58 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.54 -29.69 66.23 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.63 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.5 tp -57.83 -49.72 75.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.783 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 13.5 mm-40 -67.78 -34.87 77.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.767 0.318 . . . . 0.0 110.316 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.403 HD13 HD22 ' A' ' 49' ' ' LEU . 80.5 mt -62.59 -37.55 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.9 -36.7 82.88 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.521 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.585 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 79.1 mt-30 -60.68 -55.68 30.37 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.316 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -55.48 -36.76 66.99 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.008 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.95 74.34 9.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.201 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -75.03 98.6 3.67 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.326 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 46.5 t -134.96 100.25 2.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.075 -179.73 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.598 0.237 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.6 mtm 61.68 75.72 0.4 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.365 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -68.31 118.96 12.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.7 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.93 67.96 2.29 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.984 0.421 . . . . 0.0 110.599 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.53 -54.85 0.1 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.398 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -124.71 -65.64 1.02 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 15.7 m -147.66 136.63 11.59 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.088 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 32.1 Cg_exo -58.96 140.15 94.05 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.803 2.335 . . . . 0.0 112.474 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt -138.0 104.34 5.22 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.856 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.6 mp -100.22 133.74 44.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.755 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.472 HG22 ' O ' ' A' ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.584 ' HD2' ' HD3' ' A' ' 42' ' ' LYS . 32.8 Cg_endo -64.8 179.9 1.21 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.776 2.318 . . . . 0.0 112.173 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.4 m -50.4 -48.82 55.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.525 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.584 ' HD3' ' HD2' ' A' ' 39' ' ' PRO . 37.0 mtpt -69.03 -31.48 70.31 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.368 -0.133 . . . . 0.0 111.274 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.81 -28.53 69.53 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.39 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.8 mtm -66.38 -30.08 70.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.027 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -57.44 -45.2 84.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.916 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.4 m -66.25 -40.35 90.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.51 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -51.95 -52.93 46.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.66 70.49 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.549 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.436 HD21 ' CD1' ' A' ' 131' ' ' ILE . 42.3 tp -56.29 -47.54 78.43 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.867 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -63.51 -40.06 96.07 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.994 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.07 -30.21 64.9 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 m -59.32 -29.03 67.33 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -97.18 37.63 1.31 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.7 t -71.11 -23.5 62.11 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.214 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . -77.28 -0.96 73.23 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.127 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.465 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 16.9 t80 -99.16 -47.06 5.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.721 0.26 . . . . 0.0 110.657 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.2 m -57.1 -37.28 71.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 19.9 pttp -63.21 -36.1 82.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.346 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.49 61.19 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 55.3 mt-30 -59.4 -28.09 66.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.408 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -82.87 -40.88 19.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -65.86 -41.85 91.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -89.16 -31.12 18.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.924 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.89 -5.87 51.04 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.617 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' A' ' 76' ' ' HIS . 85.2 mt -51.43 124.13 23.71 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.61 0.243 . . . . 0.0 110.889 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.62 171.74 16.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.675 2.25 . . . . 0.0 112.714 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -100.3 45.57 0.98 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -140.05 102.76 6.83 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.406 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 32.1 Cg_exo -59.06 -31.33 95.42 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.865 2.377 . . . . 0.0 112.555 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.98 -36.03 59.38 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -95.73 38.45 1.17 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.743 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.465 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.0 OUTLIER -108.43 170.78 7.81 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.322 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.5 p -133.24 -179.01 5.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.464 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -52.18 -40.45 61.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -64.25 -50.63 67.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.324 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CD2' HG12 ' A' ' 65' ' ' ILE . 25.4 m170 -63.42 -41.3 98.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.81 -54.83 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 111.002 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -63.31 -49.52 73.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.385 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.77 -41.03 76.91 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.3 t90 -63.88 -61.88 2.0 Allowed 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.491 HG13 HD21 ' A' ' 125' ' ' LEU . 53.5 t -41.08 -55.36 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.775 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 30.0 ttm -57.68 -45.65 85.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.711 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.535 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 14.4 t90 -56.59 -35.84 68.68 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.933 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.2 -19.72 61.03 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.209 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 81' ' ' VAL . 58.2 t -81.37 -33.47 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.041 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -84.76 -40.26 17.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.61 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 12.2 mm-40 -72.15 -38.7 69.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -102.62 9.22 39.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t 44.71 52.87 7.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.818 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.833 HD13 HG13 ' A' ' 121' ' ' VAL . 69.4 mt -86.85 176.23 7.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.314 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.438 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.82 152.97 16.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.004 0.431 . . . . 0.0 111.745 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.49 -14.21 65.37 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.9 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.499 ' HB ' HG11 ' A' ' 121' ' ' VAL . 13.0 p -75.54 130.55 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.39 0.595 . . . . 0.0 110.879 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 9.4 m-20 -98.71 134.68 41.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -86.37 -26.99 24.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.474 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 15.8 mm100 -60.52 -37.58 81.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.973 0.415 . . . . 0.0 109.91 177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 99.5 mttt -66.88 -29.57 69.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.51 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.465 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 50.9 m-85 -101.84 33.07 3.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 59.3 m -86.24 65.24 8.98 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.113 0.482 . . . . 0.0 110.32 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.518 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.7 ptp -153.48 165.46 35.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -74.73 164.68 26.3 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.341 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.13 -42.67 95.3 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.717 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.03 -38.33 62.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.97 55.62 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.71 -47.55 73.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.152 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.7 m -65.85 -38.8 89.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.99 -21.25 66.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.8 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 43.4 mt -71.31 -34.91 71.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.18 179.77 46.87 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.45 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.416 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.1 ttpt -60.92 -47.81 84.7 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -50.56 -65.15 0.61 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 94.9 m -60.53 -42.27 96.15 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 52.8 t80 -61.61 -46.35 90.21 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.281 -0.168 . . . . 0.0 111.119 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.3 mt -62.44 -31.35 72.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.598 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.98 -25.65 64.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.748 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 97' ' ' LYS . 65.2 mt -87.47 -31.23 20.1 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.214 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.514 ' CB ' ' HA2' ' A' ' 122' ' ' GLY . . . -99.13 166.42 13.04 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.82 0.343 . . . . 0.0 111.6 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 21.0 Cg_exo -66.59 173.5 7.75 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.095 2.53 . . . . 0.0 113.225 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.42 -28.21 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.088 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.2 -53.06 2.68 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.475 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.833 HG13 HD13 ' A' ' 90' ' ' LEU . 81.8 t -57.18 -39.55 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 117' ' ' ALA . . . -50.99 -43.48 49.43 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.15 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 12.6 m-20 -63.04 -46.09 89.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.0 mt -57.94 -50.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.631 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.491 HD21 HG13 ' A' ' 81' ' ' VAL . 10.5 mp -63.95 -57.81 8.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.258 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.416 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.06 -31.73 71.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.632 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 123' ' ' ASP . 8.2 tp10 -62.75 -52.45 63.18 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.01 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.568 ' HA ' HD12 ' A' ' 131' ' ' ILE . 18.6 t-160 -71.98 -30.66 65.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.424 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 40.4 tp -62.39 -46.2 89.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.605 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 64.6 mm-40 -67.07 -33.62 75.89 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.9 mt -59.89 -42.89 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.38 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.23 -38.4 89.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.544 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.478 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 -65.89 -49.35 68.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.158 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -66.63 -47.46 72.53 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.05 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.85 -39.77 82.28 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -126.92 77.46 1.73 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.367 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.2 m -72.69 80.3 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.246 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 mttp . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.404 -0.808 . . . . 0.0 110.724 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 48.9 t60 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.304 0.097 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.476 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 24.7 mmt 62.71 84.91 0.14 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.933 0.396 . . . . 0.0 110.652 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -74.84 -41.0 60.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.209 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.8 m -67.56 -41.36 84.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.036 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 29' ' ' MET . . . -68.0 -45.41 74.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.082 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -137.31 131.26 31.97 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.909 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.08 91.91 17.0 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.06 -174.94 2.4 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.577 2.185 . . . . 0.0 112.454 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.4 tp -52.3 -47.09 66.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.92 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.449 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.6 pp -98.52 168.81 9.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.065 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.44 168.23 18.41 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.97 2.447 . . . . 0.0 112.806 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.6 m -96.31 98.55 10.37 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.747 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SEP . . . . . 0.488 ' HA ' ' HE2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -69.55 -39.98 77.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.678 0.275 . . . . 0.0 110.967 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -69.86 -40.91 75.49 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.155 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.488 ' HE2' ' HA ' ' A' ' 41' ' ' SEP . 70.9 mtm -66.87 -40.76 87.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.434 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 84.1 mmm -60.06 -41.85 93.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.676 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -81.79 -29.22 32.81 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.226 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -53.56 -52.04 61.01 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.156 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.5 81.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.479 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.5 mt -58.77 -43.87 90.5 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.404 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -77.07 -42.3 38.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.597 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.47 -44.69 90.26 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 m -71.46 -50.13 34.7 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 135' ' ' GLU . 9.3 m-85 -55.25 -39.34 69.64 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 74.3 m -58.12 -44.57 87.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 121.304 -0.158 . . . . 0.0 111.079 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.22 -20.74 74.82 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.36 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.446 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 11.7 t80 -77.62 -49.76 13.91 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.0 m -55.31 -32.54 62.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.399 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 54' ' ' SER . 34.7 mmtp -59.42 -33.65 71.51 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.809 0.338 . . . . 0.0 110.57 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -83.21 -41.61 18.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 43.6 mt-30 -57.66 -29.45 64.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.736 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 3.1 pt20 -83.25 -32.21 26.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -71.25 -40.16 71.19 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.77 -26.81 13.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.75 11.69 39.85 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.916 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 75.5 mt -56.94 121.22 44.24 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.62 0.248 . . . . 0.0 111.4 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.8 Cg_exo -68.07 170.32 14.68 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.747 2.298 . . . . 0.0 112.241 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -94.05 -4.09 50.07 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.606 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 6.5 t70 -98.5 108.24 46.77 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.715 0.293 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.571 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 33.2 Cg_endo -63.59 -26.96 69.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.001 2.467 . . . . 0.0 112.973 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -76.53 -35.22 58.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -94.7 40.48 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.078 0.466 . . . . 0.0 110.558 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.55 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.2 m0 -108.51 170.35 8.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.375 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.9 p -130.96 179.69 5.84 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -39.49 58.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.0 m -64.24 -53.3 51.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -61.56 -39.38 90.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 81' ' ' VAL . 50.5 t -64.18 -52.13 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.136 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -66.01 -48.17 72.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.911 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.81 -32.13 72.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.7 t90 -72.58 -65.86 0.73 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.2 p -40.99 -47.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.506 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.429 ' N ' HG13 ' A' ' 81' ' ' VAL . 38.5 ttm -59.3 -48.43 81.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.819 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.423 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 87.2 t90 -61.55 -40.22 93.91 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.3 62.76 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.264 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.61 ' CG2' HG11 ' A' ' 93' ' ' VAL . 40.2 t -82.49 -31.4 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.9 -38.43 37.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 11.6 mm-40 -70.27 -36.68 74.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.21 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -104.28 5.67 34.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m 44.64 55.59 5.75 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 110.779 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.557 HD21 HG13 ' A' ' 124' ' ' ILE . 83.0 mt -78.2 127.34 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.088 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -108.47 142.34 39.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.464 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 -5.72 84.42 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.756 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.61 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.5 p -76.34 137.57 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.298 0.549 . . . . 0.0 110.926 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -112.93 138.82 49.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.437 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -89.46 -26.02 21.17 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.598 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -60.61 -34.15 73.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.006 0.431 . . . . 0.0 109.916 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.8 mmmm -68.02 -34.33 76.3 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.847 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.2 m-85 -99.34 35.45 1.94 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.443 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.91 69.08 10.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.21 169.15 24.75 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.778 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -76.9 165.18 25.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.55 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.27 -43.19 95.66 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.103 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.23 66.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.989 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.21 53.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.841 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.427 HD22 HG13 ' A' ' 77' ' ' VAL . 14.7 tp -56.73 -46.59 81.24 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.345 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 80.5 m -66.52 -40.66 89.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.71 0.291 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.57 76.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.215 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.2 mt -58.82 -32.51 69.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.997 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.23 177.18 45.57 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.662 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.521 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -60.66 -45.51 93.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.367 0.136 . . . . 0.0 111.367 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 35.2 tt0 -50.88 -66.73 0.34 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.0 m -57.98 -40.16 79.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.767 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.98 -45.42 93.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.554 0.216 . . . . 0.0 111.018 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.46 -26.19 68.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.745 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 18.5 mm-40 -73.92 -24.03 59.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 110.771 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.1 mt -82.39 -35.47 27.67 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.508 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -109.69 160.23 28.71 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 120.716 0.293 . . . . 0.0 111.62 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.674 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 50.4 Cg_exo -52.91 171.89 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.116 2.544 . . . . 0.0 113.651 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.73 -22.77 66.05 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.774 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.76 -58.75 1.93 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.674 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.9 m -62.39 -32.83 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.0 -38.51 38.77 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.599 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.49 -46.35 88.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.653 0.264 . . . . 0.0 111.007 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.557 HG13 HD21 ' A' ' 90' ' ' LEU . 50.5 mm -51.29 -51.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.132 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -63.65 -57.09 11.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.418 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.521 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -61.32 -26.95 68.14 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.08 -57.27 12.2 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.473 ' HA ' HD12 ' A' ' 131' ' ' ILE . 20.8 t-160 -73.28 -35.15 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.688 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.533 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 29.7 tp -57.8 -45.63 85.79 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 1.7 tm-20 -68.29 -38.93 82.15 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 128' ' ' HIS . 66.5 mt -55.15 -45.24 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.627 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.479 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.2 mt -53.25 -36.31 60.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.318 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.571 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 63.5 mt-30 -61.94 -48.17 81.63 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.926 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -66.14 -35.67 81.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.563 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 131' ' ' ILE . 20.2 mm-40 -52.27 -37.33 55.18 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.622 0.248 . . . . 0.0 111.33 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.09 76.86 1.53 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.038 0.447 . . . . 0.0 110.909 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.8 m -75.8 168.03 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.352 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.865 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 111.414 0.154 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 90.4 mtp 58.9 66.66 1.02 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.035 0.445 . . . . 0.0 110.711 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.44 -45.36 13.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.957 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.9 p -112.52 124.8 53.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.624 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.07 -57.44 2.22 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.575 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -103.89 -56.91 2.12 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.268 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.43 124.43 28.55 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.203 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.32 154.68 56.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.622 2.214 . . . . 0.0 112.039 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.436 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 28.4 tp -144.76 141.73 29.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.23 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.543 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 6.5 mp -95.54 159.84 14.8 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.852 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.469 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 37' ' ' LEU . 43.8 Cg_endo -67.88 177.82 3.93 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.554 2.17 . . . . 0.0 112.446 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.2 p -50.84 -64.48 0.8 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.41 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SEP . . . . . 0.437 ' HA ' ' HE1' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 38' ' ' TPO . 21.2 tptm -65.4 -25.73 67.68 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -38.08 74.66 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.429 0.104 . . . . 0.0 111.131 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.437 ' HE1' ' HA ' ' A' ' 41' ' ' SEP . 2.9 mpp? -56.66 -41.49 77.33 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.673 0.273 . . . . 0.0 110.552 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.7 mtp -67.76 -42.67 81.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.406 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.4 m -60.77 -34.4 74.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.696 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -49.41 -52.71 26.86 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.071 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.75 -49.86 76.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.572 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -59.44 -44.85 92.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.525 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.17 -39.65 75.75 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.897 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.63 -30.31 29.5 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.3 m -70.06 -33.57 72.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.439 0.162 . . . . 0.0 111.267 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -93.06 41.01 1.07 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.861 0.363 . . . . 0.0 111.389 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.3 p -76.09 -16.53 59.9 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.237 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' HA2' ' HE2' ' A' ' 58' ' ' LYS . . . -78.23 -14.11 82.58 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.803 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 9.5 t80 -88.77 -51.08 5.84 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 116.745 0.273 . . . . 0.0 110.628 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 91.0 m -56.11 -42.24 76.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.112 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HE2' ' HA2' ' A' ' 55' ' ' GLY . 56.4 pttt -60.01 -33.85 72.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.734 0.302 . . . . 0.0 110.419 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -77.27 -42.89 35.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.66 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.3 mt-30 -60.66 -27.34 67.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.832 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 57' ' ' THR . 87.1 mm-40 -80.45 -14.34 58.37 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 78.6 mtt180 -85.01 -34.41 22.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.109 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.79 -24.56 12.89 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.72 9.94 48.25 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.073 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.451 HG12 ' CD2' ' A' ' 76' ' ' HIS . 25.9 mt -56.53 126.01 68.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.742 0.271 . . . . 0.0 111.281 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 63.6 Cg_endo -73.89 175.51 10.71 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.617 2.211 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -98.99 39.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.517 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -148.02 110.48 3.78 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.543 0.211 . . . . 0.0 111.439 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 34.4 Cg_exo -57.32 -37.96 96.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.181 2.587 . . . . 0.0 112.597 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -63.34 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.668 0.27 . . . . 0.0 110.494 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -96.47 38.7 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.526 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -114.82 169.32 9.16 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.681 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.4 t -132.25 -177.77 4.61 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -49.31 -42.0 40.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.2 m -67.01 -50.08 63.25 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.451 ' CD2' HG12 ' A' ' 65' ' ' ILE . 37.1 m170 -61.66 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.631 0.253 . . . . 0.0 111.176 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.473 HG13 HD22 ' A' ' 105' ' ' LEU . 54.6 t -59.7 -51.73 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -71.03 -43.37 68.04 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.785 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.03 -39.45 74.82 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.58 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.541 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.4 t90 -68.35 -60.57 2.35 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.2 t -41.61 -55.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.647 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 ttm -55.8 -46.15 78.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.69 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 14.5 t90 -57.2 -37.13 71.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -18.68 62.22 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.273 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 HG11 ' A' ' 93' ' ' VAL . 24.4 t -81.9 -35.91 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.853 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -90.9 -30.36 16.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.051 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.67 -38.81 53.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -108.2 11.15 27.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.746 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 45.72 57.11 5.28 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.905 0.383 . . . . 0.0 111.624 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HB3' HG12 ' A' ' 121' ' ' VAL . 70.8 mt -89.16 172.74 8.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -155.37 153.89 31.16 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 111.643 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.12 -6.23 80.13 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG22 ' A' ' 85' ' ' VAL . 13.2 p -78.07 133.7 29.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 117.348 0.574 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -104.66 135.98 45.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.74 -28.33 21.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.528 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.15 -34.58 75.25 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.0 mmtt -66.72 -34.98 79.05 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.026 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.605 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 42.3 m-85 -100.62 34.21 2.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.386 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.8 t -86.94 66.51 9.46 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.119 0.485 . . . . 0.0 110.077 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.6 ptp -159.0 170.76 21.37 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.871 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.9 m -74.24 157.11 36.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -60.27 -36.36 90.62 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.925 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.2 -39.46 72.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 110.645 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.28 -43.16 61.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.425 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 77' ' ' VAL . 14.4 tp -56.48 -44.89 81.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.074 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.6 -40.22 88.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.723 0.297 . . . . 0.0 110.676 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.08 -24.28 66.68 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.749 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 39.9 mt -68.49 -35.09 77.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.79 172.11 48.56 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.329 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.491 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.8 ttpt -61.47 -48.75 79.7 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.47 -51.81 51.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.8 m -66.69 -39.65 88.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.558 0.218 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 64.1 t80 -63.0 -43.72 98.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.796 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.27 -25.95 66.31 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.68 -23.53 59.84 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.639 0.257 . . . . 0.0 110.617 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 78.1 mt -85.84 -35.04 20.88 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.302 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -104.89 161.5 22.59 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.795 ' HG2' HG22 ' A' ' 121' ' ' VAL . 18.9 Cg_endo -59.42 176.12 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.748 2.298 . . . . 0.0 112.888 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.35 -12.91 59.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -108.67 -56.44 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.773 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.795 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.6 m -62.98 -31.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.72 -43.96 38.47 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.782 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.29 -49.36 43.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.647 0.26 . . . . 0.0 110.846 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.86 -55.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.517 HD21 HG13 ' A' ' 81' ' ' VAL . 10.3 mp -56.81 -53.08 61.96 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.753 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.491 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 17.4 t90 -61.43 -28.18 69.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -63.95 -54.84 28.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.147 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.451 ' HA ' HD12 ' A' ' 131' ' ' ILE . 2.0 t60 -72.37 -34.33 67.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.613 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.541 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.7 tp -61.93 -45.29 94.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.623 ' HG2' ' HE2' ' A' ' 134' ' ' LYS . 31.9 tt0 -67.58 -27.73 67.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.48 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 128' ' ' HIS . 62.2 mt -68.28 -37.57 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.44 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.414 ' HB2' ' HG3' ' A' ' 69' ' ' PRO . 96.2 mt -64.67 -48.52 74.43 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.68 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.65 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 8.4 pt20 -57.13 -38.18 73.09 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.623 ' HE2' ' HG2' ' A' ' 130' ' ' GLU . 64.5 mttm -68.67 -38.46 80.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.914 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.64 130.28 36.64 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.86 90.58 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.881 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.9 m -122.02 147.15 26.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.16 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.698 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.0 m80 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 51.7 ttm -157.79 -59.7 0.08 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.749 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -139.29 96.57 3.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.57 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.5 m 59.18 44.26 16.0 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.145 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.25 100.96 5.19 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -128.36 140.81 51.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.033 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.458 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.2 m -93.36 135.15 25.79 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 23.4 Cg_exo -64.67 146.4 88.65 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.943 2.429 . . . . 0.0 112.497 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.91 100.86 1.01 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.4 mt -127.57 156.95 41.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.397 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.84 -178.97 3.81 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.811 2.341 . . . . 0.0 112.388 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -49.97 -47.79 52.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.948 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SEP . . . . . 0.418 ' HA ' ' CE ' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 38' ' ' TPO . 59.4 tptt -69.94 -40.02 75.75 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.784 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.86 -39.23 93.71 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.948 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.418 ' CE ' ' HA ' ' A' ' 41' ' ' SEP . 66.3 mtm -74.27 -26.71 60.37 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.142 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.4 ttt -56.71 -38.09 71.82 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.339 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 136' ' ' ASP . 24.8 t -69.37 -36.76 77.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.905 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -47.46 -52.23 17.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.565 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.34 -45.93 71.56 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.64 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.86 -45.76 82.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.776 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 21.7 ptmt -74.6 -30.52 61.71 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.629 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.94 73.34 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.4 p -56.63 -33.41 66.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.378 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -96.74 68.13 2.39 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 110.73 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -72.68 -26.42 61.61 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.442 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.8 -17.14 80.22 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.698 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.496 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.3 t80 -96.43 -49.67 5.07 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.646 0.223 . . . . 0.0 110.9 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -54.52 -33.23 59.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.248 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 110.115 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.03 -38.89 35.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.952 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 25.0 mt-30 -58.98 -31.72 69.01 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.608 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -85.75 -37.06 19.74 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -71.98 -31.98 66.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 mt -105.54 -32.14 8.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.0 0.49 41.75 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.157 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 48.9 mt -55.83 122.66 47.92 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.762 0.281 . . . . 0.0 110.917 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 74.4 Cg_endo -76.35 171.77 17.47 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.455 2.103 . . . . 0.0 112.648 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HE3' ' HG2' ' A' ' 135' ' ' GLU . 30.9 mtpp -98.75 45.91 1.0 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.927 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -146.17 103.31 4.09 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.068 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.6 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 51.0 Cg_exo -57.08 -46.88 25.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.921 2.414 . . . . 0.0 112.238 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -57.71 -33.09 68.05 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.555 0.217 . . . . 0.0 110.805 178.434 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG3' ' HG2' ' A' ' 70' ' ' ARG . 46.0 mt-30 -99.98 42.04 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.186 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.635 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.9 m0 -115.33 170.21 8.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.363 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -130.66 -179.46 5.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.23 -43.04 52.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.5 m -62.52 -50.39 71.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.301 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.159 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.49 -52.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.34 -48.74 69.29 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.482 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.25 -36.22 77.26 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.008 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 33.5 t90 -69.56 -65.17 0.75 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 85' ' ' VAL . 11.6 p -41.7 -47.53 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.227 0.329 . . . . 0.0 111.378 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.427 ' N ' HG13 ' A' ' 81' ' ' VAL . 60.4 tpp -59.84 -47.64 84.89 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.101 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.516 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.3 t90 -61.22 -38.17 85.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.988 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.45 61.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.43 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 81' ' ' VAL . 54.1 t -83.17 -32.84 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.161 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -81.16 -33.84 32.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.2 mm-40 -73.59 -39.9 64.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.989 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -102.19 7.49 40.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m 44.67 55.22 6.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 110.976 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.626 HD13 ' HB ' ' A' ' 121' ' ' VAL . 53.4 mt -83.12 168.75 16.57 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.36 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -150.99 153.77 35.81 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.733 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.1 -7.61 63.02 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.008 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 85' ' ' VAL . 12.3 p -73.81 131.97 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 117.547 0.673 . . . . 0.0 111.167 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.66 131.1 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -86.29 -23.09 26.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.754 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -61.95 -35.7 79.24 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 6.1 mptp? -65.56 -34.27 77.86 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.32 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 36.6 m-85 -101.1 29.95 4.39 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.693 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.3 t -84.86 66.55 9.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.1 0.476 . . . . 0.0 110.241 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.1 ptp -158.43 171.66 19.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.657 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 m -75.92 158.26 32.23 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.635 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.57 -37.95 90.11 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.872 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.42 -39.51 67.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 110.64 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 108' ' ' LEU . . . -73.49 -46.76 46.05 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -52.89 -47.5 67.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.323 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.71 -38.52 86.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.785 0.326 . . . . 0.0 110.492 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -18.46 64.16 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.932 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 112' ' ' CYS . 41.9 mt -74.36 -28.49 61.14 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.18 169.8 42.44 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.673 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.58 -44.92 95.67 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.95 -60.79 2.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.734 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 49.8 t -59.61 -44.21 93.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.395 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -59.78 -43.34 94.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.973 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.48 -30.15 70.89 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.723 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.04 -21.85 60.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.733 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 89.0 mt -83.65 -32.21 25.77 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.586 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -112.02 154.62 44.16 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.724 0.297 . . . . 0.0 111.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.639 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.0 Cg_exo -45.77 167.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.398 2.732 . . . . 0.0 113.796 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.21 -21.88 66.74 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.087 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.422 ' CE2' HG13 ' A' ' 121' ' ' VAL . 18.9 p90 -108.63 -51.51 2.88 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.639 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 9.9 m -61.69 -35.76 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.39 -35.1 49.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.238 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.11 -49.91 72.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.706 0.253 . . . . 0.0 111.202 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.535 HD12 HD21 ' A' ' 90' ' ' LEU . 74.1 mt -60.16 -53.33 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.565 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -52.62 -58.1 7.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.278 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 1.4 t90 -64.74 -25.45 67.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.427 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.51 -56.69 17.29 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.423 ' HA ' HD12 ' A' ' 131' ' ' ILE . 2.5 t60 -73.17 -36.63 66.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.523 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.55 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.9 tp -57.23 -45.16 84.14 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.22 -36.42 79.48 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 128' ' ' HIS . 64.8 mt -58.31 -41.51 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.698 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.507 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 86.7 mt -57.22 -37.37 72.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.683 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.6 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 45.4 mt-30 -68.31 -46.84 69.19 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.164 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -90.04 31.54 0.97 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.732 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.468 ' HG2' ' HE3' ' A' ' 67' ' ' LYS . 19.0 tp10 -63.54 -56.97 11.83 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.519 0.199 . . . . 0.0 111.002 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 3.7 t70 -176.84 111.54 0.09 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.8 m -131.53 150.88 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.387 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.421 ' HA ' ' HB ' ' A' ' 38' ' ' TPO . 65.6 tttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.161 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.461 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 14.4 p80 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.721 0.296 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.416 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 53.9 ttm -93.04 -63.02 1.27 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.091 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 29' ' ' MET . 41.6 mt-10 -121.7 -57.43 1.81 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.234 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.2 t -105.94 128.57 53.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.006 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' HB2' ' CD2' ' A' ' 28' ' ' HIS . . . -91.97 -49.85 6.01 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.152 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.17 139.69 39.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 26.9 m -85.83 133.69 40.98 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.152 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 24.5 Cg_exo -63.57 139.18 68.69 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.852 2.368 . . . . 0.0 112.33 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.0 mt -139.41 142.73 37.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.186 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.8 tp -91.34 125.22 36.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.592 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.97 166.97 26.07 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.785 2.323 . . . . 0.0 112.237 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.8 p -66.72 129.39 39.7 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.164 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.488 ' O ' ' HE2' ' A' ' 45' ' ' MET . 39.2 mmtm -80.26 -21.16 43.02 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.629 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 31.9 mt-10 -75.31 -32.72 61.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.434 0.159 . . . . 0.0 110.952 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 73.1 mtm -64.62 -26.77 68.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.54 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.488 ' HE2' ' O ' ' A' ' 42' ' ' LYS . 69.5 mtm -56.22 -32.1 64.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 49' ' ' LEU . 66.5 m -52.24 -37.79 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.574 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.401 ' HA ' ' CE ' ' A' ' 50' ' ' LYS . 48.9 mt-30 -51.35 -52.31 46.67 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.463 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.57 -28.84 41.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.444 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.588 HD13 ' CG2' ' A' ' 131' ' ' ILE . 62.4 mt -61.67 -32.44 72.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.565 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' CE ' ' HA ' ' A' ' 47' ' ' GLN . 49.5 mtmt -64.54 -27.44 68.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.613 0.244 . . . . 0.0 111.094 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.33 -30.65 16.45 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.474 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.1 p -71.14 -32.04 68.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.396 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -88.9 74.41 8.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.019 0.438 . . . . 0.0 110.775 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -72.77 -24.17 60.91 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.116 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.69 -16.61 72.67 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.735 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.1 t80 -96.42 -53.73 3.5 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.697 0.249 . . . . 0.0 110.864 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.6 m -54.7 -33.66 61.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.402 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 14.7 ptmm? -62.15 -31.27 71.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.856 0.36 . . . . 0.0 110.569 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -83.3 -39.3 20.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.087 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 28.4 mt-30 -58.29 -28.32 64.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.455 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 29.1 pt20 -84.78 -37.03 21.3 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.564 0.221 . . . . 0.0 110.962 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -65.06 -42.95 93.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.7 mt -99.14 -29.33 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.29 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.66 6.66 54.51 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.56 119.21 14.8 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 122.31 0.244 . . . . 0.0 111.283 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.14 166.93 13.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.739 2.293 . . . . 0.0 112.386 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -98.92 41.07 1.16 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.725 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -156.28 125.15 3.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 132' ' ' LEU . 38.2 Cg_endo -67.59 -37.73 16.04 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.089 2.526 . . . . 0.0 113.02 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.442 ' HD3' ' HG2' ' A' ' 69' ' ' PRO . 1.5 mpp_? -61.91 -33.06 73.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.519 0.199 . . . . 0.0 110.763 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -99.37 41.92 1.13 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.932 0.396 . . . . 0.0 110.843 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.595 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 4.9 m0 -119.8 170.05 9.58 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.509 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -133.59 -178.86 5.19 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -49.87 -43.31 49.11 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -63.1 -49.64 73.65 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.335 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -61.67 -41.6 97.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.605 HG13 HD22 ' A' ' 105' ' ' LEU . 64.8 t -62.35 -56.14 19.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.19 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 7.0 tmm_? -64.08 -46.97 81.94 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.347 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.1 -43.21 99.24 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.724 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 22.0 t90 -61.13 -62.93 1.49 Allowed 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 85' ' ' VAL . 55.8 t -40.91 -49.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.791 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.403 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 29.9 ttm -58.17 -45.02 88.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.788 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.595 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 17.3 t90 -59.26 -37.82 78.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.68 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.52 -20.28 61.37 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.173 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 81' ' ' VAL . 69.7 t -81.35 -32.07 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.188 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.7 -35.48 24.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.134 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.595 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.1 mm-40 -73.04 -40.13 65.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.84 10.78 36.33 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p 41.83 51.72 4.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.978 0.418 . . . . 0.0 111.183 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.432 ' HB3' HG12 ' A' ' 121' ' ' VAL . 79.5 mt -80.11 171.25 15.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -155.08 160.35 40.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.199 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.06 -7.88 58.85 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.783 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.549 ' HB ' HG21 ' A' ' 121' ' ' VAL . 11.4 p -79.9 131.61 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.497 0.648 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -103.53 139.47 38.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.3 -25.33 21.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -61.59 -30.65 70.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 29.9 mmmt -68.41 -34.59 76.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.872 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.6 m-85 -101.52 32.4 3.35 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.189 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.1 t -84.07 67.51 9.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 110.232 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.428 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.6 ptp -157.42 168.56 26.98 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.804 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -73.3 161.02 30.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.336 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.37 -44.79 89.78 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.866 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.8 63.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.656 0.265 . . . . 0.0 110.836 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.55 61.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.605 HD22 HG13 ' A' ' 77' ' ' VAL . 16.2 tp -55.95 -47.51 77.45 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.182 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.41 -38.77 85.15 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.799 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.66 67.64 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.794 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.6 mt -67.67 -30.53 70.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.86 173.48 40.82 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.628 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -59.18 -46.81 87.44 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.087 0.155 . . . . 0.0 111.263 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.49 -64.74 0.71 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.894 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.7 m -61.02 -40.78 94.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -60.19 -46.83 88.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.459 0.171 . . . . 0.0 111.23 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.83 -28.51 69.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.28 -20.69 60.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.89 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 69.2 mt -87.24 -35.49 18.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.791 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.604 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -111.93 159.52 33.24 Favored Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.741 ' HG2' HG22 ' A' ' 121' ' ' VAL . 10.2 Cg_endo -56.3 172.59 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.673 2.249 . . . . 0.0 113.213 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.04 -19.03 60.89 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -108.66 -50.63 2.99 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.741 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -63.02 -34.2 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.532 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.36 -39.43 65.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.801 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -68.53 -48.18 65.0 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.628 0.251 . . . . 0.0 110.93 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.33 -55.52 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.41 ' HB3' ' CH2' ' A' ' 80' ' ' TRP . 92.7 mt -57.73 -59.93 4.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.188 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.47 -28.58 69.39 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.36 -52.54 26.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.298 0.499 . . . . 0.0 110.088 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.404 ' HA ' HD12 ' A' ' 131' ' ' ILE . 3.9 t60 -67.61 -34.42 76.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.508 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.7 tp -64.28 -39.39 93.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.972 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' A' ' 133' ' ' GLN . 34.9 tt0 -67.21 -29.12 68.7 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.182 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.588 ' CG2' HD13 ' A' ' 49' ' ' LEU . 51.6 mt -67.86 -35.65 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.571 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.593 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 99.1 mt -68.63 -40.87 80.11 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.563 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.503 ' HB3' ' CG ' ' A' ' 69' ' ' PRO . 15.8 pt20 -68.5 -47.44 67.0 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 43' ' ' GLU . 19.8 ptpt -58.58 -21.7 53.79 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.75 -42.09 67.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.622 0.249 . . . . 0.0 111.317 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -133.23 -171.41 2.68 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.082 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.33 -55.82 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.292 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.947 -179.658 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.6 p80 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mpp? 67.69 -80.6 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.756 0.422 . . . . 0.0 111.184 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -115.57 -57.6 2.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.642 0.258 . . . . 0.0 110.55 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 77.0 m -94.39 132.71 38.73 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.509 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.73 145.31 24.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.532 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.88 111.75 2.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.9 t -70.39 113.47 18.43 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.212 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -91.42 135.67 1.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.054 2.503 . . . . 0.0 112.565 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.77 HD22 ' HG3' ' A' ' 130' ' ' GLU . 21.8 tp -158.49 -67.78 0.09 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.924 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.9 tp -161.88 81.72 0.57 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.716 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.596 HG22 ' O ' ' A' ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 71.2 Cg_endo -73.59 -178.64 3.86 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.915 2.41 . . . . 0.0 112.699 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.9 t -98.12 -75.48 0.55 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.768 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 39' ' ' PRO . 59.4 mtpt -76.36 -17.86 59.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.746 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 4.9 tp10 -57.44 -22.85 46.04 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -30.55 62.57 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -72.91 -39.91 65.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.951 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.4 t -69.8 -26.63 64.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.281 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -45.25 -52.3 9.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.786 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.68 -45.22 85.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.429 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.07 -40.46 94.71 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.96 -40.47 97.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.066 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.39 -36.14 66.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.69 0.281 . . . . 0.0 111.268 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.6 m -62.83 -34.1 76.62 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.341 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -83.67 11.92 6.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.6 m -66.69 -19.85 65.85 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.372 0.129 . . . . 0.0 111.006 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.423 ' CA ' ' HE3' ' A' ' 58' ' ' LYS . . . -76.08 -0.71 66.2 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.814 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.9 t80 -95.21 -45.42 7.19 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m -57.61 -37.27 72.96 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 20.6 pttp -63.35 -32.79 74.3 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.747 0.308 . . . . 0.0 110.625 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -82.84 -38.98 22.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 56.6 mt-30 -57.7 -27.43 62.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.82 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 30.1 pt20 -85.11 -34.64 22.15 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 110.959 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -73.05 -33.67 65.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.3 mt -101.53 -30.84 11.17 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.701 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.18 -1.99 56.38 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.701 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.645 HD11 ' HB3' ' A' ' 79' ' ' ASP . 54.7 mt -55.55 122.05 42.43 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.73 0.265 . . . . 0.0 111.203 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.4 Cg_exo -68.13 177.83 4.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.834 2.356 . . . . 0.0 112.252 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -108.47 31.57 5.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.73 98.85 27.27 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.273 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.55 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 32.9 Cg_exo -61.35 -27.03 82.42 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.919 2.413 . . . . 0.0 112.907 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -78.65 -38.38 39.66 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -96.57 39.32 1.17 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.667 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -107.18 175.61 5.44 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.351 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.66 -179.56 5.72 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.55 -43.79 56.28 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -62.43 -53.39 55.55 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -58.49 -40.71 83.52 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.24 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 81' ' ' VAL . 60.3 t -62.7 -51.52 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.659 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -64.12 -53.86 42.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.352 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.645 ' HB3' HD11 ' A' ' 65' ' ' ILE . 1.2 m-20 -55.99 -35.21 66.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.375 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.9 t90 -70.34 -63.24 1.12 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 85' ' ' VAL . 79.3 t -40.51 -54.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.435 ' HG2' ' CE1' ' A' ' 95' ' ' PHE . 63.5 mtt -55.53 -47.41 76.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.564 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 7.0 t90 -55.8 -37.83 69.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -18.56 61.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.523 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 HG11 ' A' ' 93' ' ' VAL . 47.5 t -79.26 -35.12 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.575 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.54 -31.71 24.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.386 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.564 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.78 -40.66 54.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 111.102 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -103.09 6.22 38.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t 45.67 55.58 6.65 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.452 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.578 ' HB3' HG12 ' A' ' 121' ' ' VAL . 64.4 mt -81.92 174.28 11.43 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.457 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.07 146.92 23.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.457 -179.412 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.07 81.3 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.739 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG22 ' A' ' 85' ' ' VAL . 14.7 p -71.98 128.19 34.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 117.472 0.636 . . . . 0.0 110.917 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.463 ' CB ' ' HD3' ' A' ' 97' ' ' LYS . 11.1 m-20 -98.8 128.68 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' ' HG2' ' A' ' 82' ' ' MET . 39.4 m-85 -86.31 -25.97 25.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.463 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.466 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 30.1 mm-40 -63.9 -34.33 77.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.1 mptt -67.05 -33.5 75.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.189 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 48.6 m-85 -98.28 33.14 2.27 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 37.2 m -88.49 67.19 8.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.041 0.448 . . . . 0.0 110.346 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.524 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.8 ptp -157.08 168.41 27.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.855 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -73.29 158.69 34.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.98 -43.93 87.91 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.743 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.23 62.79 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.98 62.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -55.95 -46.75 78.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.264 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.21 -40.85 94.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.716 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -26.17 67.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.654 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 38.6 mt -65.27 -37.61 87.74 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.09 172.95 49.47 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.331 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.0 ttpt -60.76 -47.2 87.38 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.38 -51.69 61.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.8 m -67.19 -39.51 86.38 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.442 0.163 . . . . 0.0 111.23 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -63.42 -43.1 98.44 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.687 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.93 -24.15 66.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.823 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.87 -23.62 48.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.454 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 95.9 mt -83.62 -36.68 23.69 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.35 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.607 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -108.29 157.79 35.46 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.782 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.0 Cg_endo -56.7 176.82 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.787 2.325 . . . . 0.0 112.978 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.51 -15.63 61.18 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.29 -57.47 2.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.706 -0.798 . . . . 0.0 112.949 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.782 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.5 m -59.17 -33.69 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.75 -34.51 50.85 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.776 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.07 -50.05 21.35 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.419 0.152 . . . . 0.0 110.987 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -57.12 -57.65 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.1 mt -51.68 -58.97 4.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.905 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -61.33 -31.03 70.89 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.559 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.19 -55.5 27.96 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.056 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -70.89 -32.41 69.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.519 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.1 tp -59.11 -49.59 77.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.77 ' HG3' HD22 ' A' ' 36' ' ' LEU . 12.6 tp10 -65.65 -33.91 76.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.485 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.519 ' HA ' ' HE2' ' A' ' 134' ' ' LYS . 67.5 mt -61.69 -39.03 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.425 ' HB2' ' HG3' ' A' ' 69' ' ' PRO . 86.2 mt -64.4 -35.69 81.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.777 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.55 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 66.7 mt-30 -64.82 -54.38 32.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.418 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.721 ' HD3' HD23 ' A' ' 36' ' ' LEU . 55.6 pttt -57.94 -38.19 75.51 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.435 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.14 -52.91 56.8 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.459 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -82.76 113.06 20.16 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.91 0.386 . . . . 0.0 111.066 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.8 m -120.68 39.92 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.119 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 138' ' ' LYS . 2.7 mptp? . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.177 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' A' ' 29' ' ' MET . 66.8 t60 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.338 0.113 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.422 ' HB3' ' O ' ' A' ' 28' ' ' HIS . 28.1 ttt 73.34 -68.8 0.21 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.487 0.492 . . . . 0.0 111.095 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.46 165.17 31.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.5 t -84.65 63.23 7.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.113 0.483 . . . . 0.0 110.45 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.47 -49.26 0.02 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.848 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -139.89 140.11 36.38 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.021 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 34.5 m -78.83 156.15 77.56 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.956 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 34' ' ' VAL . 23.8 Cg_endo -61.56 103.94 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.566 2.177 . . . . 0.0 112.092 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.4 tp 177.81 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.603 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 37' ' ' LEU . 6.6 mp -81.87 178.2 8.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.439 HG22 ' O ' ' A' ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.81 147.92 22.03 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.533 2.155 . . . . 0.0 112.225 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.9 m -103.52 68.77 0.96 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 111.285 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -62.01 -40.07 94.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.863 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -73.26 -37.43 66.31 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.08 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.2 ttp -67.48 -44.24 79.04 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.112 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 92.3 mtp -61.02 -43.89 98.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.373 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.3 p -75.89 -26.92 57.46 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -47.86 -49.41 29.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.339 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.34 -44.62 95.37 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.486 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.6 mp -61.58 -44.0 97.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.971 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.408 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 90.3 mttt -62.75 -41.48 99.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.41 80.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.416 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.8 m -67.12 -44.19 80.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.421 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 21.8 m-85 -45.95 -61.33 1.79 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.9 t -60.38 -39.72 88.29 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.05 -9.85 76.91 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.222 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.589 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 8.5 t80 -101.52 -38.11 8.11 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.823 0.312 . . . . 0.0 110.986 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 m -65.25 -24.56 67.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.194 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -74.66 -36.21 62.82 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.003 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -83.6 -31.68 26.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.667 179.247 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.9 mt-30 -61.32 -29.16 69.71 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.5 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 3.9 pt20 -85.68 -39.5 17.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.521 0.2 . . . . 0.0 111.132 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -71.49 -33.23 69.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.443 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.441 HD13 ' OD1' ' A' ' 79' ' ' ASP . 12.5 mt -99.3 -34.7 10.21 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.638 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.67 -5.0 53.97 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.569 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 85.4 mt -50.74 122.92 17.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.522 0.329 . . . . 0.0 111.483 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 22.9 Cg_exo -64.79 172.23 7.33 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.093 2.528 . . . . 0.0 112.719 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' HD3' ' HG2' ' A' ' 135' ' ' GLU . 40.0 ttmt -93.08 -12.17 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 14.5 t70 -104.12 122.77 43.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.547 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 41.8 Cg_endo -67.51 -24.99 41.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.05 2.5 . . . . 0.0 113.405 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 5.9 mpt_? -70.27 -32.27 70.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.145 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 2.7 pt20 -93.78 24.7 3.98 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.654 0.264 . . . . 0.0 111.213 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.466 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -97.69 169.96 9.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.211 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.6 p -136.9 -174.55 3.76 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.55 -36.73 62.16 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.473 0.178 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.2 m -68.17 -52.85 29.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.349 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -60.79 -39.72 89.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.678 0.275 . . . . 0.0 111.12 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.95 -52.47 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -67.5 -47.75 69.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.376 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD1' HD13 ' A' ' 63' ' ' LEU . 10.1 t70 -61.41 -34.65 75.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.678 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -66.87 -65.16 0.72 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.3 p -42.87 -45.41 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.097 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -58.54 -48.13 81.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -59.18 -38.84 80.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.638 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -20.89 62.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.335 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 81' ' ' VAL . 62.5 t -82.16 -32.39 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.469 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -82.03 -36.92 27.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.82 -38.45 67.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.262 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.61 6.31 39.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 44.97 56.4 5.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.092 0.472 . . . . 0.0 110.768 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.544 ' HB3' HG12 ' A' ' 121' ' ' VAL . 77.0 mt -85.19 172.78 10.91 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 153.59 29.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.323 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.26 77.32 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.828 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.619 ' HB ' HG21 ' A' ' 121' ' ' VAL . 11.1 p -77.97 132.58 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 117.416 0.608 . . . . 0.0 111.118 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 97' ' ' LYS . 29.0 t70 -102.56 136.53 42.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.737 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.22 -23.45 22.36 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.446 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.75 -31.45 72.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 74.5 mmtt -68.11 -35.46 78.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.876 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.543 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 33.7 m-85 -100.17 34.59 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.26 68.9 7.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.466 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.7 ptp -157.78 170.9 21.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.239 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 t -72.12 160.5 32.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.278 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.06 -48.5 79.04 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.62 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.76 -37.48 51.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.647 0.261 . . . . 0.0 111.181 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.46 -45.79 65.07 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.72 -44.67 81.84 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 81.3 m -66.48 -39.49 88.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.825 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.9 73.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.479 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -60.46 -37.92 82.54 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.807 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 175.92 50.69 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.662 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 26.2 ttpp -59.85 -53.86 52.95 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 10.6 pt-20 -48.84 -51.87 27.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.1 m -67.51 -41.77 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.436 ' HE1' ' HB2' ' A' ' 125' ' ' LEU . 50.4 t80 -62.53 -44.91 95.18 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.06 -28.95 70.13 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.941 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 19.3 mm-40 -73.08 -23.68 60.58 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.638 0.256 . . . . 0.0 110.807 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 76.9 mt -83.29 -34.73 25.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.52 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.598 ' HB1' HG23 ' A' ' 121' ' ' VAL . . . -104.99 158.12 32.73 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.471 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.798 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.5 Cg_endo -57.43 176.88 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.778 2.318 . . . . 0.0 112.927 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.75 -14.77 60.06 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.16 -59.01 1.95 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.913 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -58.76 -32.33 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.34 -33.48 46.55 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.1 -45.86 46.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.497 0.189 . . . . 0.0 111.27 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.401 HD12 HD21 ' A' ' 90' ' ' LEU . 50.3 mt -63.64 -60.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.539 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.436 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . 71.6 mt -49.74 -56.82 8.8 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.085 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.474 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -63.7 -34.28 77.52 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.16 -55.51 32.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.579 ' HA ' HD12 ' A' ' 131' ' ' ILE . 17.9 t-160 -71.14 -31.35 67.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 34.3 tp -57.93 -46.07 85.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.0 mm-40 -70.32 -32.4 70.12 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.377 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.8 mt -60.96 -39.42 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 93.7 mt -60.77 -33.62 73.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.534 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 76.3 mt-30 -65.98 -57.43 7.83 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.032 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -65.06 -32.69 74.53 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.681 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.477 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 42.8 tt0 -71.63 -38.0 70.8 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.397 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -151.77 112.53 4.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.793 0.33 . . . . 0.0 110.704 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.39 -27.61 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.772 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.042 -179.752 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 32' ' ' ALA . 40.9 t60 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.46 0.172 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.5 mmt 64.59 -82.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.37 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -145.5 110.02 5.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.641 0.257 . . . . 0.0 111.098 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.3 m 58.14 88.97 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.697 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 28' ' ' HIS . . . -107.33 87.48 2.51 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.77 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -152.25 151.94 31.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.319 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.02 93.56 22.68 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.96 126.17 18.19 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.742 2.294 . . . . 0.0 112.13 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.1 mt -144.24 144.3 31.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.281 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 38' ' ' TPO . 6.4 tt -80.64 125.79 30.46 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.425 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.465 ' N ' HD23 ' A' ' 37' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.08 162.44 32.78 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.786 2.324 . . . . 0.0 112.282 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.0 m -138.88 163.13 33.09 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' C ' ' HD3' ' A' ' 42' ' ' LYS . 1.1 tmtp? -70.15 -40.51 74.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.502 0.191 . . . . 0.0 110.87 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -60.3 -38.85 84.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.051 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 39.6 mtm -85.88 -26.42 25.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.546 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 46.5 ttm -55.91 -39.13 71.18 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.8 m -71.26 -38.49 71.88 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -52.88 -49.75 65.24 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.749 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.69 -38.09 62.47 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.681 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.01 -44.66 94.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.658 0.266 . . . . 0.0 111.079 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HE3' ' HD3' ' A' ' 67' ' ' LYS . 4.6 mptp? -73.3 -30.01 63.1 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.102 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.72 -32.91 64.12 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.93 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.0 p -78.73 -37.7 40.75 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.521 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -98.43 65.63 1.66 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.088 0.47 . . . . 0.0 109.999 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -68.17 -25.31 65.19 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.666 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.56 -18.2 77.98 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.602 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -97.79 -48.84 5.04 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.694 0.247 . . . . 0.0 111.085 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -59.42 -35.98 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.191 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.01 -31.96 73.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 39.8 tt0 -68.6 -37.62 79.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.061 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -59.77 -24.81 64.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -84.17 -18.19 37.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.764 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 51.7 mtt180 -87.99 -42.67 12.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.601 0.239 . . . . 0.0 111.379 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mp -106.6 -25.56 11.75 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.29 10.59 50.91 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 81.4 mt -50.43 125.21 19.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.667 0.233 . . . . 0.0 111.484 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 27.0 Cg_exo -61.69 170.11 6.15 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.876 2.384 . . . . 0.0 112.361 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HD3' ' HE3' ' A' ' 50' ' ' LYS . 57.6 mttp -98.69 39.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.575 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . 12.5 t70 -172.75 126.45 0.51 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 111.453 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.663 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 22.2 Cg_endo -60.4 -40.7 55.65 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.397 2.731 . . . . 0.0 113.01 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -52.85 -36.23 58.58 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.13 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 29.4 pt20 -99.06 36.73 1.65 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.931 0.396 . . . . 0.0 111.373 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.517 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 17.1 m0 -113.03 174.85 5.7 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.625 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -134.86 -175.42 3.9 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' MET . 42.0 mt-10 -52.42 -37.9 57.82 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.9 m -68.72 -52.76 27.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.641 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.64 -42.24 96.52 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.668 0.27 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.558 HG13 HD22 ' A' ' 105' ' ' LEU . 42.6 t -59.72 -52.95 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.226 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -69.98 -45.14 67.98 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.599 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.36 -37.45 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.484 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -68.82 -60.69 2.21 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.9 t -41.26 -55.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.538 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.4 ttm -54.5 -45.66 73.32 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -59.23 -35.62 73.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.998 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.18 -18.85 58.89 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.304 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.811 ' CG2' HG11 ' A' ' 93' ' ' VAL . 96.3 t -83.18 -33.39 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.659 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.41 -35.06 17.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -41.15 63.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -100.61 7.68 43.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.817 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.7 m 45.52 56.74 5.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.977 0.418 . . . . 0.0 111.172 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.656 ' HB3' HG12 ' A' ' 121' ' ' VAL . 71.3 mt -85.14 173.11 10.69 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.321 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.31 152.27 32.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.673 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.95 -2.75 87.17 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.699 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.811 HG11 ' CG2' ' A' ' 85' ' ' VAL . 13.2 p -78.86 135.03 26.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 117.201 0.5 . . . . 0.0 111.318 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.8 m-20 -112.41 137.69 50.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.98 -24.54 23.51 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.929 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -61.21 -33.69 73.88 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.2 mptt -70.41 -34.01 72.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.721 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 47.9 m-85 -98.26 33.33 2.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.5 66.16 8.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.123 0.487 . . . . 0.0 110.32 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.5 ptp -157.74 167.01 31.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.791 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 m -72.88 160.57 31.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.45 -42.34 95.76 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.871 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.93 68.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.76 68.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.529 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.558 HD22 HG13 ' A' ' 77' ' ' VAL . 15.4 tp -56.08 -43.62 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.085 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.8 m -67.17 -41.74 85.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.842 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -27.98 69.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.556 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 26.3 mt -63.69 -36.19 83.05 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.746 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.7 178.21 50.0 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.725 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -59.96 -53.28 59.69 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -46.66 -52.2 14.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.3 m -70.27 -41.37 73.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.443 ' HE2' HD21 ' A' ' 105' ' ' LEU . 36.6 t80 -61.79 -45.53 93.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.41 0.148 . . . . 0.0 111.232 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.45 -25.73 67.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.884 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.58 -21.6 55.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.669 0.271 . . . . 0.0 110.48 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -86.51 -39.74 15.95 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.721 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -104.2 158.37 32.08 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.21 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.677 ' HG2' HG22 ' A' ' 121' ' ' VAL . 19.2 Cg_endo -58.16 175.11 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.864 2.376 . . . . 0.0 113.17 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.66 -15.94 54.55 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.28 -55.08 2.42 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.631 -0.827 . . . . 0.0 112.902 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.705 ' CG2' ' HB1' ' A' ' 117' ' ' ALA . 2.2 m -62.19 -33.64 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.83 -35.87 54.05 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.781 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.59 -43.86 53.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.74 0.305 . . . . 0.0 111.139 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.33 -56.48 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 111.568 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.523 HD23 HG22 ' A' ' 81' ' ' VAL . 11.0 mp -58.44 -58.9 6.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -30.94 70.81 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.49 -53.44 48.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.316 0.507 . . . . 0.0 109.921 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.488 ' HA ' HD12 ' A' ' 131' ' ' ILE . 19.9 t-80 -68.79 -31.56 70.67 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.241 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.456 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 29.3 tp -58.3 -45.9 87.14 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.288 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.58 -41.81 99.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.035 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 128' ' ' HIS . 95.8 mt -55.68 -43.3 72.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.284 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.581 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.3 mt -63.36 -41.68 98.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.663 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 25.4 mt-30 -56.14 -45.32 79.64 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.068 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -60.74 -40.37 92.14 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.455 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -102.66 82.89 2.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.417 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' A' ' 68' ' ' ASP . 12.3 t70 -75.84 -48.02 23.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.235 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.72 -179.37 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.538 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 mptt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.85 179.865 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.2 p80 . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.632 0.254 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt 54.33 67.46 1.01 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.962 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -95.28 139.71 31.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.186 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.401 ' HA ' ' H ' ' A' ' 110' ' ' LYS . 50.1 t -148.0 -67.33 0.24 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.68 102.87 13.09 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.835 0.35 . . . . 0.0 111.109 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -137.43 80.95 1.84 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.528 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.47 126.87 27.05 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.159 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.94 170.99 18.77 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.908 2.406 . . . . 0.0 112.487 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 36' ' ' LEU . 3.2 mm? -91.15 84.88 5.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.821 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.59 ' HG ' ' HD3' ' A' ' 39' ' ' PRO . 14.8 tp -167.99 139.44 2.9 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.618 ' HG2' ' HD3' ' A' ' 42' ' ' LYS . 74.4 Cg_endo -74.39 -179.83 5.16 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.539 2.16 . . . . 0.0 112.072 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.2 t -55.92 -50.54 70.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.411 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.618 ' HD3' ' HG2' ' A' ' 39' ' ' PRO . 12.8 mptt -73.4 -39.45 65.07 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.535 0.207 . . . . 0.0 111.25 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -61.53 -40.08 93.37 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.235 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -81.5 -28.87 33.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.315 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.454 ' HE3' ' HA ' ' A' ' 45' ' ' MET . 4.2 tpt -59.89 -48.85 80.03 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.23 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.6 m -79.1 -26.79 42.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.051 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -49.05 -49.88 39.2 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.117 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.28 -44.13 84.44 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.666 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.577 HD12 ' HB2' ' A' ' 128' ' ' HIS . 4.6 mm? -60.86 -42.09 97.18 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.619 0.247 . . . . 0.0 111.289 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -64.56 -29.26 70.28 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.145 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.58 -30.55 59.67 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.85 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.8 p -54.57 -28.54 46.64 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -43.58 -57.09 3.32 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 m -60.26 -39.95 88.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.432 0.158 . . . . 0.0 111.414 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . -76.58 -8.83 86.23 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.901 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.441 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.0 t80 -95.39 -46.72 6.59 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 116.621 0.211 . . . . 0.0 110.473 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -57.05 -35.87 69.82 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.232 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 20.4 pttp -63.32 -32.88 74.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.31 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -41.3 21.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.349 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.3 mt-30 -59.85 -27.08 66.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.719 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -85.85 -38.34 18.22 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.505 0.193 . . . . 0.0 111.106 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -70.25 -33.59 71.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.475 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.9 mt -100.17 -33.79 10.3 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.32 -1.68 50.34 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.705 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 79' ' ' ASP . 56.3 mt -53.52 125.68 45.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 111.316 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 20.2 Cg_exo -65.23 173.81 5.75 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.828 2.352 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.404 ' CG ' ' HB2' ' A' ' 136' ' ' ASP . 56.4 tptt -93.02 -18.67 22.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.485 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.462 ' HB2' ' N ' ' A' ' 138' ' ' LYS . 38.7 t70 -94.1 121.44 63.96 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.73 0.3 . . . . 0.0 111.295 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.561 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 38.5 Cg_endo -66.93 -26.99 43.52 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.075 2.517 . . . . 0.0 113.151 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 3.7 mpt_? -72.88 -33.58 66.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.601 0.239 . . . . 0.0 110.399 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.23 40.98 1.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.505 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.7 m0 -113.38 171.47 7.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.661 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.2 p -134.12 -178.38 5.01 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -50.62 -38.99 48.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.489 0.185 . . . . 0.0 111.214 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.5 m -66.61 -55.82 13.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.345 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -58.45 -39.07 78.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.161 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 81' ' ' VAL . 44.7 t -61.87 -49.52 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.554 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -74.62 -40.4 61.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.326 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -60.14 -36.25 77.11 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.506 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.505 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 15.3 t90 -71.96 -60.99 1.95 Allowed 'General case' 0 C--N 1.339 0.124 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.8 t -40.77 -53.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 123.421 0.451 . . . . 0.0 110.842 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.4 ttm -56.03 -46.33 78.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.445 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 19.1 t90 -60.93 -39.7 90.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.776 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.67 64.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.993 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 81' ' ' VAL . 77.6 t -80.22 -29.56 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.954 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -82.25 -34.41 28.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.49 -40.41 70.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -103.27 6.55 38.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.808 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.2 m 43.99 54.58 5.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.617 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.522 HD13 ' HB ' ' A' ' 121' ' ' VAL . 72.8 mt -81.23 174.12 11.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.472 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.4 OUTLIER -156.52 151.52 26.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.501 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 -8.01 78.55 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.901 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 121' ' ' VAL . 12.6 p -76.77 135.35 26.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.53 0.665 . . . . 0.0 110.911 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.79 138.34 41.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.05 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.75 -27.11 20.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.285 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.518 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 14.7 tt0 -60.48 -31.52 70.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 35.5 mmtp -65.32 -36.88 85.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.867 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 33.3 m-85 -99.82 34.28 2.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.643 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 9.6 m -87.3 69.16 9.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.194 0.521 . . . . 0.0 110.208 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.433 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.4 ptp -158.97 171.03 20.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.824 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.9 p -72.18 159.85 33.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.37 -43.5 93.81 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.54 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.39 63.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.48 -46.18 60.56 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.6 -46.18 84.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.146 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 72.6 m -64.18 -38.78 92.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 110.516 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.69 74.44 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 54.3 mt -61.54 -34.97 76.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 177.49 41.19 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.609 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.506 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.5 ttpt -62.89 -40.96 99.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.565 0.221 . . . . 0.0 110.986 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.35 -64.06 0.93 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.301 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.4 m -64.52 -37.54 87.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.06 -46.2 90.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.541 0.21 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.1 -30.29 71.36 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.673 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.4 -22.96 61.04 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.734 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 88.5 mt -85.01 -41.4 15.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.543 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.478 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -102.74 157.62 33.36 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.849 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.639 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 74.1 Cg_exo -47.14 166.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.309 2.672 . . . . 0.0 113.662 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.44 -15.01 63.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.719 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -108.25 -60.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.98 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.639 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 11.8 m -59.24 -34.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -52.85 -36.65 50.82 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.934 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.47 -49.22 67.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.447 0.165 . . . . 0.0 111.188 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.0 mt -58.92 -57.34 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.722 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -50.35 -53.94 25.24 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 4.7 t90 -66.18 -28.74 69.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.178 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.31 -51.8 68.29 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.577 ' HB2' HD12 ' A' ' 49' ' ' LEU . 20.6 t-160 -76.45 -37.26 57.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 41.5 tp -54.22 -48.58 70.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.85 -40.73 91.97 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.619 ' HA ' ' HE2' ' A' ' 134' ' ' LYS . 64.0 mt -54.72 -46.33 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.641 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.1 mt -51.63 -36.9 47.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.126 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.561 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 64.4 mt-30 -63.0 -56.48 16.69 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.393 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.619 ' HE2' ' HA ' ' A' ' 131' ' ' ILE . 60.6 pttt -69.58 -30.59 68.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.449 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 131' ' ' ILE . 40.1 mm-40 -62.42 -69.39 0.26 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.404 ' HB2' ' CG ' ' A' ' 67' ' ' LYS . 12.1 m-20 -143.79 160.61 40.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.084 0.469 . . . . 0.0 111.685 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 68' ' ' ASP . 17.3 m -121.86 52.19 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.652 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' N ' ' HB2' ' A' ' 68' ' ' ASP . 90.6 mttt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.999 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.5 p80 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.5 mmt 73.1 -73.1 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.773 0.429 . . . . 0.0 111.177 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -174.45 -49.66 0.01 OUTLIER 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.578 0.228 . . . . 0.0 111.041 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.2 t -93.11 -42.73 9.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.33 97.89 0.59 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.808 0.337 . . . . 0.0 111.215 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -143.73 121.9 12.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 38' ' ' TPO . 47.0 t -118.69 103.8 48.09 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HG2' ' HB ' ' A' ' 38' ' ' TPO . 82.0 Cg_endo -77.42 -177.37 3.79 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.791 2.327 . . . . 0.0 112.685 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.0 mt -61.07 -53.83 52.24 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.175 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.3 mt -108.62 103.1 12.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TPO . . . . . 0.479 ' HB ' ' HG2' ' A' ' 35' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.93 153.68 72.21 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.721 2.281 . . . . 0.0 112.417 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.3 t -71.21 107.83 4.41 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.933 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -60.57 -41.08 93.9 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.692 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -79.47 -38.88 33.5 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.608 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.2 ttm -54.91 -46.38 74.86 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.16 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.6 mtp -58.88 -33.78 70.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.722 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -85.56 -28.4 24.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 121.291 -0.163 . . . . 0.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -54.97 -52.24 63.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.725 0.297 . . . . 0.0 110.954 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.99 -34.76 50.67 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.563 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.581 HD11 HD13 ' A' ' 131' ' ' ILE . 40.6 tp -61.45 -45.74 93.02 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.535 0.207 . . . . 0.0 111.113 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 43.4 mmtm -70.29 -34.85 73.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.432 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.96 -35.31 80.75 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.729 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 m -67.48 -46.57 72.59 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 22.7 m-85 -48.46 -44.17 35.34 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.311 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.469 ' O ' ' HD3' ' A' ' 58' ' ' LYS . 42.9 m -58.83 -44.43 90.91 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.814 -0.175 . . . . 0.0 111.129 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.57 -14.57 79.55 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.546 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -89.31 -48.3 7.45 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.3 m -55.04 -38.86 68.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 54' ' ' SER . 6.1 mptp? -57.99 -35.96 71.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.461 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -77.97 -41.38 36.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.847 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -58.58 -29.32 66.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.477 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.84 -19.27 52.43 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.416 ' HB2' HD12 ' A' ' 63' ' ' LEU . 81.6 mtt180 -77.46 -42.9 34.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 111.31 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 62' ' ' ARG . 5.7 mp -101.34 -24.73 14.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.2 11.03 53.67 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.495 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.43 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.5 mt -60.51 129.44 89.33 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.312 0.245 . . . . 0.0 111.249 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.8 Cg_endo -74.29 167.72 26.49 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.394 2.063 . . . . 0.0 112.112 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -93.52 55.61 2.25 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 111.194 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 25.1 t70 -168.14 124.84 0.86 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.602 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 22.8 Cg_exo -65.12 -44.06 10.24 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.523 2.815 . . . . 0.0 113.517 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.47 -37.19 37.2 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.252 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.471 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 10.5 pt20 -100.56 44.36 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.901 0.381 . . . . 0.0 111.377 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.595 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 7.0 m0 -119.88 169.51 10.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -132.53 179.67 5.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.99 -42.6 49.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.6 m -63.47 -49.44 73.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.527 0.203 . . . . 0.0 111.357 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.43 ' CD2' HG12 ' A' ' 65' ' ' ILE . 44.0 m170 -61.2 -41.26 96.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.009 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.75 -53.59 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -65.64 -47.96 73.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.513 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.15 -37.7 72.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 121.149 -0.22 . . . . 0.0 110.776 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.544 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 17.4 t90 -69.2 -62.02 1.55 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 85' ' ' VAL . 54.5 t -41.47 -53.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.4 ttm -55.22 -46.73 75.94 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.493 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 16.0 t90 -60.37 -38.1 82.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.91 61.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.571 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 81' ' ' VAL . 78.6 t -83.16 -33.71 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 120.67 0.271 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -82.1 -37.66 26.0 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.5 -39.04 71.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.097 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -100.48 4.81 43.94 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 m 45.38 53.8 7.9 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 121' ' ' VAL . 63.3 mt -85.34 166.55 16.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.498 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.37 152.82 33.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.82 -10.97 71.94 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.605 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.644 ' HB ' HG11 ' A' ' 121' ' ' VAL . 14.7 p -79.74 135.86 24.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 117.361 0.581 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.71 138.97 41.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.293 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.18 -27.18 23.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.755 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -61.59 -29.69 70.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 49.6 mmtm -67.02 -33.14 74.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.292 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.62 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 28.3 m-85 -100.13 32.25 3.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.709 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.35 65.63 8.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.218 0.532 . . . . 0.0 110.533 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.448 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.9 ptp -158.77 167.73 28.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.7 p -74.04 161.7 29.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -59.45 -40.28 95.96 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.38 76.87 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 110.743 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.95 64.77 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.553 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.98 -42.24 84.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.01 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.56 -42.12 92.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.539 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.65 72.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.0 mt -59.95 -33.57 72.1 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.39 177.72 48.77 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.36 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.72 -47.11 86.74 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 10.0 tp10 -50.1 -67.35 0.27 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.701 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.574 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.6 m -55.75 -40.99 73.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.704 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -62.54 -43.78 97.97 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.0 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.88 -30.84 71.85 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.679 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 14.4 mm-40 -70.33 -25.08 63.13 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.4 mt -86.92 -36.74 18.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.62 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -97.14 167.44 11.97 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.827 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 18.1 Cg_exo -67.65 174.39 7.58 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.054 2.503 . . . . 0.0 113.178 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.78 -29.92 71.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.324 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.4 -49.91 3.11 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.885 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 90' ' ' LEU . 98.9 t -59.44 -39.45 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.399 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 117' ' ' ALA . . . -52.5 -38.77 51.89 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.909 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.31 -49.22 70.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 111.054 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mt -56.95 -47.87 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.713 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.7 -59.21 4.87 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.87 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -63.34 -27.16 69.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.18 -54.97 25.2 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.945 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -71.25 -35.55 71.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.177 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.544 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.0 tp -61.02 -46.54 90.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.72 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.21 -35.63 81.45 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.126 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.591 ' HA ' ' HE2' ' A' ' 134' ' ' LYS . 70.4 mt -62.67 -44.33 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.6 mt -57.22 -35.83 70.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.974 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.602 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 70.1 mt-30 -60.48 -53.44 57.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 131' ' ' ILE . 53.5 mtmt -51.99 -43.23 63.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.255 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.94 81.17 6.93 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.935 0.398 . . . . 0.0 110.402 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -81.06 84.98 6.37 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.593 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.68 128.04 41.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.986 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.835 179.843 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.465 ' HA2' ' HD2' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.672 0 CA-C-O 120.186 -0.23 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.485 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.8 t80 -87.18 -55.14 3.95 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 116.932 0.366 . . . . 0.0 110.402 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.7 m -53.71 -33.35 55.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.209 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.465 ' HD2' ' HA2' ' A' ' 55' ' ' GLY . 90.0 mttt -63.93 -31.8 73.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -86.17 -39.92 16.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 46.5 mt-30 -56.43 -31.67 64.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.302 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -82.98 -33.83 26.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.731 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -69.51 -37.65 77.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.398 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.27 -34.93 10.51 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.33 -0.69 31.08 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.636 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.0 mt -55.88 124.23 56.93 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 122.308 0.243 . . . . 0.0 111.078 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.1 Cg_endo -73.33 167.22 27.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.556 2.171 . . . . 0.0 112.467 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -76.48 -31.02 57.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.585 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.455 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 30.1 t70 -83.99 126.55 69.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.47 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 61.4 Cg_endo -72.62 -24.89 18.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.289 2.659 . . . . 0.0 113.869 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 6.2 mpt_? -69.29 -31.66 70.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.99 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 10.7 pt20 -93.97 36.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 111.084 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.639 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.6 m0 -103.77 166.19 10.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -134.15 179.19 6.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.01 -41.58 47.56 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -63.24 -54.14 42.06 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.274 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.482 ' CD2' HG12 ' A' ' 65' ' ' ILE . 38.0 m170 -58.54 -39.41 80.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 81' ' ' VAL . 54.4 t -62.16 -52.24 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.4 ttm105 -69.18 -47.31 65.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.27 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -35.01 69.14 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 26.5 t90 -72.33 -61.67 1.71 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.525 HG13 HD21 ' A' ' 125' ' ' LEU . 48.3 t -40.11 -52.48 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.383 0.427 . . . . 0.0 110.902 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.411 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 40.9 ttm -57.2 -47.79 80.39 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.574 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.423 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 18.8 t90 -59.96 -39.27 85.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.826 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.7 65.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 81' ' ' VAL . 77.9 t -76.3 -31.23 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.966 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.4 -31.98 32.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.071 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 11.0 mm-40 -70.15 -41.32 73.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.28 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -107.08 9.91 30.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.873 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.8 m 44.66 54.26 6.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 110.527 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 121' ' ' VAL . 62.9 mt -82.02 178.21 8.41 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.467 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.18 151.34 15.61 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.553 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.86 -8.69 77.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.716 ' HB ' HG21 ' A' ' 121' ' ' VAL . 12.7 p -83.44 138.7 18.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 117.543 0.672 . . . . 0.0 111.158 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -116.56 152.9 33.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -95.41 -9.85 31.59 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.409 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -63.72 -42.83 97.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 71.0 mmtt -65.99 -32.5 74.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.171 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 38.4 m-85 -99.5 33.45 2.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.583 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.7 t -87.69 64.7 8.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.115 0.483 . . . . 0.0 110.271 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.4 ptp -157.17 169.91 23.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.779 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.9 p -76.87 166.53 23.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.322 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.92 -43.65 96.61 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.803 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.42 63.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.689 0.28 . . . . 0.0 110.929 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.72 -46.41 53.77 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.06 -45.67 79.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.182 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.33 -41.39 85.33 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.674 0.273 . . . . 0.0 110.821 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.21 71.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.496 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.494 HD13 HD11 ' A' ' 116' ' ' LEU . 61.9 mt -60.72 -39.79 89.94 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.22 172.47 44.65 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.507 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.1 ttpt -59.06 -55.07 39.75 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.37 -49.9 63.46 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 98.8 m -63.58 -43.61 96.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.509 0.195 . . . . 0.0 111.004 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -62.97 -41.25 99.48 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.675 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.62 -27.43 68.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.721 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -76.31 -23.95 54.34 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.693 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 97.5 mt -79.94 -34.04 39.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -109.33 161.53 23.58 Favored Pre-proline 0 N--CA 1.462 0.137 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.243 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.651 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 68.1 Cg_exo -50.06 165.64 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.878 2.386 . . . . 0.0 113.139 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.84 -15.42 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.644 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -108.21 -61.1 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.992 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.716 HG21 ' HB ' ' A' ' 93' ' ' VAL . 12.1 m -60.43 -34.33 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.8 -36.14 40.58 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.129 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -65.56 -47.82 74.53 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.519 0.2 . . . . 0.0 111.313 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.26 -54.64 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.328 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.525 HD21 HG13 ' A' ' 81' ' ' VAL . 10.9 mp -53.33 -54.67 33.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.341 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.451 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 2.6 t90 -62.04 -29.92 70.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.11 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.07 -59.26 5.71 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.424 ' HA ' HD12 ' A' ' 131' ' ' ILE . 21.8 t-160 -69.54 -36.18 76.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.818 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.514 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.2 tp -61.29 -43.04 99.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.83 -33.33 74.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 128' ' ' HIS . 59.4 mt -59.18 -42.19 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.029 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.42 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 95.8 mt -57.98 -38.36 75.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.596 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 . . . . . 0 C--O 1.232 0.155 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.919 179.614 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.529 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 17.7 t80 -94.69 -45.46 7.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 116.701 0.251 . . . . 0.0 110.338 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 95.0 m -58.3 -37.02 74.22 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.978 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 4.7 ptpp? -63.15 -30.64 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.298 . . . . 0.0 110.41 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.51 -40.12 23.68 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.045 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 57.1 mt-30 -56.14 -28.7 58.95 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.705 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 28.1 pt20 -88.44 -37.51 15.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.591 0.234 . . . . 0.0 110.992 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -67.25 -39.86 86.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.281 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.79 -29.57 12.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.6 -1.05 49.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -52.45 123.55 29.69 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 122.348 0.259 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 58.1 Cg_endo -71.73 168.94 22.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.494 2.129 . . . . 0.0 112.507 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -97.21 39.74 1.18 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.225 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 5.5 t70 -144.07 114.22 5.38 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 36.8 Cg_endo -65.7 -24.59 54.86 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.799 2.333 . . . . 0.0 112.775 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.512 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 3.4 mpt_? -77.71 -31.24 52.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 11.4 mm-40 -96.77 34.92 1.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.935 0.397 . . . . 0.0 110.487 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.512 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 4.1 m0 -107.91 170.35 8.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.69 -177.56 4.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.242 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HG2' ' CA ' ' A' ' 100' ' ' MET . 46.0 mt-10 -50.04 -42.81 50.33 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 m -64.34 -51.69 62.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.537 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -60.15 -42.01 93.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.25 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.425 HG13 HD22 ' A' ' 105' ' ' LEU . 56.0 t -60.26 -53.4 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -68.02 -46.71 70.47 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.696 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -56.49 -41.31 76.43 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.512 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.433 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.8 t90 -64.7 -61.98 1.86 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . 55.9 t -41.12 -53.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.793 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.4 ttm -58.22 -48.19 81.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.77 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 15.4 t90 -56.95 -38.43 72.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.836 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.14 83.47 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.515 ' CG2' HG11 ' A' ' 93' ' ' VAL . 81.6 t -53.1 -34.5 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.592 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -79.65 -36.19 38.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.157 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 9.3 mm-40 -68.2 -39.43 82.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.446 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.7 8.55 29.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 46.08 50.79 11.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 110.467 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 121' ' ' VAL . 67.6 mt -78.75 177.68 8.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.481 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.457 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.34 152.82 17.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.26 73.63 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.811 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.597 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.9 p -74.96 132.04 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 117.58 0.69 . . . . 0.0 110.873 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 7.9 m-20 -99.12 133.93 42.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.1 -23.78 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.411 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.574 ' HG3' ' HD2' ' A' ' 97' ' ' LYS . 14.1 pt20 -63.22 -33.22 75.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.626 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.3 mptp? -67.49 -34.94 78.18 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.999 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 38.7 m-85 -100.62 34.85 2.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.662 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.4 t -87.76 64.62 8.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.138 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.46 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.3 ptp -155.7 167.95 28.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.756 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -73.77 159.69 32.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.344 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -55.29 -43.51 84.41 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.961 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.66 -38.6 60.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.665 0.269 . . . . 0.0 111.037 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.02 58.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 77' ' ' VAL . 14.1 tp -55.79 -44.72 78.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.079 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.77 -41.76 91.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.777 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.25 72.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.8 mt -61.37 -36.98 81.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.93 176.4 51.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.678 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 52.0 tttp -61.36 -51.3 69.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -50.48 -52.33 39.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.4 m -66.55 -42.67 86.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 126' ' ' TRP . 59.0 t80 -63.72 -42.14 97.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.99 -29.65 70.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.717 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.67 -21.25 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.664 0.268 . . . . 0.0 110.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.6 mt -85.8 -32.59 21.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.835 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -112.4 150.91 43.32 Favored Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.626 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 85.6 Cg_exo -44.23 167.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.691 2.927 . . . . 0.0 114.079 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.95 -24.05 67.7 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.3 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.06 -49.19 3.24 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.524 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.626 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.2 m -63.11 -34.37 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.168 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.91 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.816 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 16.3 t70 -61.34 -45.35 94.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.577 0.227 . . . . 0.0 110.945 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.463 ' CD1' HD21 ' A' ' 90' ' ' LEU . 73.7 mt -61.98 -56.93 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.268 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.8 mt -55.07 -57.36 12.05 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.3 -36.1 79.14 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.335 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 123' ' ' ASP . 30.9 tt0 -56.47 -54.87 40.63 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.49 ' HA ' HD12 ' A' ' 131' ' ' ILE . 22.3 t-160 -72.47 -30.3 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.653 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 52.4 tp -59.59 -49.85 76.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.104 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 15.3 mm-40 -67.29 -33.69 75.83 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.222 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 128' ' ' HIS . 69.3 mt -58.64 -40.17 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.315 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.517 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.0 mt -62.39 -39.08 92.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.456 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.3 mt-30 . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.798 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.7 t80 -89.01 -47.78 7.88 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.675 0.237 . . . . 0.0 110.779 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.9 m -55.06 -31.75 61.38 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.52 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -62.19 -30.33 71.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.342 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -84.38 -42.18 15.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 31.8 mt-30 -58.33 -31.76 67.86 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.374 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -82.9 -35.73 25.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.517 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -65.86 -35.23 80.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.46 -32.44 9.5 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.85 4.46 39.28 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.627 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.96 127.74 69.49 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.354 0.262 . . . . 0.0 110.929 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.53 174.49 12.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 112.76 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -100.84 45.95 0.96 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 5.8 m-20 -144.48 113.32 5.12 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.504 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 20.3 Cg_endo -61.77 -29.72 83.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.765 2.31 . . . . 0.0 112.823 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.504 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 5.5 mpt_? -74.47 -33.45 62.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.558 0.218 . . . . 0.0 110.495 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -95.7 35.03 1.41 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.079 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.546 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.3 m0 -109.73 160.43 16.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.4 t -127.04 -179.32 4.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.345 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.48 -49.63 44.75 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 m -58.16 -45.95 86.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.314 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -64.19 -41.68 96.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.528 HG13 HD22 ' A' ' 105' ' ' LEU . 55.8 t -62.5 -54.54 32.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.117 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -65.75 -45.49 82.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.55 -42.28 92.01 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.581 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 21.9 t90 -63.4 -60.33 3.51 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.624 HG13 HD21 ' A' ' 125' ' ' LEU . 40.3 t -42.19 -53.9 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.365 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.433 ' HB2' ' HE3' ' A' ' 82' ' ' MET . 37.7 ttm -56.24 -45.97 79.77 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.705 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.532 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 52.1 t90 -56.77 -36.44 69.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.88 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.35 58.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.156 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.519 HG22 HG11 ' A' ' 93' ' ' VAL . 89.0 t -78.52 -34.81 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.484 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -83.35 -37.45 23.33 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.138 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 7.3 mm-40 -70.23 -36.07 74.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.309 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.7 8.78 24.91 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t 43.62 62.11 2.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.121 0.486 . . . . 0.0 110.498 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.58 HD13 ' HB ' ' A' ' 121' ' ' VAL . 59.9 mt -90.43 153.47 20.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.475 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 151.27 49.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.77 -10.62 73.09 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.707 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.583 ' HB ' HG21 ' A' ' 121' ' ' VAL . 13.8 p -79.54 139.75 17.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 117.404 0.602 . . . . 0.0 110.938 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 10.5 m-20 -117.55 144.17 45.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.212 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.25 -18.66 26.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.977 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.09 -36.44 81.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.041 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.0 mptt -69.24 -34.43 74.79 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.527 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 42.8 m-85 -99.96 33.5 2.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.1 t -86.88 64.29 8.41 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.219 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.449 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.7 ptp -156.45 169.32 24.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.735 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.2 m -75.81 161.5 28.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.373 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.84 -44.09 92.2 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.014 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.75 59.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.987 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.0 -44.48 63.41 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.528 HD22 HG13 ' A' ' 77' ' ' VAL . 13.9 tp -57.62 -46.64 83.84 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.271 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.92 -38.48 91.26 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 110.604 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.21 67.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.561 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 66.4 mt -64.17 -35.22 80.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.04 175.79 45.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.589 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.28 -66.62 0.37 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.4 m -58.57 -39.53 80.58 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 54.1 t80 -64.17 -45.88 86.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.305 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.1 mt -63.09 -26.37 68.8 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.036 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -75.47 -22.63 57.09 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.603 0.24 . . . . 0.0 110.76 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -83.04 -36.26 25.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.585 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.527 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -108.39 155.27 40.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.601 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.665 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 76.9 Cg_exo -48.53 169.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.233 2.622 . . . . 0.0 113.775 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.89 -22.97 67.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.983 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -107.81 -57.04 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.364 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.665 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 6.1 m -60.24 -33.29 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.34 -32.99 57.93 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.229 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.17 -48.63 77.58 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.64 0.22 . . . . 0.0 111.422 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.547 ' CD1' HD21 ' A' ' 90' ' ' LEU . 74.0 mt -54.6 -54.48 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.493 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.624 HD21 HG13 ' A' ' 81' ' ' VAL . 10.0 mp -54.28 -59.73 4.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.275 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.76 -30.77 67.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.939 -0.077 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.09 -57.75 11.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -73.77 -39.39 64.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.006 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.581 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.8 tp -54.08 -46.11 71.95 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.36 -35.19 75.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.192 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.48 -42.98 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.473 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.8 mt -52.14 -39.62 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.78 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 . . . . . 0 C--O 1.231 0.131 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.823 179.427 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.54 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 29.8 t80 -83.25 -50.45 8.4 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 116.453 0.126 . . . . 0.0 110.796 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.71 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 28.8 m -55.72 -40.78 72.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.45 ' HD2' ' NE2' ' A' ' 61' ' ' GLN . 32.0 mmmt -64.95 -25.17 67.76 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 110.851 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.89 -48.17 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.71 ' HG2' ' HA ' ' A' ' 57' ' ' THR . 5.2 pt20 -65.95 -24.96 66.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.043 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.45 ' NE2' ' HD2' ' A' ' 58' ' ' LYS . 9.3 pt20 -79.92 -31.04 40.13 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.697 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -67.65 -30.83 70.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.787 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.13 -30.74 11.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.079 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.82 -1.64 27.35 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.173 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 60' ' ' GLN . 51.5 mt -60.41 128.27 87.73 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.843 0.321 . . . . 0.0 110.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 77.0 Cg_endo -78.95 175.06 11.38 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.614 2.21 . . . . 0.0 112.505 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 43.63 1.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 111.154 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 11.1 m-20 -153.57 111.03 2.57 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.57 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 40.9 Cg_exo -57.42 -36.51 98.8 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.988 2.459 . . . . 0.0 112.48 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -55.4 -37.91 68.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.468 0.175 . . . . 0.0 111.105 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 68' ' ' ASP . 12.0 pt20 -99.95 44.31 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.969 0.414 . . . . 0.0 111.156 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.583 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.4 m0 -117.23 169.61 9.33 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.086 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -131.54 -177.84 4.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -51.32 -44.28 61.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.3 m -63.62 -48.59 76.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.628 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CD2' HG12 ' A' ' 65' ' ' ILE . 45.3 m170 -60.83 -42.13 97.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.316 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 81' ' ' VAL . 60.5 t -61.28 -52.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.21 -47.1 68.79 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.498 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.18 -43.18 82.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.55 0.214 . . . . 0.0 110.54 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.513 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 13.7 t90 -63.59 -62.49 1.63 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 85' ' ' VAL . 43.9 t -39.69 -51.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.422 0.451 . . . . 0.0 110.939 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 29.0 ttm -53.39 -49.8 66.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.174 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.489 ' CZ2' ' HG3' ' A' ' 87' ' ' GLU . 76.8 t90 -61.93 -42.8 99.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.92 -20.92 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.652 HG21 HG11 ' A' ' 93' ' ' VAL . 55.5 t -82.33 -31.7 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.336 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.78 -36.84 42.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.936 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 11.1 mm-40 -71.79 -39.71 69.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.335 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -100.94 5.27 43.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.4 m 44.88 55.2 6.23 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 110.638 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.613 HD13 ' HB ' ' A' ' 121' ' ' VAL . 86.2 mt -75.9 151.32 37.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.908 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -130.64 143.04 50.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 111.623 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.4 ' C ' ' HG3' ' A' ' 118' ' ' PRO . . . 85.61 -0.44 88.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.512 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.652 HG11 HG21 ' A' ' 85' ' ' VAL . 12.6 p -74.55 132.21 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.286 0.543 . . . . 0.0 111.161 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.98 136.78 47.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.058 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.26 -29.56 20.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.397 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.99 -33.69 72.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 47.1 mmtm -66.43 -36.6 83.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.894 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.537 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 35.5 m-85 -97.58 34.73 1.78 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.223 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.61 66.12 8.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.388 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.461 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.6 ptp -158.43 169.08 25.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -73.54 156.48 38.09 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.227 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.583 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.07 -41.04 92.34 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.92 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.61 -39.59 65.05 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.726 0.298 . . . . 0.0 110.839 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.49 64.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.7 tp -55.79 -44.29 77.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.002 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 86.1 m -65.62 -42.45 91.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.55 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.1 -30.05 71.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 31.6 mt -62.39 -38.83 91.14 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.882 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.07 170.8 47.37 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.474 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.8 ttpt -59.27 -47.79 84.07 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.67 -51.1 61.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 70.2 m -66.13 -39.64 90.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.477 0.18 . . . . 0.0 111.123 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.419 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 48.2 t80 -63.51 -41.89 98.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.64 -23.13 65.31 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.813 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.72 -22.14 50.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.4 mt -85.86 -36.58 19.89 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.249 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.541 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -110.6 154.75 42.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.184 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.719 ' HG2' HG22 ' A' ' 121' ' ' VAL . 10.1 Cg_endo -54.79 172.32 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.749 2.3 . . . . 0.0 113.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.78 -21.99 57.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.33 -53.4 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 113.251 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.719 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.0 m -59.04 -34.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.49 -36.11 52.94 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.82 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.65 -49.82 56.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.47 0.176 . . . . 0.0 111.09 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 124' ' ' ILE . 3.3 mp -57.43 -46.44 85.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.588 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 113' ' ' PHE . 85.0 mt -67.5 -57.16 7.01 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.32 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.52 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -60.73 -33.63 73.19 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.18 -54.63 44.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -71.89 -30.01 64.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.459 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.513 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 43.0 tp -60.27 -50.78 72.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.8 mm-40 -66.13 -33.82 76.65 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 69.4 mt -61.68 -36.58 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.444 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.458 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.9 mt -62.96 -40.94 99.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 69.6 mt-30 . . . . . 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.471 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.558 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.526 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 7.9 t80 -83.91 -50.43 8.05 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.4 m -56.68 -36.85 70.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.55 -30.55 70.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.774 0.321 . . . . 0.0 110.303 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -84.58 -42.79 15.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 8.3 mm100 -56.96 -30.9 64.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -80.31 -36.69 33.94 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.478 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.57 -39.47 84.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.524 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 63' ' ' LEU . 7.4 mp -93.8 -32.24 14.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.21 -0.53 40.73 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.231 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.04 128.87 66.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 117.011 0.406 . . . . 0.0 110.913 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.87 172.82 14.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.754 2.303 . . . . 0.0 112.85 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.01 48.11 0.9 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.518 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 12.0 m-20 -140.8 105.99 6.32 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.9 Cg_endo -62.65 -37.06 60.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.659 2.24 . . . . 0.0 112.423 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -70.19 -32.67 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 68' ' ' ASP . 2.0 mp0 -97.85 42.21 1.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.55 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -115.68 168.33 10.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 101' ' ' SER . 15.3 t -133.55 -177.03 4.36 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.562 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HG3' ' CA ' ' A' ' 100' ' ' MET . 2.6 mp0 -49.41 -46.79 47.96 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -63.27 -49.53 73.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.668 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -62.16 -43.06 99.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.688 0.28 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 105' ' ' LEU . 54.3 t -61.47 -52.53 60.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.466 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -68.8 -46.07 69.61 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.784 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.39 -38.67 71.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.547 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 12.8 t90 -66.93 -61.07 2.13 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 85' ' ' VAL . 50.9 t -41.37 -53.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.419 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 40.0 ttm -56.57 -46.15 80.92 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.835 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 54.3 t90 -58.32 -35.94 72.64 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.691 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.35 -21.2 60.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.129 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.543 ' CG2' HG11 ' A' ' 93' ' ' VAL . 84.6 t -77.83 -32.78 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -81.52 -36.66 28.94 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.036 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 10.9 mm-40 -71.27 -40.29 71.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -104.32 6.14 35.05 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.9 m 45.15 56.57 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 110.599 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HB3' HG12 ' A' ' 121' ' ' VAL . 74.5 mt -82.08 169.67 16.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.36 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.1 147.98 27.73 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.358 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -8.52 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.741 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.599 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.5 p -76.4 135.85 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.418 0.609 . . . . 0.0 110.785 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.454 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 12.1 m-20 -109.82 139.16 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.392 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -89.11 -25.08 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.704 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -61.89 -34.48 76.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.649 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 2.0 mptm? -67.15 -35.15 79.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 35.9 m-85 -100.49 34.98 2.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.479 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.1 t -89.41 68.42 7.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.069 0.461 . . . . 0.0 110.251 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.414 ' CA ' ' HG3' ' A' ' 74' ' ' GLU . 14.4 ptp -160.66 172.97 16.16 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.788 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 72.1 m -73.43 156.59 38.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -57.91 -38.66 89.68 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.601 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.82 -39.58 71.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.283 . . . . 0.0 110.666 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.56 -45.02 66.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.424 HD22 HG13 ' A' ' 77' ' ' VAL . 15.7 tp -56.72 -44.6 81.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.031 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.1 m -64.43 -40.35 95.57 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.15 73.67 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.305 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 60.1 mt -61.28 -36.14 79.25 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.895 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.7 176.22 48.92 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.601 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 27.5 ttpp -61.73 -46.82 88.01 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.25 -61.53 2.11 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.473 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 85.5 m -60.6 -39.33 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.438 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HE1' ' HB2' ' A' ' 125' ' ' LEU . 45.3 t80 -63.36 -43.6 97.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.833 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -66.42 -25.92 66.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -76.63 -21.85 54.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.725 0.297 . . . . 0.0 110.347 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.649 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 80.6 mt -86.28 -36.77 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -116.47 151.74 47.33 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.815 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.8 Cg_exo -43.02 164.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.587 2.858 . . . . 0.0 114.09 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.47 -20.2 62.88 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.053 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -108.07 -52.69 2.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.188 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' A' ' 93' ' ' VAL . 5.2 m -62.01 -37.12 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.335 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.77 -36.91 88.9 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.669 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.56 -47.39 78.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.456 HD12 HD21 ' A' ' 90' ' ' LEU . 61.0 mt -59.36 -53.73 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . 84.4 mt -55.63 -55.67 29.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.386 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.506 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -62.24 -28.91 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.04 -57.27 13.29 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.499 ' HA ' HD12 ' A' ' 131' ' ' ILE . 23.7 t-160 -70.98 -32.42 69.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.311 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.506 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 50.0 tp -57.49 -46.29 83.91 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.638 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -68.08 -33.49 74.63 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.233 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 128' ' ' HIS . 85.1 mt -61.12 -43.19 95.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.05 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.2 mt -58.27 -35.31 71.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.396 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.422 ' N ' ' HG3' ' A' ' 69' ' ' PRO . 59.1 mt-30 . . . . . 0 C--N 1.339 0.118 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.443 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 CA-C-O 120.291 -0.172 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.484 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 14.4 t80 -99.47 -50.28 4.14 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.811 0.306 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.8 m -55.67 -31.5 62.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.434 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -61.27 -33.69 73.97 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.674 0.273 . . . . 0.0 110.408 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.14 -38.98 23.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 33.4 mt-30 -58.24 -32.28 68.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.723 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -81.61 -36.89 28.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.796 -0.184 . . . . 0.0 111.48 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -70.76 -39.74 73.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.685 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.3 mt -98.05 -26.36 14.64 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.07 6.24 59.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.533 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 62.8 mt -54.93 122.17 39.69 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 122.305 0.242 . . . . 0.0 111.213 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 23.9 Cg_exo -63.21 169.4 9.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.783 2.322 . . . . 0.0 112.558 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -99.24 34.36 2.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 38.4 t70 -153.78 116.51 2.65 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.3 Cg_endo -61.39 -40.53 47.91 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.145 2.563 . . . . 0.0 112.479 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -54.75 -36.33 64.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.67 0.271 . . . . 0.0 110.456 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -100.15 46.37 0.96 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.762 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.538 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 7.4 m0 -122.07 174.06 7.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.505 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.1 t -132.61 -179.05 5.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.95 -42.93 49.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.3 m -64.19 -50.08 69.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -60.77 -40.6 93.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.544 0.211 . . . . 0.0 111.199 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 HD22 ' A' ' 105' ' ' LEU . 65.6 t -63.2 -55.54 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -64.82 -48.55 74.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.721 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -56.53 -40.1 74.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.576 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.1 t90 -66.12 -61.11 2.21 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 85' ' ' VAL . 53.6 t -40.74 -55.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.422 ' HG2' ' CE1' ' A' ' 95' ' ' PHE . 62.1 mtt -55.55 -47.02 77.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.527 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.2 t90 -58.01 -35.95 71.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.938 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.77 -18.41 60.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.556 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 81' ' ' VAL . 96.7 t -81.04 -34.3 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.488 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -83.81 -32.85 25.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 6.9 mm-40 -75.53 -40.55 56.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -102.21 6.12 40.51 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.946 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 46.08 53.87 8.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 110.746 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.546 HD13 ' HB ' ' A' ' 121' ' ' VAL . 67.5 mt -81.95 169.23 17.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.118 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -152.54 148.88 27.9 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -7.4 81.33 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.855 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.623 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.5 p -76.74 134.48 28.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.423 0.612 . . . . 0.0 111.073 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.4 131.78 48.83 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.442 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 82' ' ' MET . 40.0 m-85 -85.07 -28.69 25.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.74 -33.33 72.76 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.5 mptm? -67.23 -34.35 77.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.123 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 51.1 m-85 -99.32 35.81 1.87 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.598 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.99 64.43 7.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.045 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.48 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.8 ptp -155.64 167.34 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.046 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.0 p -70.9 158.12 36.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.538 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.51 -42.04 93.75 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.83 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.95 64.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.719 0.295 . . . . 0.0 110.876 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.5 -44.93 63.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.571 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.448 HD22 HG13 ' A' ' 77' ' ' VAL . 18.9 tp -55.15 -44.28 75.01 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.264 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 70.8 m -66.93 -40.61 87.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.713 0.292 . . . . 0.0 110.763 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.16 67.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.642 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.9 mt -68.01 -38.46 82.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.88 176.42 51.49 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.331 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.2 ttpt -61.6 -51.22 69.4 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.76 -51.75 36.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.3 m -66.73 -40.93 88.54 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.445 0.164 . . . . 0.0 111.356 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 125' ' ' LEU . 32.2 t80 -62.31 -43.59 98.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.95 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.8 -25.06 66.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.831 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -76.15 -22.38 55.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 110.216 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 91.4 mt -89.07 -35.63 16.21 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.37 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.523 ' HB1' HG23 ' A' ' 121' ' ' VAL . . . -118.32 148.96 44.97 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.934 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.4 Cg_exo -41.89 163.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.752 2.968 . . . . 0.0 114.355 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.5 -21.49 62.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.131 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 121' ' ' VAL . 11.3 p90 -108.1 -48.63 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.374 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.623 HG21 ' HB ' ' A' ' 93' ' ' VAL . 6.2 m -64.15 -37.52 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.48 0.181 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.02 89.59 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.96 -49.35 75.07 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.621 0.248 . . . . 0.0 110.957 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.483 HD12 HD21 ' A' ' 90' ' ' LEU . 47.7 mt -58.09 -57.33 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.0 0.428 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 90.4 mt -52.3 -59.21 4.67 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.057 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.583 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -61.74 -32.97 73.25 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.36 -56.35 21.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.236 0.471 . . . . 0.0 110.159 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.43 ' HA ' HD12 ' A' ' 131' ' ' ILE . 12.8 t-80 -68.13 -36.94 80.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.097 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 69' ' ' PRO . 32.9 tp -58.71 -46.51 87.18 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.474 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.16 -39.5 86.65 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 128' ' ' HIS . 88.7 mt -60.11 -41.69 87.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.177 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.6 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 85.4 mt -66.52 -37.72 85.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.11 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.583 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.249 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.678 0 N-CA-C 112.792 -0.123 . . . . 0.0 112.792 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.428 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 9.0 t80 -99.43 -46.5 5.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.647 0.223 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.0 m -55.91 -34.9 66.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.626 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 55' ' ' GLY . 56.9 pttt -58.37 -39.11 78.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.129 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -41.08 40.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.94 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.8 mt-30 -58.53 -29.19 66.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.677 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.11 -37.6 18.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.211 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -70.18 -30.64 67.81 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.663 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.55 -36.79 6.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.07 -2.91 29.98 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.915 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 69.0 mt -56.29 122.9 52.21 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.784 0.292 . . . . 0.0 111.026 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 70.5 Cg_endo -75.27 174.8 12.18 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.461 2.107 . . . . 0.0 112.249 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -101.22 42.59 1.11 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.028 0.442 . . . . 0.0 110.729 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -132.7 97.76 16.98 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HG2' ' HB3' ' A' ' 133' ' ' GLN . 27.6 Cg_endo -61.66 -26.94 80.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -79.64 -37.83 35.15 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -95.21 41.7 1.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.23 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.484 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.3 m0 -111.01 172.31 6.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.675 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -131.82 -179.14 5.21 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.99 -43.49 60.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.3 m -63.59 -49.24 74.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.389 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -62.2 -41.16 98.1 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.186 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.527 HG13 HD22 ' A' ' 105' ' ' LEU . 67.1 t -64.06 -52.97 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.39 -46.16 77.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.594 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.23 -37.04 85.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.776 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.6 t90 -64.9 -65.64 0.65 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.5 p -42.14 -46.54 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.215 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.402 ' N ' HG13 ' A' ' 81' ' ' VAL . 43.8 ttm -60.21 -45.93 91.49 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.393 . . . . 0.0 110.432 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 11.7 t90 -60.65 -37.53 81.83 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.558 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -17.06 62.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 81' ' ' VAL . 75.4 t -84.28 -32.37 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.164 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -81.55 -35.37 30.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.541 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.72 -40.73 55.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.63 7.67 43.84 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t 43.34 59.5 2.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 110.883 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.566 HD21 HD12 ' A' ' 124' ' ' ILE . 62.3 mt -89.35 171.63 9.62 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.024 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.99 148.32 23.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.947 0.403 . . . . 0.0 111.547 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.04 -9.1 78.71 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.694 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.6 p -74.23 136.86 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 117.39 0.595 . . . . 0.0 110.837 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.77 132.81 50.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.524 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -86.36 -24.18 25.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.371 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.31 -36.57 84.53 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.8 mptp? -65.38 -36.18 83.2 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.855 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.4 m-85 -98.54 32.18 2.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.381 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 46.2 t -87.29 67.65 9.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 110.25 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.8 ptp -159.73 171.38 19.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.897 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.4 p -72.33 159.45 34.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.252 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.44 -42.9 94.06 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.636 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.54 -38.74 64.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 110.964 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.77 -47.55 58.99 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.527 HD22 HG13 ' A' ' 77' ' ' VAL . 22.3 tp -55.71 -47.21 77.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.389 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.51 -38.53 91.34 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.681 0.277 . . . . 0.0 110.634 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -32.31 73.97 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.409 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 58.4 mt -59.77 -34.72 73.36 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.88 173.42 45.43 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.471 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.536 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.9 ttpt -59.98 -45.92 91.15 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.34 0.126 . . . . 0.0 111.34 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -49.75 -65.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.19 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 93.0 m -58.07 -38.7 76.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.435 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.95 -43.43 98.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.748 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.34 -26.19 67.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 12.5 mm-40 -75.39 -22.62 57.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.77 0.319 . . . . 0.0 110.149 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -87.36 -39.61 15.17 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.46 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -111.54 150.92 42.88 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.606 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.3 Cg_exo -44.04 165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.606 2.871 . . . . 0.0 114.111 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.37 -20.14 62.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.938 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.53 -55.0 2.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.606 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.8 m -59.99 -33.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.73 -32.13 58.47 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.208 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.59 -52.52 30.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.66 0.23 . . . . 0.0 111.305 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 90' ' ' LEU . 56.3 mt -56.18 -47.11 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.714 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.12 -60.48 3.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.753 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -62.33 -28.78 69.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.33 -54.75 17.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.062 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.404 ' HA ' HD12 ' A' ' 131' ' ' ILE . 12.7 t-160 -66.71 -32.84 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.17 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.6 tp -63.73 -41.32 98.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.247 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 32.6 tt0 -70.26 -23.57 62.91 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.395 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 128' ' ' HIS . 78.0 mt -77.21 -37.49 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.887 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 95.4 mt -58.95 -47.9 83.44 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.542 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.524 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 6.7 pt20 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.542 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 CA-C-O 120.249 -0.195 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.421 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 16.7 t80 -95.39 -45.77 6.98 Favored 'General case' 0 CA--C 1.526 0.043 0 CA-C-N 116.735 0.267 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.2 m -56.52 -39.17 72.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.954 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -62.03 -36.1 80.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.66 0.267 . . . . 0.0 110.479 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.84 -41.13 60.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.4 mt-30 -58.04 -26.69 62.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.331 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -83.31 -31.4 26.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.186 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -71.76 -43.21 66.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.188 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HB2' HG13 ' A' ' 65' ' ' ILE . 36.5 mt -94.73 -25.79 16.55 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.198 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.56 1.82 61.95 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.595 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 79' ' ' ASP . 67.4 mt -49.81 126.48 18.76 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 122.525 0.33 . . . . 0.0 111.418 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 37.1 Cg_exo -60.36 170.09 4.51 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.095 2.53 . . . . 0.0 112.956 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -100.99 38.91 1.46 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -163.96 122.37 1.24 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.587 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 35.3 Cg_exo -60.25 -44.66 27.11 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.601 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 13.5 mtt180 -53.71 -34.24 58.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.611 0.244 . . . . 0.0 110.957 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.85 42.29 1.1 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 12.9 m0 -120.74 175.94 5.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.636 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 p -137.36 -176.06 4.27 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.029 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' CA ' ' A' ' 100' ' ' MET . 46.2 mt-10 -51.77 -37.76 52.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.572 0.225 . . . . 0.0 111.188 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.4 m -67.62 -56.0 11.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.546 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -59.76 -42.72 93.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.607 0.241 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 81' ' ' VAL . 47.2 t -58.35 -47.69 87.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 5.4 tmm_? -73.24 -42.4 62.6 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.037 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 65' ' ' ILE . 1.3 m-20 -58.51 -36.82 74.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.509 0.195 . . . . 0.0 110.617 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.593 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -71.84 -62.24 1.49 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 85' ' ' VAL . 58.1 t -41.53 -51.86 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 56.9 tpp -54.06 -49.06 69.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.7 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -57.27 -38.4 73.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.108 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' PHE . . . -76.18 -18.69 58.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.513 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 81' ' ' VAL . 78.8 t -85.88 -30.48 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.7 -39.66 15.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.096 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.71 -34.95 62.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.528 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 51.3 m-85 -100.79 4.21 42.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.448 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 46.71 55.97 7.11 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 122.611 0.364 . . . . 0.0 111.506 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD13 ' HB ' ' A' ' 121' ' ' VAL . 71.8 mt -86.34 167.32 14.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.588 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.64 154.88 38.29 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 111.724 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -8.24 66.58 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.69 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.574 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.1 p -74.84 130.54 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 117.403 0.601 . . . . 0.0 111.029 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.87 130.68 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.339 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.0 -20.85 29.89 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.43 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -65.49 -33.5 76.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 34.9 mmtp -66.48 -35.76 81.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.697 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 28.8 m-85 -100.08 29.75 4.11 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.325 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.5 t -82.4 67.93 8.63 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.406 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.2 ptp -160.75 172.2 17.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.697 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.7 p -73.28 158.65 34.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.173 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -60.81 -37.62 93.94 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.804 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.41 72.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.684 0.278 . . . . 0.0 110.694 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.2 63.5 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.387 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.32 -43.76 75.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.113 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 71.2 m -67.31 -42.42 83.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.815 0.341 . . . . 0.0 110.575 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.09 67.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.669 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 64.8 mt -68.53 -31.95 71.55 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.71 174.98 49.0 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.326 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.487 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.0 ttpt -63.59 -42.52 98.25 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.571 0.185 . . . . 0.0 111.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.82 -63.37 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.511 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.8 m -59.06 -40.68 85.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.357 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.98 -43.35 99.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.49 HD12 ' HA3' ' A' ' 122' ' ' GLY . 12.0 tp -66.48 -27.15 67.57 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.632 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -75.05 -22.48 58.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.695 0.284 . . . . 0.0 110.653 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.1 mt -84.98 -32.22 23.1 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.451 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -113.04 154.2 45.11 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.608 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.2 Cg_exo -44.32 164.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.502 2.802 . . . . 0.0 113.901 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.1 -19.45 62.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.031 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.458 ' CE2' HG13 ' A' ' 121' ' ' VAL . 13.4 p90 -108.75 -51.72 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.608 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.8 m -62.93 -34.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.49 ' HA3' HD12 ' A' ' 114' ' ' LEU . . . -52.41 -39.74 52.79 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.95 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.54 -47.6 75.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.611 0.244 . . . . 0.0 110.967 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.78 -55.1 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.372 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.85 -57.2 13.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.505 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 5.9 t90 -60.78 -28.27 68.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.04 -57.72 11.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -71.99 -35.24 69.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.459 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.593 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.8 tp -56.78 -49.87 74.0 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.788 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.36 -36.71 84.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 70.2 mt -61.47 -45.71 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.177 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.8 mt -55.48 -36.84 67.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.052 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 68.4 mt-30 . . . . . 0 C--O 1.233 0.22 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.557 0 N-CA-C 112.304 -0.318 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 13.1 t80 -81.03 -49.23 11.17 Favored 'General case' 0 C--N 1.338 0.072 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.7 m -55.54 -34.0 64.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.051 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -63.97 -31.78 73.09 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.831 0.348 . . . . 0.0 110.485 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.18 -41.75 21.89 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.132 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 47.6 mt-30 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.791 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -83.04 -13.61 55.49 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 48.8 mtp180 -85.1 -37.38 20.34 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.66 0.267 . . . . 0.0 111.143 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 mp -105.19 -27.42 11.57 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.69 5.26 42.16 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.129 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 86.9 mt -57.14 125.23 69.85 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.891 0.346 . . . . 0.0 111.027 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 64.4 Cg_endo -74.65 170.45 20.29 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.375 2.05 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -75.84 -36.93 59.45 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.617 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.19 125.22 90.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.59 0.233 . . . . 0.0 111.075 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 63.5 Cg_endo -74.51 -32.98 5.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.015 2.477 . . . . 0.0 113.183 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -29.06 70.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.593 0.235 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -96.56 40.48 1.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.885 0.374 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.648 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 11.0 m0 -112.12 169.56 8.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -128.62 -178.4 4.57 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.76 -39.31 62.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.444 0.164 . . . . 0.0 111.373 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.5 m -66.81 -49.34 66.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.597 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CD2' HG12 ' A' ' 65' ' ' ILE . 47.3 m170 -61.45 -42.66 99.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.654 0.264 . . . . 0.0 110.965 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 81' ' ' VAL . 54.0 t -60.71 -52.64 59.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.8 ttm105 -66.92 -46.71 73.98 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.708 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.69 -40.72 88.82 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.838 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 14.3 t90 -63.43 -62.69 1.51 Allowed 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 85' ' ' VAL . 73.5 t -41.17 -49.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 55.2 tpp -55.68 -50.73 69.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.832 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -55.19 -39.9 70.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.85 -48.47 53.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.874 0.369 . . . . 0.0 110.27 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.568 ' CG2' HG11 ' A' ' 93' ' ' VAL . 79.4 t -52.85 -30.46 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.38 -46.92 12.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.356 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -66.39 -32.19 73.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.56 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.34 2.5 28.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.4 m 45.02 59.69 3.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.078 0.466 . . . . 0.0 110.63 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 121' ' ' VAL . 71.3 mt -86.96 153.08 21.85 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.464 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 155.52 49.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.712 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.83 -7.35 59.28 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.721 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.579 ' HB ' HG21 ' A' ' 121' ' ' VAL . 13.0 p -74.62 132.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 117.315 0.557 . . . . 0.0 111.044 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -105.01 132.26 51.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.375 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.07 -25.52 24.13 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -62.0 -34.05 75.47 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.5 mmtt -66.54 -34.94 79.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.713 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 30.3 m-85 -97.97 32.94 2.24 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.43 65.13 9.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 110.209 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.7 ptp -158.9 169.81 23.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -75.43 161.59 29.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.332 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.648 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.47 -38.37 90.75 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.825 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.01 70.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.773 0.321 . . . . 0.0 110.634 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.48 -44.98 56.72 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.421 HD22 HG13 ' A' ' 77' ' ' VAL . 15.1 tp -56.06 -46.88 78.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.195 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 95.1 m -66.71 -38.75 87.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.813 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.57 69.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.436 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.3 mt -65.72 -32.96 74.81 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 175.39 48.75 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.459 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -62.71 -42.12 99.49 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.36 -63.28 1.2 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.353 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.8 m -60.85 -38.01 84.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.394 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -63.27 -45.26 92.33 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.488 0.185 . . . . 0.0 110.828 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.04 -25.86 68.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.704 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.2 -21.81 58.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.613 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 72.7 mt -87.21 -35.22 18.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.599 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -115.84 151.25 46.17 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.8 Cg_exo -43.05 163.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.61 2.873 . . . . 0.0 114.065 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.56 -21.3 62.4 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.193 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.81 -52.8 2.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.179 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.605 ' HB ' HD13 ' A' ' 90' ' ' LEU . 3.8 m -61.26 -37.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.434 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.2 74.74 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.658 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.64 -50.0 72.94 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.468 0.175 . . . . 0.0 110.884 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.547 HD12 HD21 ' A' ' 90' ' ' LEU . 64.2 mt -56.8 -55.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.431 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.28 -56.36 17.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.274 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 21.4 t90 -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.234 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.66 -54.59 43.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -73.0 -36.05 66.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.312 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.532 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.1 tp -59.08 -43.42 91.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.596 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -68.24 -32.84 73.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.192 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.9 mt -65.04 -37.71 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.502 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.8 mt -61.55 -53.6 54.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.407 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 8.8 pt20 . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.855 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.742 0 N-CA-C 112.669 -0.172 . . . . 0.0 112.669 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 15.3 t80 -98.89 -47.33 5.31 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.598 0.199 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -55.51 -32.81 63.2 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.33 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -60.36 -32.34 71.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.415 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 43.1 tt0 -82.6 -40.08 21.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 11.8 mm100 -58.63 -30.99 67.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.284 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -84.93 -38.45 19.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.238 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.19 -40.22 86.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.678 0.275 . . . . 0.0 111.264 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 mt -96.42 -31.17 12.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.187 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -2.41 55.98 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.685 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.6 mt -53.62 129.26 54.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 122.291 0.236 . . . . 0.0 111.178 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.0 166.69 26.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -97.06 52.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 110.437 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.23 98.82 5.04 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.145 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.585 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 32.0 Cg_exo -58.38 -38.83 88.63 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.857 2.371 . . . . 0.0 112.32 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 12.1 mtt180 -66.44 -35.63 80.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -98.15 43.55 1.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 2.0 m0 -115.02 174.75 5.82 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.267 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.7 t -133.51 -179.31 5.44 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -50.36 -44.41 54.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -63.39 -49.09 75.17 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.422 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -62.31 -41.9 98.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.234 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.508 HG13 HD22 ' A' ' 105' ' ' LEU . 56.1 t -60.37 -49.91 82.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HA ' HG12 ' A' ' 81' ' ' VAL . 70.9 ttt180 -71.43 -41.86 68.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.518 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.27 -35.57 79.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.485 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -69.36 -65.49 0.7 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.7 p -42.39 -46.88 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.174 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.415 ' N ' HG13 ' A' ' 81' ' ' VAL . 43.8 ttm -60.82 -47.78 84.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.407 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 17.6 t90 -55.94 -37.95 69.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.87 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.98 60.42 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.627 ' CG2' HG11 ' A' ' 93' ' ' VAL . 88.8 t -49.59 -34.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.244 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -79.47 -42.22 25.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.255 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 7.2 mm-40 -68.27 -36.28 79.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.564 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -105.63 6.6 32.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.7 m 44.36 53.36 6.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.948 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.522 ' HB3' HG12 ' A' ' 121' ' ' VAL . 68.1 mt -80.32 166.85 20.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.513 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.87 157.83 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.63 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.98 -5.74 69.76 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.677 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' A' ' 85' ' ' VAL . 13.6 p -81.92 142.71 13.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.238 0.519 . . . . 0.0 111.338 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.5 m-20 -116.58 141.96 47.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -90.34 -23.58 21.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.938 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -60.6 -36.25 78.1 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.9 mptt -67.09 -35.12 79.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.281 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.634 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 43.1 m-85 -96.26 32.28 2.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.565 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.2 t -89.84 67.67 7.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.193 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.5 ptp -156.56 166.59 32.96 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -69.68 157.58 36.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.49 74.36 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.634 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.17 61.42 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.669 0.271 . . . . 0.0 111.182 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.58 -48.1 61.36 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.789 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.508 HD22 HG13 ' A' ' 77' ' ' VAL . 18.8 tp -57.25 -46.29 83.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.162 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.9 m -64.04 -38.9 92.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.796 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.53 76.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.368 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -58.56 -36.05 73.32 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.51 176.76 49.41 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.473 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 57.5 tttp -59.67 -47.45 85.58 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 1.0 OUTLIER -50.75 -66.94 0.3 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.4 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.7 m -57.48 -37.58 73.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -62.41 -42.93 99.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.738 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -65.72 -24.49 66.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 10.5 mm-40 -74.55 -22.89 58.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.5 mt -84.11 -40.11 18.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.629 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -105.77 157.43 34.65 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.265 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.752 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.2 Cg_endo -56.71 174.26 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.685 2.257 . . . . 0.0 112.958 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -63.07 -14.39 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -107.93 -59.79 1.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.755 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.752 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -58.52 -31.25 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.04 -32.43 42.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.115 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.81 -46.35 53.62 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.68 0.24 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.424 HD12 HD21 ' A' ' 90' ' ' LEU . 57.0 mt -62.64 -58.64 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 111.658 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.403 HD13 HG23 ' A' ' 81' ' ' VAL . 66.5 mt -51.19 -58.77 5.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.793 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.517 ' CZ2' ' HD2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.42 -31.59 71.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.288 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.1 -57.09 14.58 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.54 -29.69 66.23 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.63 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.438 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.5 tp -57.83 -49.72 75.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.783 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 13.5 mm-40 -67.78 -34.87 77.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.767 0.318 . . . . 0.0 110.316 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.59 -37.55 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.9 -36.7 82.88 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.521 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.585 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 79.1 mt-30 . . . . . 0 N--CA 1.462 0.139 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.316 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.669 0 CA-C-O 120.242 -0.199 . . . . 0.0 113.127 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.465 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 16.9 t80 -99.16 -47.06 5.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.721 0.26 . . . . 0.0 110.657 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.2 m -57.1 -37.28 71.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 19.9 pttp -63.21 -36.1 82.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.346 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.49 61.19 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 55.3 mt-30 -59.4 -28.09 66.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.408 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -82.87 -40.88 19.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -65.86 -41.85 91.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -89.16 -31.12 18.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.924 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.89 -5.87 51.04 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.617 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' A' ' 76' ' ' HIS . 85.2 mt -51.43 124.13 23.71 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.61 0.243 . . . . 0.0 110.889 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.62 171.74 16.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.675 2.25 . . . . 0.0 112.714 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -100.3 45.57 0.98 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -140.05 102.76 6.83 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.406 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 32.1 Cg_exo -59.06 -31.33 95.42 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.865 2.377 . . . . 0.0 112.555 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.98 -36.03 59.38 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -95.73 38.45 1.17 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.743 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.465 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.0 OUTLIER -108.43 170.78 7.81 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.322 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.5 p -133.24 -179.01 5.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.464 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -52.18 -40.45 61.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -64.25 -50.63 67.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.324 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CD2' HG12 ' A' ' 65' ' ' ILE . 25.4 m170 -63.42 -41.3 98.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.81 -54.83 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 111.002 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -63.31 -49.52 73.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.385 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.77 -41.03 76.91 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.3 t90 -63.88 -61.88 2.0 Allowed 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.491 HG13 HD21 ' A' ' 125' ' ' LEU . 53.5 t -41.08 -55.36 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.775 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 30.0 ttm -57.68 -45.65 85.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.711 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.535 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 14.4 t90 -56.59 -35.84 68.68 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.933 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.2 -19.72 61.03 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.209 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 81' ' ' VAL . 58.2 t -81.37 -33.47 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.041 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -84.76 -40.26 17.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.61 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 12.2 mm-40 -72.15 -38.7 69.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -102.62 9.22 39.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t 44.71 52.87 7.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.818 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.833 HD13 HG13 ' A' ' 121' ' ' VAL . 69.4 mt -86.85 176.23 7.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.314 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.438 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.82 152.97 16.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.004 0.431 . . . . 0.0 111.745 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.49 -14.21 65.37 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.9 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.499 ' HB ' HG11 ' A' ' 121' ' ' VAL . 13.0 p -75.54 130.55 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.39 0.595 . . . . 0.0 110.879 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 9.4 m-20 -98.71 134.68 41.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -86.37 -26.99 24.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.474 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 15.8 mm100 -60.52 -37.58 81.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.973 0.415 . . . . 0.0 109.91 177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 99.5 mttt -66.88 -29.57 69.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.51 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.465 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 50.9 m-85 -101.84 33.07 3.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 59.3 m -86.24 65.24 8.98 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.113 0.482 . . . . 0.0 110.32 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.518 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.7 ptp -153.48 165.46 35.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -74.73 164.68 26.3 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.341 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.13 -42.67 95.3 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.717 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.03 -38.33 62.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.97 55.62 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.71 -47.55 73.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.152 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.7 m -65.85 -38.8 89.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.99 -21.25 66.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.8 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 43.4 mt -71.31 -34.91 71.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.18 179.77 46.87 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.45 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.416 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.1 ttpt -60.92 -47.81 84.7 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -50.56 -65.15 0.61 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 94.9 m -60.53 -42.27 96.15 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 52.8 t80 -61.61 -46.35 90.21 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.281 -0.168 . . . . 0.0 111.119 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.3 mt -62.44 -31.35 72.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.598 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.98 -25.65 64.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.748 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 97' ' ' LYS . 65.2 mt -87.47 -31.23 20.1 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.214 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.514 ' CB ' ' HA2' ' A' ' 122' ' ' GLY . . . -99.13 166.42 13.04 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.82 0.343 . . . . 0.0 111.6 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 21.0 Cg_exo -66.59 173.5 7.75 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.095 2.53 . . . . 0.0 113.225 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.42 -28.21 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.088 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.2 -53.06 2.68 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.475 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.833 HG13 HD13 ' A' ' 90' ' ' LEU . 81.8 t -57.18 -39.55 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 117' ' ' ALA . . . -50.99 -43.48 49.43 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.15 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 12.6 m-20 -63.04 -46.09 89.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.0 mt -57.94 -50.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.631 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.491 HD21 HG13 ' A' ' 81' ' ' VAL . 10.5 mp -63.95 -57.81 8.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.258 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.416 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.06 -31.73 71.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.632 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 123' ' ' ASP . 8.2 tp10 -62.75 -52.45 63.18 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.01 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.568 ' HA ' HD12 ' A' ' 131' ' ' ILE . 18.6 t-160 -71.98 -30.66 65.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.424 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 40.4 tp -62.39 -46.2 89.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.605 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 64.6 mm-40 -67.07 -33.62 75.89 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.9 mt -59.89 -42.89 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.38 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.23 -38.4 89.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.544 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.478 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.158 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 112.36 -0.296 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.446 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 11.7 t80 -77.62 -49.76 13.91 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.0 m -55.31 -32.54 62.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.399 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 34.7 mmtp -59.42 -33.65 71.51 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.809 0.338 . . . . 0.0 110.57 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -83.21 -41.61 18.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 43.6 mt-30 -57.66 -29.45 64.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.736 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 28.2 pt20 -83.25 -32.21 26.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -71.25 -40.16 71.19 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.77 -26.81 13.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.75 11.69 39.85 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.916 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 75.5 mt -56.94 121.22 44.24 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.62 0.248 . . . . 0.0 111.4 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.8 Cg_exo -68.07 170.32 14.68 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.747 2.298 . . . . 0.0 112.241 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -94.05 -4.09 50.07 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.606 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 6.5 t70 -98.5 108.24 46.77 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.715 0.293 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.571 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 33.2 Cg_endo -63.59 -26.96 69.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.001 2.467 . . . . 0.0 112.973 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -76.53 -35.22 58.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -94.7 40.48 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.078 0.466 . . . . 0.0 110.558 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.55 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.2 m0 -108.51 170.35 8.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.375 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.9 p -130.96 179.69 5.84 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -39.49 58.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.0 m -64.24 -53.3 51.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -61.56 -39.38 90.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 81' ' ' VAL . 50.5 t -64.18 -52.13 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.136 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -66.01 -48.17 72.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.911 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.81 -32.13 72.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.7 t90 -72.58 -65.86 0.73 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.2 p -40.99 -47.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.506 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.429 ' N ' HG13 ' A' ' 81' ' ' VAL . 38.5 ttm -59.3 -48.43 81.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.819 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.423 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 87.2 t90 -61.55 -40.22 93.91 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.3 62.76 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.264 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.61 ' CG2' HG11 ' A' ' 93' ' ' VAL . 40.2 t -82.49 -31.4 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.9 -38.43 37.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 11.6 mm-40 -70.27 -36.68 74.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.21 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -104.28 5.67 34.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m 44.64 55.59 5.75 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 110.779 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.557 HD21 HG13 ' A' ' 124' ' ' ILE . 83.0 mt -78.2 127.34 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.088 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -108.47 142.34 39.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.464 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 -5.72 84.42 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.756 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.61 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.5 p -76.34 137.57 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.298 0.549 . . . . 0.0 110.926 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -112.93 138.82 49.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.437 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -89.46 -26.02 21.17 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.598 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -60.61 -34.15 73.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.006 0.431 . . . . 0.0 109.916 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.8 mmmm -68.02 -34.33 76.3 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.847 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.2 m-85 -99.34 35.45 1.94 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.443 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.91 69.08 10.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.21 169.15 24.75 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.778 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -76.9 165.18 25.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.55 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.27 -43.19 95.66 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.103 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.23 66.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.989 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.21 53.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.841 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.427 HD22 HG13 ' A' ' 77' ' ' VAL . 14.7 tp -56.73 -46.59 81.24 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.345 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 80.5 m -66.52 -40.66 89.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.71 0.291 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.57 76.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.215 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.2 mt -58.82 -32.51 69.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.997 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.23 177.18 45.57 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.662 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.521 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -60.66 -45.51 93.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.367 0.136 . . . . 0.0 111.367 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 35.2 tt0 -50.88 -66.73 0.34 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.0 m -57.98 -40.16 79.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.767 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.98 -45.42 93.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.554 0.216 . . . . 0.0 111.018 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.46 -26.19 68.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.745 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 18.5 mm-40 -73.92 -24.03 59.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 110.771 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.1 mt -82.39 -35.47 27.67 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.508 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -109.69 160.23 28.71 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 120.716 0.293 . . . . 0.0 111.62 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.674 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 50.4 Cg_exo -52.91 171.89 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.116 2.544 . . . . 0.0 113.651 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.73 -22.77 66.05 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.774 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.76 -58.75 1.93 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.674 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.9 m -62.39 -32.83 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.0 -38.51 38.77 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.599 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.49 -46.35 88.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.653 0.264 . . . . 0.0 111.007 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.557 HG13 HD21 ' A' ' 90' ' ' LEU . 50.5 mm -51.29 -51.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.132 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -63.65 -57.09 11.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.418 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.521 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -61.32 -26.95 68.14 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.08 -57.27 12.2 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.473 ' HA ' HD12 ' A' ' 131' ' ' ILE . 20.8 t-160 -73.28 -35.15 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.688 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.533 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 29.7 tp -57.8 -45.63 85.79 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 1.7 tm-20 -68.29 -38.93 82.15 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 128' ' ' HIS . 66.5 mt -55.15 -45.24 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.627 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.479 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.2 mt -53.25 -36.31 60.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.318 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.571 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 63.5 mt-30 . . . . . 0 N--CA 1.462 0.171 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.926 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' HA2' ' HE2' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 120.315 -0.158 . . . . 0.0 112.803 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 9.5 t80 -88.77 -51.08 5.84 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 116.745 0.273 . . . . 0.0 110.628 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 91.0 m -56.11 -42.24 76.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.112 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HE2' ' HA2' ' A' ' 55' ' ' GLY . 56.4 pttt -60.01 -33.85 72.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.734 0.302 . . . . 0.0 110.419 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -77.27 -42.89 35.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.66 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.3 mt-30 -60.66 -27.34 67.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.832 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 57' ' ' THR . 87.1 mm-40 -80.45 -14.34 58.37 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 78.6 mtt180 -85.01 -34.41 22.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.109 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.79 -24.56 12.89 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.72 9.94 48.25 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.073 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.451 HG12 ' CD2' ' A' ' 76' ' ' HIS . 25.9 mt -56.53 126.01 68.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.742 0.271 . . . . 0.0 111.281 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 63.6 Cg_endo -73.89 175.51 10.71 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.617 2.211 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -98.99 39.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.517 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -148.02 110.48 3.78 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.543 0.211 . . . . 0.0 111.439 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 34.4 Cg_exo -57.32 -37.96 96.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.181 2.587 . . . . 0.0 112.597 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -63.34 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.668 0.27 . . . . 0.0 110.494 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -96.47 38.7 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.526 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -114.82 169.32 9.16 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.681 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.4 t -132.25 -177.77 4.61 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -49.31 -42.0 40.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.2 m -67.01 -50.08 63.25 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.451 ' CD2' HG12 ' A' ' 65' ' ' ILE . 37.1 m170 -61.66 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.631 0.253 . . . . 0.0 111.176 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.473 HG13 HD22 ' A' ' 105' ' ' LEU . 54.6 t -59.7 -51.73 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -71.03 -43.37 68.04 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.785 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.03 -39.45 74.82 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.58 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.541 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.4 t90 -68.35 -60.57 2.35 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.2 t -41.61 -55.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.647 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 ttm -55.8 -46.15 78.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.69 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 14.5 t90 -57.2 -37.13 71.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -18.68 62.22 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.273 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 HG11 ' A' ' 93' ' ' VAL . 24.4 t -81.9 -35.91 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.853 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -90.9 -30.36 16.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.051 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.67 -38.81 53.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -108.2 11.15 27.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.746 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 45.72 57.11 5.28 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.905 0.383 . . . . 0.0 111.624 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HB3' HG12 ' A' ' 121' ' ' VAL . 70.8 mt -89.16 172.74 8.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -155.37 153.89 31.16 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 111.643 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.12 -6.23 80.13 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG22 ' A' ' 85' ' ' VAL . 13.2 p -78.07 133.7 29.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 117.348 0.574 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -104.66 135.98 45.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.74 -28.33 21.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.528 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.15 -34.58 75.25 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.0 mmtt -66.72 -34.98 79.05 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.026 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.605 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 42.3 m-85 -100.62 34.21 2.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.386 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.8 t -86.94 66.51 9.46 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.119 0.485 . . . . 0.0 110.077 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.6 ptp -159.0 170.76 21.37 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.871 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.9 m -74.24 157.11 36.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -60.27 -36.36 90.62 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.925 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.2 -39.46 72.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 110.645 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.28 -43.16 61.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.425 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 77' ' ' VAL . 14.4 tp -56.48 -44.89 81.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.074 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.6 -40.22 88.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.723 0.297 . . . . 0.0 110.676 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.08 -24.28 66.68 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.749 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 39.9 mt -68.49 -35.09 77.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.79 172.11 48.56 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.329 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.491 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.8 ttpt -61.47 -48.75 79.7 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.47 -51.81 51.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.8 m -66.69 -39.65 88.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.558 0.218 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 64.1 t80 -63.0 -43.72 98.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.796 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.27 -25.95 66.31 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.68 -23.53 59.84 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.639 0.257 . . . . 0.0 110.617 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 78.1 mt -85.84 -35.04 20.88 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.302 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -104.89 161.5 22.59 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.795 ' HG2' HG22 ' A' ' 121' ' ' VAL . 18.9 Cg_endo -59.42 176.12 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.748 2.298 . . . . 0.0 112.888 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.35 -12.91 59.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -108.67 -56.44 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.773 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.795 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.6 m -62.98 -31.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.72 -43.96 38.47 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.782 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.29 -49.36 43.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.647 0.26 . . . . 0.0 110.846 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.86 -55.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.517 HD21 HG13 ' A' ' 81' ' ' VAL . 10.3 mp -56.81 -53.08 61.96 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.753 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.491 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 17.4 t90 -61.43 -28.18 69.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -63.95 -54.84 28.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.147 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.451 ' HA ' HD12 ' A' ' 131' ' ' ILE . 22.7 t-160 -72.37 -34.33 67.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.613 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.541 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.7 tp -61.93 -45.29 94.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.401 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 31.9 tt0 -67.58 -27.73 67.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.48 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 128' ' ' HIS . 62.2 mt -68.28 -37.57 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.44 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.414 ' HB2' ' HG3' ' A' ' 69' ' ' PRO . 96.2 mt -64.67 -48.52 74.43 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.68 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.65 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 8.4 pt20 . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 120.213 -0.215 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.496 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.3 t80 -96.43 -49.67 5.07 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.646 0.223 . . . . 0.0 110.9 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -54.52 -33.23 59.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.248 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 110.115 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.03 -38.89 35.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.952 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 25.0 mt-30 -58.98 -31.72 69.01 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.608 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -85.75 -37.06 19.74 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -71.98 -31.98 66.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 mt -105.54 -32.14 8.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.0 0.49 41.75 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.157 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 48.9 mt -55.83 122.66 47.92 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.762 0.281 . . . . 0.0 110.917 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 74.4 Cg_endo -76.35 171.77 17.47 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.455 2.103 . . . . 0.0 112.648 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -98.75 45.91 1.0 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.927 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -146.17 103.31 4.09 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.068 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.6 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 51.0 Cg_exo -57.08 -46.88 25.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.921 2.414 . . . . 0.0 112.238 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -57.71 -33.09 68.05 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.555 0.217 . . . . 0.0 110.805 178.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG3' ' HG2' ' A' ' 70' ' ' ARG . 46.0 mt-30 -99.98 42.04 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.186 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.635 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.9 m0 -115.33 170.21 8.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.363 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -130.66 -179.46 5.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.23 -43.04 52.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.5 m -62.52 -50.39 71.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.301 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.159 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.49 -52.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.34 -48.74 69.29 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.482 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.25 -36.22 77.26 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.008 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 33.5 t90 -69.56 -65.17 0.75 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 85' ' ' VAL . 11.6 p -41.7 -47.53 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.227 0.329 . . . . 0.0 111.378 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.427 ' N ' HG13 ' A' ' 81' ' ' VAL . 60.4 tpp -59.84 -47.64 84.89 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.101 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.516 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.3 t90 -61.22 -38.17 85.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.988 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.45 61.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.43 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 81' ' ' VAL . 54.1 t -83.17 -32.84 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.161 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -81.16 -33.84 32.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.2 mm-40 -73.59 -39.9 64.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.989 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -102.19 7.49 40.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m 44.67 55.22 6.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 110.976 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.626 HD13 ' HB ' ' A' ' 121' ' ' VAL . 53.4 mt -83.12 168.75 16.57 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.36 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -150.99 153.77 35.81 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.733 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.1 -7.61 63.02 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.008 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 85' ' ' VAL . 12.3 p -73.81 131.97 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 117.547 0.673 . . . . 0.0 111.167 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.66 131.1 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -86.29 -23.09 26.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.754 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -61.95 -35.7 79.24 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 6.1 mptp? -65.56 -34.27 77.86 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.32 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 36.6 m-85 -101.1 29.95 4.39 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.693 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.3 t -84.86 66.55 9.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.1 0.476 . . . . 0.0 110.241 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.1 ptp -158.43 171.66 19.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.657 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 m -75.92 158.26 32.23 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.635 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.57 -37.95 90.11 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.872 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.42 -39.51 67.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 110.64 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 108' ' ' LEU . . . -73.49 -46.76 46.05 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -52.89 -47.5 67.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.323 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.71 -38.52 86.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.785 0.326 . . . . 0.0 110.492 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -18.46 64.16 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.932 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 112' ' ' CYS . 41.9 mt -74.36 -28.49 61.14 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.18 169.8 42.44 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.673 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.58 -44.92 95.67 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.95 -60.79 2.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.734 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 49.8 t -59.61 -44.21 93.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.395 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -59.78 -43.34 94.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.973 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.48 -30.15 70.89 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.723 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.04 -21.85 60.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.733 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 89.0 mt -83.65 -32.21 25.77 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.586 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -112.02 154.62 44.16 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.724 0.297 . . . . 0.0 111.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.639 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.0 Cg_exo -45.77 167.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.398 2.732 . . . . 0.0 113.796 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.21 -21.88 66.74 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.087 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.422 ' CE2' HG13 ' A' ' 121' ' ' VAL . 18.9 p90 -108.63 -51.51 2.88 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.639 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 9.9 m -61.69 -35.76 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.39 -35.1 49.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.238 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.11 -49.91 72.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.706 0.253 . . . . 0.0 111.202 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.535 HD12 HD21 ' A' ' 90' ' ' LEU . 74.1 mt -60.16 -53.33 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.565 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -52.62 -58.1 7.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.278 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 1.4 t90 -64.74 -25.45 67.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.427 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.51 -56.69 17.29 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.423 ' HA ' HD12 ' A' ' 131' ' ' ILE . 21.9 t-160 -73.17 -36.63 66.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.523 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.55 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.9 tp -57.23 -45.16 84.14 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.22 -36.42 79.48 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 128' ' ' HIS . 64.8 mt -58.31 -41.51 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.698 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.507 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 86.7 mt -57.22 -37.37 72.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.683 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.6 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 45.4 mt-30 . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.164 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.564 0 CA-C-O 120.261 -0.188 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.1 t80 -96.42 -53.73 3.5 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.697 0.249 . . . . 0.0 110.864 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.6 m -54.7 -33.66 61.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.402 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 14.7 ptmm? -62.15 -31.27 71.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.856 0.36 . . . . 0.0 110.569 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -83.3 -39.3 20.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.087 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 28.4 mt-30 -58.29 -28.32 64.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.455 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 29.1 pt20 -84.78 -37.03 21.3 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.564 0.221 . . . . 0.0 110.962 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -65.06 -42.95 93.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.7 mt -99.14 -29.33 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.29 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.66 6.66 54.51 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.56 119.21 14.8 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 122.31 0.244 . . . . 0.0 111.283 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.14 166.93 13.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.739 2.293 . . . . 0.0 112.386 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -98.92 41.07 1.16 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.725 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -156.28 125.15 3.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 132' ' ' LEU . 38.2 Cg_endo -67.59 -37.73 16.04 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.089 2.526 . . . . 0.0 113.02 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.442 ' HD3' ' HG2' ' A' ' 69' ' ' PRO . 1.5 mpp_? -61.91 -33.06 73.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.519 0.199 . . . . 0.0 110.763 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.37 41.92 1.13 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.932 0.396 . . . . 0.0 110.843 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.595 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 4.9 m0 -119.8 170.05 9.58 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.509 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -133.59 -178.86 5.19 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -49.87 -43.31 49.11 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -63.1 -49.64 73.65 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.335 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -61.67 -41.6 97.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.605 HG13 HD22 ' A' ' 105' ' ' LEU . 64.8 t -62.35 -56.14 19.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.19 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.432 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 7.0 tmm_? -64.08 -46.97 81.94 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.347 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.1 -43.21 99.24 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.724 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 22.0 t90 -61.13 -62.93 1.49 Allowed 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 85' ' ' VAL . 55.8 t -40.91 -49.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.791 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.403 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 29.9 ttm -58.17 -45.02 88.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.788 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.595 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 17.3 t90 -59.26 -37.82 78.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.68 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.52 -20.28 61.37 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.173 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 81' ' ' VAL . 69.7 t -81.35 -32.07 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.188 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.7 -35.48 24.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.134 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.595 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.1 mm-40 -73.04 -40.13 65.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.84 10.78 36.33 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p 41.83 51.72 4.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.978 0.418 . . . . 0.0 111.183 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.432 ' HB3' HG12 ' A' ' 121' ' ' VAL . 79.5 mt -80.11 171.25 15.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -155.08 160.35 40.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.199 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.06 -7.88 58.85 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.783 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.549 ' HB ' HG21 ' A' ' 121' ' ' VAL . 11.4 p -79.9 131.61 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.497 0.648 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -103.53 139.47 38.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.3 -25.33 21.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -61.59 -30.65 70.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 29.9 mmmt -68.41 -34.59 76.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.872 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.6 m-85 -101.52 32.4 3.35 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.189 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.1 t -84.07 67.51 9.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 110.232 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.428 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.6 ptp -157.42 168.56 26.98 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.804 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -73.3 161.02 30.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.336 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.37 -44.79 89.78 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.866 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.8 63.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.656 0.265 . . . . 0.0 110.836 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.55 61.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.605 HD22 HG13 ' A' ' 77' ' ' VAL . 16.2 tp -55.95 -47.51 77.45 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.182 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.41 -38.77 85.15 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.799 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.66 67.64 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.794 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.6 mt -67.67 -30.53 70.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.86 173.48 40.82 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.628 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -59.18 -46.81 87.44 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.087 0.155 . . . . 0.0 111.263 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.49 -64.74 0.71 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.894 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.7 m -61.02 -40.78 94.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -60.19 -46.83 88.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.459 0.171 . . . . 0.0 111.23 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.83 -28.51 69.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.28 -20.69 60.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.89 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 69.2 mt -87.24 -35.49 18.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.791 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.604 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -111.93 159.52 33.24 Favored Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.741 ' HG2' HG22 ' A' ' 121' ' ' VAL . 10.2 Cg_endo -56.3 172.59 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.673 2.249 . . . . 0.0 113.213 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.04 -19.03 60.89 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -108.66 -50.63 2.99 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.741 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -63.02 -34.2 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.532 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.36 -39.43 65.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.801 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -68.53 -48.18 65.0 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.628 0.251 . . . . 0.0 110.93 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.33 -55.52 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.41 ' HB3' ' CH2' ' A' ' 80' ' ' TRP . 92.7 mt -57.73 -59.93 4.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.188 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.47 -28.58 69.39 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.36 -52.54 26.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.298 0.499 . . . . 0.0 110.088 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.404 ' HA ' HD12 ' A' ' 131' ' ' ILE . 18.4 t-160 -67.61 -34.42 76.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.508 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.7 tp -64.28 -39.39 93.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.972 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' A' ' 133' ' ' GLN . 34.9 tt0 -67.21 -29.12 68.7 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.182 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 128' ' ' HIS . 51.6 mt -67.86 -35.65 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.571 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.593 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 99.1 mt -68.63 -40.87 80.11 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.563 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.503 ' HB3' ' CG ' ' A' ' 69' ' ' PRO . 9.4 pt20 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.423 ' CA ' ' HE3' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.527 0.793 0 CA-C-O 120.347 -0.141 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.9 t80 -95.21 -45.42 7.19 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m -57.61 -37.27 72.96 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 20.6 pttp -63.35 -32.79 74.3 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.747 0.308 . . . . 0.0 110.625 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -82.84 -38.98 22.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 56.6 mt-30 -57.7 -27.43 62.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.82 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 30.1 pt20 -85.11 -34.64 22.15 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 110.959 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -73.05 -33.67 65.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.3 mt -101.53 -30.84 11.17 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.701 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.18 -1.99 56.38 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.701 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.645 HD11 ' HB3' ' A' ' 79' ' ' ASP . 54.7 mt -55.55 122.05 42.43 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.73 0.265 . . . . 0.0 111.203 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.4 Cg_exo -68.13 177.83 4.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.834 2.356 . . . . 0.0 112.252 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -108.47 31.57 5.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.73 98.85 27.27 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.273 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.55 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 32.9 Cg_exo -61.35 -27.03 82.42 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.919 2.413 . . . . 0.0 112.907 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -78.65 -38.38 39.66 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -96.57 39.32 1.17 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.667 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -107.18 175.61 5.44 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.351 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.66 -179.56 5.72 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.55 -43.79 56.28 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -62.43 -53.39 55.55 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -58.49 -40.71 83.52 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.24 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 81' ' ' VAL . 60.3 t -62.7 -51.52 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.659 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -64.12 -53.86 42.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.352 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.645 ' HB3' HD11 ' A' ' 65' ' ' ILE . 1.2 m-20 -55.99 -35.21 66.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.375 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.9 t90 -70.34 -63.24 1.12 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 85' ' ' VAL . 79.3 t -40.51 -54.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.435 ' HG2' ' CE1' ' A' ' 95' ' ' PHE . 63.5 mtt -55.53 -47.41 76.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.564 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 7.0 t90 -55.8 -37.83 69.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -18.56 61.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.523 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 HG11 ' A' ' 93' ' ' VAL . 47.5 t -79.26 -35.12 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.575 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.54 -31.71 24.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.386 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.564 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.78 -40.66 54.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 111.102 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -103.09 6.22 38.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t 45.67 55.58 6.65 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.452 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.578 ' HB3' HG12 ' A' ' 121' ' ' VAL . 64.4 mt -81.92 174.28 11.43 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.457 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.07 146.92 23.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.457 -179.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.07 81.3 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.739 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG22 ' A' ' 85' ' ' VAL . 14.7 p -71.98 128.19 34.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 117.472 0.636 . . . . 0.0 110.917 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.463 ' CB ' ' HD3' ' A' ' 97' ' ' LYS . 11.1 m-20 -98.8 128.68 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' ' HG2' ' A' ' 82' ' ' MET . 39.4 m-85 -86.31 -25.97 25.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.463 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.466 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 30.1 mm-40 -63.9 -34.33 77.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.1 mptt -67.05 -33.5 75.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.189 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 48.6 m-85 -98.28 33.14 2.27 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 37.2 m -88.49 67.19 8.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.041 0.448 . . . . 0.0 110.346 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.524 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.8 ptp -157.08 168.41 27.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.855 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -73.29 158.69 34.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.98 -43.93 87.91 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.743 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.23 62.79 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.98 62.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -55.95 -46.75 78.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.264 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.21 -40.85 94.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.716 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -26.17 67.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.654 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 38.6 mt -65.27 -37.61 87.74 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.09 172.95 49.47 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.331 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.0 ttpt -60.76 -47.2 87.38 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.38 -51.69 61.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.8 m -67.19 -39.51 86.38 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.442 0.163 . . . . 0.0 111.23 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -63.42 -43.1 98.44 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.687 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.93 -24.15 66.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.823 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.87 -23.62 48.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.454 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 95.9 mt -83.62 -36.68 23.69 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.35 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.607 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -108.29 157.79 35.46 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.782 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.0 Cg_endo -56.7 176.82 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.787 2.325 . . . . 0.0 112.978 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.51 -15.63 61.18 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.29 -57.47 2.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.706 -0.798 . . . . 0.0 112.949 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.782 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.5 m -59.17 -33.69 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.75 -34.51 50.85 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.776 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.07 -50.05 21.35 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.419 0.152 . . . . 0.0 110.987 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -57.12 -57.65 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.1 mt -51.68 -58.97 4.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.905 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -61.33 -31.03 70.89 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.559 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.19 -55.5 27.96 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.056 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -70.89 -32.41 69.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.519 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.1 tp -59.11 -49.59 77.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -65.65 -33.91 76.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.485 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.5 mt -61.69 -39.03 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.425 ' HB2' ' HG3' ' A' ' 69' ' ' PRO . 86.2 mt -64.4 -35.69 81.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.777 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.55 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 66.7 mt-30 . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.418 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 CA-C-O 120.165 -0.241 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.589 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 8.5 t80 -101.52 -38.11 8.11 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.823 0.312 . . . . 0.0 110.986 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 m -65.25 -24.56 67.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.194 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -74.66 -36.21 62.82 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.003 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -83.6 -31.68 26.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.667 179.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.9 mt-30 -61.32 -29.16 69.71 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.5 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 29.8 pt20 -85.68 -39.5 17.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.521 0.2 . . . . 0.0 111.132 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -71.49 -33.23 69.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.443 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.441 HD13 ' OD1' ' A' ' 79' ' ' ASP . 12.5 mt -99.3 -34.7 10.21 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.638 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.67 -5.0 53.97 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.569 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 85.4 mt -50.74 122.92 17.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.522 0.329 . . . . 0.0 111.483 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 22.9 Cg_exo -64.79 172.23 7.33 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.093 2.528 . . . . 0.0 112.719 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.08 -12.17 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 14.5 t70 -104.12 122.77 43.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.547 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 41.8 Cg_endo -67.51 -24.99 41.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.05 2.5 . . . . 0.0 113.405 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 5.9 mpt_? -70.27 -32.27 70.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.145 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 27.3 pt20 -93.78 24.7 3.98 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.654 0.264 . . . . 0.0 111.213 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.466 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -97.69 169.96 9.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.211 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.6 p -136.9 -174.55 3.76 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.55 -36.73 62.16 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.473 0.178 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.2 m -68.17 -52.85 29.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.349 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -60.79 -39.72 89.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.678 0.275 . . . . 0.0 111.12 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.95 -52.47 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -67.5 -47.75 69.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.376 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD1' HD13 ' A' ' 63' ' ' LEU . 10.1 t70 -61.41 -34.65 75.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.678 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -66.87 -65.16 0.72 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.3 p -42.87 -45.41 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.097 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -58.54 -48.13 81.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -59.18 -38.84 80.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.638 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -20.89 62.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.335 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 81' ' ' VAL . 62.5 t -82.16 -32.39 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.469 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -82.03 -36.92 27.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.82 -38.45 67.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.262 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.61 6.31 39.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 44.97 56.4 5.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.092 0.472 . . . . 0.0 110.768 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.544 ' HB3' HG12 ' A' ' 121' ' ' VAL . 77.0 mt -85.19 172.78 10.91 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 153.59 29.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.323 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.26 77.32 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.828 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.619 ' HB ' HG21 ' A' ' 121' ' ' VAL . 11.1 p -77.97 132.58 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 117.416 0.608 . . . . 0.0 111.118 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 97' ' ' LYS . 29.0 t70 -102.56 136.53 42.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.737 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.22 -23.45 22.36 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.446 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.75 -31.45 72.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 74.5 mmtt -68.11 -35.46 78.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.876 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.543 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 33.7 m-85 -100.17 34.59 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.26 68.9 7.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.466 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.7 ptp -157.78 170.9 21.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.239 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 t -72.12 160.5 32.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.278 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.06 -48.5 79.04 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.62 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.76 -37.48 51.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.647 0.261 . . . . 0.0 111.181 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.46 -45.79 65.07 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.72 -44.67 81.84 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 81.3 m -66.48 -39.49 88.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.825 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.9 73.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.479 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -60.46 -37.92 82.54 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.807 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 175.92 50.69 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.662 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 26.2 ttpp -59.85 -53.86 52.95 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 10.6 pt-20 -48.84 -51.87 27.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.1 m -67.51 -41.77 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.436 ' HE1' ' HB2' ' A' ' 125' ' ' LEU . 50.4 t80 -62.53 -44.91 95.18 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.06 -28.95 70.13 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.941 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 19.3 mm-40 -73.08 -23.68 60.58 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.638 0.256 . . . . 0.0 110.807 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 76.9 mt -83.29 -34.73 25.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.52 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.598 ' HB1' HG23 ' A' ' 121' ' ' VAL . . . -104.99 158.12 32.73 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.471 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.798 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.5 Cg_endo -57.43 176.88 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.778 2.318 . . . . 0.0 112.927 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.75 -14.77 60.06 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.16 -59.01 1.95 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.913 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -58.76 -32.33 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.34 -33.48 46.55 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.1 -45.86 46.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.497 0.189 . . . . 0.0 111.27 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.401 HD12 HD21 ' A' ' 90' ' ' LEU . 50.3 mt -63.64 -60.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.539 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.436 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . 71.6 mt -49.74 -56.82 8.8 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.085 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.474 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -63.7 -34.28 77.52 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.16 -55.51 32.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.579 ' HA ' HD12 ' A' ' 131' ' ' ILE . 17.9 t-160 -71.14 -31.35 67.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 34.3 tp -57.93 -46.07 85.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.0 mm-40 -70.32 -32.4 70.12 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.377 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.8 mt -60.96 -39.42 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 93.7 mt -60.77 -33.62 73.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.534 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 76.3 mt-30 . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.032 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.547 0 CA-C-O 120.221 -0.21 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -97.79 -48.84 5.04 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.694 0.247 . . . . 0.0 111.085 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -59.42 -35.98 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.191 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.01 -31.96 73.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 39.8 tt0 -68.6 -37.62 79.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.061 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -59.77 -24.81 64.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -84.17 -18.19 37.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.764 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 51.7 mtt180 -87.99 -42.67 12.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.601 0.239 . . . . 0.0 111.379 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mp -106.6 -25.56 11.75 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.29 10.59 50.91 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 81.4 mt -50.43 125.21 19.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.667 0.233 . . . . 0.0 111.484 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 27.0 Cg_exo -61.69 170.11 6.15 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.876 2.384 . . . . 0.0 112.361 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -98.69 39.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.201 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.529 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 12.5 t70 -172.75 126.45 0.51 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 111.453 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.663 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 22.2 Cg_endo -60.4 -40.7 55.65 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.397 2.731 . . . . 0.0 113.01 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -52.85 -36.23 58.58 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.13 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 29.4 pt20 -99.06 36.73 1.65 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.931 0.396 . . . . 0.0 111.373 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.517 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 17.1 m0 -113.03 174.85 5.7 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.625 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -134.86 -175.42 3.9 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' MET . 42.0 mt-10 -52.42 -37.9 57.82 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.9 m -68.72 -52.76 27.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.641 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.64 -42.24 96.52 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.668 0.27 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.558 HG13 HD22 ' A' ' 105' ' ' LEU . 42.6 t -59.72 -52.95 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.226 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -69.98 -45.14 67.98 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.599 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.36 -37.45 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.484 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -68.82 -60.69 2.21 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.9 t -41.26 -55.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.538 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.4 ttm -54.5 -45.66 73.32 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -59.23 -35.62 73.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.998 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.18 -18.85 58.89 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.304 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.811 ' CG2' HG11 ' A' ' 93' ' ' VAL . 96.3 t -83.18 -33.39 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.659 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.41 -35.06 17.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -41.15 63.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -100.61 7.68 43.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.817 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.7 m 45.52 56.74 5.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.977 0.418 . . . . 0.0 111.172 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.656 ' HB3' HG12 ' A' ' 121' ' ' VAL . 71.3 mt -85.14 173.11 10.69 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.321 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.31 152.27 32.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.673 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.95 -2.75 87.17 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.699 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.811 HG11 ' CG2' ' A' ' 85' ' ' VAL . 13.2 p -78.86 135.03 26.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 117.201 0.5 . . . . 0.0 111.318 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.8 m-20 -112.41 137.69 50.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.98 -24.54 23.51 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.929 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -61.21 -33.69 73.88 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.2 mptt -70.41 -34.01 72.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.721 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 47.9 m-85 -98.26 33.33 2.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.5 66.16 8.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.123 0.487 . . . . 0.0 110.32 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.5 ptp -157.74 167.01 31.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.791 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 m -72.88 160.57 31.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.45 -42.34 95.76 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.871 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.93 68.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.76 68.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.529 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.558 HD22 HG13 ' A' ' 77' ' ' VAL . 15.4 tp -56.08 -43.62 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.085 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.8 m -67.17 -41.74 85.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.842 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -27.98 69.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.556 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 26.3 mt -63.69 -36.19 83.05 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.746 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.7 178.21 50.0 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.725 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -59.96 -53.28 59.69 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -46.66 -52.2 14.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.3 m -70.27 -41.37 73.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.443 ' HE2' HD21 ' A' ' 105' ' ' LEU . 36.6 t80 -61.79 -45.53 93.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.41 0.148 . . . . 0.0 111.232 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.45 -25.73 67.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.884 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.58 -21.6 55.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.669 0.271 . . . . 0.0 110.48 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -86.51 -39.74 15.95 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.721 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -104.2 158.37 32.08 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.21 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.677 ' HG2' HG22 ' A' ' 121' ' ' VAL . 19.2 Cg_endo -58.16 175.11 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.864 2.376 . . . . 0.0 113.17 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.66 -15.94 54.55 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.28 -55.08 2.42 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.631 -0.827 . . . . 0.0 112.902 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.705 ' CG2' ' HB1' ' A' ' 117' ' ' ALA . 2.2 m -62.19 -33.64 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.83 -35.87 54.05 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.781 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.59 -43.86 53.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.74 0.305 . . . . 0.0 111.139 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.33 -56.48 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 111.568 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.523 HD23 HG22 ' A' ' 81' ' ' VAL . 11.0 mp -58.44 -58.9 6.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -30.94 70.81 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.49 -53.44 48.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.316 0.507 . . . . 0.0 109.921 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.488 ' HA ' HD12 ' A' ' 131' ' ' ILE . 19.9 t-80 -68.79 -31.56 70.67 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.241 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.456 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 29.3 tp -58.3 -45.9 87.14 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.288 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.58 -41.81 99.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.035 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 128' ' ' HIS . 95.8 mt -55.68 -43.3 72.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.284 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.581 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.3 mt -63.36 -41.68 98.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.663 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 71.3 mt-30 . . . . . 0 N--CA 1.468 0.431 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.068 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.484 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.691 0 CA-C-O 120.377 -0.124 . . . . 0.0 112.901 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.441 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.0 t80 -95.39 -46.72 6.59 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 116.621 0.211 . . . . 0.0 110.473 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -57.05 -35.87 69.82 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.232 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 20.4 pttp -63.32 -32.88 74.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.31 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -41.3 21.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.349 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.3 mt-30 -59.85 -27.08 66.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.719 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -85.85 -38.34 18.22 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.505 0.193 . . . . 0.0 111.106 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -70.25 -33.59 71.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.475 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.9 mt -100.17 -33.79 10.3 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.32 -1.68 50.34 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.705 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 79' ' ' ASP . 56.3 mt -53.52 125.68 45.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 111.316 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 20.2 Cg_exo -65.23 173.81 5.75 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.828 2.352 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -93.02 -18.67 22.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.485 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -94.1 121.44 63.96 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.73 0.3 . . . . 0.0 111.295 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.561 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 38.5 Cg_endo -66.93 -26.99 43.52 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.075 2.517 . . . . 0.0 113.151 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 3.7 mpt_? -72.88 -33.58 66.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.601 0.239 . . . . 0.0 110.399 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.23 40.98 1.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.505 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.7 m0 -113.38 171.47 7.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.661 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.2 p -134.12 -178.38 5.01 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -50.62 -38.99 48.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.489 0.185 . . . . 0.0 111.214 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.5 m -66.61 -55.82 13.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.345 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -58.45 -39.07 78.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.161 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 81' ' ' VAL . 44.7 t -61.87 -49.52 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.554 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -74.62 -40.4 61.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.326 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -60.14 -36.25 77.11 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.506 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.505 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 15.3 t90 -71.96 -60.99 1.95 Allowed 'General case' 0 C--N 1.339 0.124 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.8 t -40.77 -53.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 123.421 0.451 . . . . 0.0 110.842 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.4 ttm -56.03 -46.33 78.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.445 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 19.1 t90 -60.93 -39.7 90.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.776 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.67 64.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.993 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 81' ' ' VAL . 77.6 t -80.22 -29.56 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.954 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -82.25 -34.41 28.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.445 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.49 -40.41 70.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -103.27 6.55 38.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.808 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.2 m 43.99 54.58 5.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.617 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.522 HD13 ' HB ' ' A' ' 121' ' ' VAL . 72.8 mt -81.23 174.12 11.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.472 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.427 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.4 OUTLIER -156.52 151.52 26.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.501 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 -8.01 78.55 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.901 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 121' ' ' VAL . 12.6 p -76.77 135.35 26.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.53 0.665 . . . . 0.0 110.911 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.79 138.34 41.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.05 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.75 -27.11 20.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.285 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.518 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 14.7 tt0 -60.48 -31.52 70.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 35.5 mmtp -65.32 -36.88 85.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.867 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 33.3 m-85 -99.82 34.28 2.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.643 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 9.6 m -87.3 69.16 9.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.194 0.521 . . . . 0.0 110.208 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.433 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.4 ptp -158.97 171.03 20.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.824 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.9 p -72.18 159.85 33.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.37 -43.5 93.81 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.54 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.39 63.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.48 -46.18 60.56 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.6 -46.18 84.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.146 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 72.6 m -64.18 -38.78 92.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 110.516 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.69 74.44 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 54.3 mt -61.54 -34.97 76.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 177.49 41.19 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.609 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.506 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.5 ttpt -62.89 -40.96 99.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.565 0.221 . . . . 0.0 110.986 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.35 -64.06 0.93 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.301 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.4 m -64.52 -37.54 87.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.06 -46.2 90.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.541 0.21 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.1 -30.29 71.36 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.673 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.4 -22.96 61.04 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.734 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 88.5 mt -85.01 -41.4 15.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.543 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.478 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -102.74 157.62 33.36 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.849 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.639 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 74.1 Cg_exo -47.14 166.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.309 2.672 . . . . 0.0 113.662 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.44 -15.01 63.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.719 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -108.25 -60.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.98 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.639 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 11.8 m -59.24 -34.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -52.85 -36.65 50.82 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.934 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.47 -49.22 67.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.447 0.165 . . . . 0.0 111.188 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.0 mt -58.92 -57.34 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.722 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -50.35 -53.94 25.24 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 4.7 t90 -66.18 -28.74 69.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.178 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.31 -51.8 68.29 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -76.45 -37.26 57.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 41.5 tp -54.22 -48.58 70.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.85 -40.73 91.97 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 64.0 mt -54.72 -46.33 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.641 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.1 mt -51.63 -36.9 47.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.126 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.561 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 64.4 mt-30 . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.393 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -89.31 -48.3 7.45 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.3 m -55.04 -38.86 68.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -57.99 -35.96 71.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.461 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -77.97 -41.38 36.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.847 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -58.58 -29.32 66.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.477 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.84 -19.27 52.43 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.416 ' HB2' HD12 ' A' ' 63' ' ' LEU . 81.6 mtt180 -77.46 -42.9 34.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 111.31 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 62' ' ' ARG . 5.7 mp -101.34 -24.73 14.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.2 11.03 53.67 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.495 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.43 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.5 mt -60.51 129.44 89.33 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.312 0.245 . . . . 0.0 111.249 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.8 Cg_endo -74.29 167.72 26.49 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.394 2.063 . . . . 0.0 112.112 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -93.52 55.61 2.25 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 111.194 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 25.1 t70 -168.14 124.84 0.86 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.602 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 22.8 Cg_exo -65.12 -44.06 10.24 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.523 2.815 . . . . 0.0 113.517 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.47 -37.19 37.2 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.252 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.471 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 10.5 pt20 -100.56 44.36 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.901 0.381 . . . . 0.0 111.377 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.595 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 7.0 m0 -119.88 169.51 10.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -132.53 179.67 5.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.99 -42.6 49.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.6 m -63.47 -49.44 73.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.527 0.203 . . . . 0.0 111.357 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.43 ' CD2' HG12 ' A' ' 65' ' ' ILE . 44.0 m170 -61.2 -41.26 96.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.009 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.75 -53.59 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -65.64 -47.96 73.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.513 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.15 -37.7 72.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 121.149 -0.22 . . . . 0.0 110.776 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.544 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 17.4 t90 -69.2 -62.02 1.55 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 85' ' ' VAL . 54.5 t -41.47 -53.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.4 ttm -55.22 -46.73 75.94 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.493 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 16.0 t90 -60.37 -38.1 82.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.91 61.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.571 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 81' ' ' VAL . 78.6 t -83.16 -33.71 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 120.67 0.271 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -82.1 -37.66 26.0 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.5 -39.04 71.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.097 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -100.48 4.81 43.94 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 m 45.38 53.8 7.9 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 121' ' ' VAL . 63.3 mt -85.34 166.55 16.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.498 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.37 152.82 33.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.82 -10.97 71.94 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.605 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.644 ' HB ' HG11 ' A' ' 121' ' ' VAL . 14.7 p -79.74 135.86 24.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 117.361 0.581 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.71 138.97 41.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.293 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.18 -27.18 23.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.755 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -61.59 -29.69 70.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 49.6 mmtm -67.02 -33.14 74.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.292 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.62 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 28.3 m-85 -100.13 32.25 3.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.709 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.35 65.63 8.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.218 0.532 . . . . 0.0 110.533 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.448 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.9 ptp -158.77 167.73 28.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.7 p -74.04 161.7 29.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -59.45 -40.28 95.96 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.38 76.87 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 110.743 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.95 64.77 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.553 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.98 -42.24 84.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.01 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.56 -42.12 92.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.539 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.65 72.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.0 mt -59.95 -33.57 72.1 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.39 177.72 48.77 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.36 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.72 -47.11 86.74 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 10.0 tp10 -50.1 -67.35 0.27 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.701 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.574 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.6 m -55.75 -40.99 73.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.704 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -62.54 -43.78 97.97 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.0 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.88 -30.84 71.85 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.679 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 14.4 mm-40 -70.33 -25.08 63.13 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.4 mt -86.92 -36.74 18.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.62 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -97.14 167.44 11.97 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.827 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 18.1 Cg_exo -67.65 174.39 7.58 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.054 2.503 . . . . 0.0 113.178 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.78 -29.92 71.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.324 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.4 -49.91 3.11 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.885 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 90' ' ' LEU . 98.9 t -59.44 -39.45 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.399 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 117' ' ' ALA . . . -52.5 -38.77 51.89 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.909 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.31 -49.22 70.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 111.054 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mt -56.95 -47.87 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.713 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.7 -59.21 4.87 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.87 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -63.34 -27.16 69.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.18 -54.97 25.2 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.945 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -71.25 -35.55 71.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.177 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.544 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.0 tp -61.02 -46.54 90.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.72 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.21 -35.63 81.45 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.126 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.67 -44.33 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.6 mt -57.22 -35.83 70.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.974 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.602 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 70.1 mt-30 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.605 0.24 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.1 ttt 72.09 -72.07 0.12 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.471 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -144.58 133.13 22.09 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.641 0.258 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 75.6 m -118.59 105.05 11.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.969 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 55.2 81.41 0.11 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -133.64 123.47 25.09 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.35 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.63 91.07 37.39 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.432 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.68 105.06 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.963 2.442 . . . . 0.0 112.904 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 mt -150.43 -67.37 0.2 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.495 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 74.4 mt -147.66 51.76 1.05 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.674 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.94 110.27 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.839 2.36 . . . . 0.0 112.173 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.9 p -145.62 151.41 38.04 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.467 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . 0.573 ' HA ' ' HE2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -59.42 -38.5 80.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.313 0.102 . . . . 0.0 111.227 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -68.03 -40.66 82.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.512 0.196 . . . . 0.0 110.788 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.573 ' HE2' ' HA ' ' A' ' 41' ' ' SEP . 74.6 mtm -65.62 -37.36 86.36 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.725 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.1 mmm -59.9 -45.32 92.91 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.801 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.5 m -67.94 -39.14 83.5 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.6 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -51.19 -52.73 41.52 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.207 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.04 -49.15 78.81 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.344 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.444 HD23 ' CZ ' ' A' ' 88' ' ' PHE . 22.0 mt -58.73 -43.12 90.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.341 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 8.3 mtpm? -61.59 -41.86 98.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.862 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.35 -30.45 57.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.418 HG22 ' CH2' ' A' ' 83' ' ' TRP . 82.6 m -67.33 -38.08 84.32 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 22.8 m-85 -45.0 -53.2 8.01 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.8 p -57.88 -33.97 69.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' HA2' ' HD2' ' A' ' 58' ' ' LYS . . . -79.55 -0.81 85.28 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.038 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.485 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.8 t80 -87.18 -55.14 3.95 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 116.932 0.366 . . . . 0.0 110.402 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.7 m -53.71 -33.35 55.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.209 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.465 ' HD2' ' HA2' ' A' ' 55' ' ' GLY . 90.0 mttt -63.93 -31.8 73.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.405 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -86.17 -39.92 16.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.302 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 46.5 mt-30 -56.43 -31.67 64.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.302 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -82.98 -33.83 26.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.731 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -69.51 -37.65 77.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.398 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.0 mt -98.27 -34.93 10.51 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.33 -0.69 31.08 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.636 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.0 mt -55.88 124.23 56.93 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 122.308 0.243 . . . . 0.0 111.078 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.1 Cg_endo -73.33 167.22 27.88 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.556 2.171 . . . . 0.0 112.467 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -76.48 -31.02 57.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.585 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.455 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 30.1 t70 -83.99 126.55 69.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.47 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 61.4 Cg_endo -72.62 -24.89 18.1 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.289 2.659 . . . . 0.0 113.869 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 6.2 mpt_? -69.29 -31.66 70.3 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.99 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 10.7 pt20 -93.97 36.74 1.1 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 111.084 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.639 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.6 m0 -103.77 166.19 10.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -134.15 179.19 6.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.01 -41.58 47.56 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.5 m -63.24 -54.14 42.06 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.274 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.482 ' CD2' HG12 ' A' ' 65' ' ' ILE . 38.0 m170 -58.54 -39.41 80.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 81' ' ' VAL . 54.4 t -62.16 -52.24 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.4 ttm105 -69.18 -47.31 65.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.27 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.22 -35.01 69.14 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.791 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 26.5 t90 -72.33 -61.67 1.71 Allowed 'General case' 0 C--N 1.338 0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.525 HG13 HD21 ' A' ' 125' ' ' LEU . 48.3 t -40.11 -52.48 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.383 0.427 . . . . 0.0 110.902 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.411 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 40.9 ttm -57.2 -47.79 80.39 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.574 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.423 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 18.8 t90 -59.96 -39.27 85.07 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.826 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.7 65.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.093 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 81' ' ' VAL . 77.9 t -76.3 -31.23 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.966 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.4 -31.98 32.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.071 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 11.0 mm-40 -70.15 -41.32 73.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.28 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.444 ' CZ ' HD23 ' A' ' 49' ' ' LEU . 88.2 m-85 -107.08 9.91 30.34 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.8 m 44.66 54.26 6.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 110.527 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 121' ' ' VAL . 62.9 mt -82.02 178.21 8.41 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.467 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.18 151.34 15.61 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.553 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.86 -8.69 77.99 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.716 ' HB ' HG21 ' A' ' 121' ' ' VAL . 12.7 p -83.44 138.7 18.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 117.543 0.672 . . . . 0.0 111.158 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -116.56 152.9 33.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -95.41 -9.85 31.59 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.409 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -63.72 -42.83 97.86 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 71.0 mmtt -65.99 -32.5 74.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.171 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 38.4 m-85 -99.5 33.45 2.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.583 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.7 t -87.69 64.7 8.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.115 0.483 . . . . 0.0 110.271 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.4 ptp -157.17 169.91 23.71 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.779 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.9 p -76.87 166.53 23.22 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.322 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.92 -43.65 96.61 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.803 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.28 -39.42 63.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.689 0.28 . . . . 0.0 110.929 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.72 -46.41 53.77 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.738 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 tp -56.06 -45.67 79.22 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.182 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.33 -41.39 85.33 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.674 0.273 . . . . 0.0 110.821 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.21 71.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.496 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.494 HD13 HD11 ' A' ' 116' ' ' LEU . 61.9 mt -60.72 -39.79 89.94 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.22 172.47 44.65 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.507 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.1 ttpt -59.06 -55.07 39.75 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -52.37 -49.9 63.46 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 98.8 m -63.58 -43.61 96.48 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.509 0.195 . . . . 0.0 111.004 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -62.97 -41.25 99.48 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.675 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.62 -27.43 68.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.721 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -76.31 -23.95 54.34 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.693 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 97.5 mt -79.94 -34.04 39.16 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.207 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -109.33 161.53 23.58 Favored Pre-proline 0 N--CA 1.462 0.137 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.243 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.651 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 68.1 Cg_exo -50.06 165.64 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.878 2.386 . . . . 0.0 113.139 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.84 -15.42 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.644 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -108.21 -61.1 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.992 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.716 HG21 ' HB ' ' A' ' 93' ' ' VAL . 12.1 m -60.43 -34.33 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.8 -36.14 40.58 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.224 -0.512 . . . . 0.0 113.129 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -65.56 -47.82 74.53 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.519 0.2 . . . . 0.0 111.313 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.26 -54.64 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.328 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.525 HD21 HG13 ' A' ' 81' ' ' VAL . 10.9 mp -53.33 -54.67 33.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.341 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.451 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 2.6 t90 -62.04 -29.92 70.62 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.11 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -60.07 -59.26 5.71 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.424 ' HA ' HD12 ' A' ' 131' ' ' ILE . 21.8 t-160 -69.54 -36.18 76.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.818 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.514 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.2 tp -61.29 -43.04 99.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.83 -33.33 74.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 128' ' ' HIS . 59.4 mt -59.18 -42.19 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.029 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.42 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 95.8 mt -57.98 -38.36 75.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.596 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -66.01 -53.91 32.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.919 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.46 -45.62 93.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.69 -41.18 98.98 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.959 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -114.33 75.59 0.94 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.323 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.22 124.33 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.25 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.234 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.472 ' ND1' HD22 ' A' ' 49' ' ' LEU . 39.8 m80 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.572 0.225 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.477 ' HG3' HG12 ' A' ' 131' ' ' ILE . 26.0 mmt 71.77 -67.92 0.24 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.325 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -83.88 153.7 23.84 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.722 0.296 . . . . 0.0 111.015 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -65.5 97.41 0.3 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.977 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.53 -52.57 0.04 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -155.71 46.67 0.49 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.07 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.76 114.37 19.63 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.175 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -86.67 151.69 8.8 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.989 2.459 . . . . 0.0 112.629 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.527 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -72.43 151.24 42.71 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 37' ' ' LEU . 1.5 tm? -92.14 89.78 7.06 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.959 0.409 . . . . 0.0 110.823 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.473 HG23 HD13 ' A' ' 36' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.83 96.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.912 2.408 . . . . 0.0 112.14 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.0 m -152.08 -174.27 4.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.872 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HB3' HD11 ' A' ' 36' ' ' LEU . 57.7 tptt -66.87 -28.19 68.14 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.383 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -75.18 -24.25 57.84 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.5 mtm -56.73 -41.45 77.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -62.88 -35.4 79.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.672 0.272 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.429 ' OG ' ' HD3' ' A' ' 50' ' ' LYS . 30.0 t -61.43 -34.8 76.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.268 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -43.82 -52.41 6.73 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.85 -43.81 66.33 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.472 HD22 ' ND1' ' A' ' 28' ' ' HIS . 7.3 mp -82.91 -35.19 26.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HD3' ' OG ' ' A' ' 46' ' ' SER . 12.8 tptt -66.09 -47.55 73.87 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.58 89.67 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.319 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.443 HG21 ' CE2' ' A' ' 88' ' ' PHE . 89.3 m -50.8 -47.92 59.77 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.192 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 27.7 m-85 -46.18 -53.72 10.01 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.351 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.2 m -62.65 -30.92 71.73 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.111 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.72 -0.75 64.57 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.712 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.529 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 17.7 t80 -94.69 -45.46 7.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 116.701 0.251 . . . . 0.0 110.338 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 95.0 m -58.3 -37.02 74.22 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.978 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 4.7 ptpp? -63.15 -30.64 71.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.298 . . . . 0.0 110.41 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.51 -40.12 23.68 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.045 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 57.1 mt-30 -56.14 -28.7 58.95 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.705 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 28.1 pt20 -88.44 -37.51 15.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.591 0.234 . . . . 0.0 110.992 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -67.25 -39.86 86.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.281 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.6 mt -98.79 -29.57 12.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.6 -1.05 49.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -52.45 123.55 29.69 Favored Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 122.348 0.259 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 58.1 Cg_endo -71.73 168.94 22.36 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.494 2.129 . . . . 0.0 112.507 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -97.21 39.74 1.18 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.225 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 5.5 t70 -144.07 114.22 5.38 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 36.8 Cg_endo -65.7 -24.59 54.86 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.799 2.333 . . . . 0.0 112.775 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.512 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 3.4 mpt_? -77.71 -31.24 52.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 11.4 mm-40 -96.77 34.92 1.6 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.935 0.397 . . . . 0.0 110.487 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.512 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 4.1 m0 -107.91 170.35 8.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.704 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.69 -177.56 4.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.242 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' HG2' ' CA ' ' A' ' 100' ' ' MET . 46.0 mt-10 -50.04 -42.81 50.33 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 m -64.34 -51.69 62.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.537 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -60.15 -42.01 93.97 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.25 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.425 HG13 HD22 ' A' ' 105' ' ' LEU . 56.0 t -60.26 -53.4 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -68.02 -46.71 70.47 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.696 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -56.49 -41.31 76.43 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.512 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.433 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.8 t90 -64.7 -61.98 1.86 Allowed 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . 55.9 t -41.12 -53.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.793 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 35.4 ttm -58.22 -48.19 81.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.77 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.529 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 15.4 t90 -56.95 -38.43 72.95 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.836 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.14 83.47 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.515 ' CG2' HG11 ' A' ' 93' ' ' VAL . 81.6 t -53.1 -34.5 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.592 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -79.65 -36.19 38.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.157 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 9.3 mm-40 -68.2 -39.43 82.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.446 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 52' ' ' THR . 97.8 m-85 -107.7 8.55 29.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 46.08 50.79 11.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 110.467 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 121' ' ' VAL . 67.6 mt -78.75 177.68 8.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.481 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.457 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.34 152.82 17.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.26 73.63 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.811 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.597 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.9 p -74.96 132.04 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 117.58 0.69 . . . . 0.0 110.873 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 7.9 m-20 -99.12 133.93 42.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.48 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.1 -23.78 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.411 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.574 ' HG3' ' HD2' ' A' ' 97' ' ' LYS . 14.1 pt20 -63.22 -33.22 75.01 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.626 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.3 mptp? -67.49 -34.94 78.18 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.999 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 38.7 m-85 -100.62 34.85 2.3 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.662 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.4 t -87.76 64.62 8.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.138 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.46 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.3 ptp -155.7 167.95 28.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.756 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -73.77 159.69 32.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.344 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -55.29 -43.51 84.41 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.961 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.66 -38.6 60.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.665 0.269 . . . . 0.0 111.037 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.02 58.96 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 77' ' ' VAL . 14.1 tp -55.79 -44.72 78.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.079 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.77 -41.76 91.65 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.777 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.25 72.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.8 mt -61.37 -36.98 81.74 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.93 176.4 51.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.678 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 52.0 tttp -61.36 -51.3 69.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -50.48 -52.33 39.15 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.4 m -66.55 -42.67 86.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 126' ' ' TRP . 59.0 t80 -63.72 -42.14 97.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.99 -29.65 70.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.717 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.67 -21.25 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.664 0.268 . . . . 0.0 110.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.6 mt -85.8 -32.59 21.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.835 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -112.4 150.91 43.32 Favored Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.626 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 85.6 Cg_exo -44.23 167.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.691 2.927 . . . . 0.0 114.079 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.95 -24.05 67.7 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.976 -1.011 . . . . 0.0 113.3 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -108.06 -49.19 3.24 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.918 -0.713 . . . . 0.0 112.524 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.626 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.2 m -63.11 -34.37 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.168 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.91 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.816 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 16.3 t70 -61.34 -45.35 94.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.577 0.227 . . . . 0.0 110.945 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.463 ' CD1' HD21 ' A' ' 90' ' ' LEU . 73.7 mt -61.98 -56.93 14.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.268 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.8 mt -55.07 -57.36 12.05 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.3 -36.1 79.14 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.335 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 123' ' ' ASP . 30.9 tt0 -56.47 -54.87 40.63 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.49 ' HA ' HD12 ' A' ' 131' ' ' ILE . 22.3 t-160 -72.47 -30.3 64.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.653 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 52.4 tp -59.59 -49.85 76.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.104 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 15.3 mm-40 -67.29 -33.69 75.83 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.222 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 128' ' ' HIS . 69.3 mt -58.64 -40.17 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.315 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.517 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.0 mt -62.39 -39.08 92.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.404 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.456 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.3 mt-30 -62.6 -50.96 69.19 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.798 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HE3' ' HA ' ' A' ' 131' ' ' ILE . 48.2 mtmt -65.89 -35.14 79.81 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.988 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -60.43 -46.68 89.16 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.809 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -148.23 111.22 4.84 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.472 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.48 -36.46 20.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.547 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.917 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.677 0.275 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.0 mtt -74.18 -61.06 1.99 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.017 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.92 -42.29 0.27 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.601 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.9 m -86.73 115.05 23.91 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.675 0.274 . . . . 0.0 110.802 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.436 ' HB3' HG23 ' A' ' 137' ' ' VAL . . . -78.74 -14.26 59.37 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.829 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.12 65.53 7.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.923 0.392 . . . . 0.0 110.599 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.0 t -140.07 128.76 13.25 Favored Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.65 156.43 49.14 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.713 2.275 . . . . 0.0 112.495 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt -122.67 75.02 1.23 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.169 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.3 tp -101.11 74.85 1.61 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.206 0.527 . . . . 0.0 110.568 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -43.9 95.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.169 2.579 . . . . 0.0 112.735 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.5 t -177.37 -165.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.339 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -64.97 -40.24 94.68 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.56 -35.83 77.94 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.514 0.197 . . . . 0.0 110.485 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.2 ttp -58.09 -32.03 67.68 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.854 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.3 mtp -61.17 -41.71 97.26 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.802 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.8 t -59.8 -46.96 87.58 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.64 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.57 -52.57 17.23 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.614 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.67 -49.75 69.88 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.9 -34.52 75.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -60.48 -42.91 97.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.595 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.32 -29.93 30.77 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.6 m -55.58 -49.44 72.72 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -101.21 41.57 1.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 47.9 m -71.8 -32.55 67.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.371 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.6 -16.81 79.8 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.804 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.7 t80 -89.01 -47.78 7.88 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 116.675 0.237 . . . . 0.0 110.779 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.9 m -55.06 -31.75 61.38 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.52 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 54' ' ' SER . 34.6 mmtp -62.19 -30.33 71.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.342 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -84.38 -42.18 15.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 31.8 mt-30 -58.33 -31.76 67.86 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.374 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -82.9 -35.73 25.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.517 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -65.86 -35.23 80.07 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.46 -32.44 9.5 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.85 4.46 39.28 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.627 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.96 127.74 69.49 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.354 0.262 . . . . 0.0 110.929 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.53 174.49 12.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.653 2.235 . . . . 0.0 112.76 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -100.84 45.95 0.96 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.373 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 5.8 m-20 -144.48 113.32 5.12 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.504 ' HG2' ' HD2' ' A' ' 70' ' ' ARG . 20.3 Cg_endo -61.77 -29.72 83.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.765 2.31 . . . . 0.0 112.823 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.504 ' HD2' ' HG2' ' A' ' 69' ' ' PRO . 5.5 mpt_? -74.47 -33.45 62.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.558 0.218 . . . . 0.0 110.495 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -95.7 35.03 1.41 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.079 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.546 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.3 m0 -109.73 160.43 16.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.4 t -127.04 -179.32 4.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.345 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.48 -49.63 44.75 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 m -58.16 -45.95 86.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.314 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -64.19 -41.68 96.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.528 HG13 HD22 ' A' ' 105' ' ' LEU . 55.8 t -62.5 -54.54 32.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.117 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -65.75 -45.49 82.38 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.55 -42.28 92.01 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.786 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.581 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 21.9 t90 -63.4 -60.33 3.51 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.624 HG13 HD21 ' A' ' 125' ' ' LEU . 40.3 t -42.19 -53.9 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.365 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.433 ' HB2' ' HE3' ' A' ' 82' ' ' MET . 37.7 ttm -56.24 -45.97 79.77 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.705 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.532 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 52.1 t90 -56.77 -36.44 69.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.88 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.91 -20.35 58.08 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.156 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.519 HG22 HG11 ' A' ' 93' ' ' VAL . 89.0 t -78.52 -34.81 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.484 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -83.35 -37.45 23.33 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.138 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 7.3 mm-40 -70.23 -36.07 74.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.309 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.7 8.78 24.91 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t 43.62 62.11 2.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.121 0.486 . . . . 0.0 110.498 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.58 HD13 ' HB ' ' A' ' 121' ' ' VAL . 59.9 mt -90.43 153.47 20.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.475 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 151.27 49.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.257 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.77 -10.62 73.09 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.707 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.583 ' HB ' HG21 ' A' ' 121' ' ' VAL . 13.8 p -79.54 139.75 17.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 117.404 0.602 . . . . 0.0 110.938 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 10.5 m-20 -117.55 144.17 45.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.212 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.25 -18.66 26.59 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.977 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.09 -36.44 81.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.041 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.0 mptt -69.24 -34.43 74.79 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.088 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.527 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 42.8 m-85 -99.96 33.5 2.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.504 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.1 t -86.88 64.29 8.41 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.219 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.449 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.7 ptp -156.45 169.32 24.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.735 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.2 m -75.81 161.5 28.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.373 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.84 -44.09 92.2 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.014 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.75 59.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.987 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.0 -44.48 63.41 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.528 HD22 HG13 ' A' ' 77' ' ' VAL . 13.9 tp -57.62 -46.64 83.84 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.271 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 41.4 t -63.92 -38.48 91.26 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 110.604 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.21 67.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.561 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 66.4 mt -64.17 -35.22 80.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.04 175.79 45.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.589 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.28 -66.62 0.37 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.4 m -58.57 -39.53 80.58 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 54.1 t80 -64.17 -45.88 86.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.493 0.187 . . . . 0.0 111.305 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.1 mt -63.09 -26.37 68.8 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.036 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -75.47 -22.63 57.09 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.603 0.24 . . . . 0.0 110.76 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -83.04 -36.26 25.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.585 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.527 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -108.39 155.27 40.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 111.601 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.665 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 76.9 Cg_exo -48.53 169.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.233 2.622 . . . . 0.0 113.775 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.89 -22.97 67.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.983 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -107.81 -57.04 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.044 -0.662 . . . . 0.0 112.364 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.665 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 6.1 m -60.24 -33.29 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.34 -32.99 57.93 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.229 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.17 -48.63 77.58 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.64 0.22 . . . . 0.0 111.422 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.547 ' CD1' HD21 ' A' ' 90' ' ' LEU . 74.0 mt -54.6 -54.48 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.493 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.624 HD21 HG13 ' A' ' 81' ' ' VAL . 10.0 mp -54.28 -59.73 4.28 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.275 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.76 -30.77 67.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.939 -0.077 . . . . 0.0 111.182 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.09 -57.75 11.66 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -73.77 -39.39 64.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.006 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.581 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.8 tp -54.08 -46.11 71.95 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.36 -35.19 75.62 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.192 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.48 -42.98 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.473 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 76.8 mt -52.14 -39.62 60.21 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.78 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -60.6 -45.81 92.61 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.823 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -69.96 -40.01 75.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.392 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -53.93 -41.31 67.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.674 0.273 . . . . 0.0 111.096 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.71 95.11 2.37 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.335 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 32' ' ' ALA . 47.6 t -75.95 92.45 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.14 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.911 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.9 p80 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.583 0.23 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.1 ttt 70.95 137.32 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.501 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -147.28 118.87 7.96 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.774 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.0 t -93.8 -56.73 2.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.309 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.32 -51.44 63.41 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.508 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.524 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 11.3 t70 -86.37 145.4 26.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.046 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -92.39 135.27 26.93 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -48.06 104.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.906 2.404 . . . . 0.0 112.796 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.3 tp -171.82 145.56 1.94 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.558 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.23 89.69 0.47 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.126 0.488 . . . . 0.0 110.683 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -43.24 118.93 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.108 2.539 . . . . 0.0 112.828 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.8 p -166.65 178.39 6.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.989 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -72.03 -39.26 69.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.825 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 6.3 tp10 -60.29 -39.17 85.96 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.721 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 58.3 mtm -78.86 -30.48 45.15 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.017 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.8 ttt -56.95 -48.83 77.41 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.088 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.0 m -83.87 -26.84 29.11 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.031 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -55.12 -52.18 64.09 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.71 0.29 . . . . 0.0 110.883 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.28 90.14 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.169 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 131' ' ' ILE . 90.6 mt -61.95 -40.24 94.87 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.74 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -70.15 -35.68 74.21 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.451 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.26 -31.21 71.39 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.618 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.5 m -58.63 -28.19 65.43 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.334 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -50.27 -28.08 7.15 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 77.7 p -52.74 -41.41 63.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.653 0.206 . . . . 0.0 111.424 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.06 -22.83 56.77 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.654 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 29.8 t80 -83.25 -50.45 8.4 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 116.453 0.126 . . . . 0.0 110.796 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.71 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 28.8 m -55.72 -40.78 72.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' HD2' ' NE2' ' A' ' 61' ' ' GLN . 32.0 mmmt -64.95 -25.17 67.76 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.713 0.292 . . . . 0.0 110.851 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.89 -48.17 8.01 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.71 ' HG2' ' HA ' ' A' ' 57' ' ' THR . 5.2 pt20 -65.95 -24.96 66.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.043 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.45 ' NE2' ' HD2' ' A' ' 58' ' ' LYS . 9.3 pt20 -79.92 -31.04 40.13 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.697 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -67.65 -30.83 70.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 110.787 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mt -100.13 -30.74 11.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.079 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.82 -1.64 27.35 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.173 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 60' ' ' GLN . 51.5 mt -60.41 128.27 87.73 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.843 0.321 . . . . 0.0 110.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 77.0 Cg_endo -78.95 175.06 11.38 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.614 2.21 . . . . 0.0 112.505 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 43.63 1.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 111.154 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 71' ' ' GLN . 11.1 m-20 -153.57 111.03 2.57 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.03 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.57 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 40.9 Cg_exo -57.42 -36.51 98.8 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.988 2.459 . . . . 0.0 112.48 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -55.4 -37.91 68.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.468 0.175 . . . . 0.0 111.105 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 68' ' ' ASP . 12.0 pt20 -99.95 44.31 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.969 0.414 . . . . 0.0 111.156 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.583 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.4 m0 -117.23 169.61 9.33 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.086 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -131.54 -177.84 4.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -51.32 -44.28 61.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.3 m -63.62 -48.59 76.7 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.628 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CD2' HG12 ' A' ' 65' ' ' ILE . 45.3 m170 -60.83 -42.13 97.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.316 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 81' ' ' VAL . 60.5 t -61.28 -52.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -68.21 -47.1 68.79 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.498 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.18 -43.18 82.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.55 0.214 . . . . 0.0 110.54 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.513 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 13.7 t90 -63.59 -62.49 1.63 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 85' ' ' VAL . 43.9 t -39.69 -51.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.422 0.451 . . . . 0.0 110.939 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 29.0 ttm -53.39 -49.8 66.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.174 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.489 ' CZ2' ' HG3' ' A' ' 87' ' ' GLU . 76.8 t90 -61.93 -42.8 99.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.92 -20.92 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.652 HG21 HG11 ' A' ' 93' ' ' VAL . 55.5 t -82.33 -31.7 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.336 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.78 -36.84 42.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.936 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 11.1 mm-40 -71.79 -39.71 69.72 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.335 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -100.94 5.27 43.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.4 m 44.88 55.2 6.23 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 110.638 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.613 HD13 ' HB ' ' A' ' 121' ' ' VAL . 86.2 mt -75.9 151.32 37.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.908 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -130.64 143.04 50.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.937 0.399 . . . . 0.0 111.623 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.4 ' C ' ' HG3' ' A' ' 118' ' ' PRO . . . 85.61 -0.44 88.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.512 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.652 HG11 HG21 ' A' ' 85' ' ' VAL . 12.6 p -74.55 132.21 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.286 0.543 . . . . 0.0 111.161 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.98 136.78 47.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.058 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.26 -29.56 20.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.397 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -59.99 -33.69 72.31 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 47.1 mmtm -66.43 -36.6 83.22 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.894 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.537 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 35.5 m-85 -97.58 34.73 1.78 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.223 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.61 66.12 8.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.388 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.461 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.6 ptp -158.43 169.08 25.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -73.54 156.48 38.09 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.227 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.583 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.07 -41.04 92.34 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.92 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.61 -39.59 65.05 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.726 0.298 . . . . 0.0 110.839 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.32 -43.49 64.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.7 tp -55.79 -44.29 77.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.002 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 86.1 m -65.62 -42.45 91.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.55 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.1 -30.05 71.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.447 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 31.6 mt -62.39 -38.83 91.14 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.882 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.07 170.8 47.37 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.474 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.8 ttpt -59.27 -47.79 84.07 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -52.67 -51.1 61.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 70.2 m -66.13 -39.64 90.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.477 0.18 . . . . 0.0 111.123 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.419 ' HE2' ' HB2' ' A' ' 125' ' ' LEU . 48.2 t80 -63.51 -41.89 98.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.857 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.64 -23.13 65.31 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.813 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.72 -22.14 50.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.4 mt -85.86 -36.58 19.89 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.249 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.541 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -110.6 154.75 42.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.184 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.719 ' HG2' HG22 ' A' ' 121' ' ' VAL . 10.1 Cg_endo -54.79 172.32 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.749 2.3 . . . . 0.0 113.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.78 -21.99 57.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.33 -53.4 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.601 -0.84 . . . . 0.0 113.251 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.719 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.0 m -59.04 -34.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.49 -36.11 52.94 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.82 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.65 -49.82 56.16 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.47 0.176 . . . . 0.0 111.09 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 124' ' ' ILE . 3.3 mp -57.43 -46.44 85.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.588 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 113' ' ' PHE . 85.0 mt -67.5 -57.16 7.01 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.32 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.52 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -60.73 -33.63 73.19 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.188 -0.205 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.18 -54.63 44.75 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -71.89 -30.01 64.94 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.459 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.513 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 43.0 tp -60.27 -50.78 72.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.069 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.8 mm-40 -66.13 -33.82 76.65 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.623 HD11 HD13 ' A' ' 49' ' ' LEU . 69.4 mt -61.68 -36.58 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.444 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.458 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.9 mt -62.96 -40.94 99.2 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 69.6 mt-30 -60.12 -53.1 61.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.471 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 131' ' ' ILE . 21.8 ptmt -65.18 -32.6 74.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.852 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.52 95.45 0.1 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.119 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 60.55 65.32 1.06 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.263 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.2 m -47.41 120.8 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.777 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.736 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.1 p80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.725 0.298 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.0 tpt 57.23 42.68 24.98 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.926 0.393 . . . . 0.0 111.04 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -90.86 -52.76 4.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.444 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 135' ' ' GLU . 45.0 t -133.09 141.01 47.96 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.86 109.08 20.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.047 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.621 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . 14.4 t70 -154.75 137.45 15.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.16 129.47 21.7 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 138' ' ' LYS . 58.0 Cg_endo -72.73 120.23 6.56 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.71 2.273 . . . . 0.0 112.04 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 41.5 tp -149.56 138.76 21.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.42 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.7 mt -90.37 80.9 6.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.479 HG22 ' O ' ' A' ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.467 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 97.2 Cg_exo -43.55 100.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.401 2.734 . . . . 0.0 112.689 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 87.7 p -174.2 -173.82 0.83 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.569 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . 0.569 ' HA ' ' HE2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.96 -40.05 79.62 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.491 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 39' ' ' PRO . 9.5 mm-40 -62.67 -38.78 91.72 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.167 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.569 ' HE2' ' HA ' ' A' ' 41' ' ' SEP . 4.7 mpp? -79.58 -28.49 41.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.571 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.9 mtp -59.01 -48.05 82.99 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.442 0.163 . . . . 0.0 110.93 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.1 m -79.57 -26.92 41.23 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.671 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -52.03 -52.1 53.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.03 -47.56 74.0 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.745 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.42 -48.34 71.75 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.534 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 96.3 mttt -70.08 -41.03 74.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.566 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.87 -39.26 91.31 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.326 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.462 HG22 ' CH2' ' A' ' 83' ' ' TRP . 26.8 m -65.15 -41.9 94.31 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.174 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 21.6 m-30 -49.93 -36.09 26.38 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -58.93 -35.27 72.83 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.439 0.161 . . . . 0.0 111.052 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.41 -8.59 85.81 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.456 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.526 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 7.9 t80 -83.91 -50.43 8.05 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 89.4 m -56.68 -36.85 70.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.55 -30.55 70.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.774 0.321 . . . . 0.0 110.303 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -84.58 -42.79 15.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.014 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 8.3 mm100 -56.96 -30.9 64.47 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.848 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -80.31 -36.69 33.94 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.478 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.57 -39.47 84.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.524 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 63' ' ' LEU . 7.4 mp -93.8 -32.24 14.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.21 -0.53 40.73 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.231 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mt -55.04 128.87 66.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 117.011 0.406 . . . . 0.0 110.913 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.87 172.82 14.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.754 2.303 . . . . 0.0 112.85 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.01 48.11 0.9 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.518 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . 12.0 m-20 -140.8 105.99 6.32 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.9 Cg_endo -62.65 -37.06 60.0 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.659 2.24 . . . . 0.0 112.423 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -70.19 -32.67 70.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 68' ' ' ASP . 2.0 mp0 -97.85 42.21 1.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.55 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -115.68 168.33 10.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 101' ' ' SER . 15.3 t -133.55 -177.03 4.36 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.562 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HG3' ' CA ' ' A' ' 100' ' ' MET . 2.6 mp0 -49.41 -46.79 47.96 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -63.27 -49.53 73.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.668 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -62.16 -43.06 99.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.688 0.28 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 105' ' ' LEU . 54.3 t -61.47 -52.53 60.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.466 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -68.8 -46.07 69.61 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.784 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.39 -38.67 71.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.547 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 12.8 t90 -66.93 -61.07 2.13 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 85' ' ' VAL . 50.9 t -41.37 -53.75 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.419 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 40.0 ttm -56.57 -46.15 80.92 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.835 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 54.3 t90 -58.32 -35.94 72.64 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.691 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.35 -21.2 60.6 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.129 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.543 ' CG2' HG11 ' A' ' 93' ' ' VAL . 84.6 t -77.83 -32.78 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.27 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -81.52 -36.66 28.94 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.036 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 10.9 mm-40 -71.27 -40.29 71.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -104.32 6.14 35.05 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.9 m 45.15 56.57 5.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 110.599 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.506 ' HB3' HG12 ' A' ' 121' ' ' VAL . 74.5 mt -82.08 169.67 16.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.36 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.1 147.98 27.73 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.358 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -8.52 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.741 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.599 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.5 p -76.4 135.85 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.418 0.609 . . . . 0.0 110.785 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.454 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 12.1 m-20 -109.82 139.16 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.392 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -89.11 -25.08 22.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.704 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -61.89 -34.48 76.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.649 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 2.0 mptm? -67.15 -35.15 79.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.068 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 35.9 m-85 -100.49 34.98 2.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.479 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.1 t -89.41 68.42 7.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.069 0.461 . . . . 0.0 110.251 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.414 ' CA ' ' HG3' ' A' ' 74' ' ' GLU . 14.4 ptp -160.66 172.97 16.16 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.788 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 72.1 m -73.43 156.59 38.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -57.91 -38.66 89.68 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.601 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.82 -39.58 71.57 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.283 . . . . 0.0 110.666 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.56 -45.02 66.23 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.404 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.424 HD22 HG13 ' A' ' 77' ' ' VAL . 15.7 tp -56.72 -44.6 81.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.031 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.1 m -64.43 -40.35 95.57 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.54 -32.15 73.67 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.305 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 60.1 mt -61.28 -36.14 79.25 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.895 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.7 176.22 48.92 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.601 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 27.5 ttpp -61.73 -46.82 88.01 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.25 -61.53 2.11 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.473 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 85.5 m -60.6 -39.33 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.438 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HE1' ' HB2' ' A' ' 125' ' ' LEU . 45.3 t80 -63.36 -43.6 97.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.833 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -66.42 -25.92 66.98 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -76.63 -21.85 54.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.725 0.297 . . . . 0.0 110.347 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.649 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 80.6 mt -86.28 -36.77 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -116.47 151.74 47.33 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.815 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.8 Cg_exo -43.02 164.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.587 2.858 . . . . 0.0 114.09 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.47 -20.2 62.88 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.053 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -108.07 -52.69 2.73 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.13 -0.628 . . . . 0.0 112.188 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' A' ' 93' ' ' VAL . 5.2 m -62.01 -37.12 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.84 -0.164 . . . . 0.0 111.335 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.77 -36.91 88.9 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.669 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.56 -47.39 78.94 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.456 HD12 HD21 ' A' ' 90' ' ' LEU . 61.0 mt -59.36 -53.73 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . 84.4 mt -55.63 -55.67 29.39 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.386 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.506 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -62.24 -28.91 70.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.04 -57.27 13.29 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.499 ' HA ' HD12 ' A' ' 131' ' ' ILE . 23.7 t-160 -70.98 -32.42 69.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.311 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.506 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 50.0 tp -57.49 -46.29 83.91 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.638 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -68.08 -33.49 74.63 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.233 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.572 ' HA ' ' CB ' ' A' ' 135' ' ' GLU . 85.1 mt -61.12 -43.19 95.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.05 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 80.2 mt -58.27 -35.31 71.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.396 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.422 ' N ' ' HG3' ' A' ' 69' ' ' PRO . 59.1 mt-30 -68.7 -71.54 0.21 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.443 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -177.78 55.79 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.954 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.572 ' CB ' ' HA ' ' A' ' 131' ' ' ILE . 28.6 tt0 -80.48 132.1 35.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.882 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -86.45 79.87 8.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.908 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.621 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 6.5 m -129.26 120.17 50.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.199 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HB2' ' HD3' ' A' ' 35' ' ' PRO . 34.9 mmtp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.834 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.4 p80 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.0 ttp 73.32 -73.35 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.711 0.405 . . . . 0.0 110.926 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -161.06 33.65 0.14 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.566 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 28.9 p -105.87 -42.22 5.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.963 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.41 96.99 6.73 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.539 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -128.94 139.59 52.04 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.17 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -80.01 132.77 59.3 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.213 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.3 104.38 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.531 2.154 . . . . 0.0 112.213 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.5 tp -174.71 106.98 0.1 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 38' ' ' TPO . 1.2 tt -164.31 131.85 3.31 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.114 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.42 ' N ' HD23 ' A' ' 37' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -47.1 98.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.398 2.732 . . . . 0.0 113.081 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.7 t -172.66 -80.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.434 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -73.85 -36.38 64.88 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.13 -40.38 95.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.425 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -84.87 -27.14 26.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.549 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 ttt -57.72 -45.45 85.75 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.244 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 80.7 p -82.36 -27.57 32.05 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.799 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -54.1 -50.66 66.34 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.31 -32.16 58.58 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.553 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.1 tp -61.99 -44.75 96.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.686 0.279 . . . . 0.0 110.84 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -65.56 -27.85 68.74 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.62 -30.46 65.8 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.6 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.4 p -80.73 -45.43 17.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.506 0.193 . . . . 0.0 111.261 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -48.07 -40.26 22.62 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.9 p -58.87 -35.17 72.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.463 0.173 . . . . 0.0 111.29 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.21 -7.39 88.49 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.837 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.484 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 14.4 t80 -99.47 -50.28 4.14 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.811 0.306 . . . . 0.0 110.645 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.8 m -55.67 -31.5 62.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.434 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -61.27 -33.69 73.97 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.674 0.273 . . . . 0.0 110.408 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.14 -38.98 23.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.324 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 33.4 mt-30 -58.24 -32.28 68.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.723 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -81.61 -36.89 28.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.796 -0.184 . . . . 0.0 111.48 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -70.76 -39.74 73.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.685 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.3 mt -98.05 -26.36 14.64 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.07 6.24 59.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.533 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 62.8 mt -54.93 122.17 39.69 Favored Pre-proline 0 N--CA 1.464 0.253 0 C-N-CA 122.305 0.242 . . . . 0.0 111.213 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 23.9 Cg_exo -63.21 169.4 9.38 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.783 2.322 . . . . 0.0 112.558 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -99.24 34.36 2.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 38.4 t70 -153.78 116.51 2.65 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 28.3 Cg_endo -61.39 -40.53 47.91 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.145 2.563 . . . . 0.0 112.479 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -54.75 -36.33 64.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.67 0.271 . . . . 0.0 110.456 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -100.15 46.37 0.96 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.762 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.538 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 7.4 m0 -122.07 174.06 7.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.505 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.1 t -132.61 -179.05 5.22 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -49.95 -42.93 49.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.3 m -64.19 -50.08 69.51 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -60.77 -40.6 93.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.544 0.211 . . . . 0.0 111.199 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 HD22 ' A' ' 105' ' ' LEU . 65.6 t -63.2 -55.54 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -64.82 -48.55 74.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.721 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -56.53 -40.1 74.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.182 -0.207 . . . . 0.0 110.576 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.1 t90 -66.12 -61.11 2.21 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 85' ' ' VAL . 53.6 t -40.74 -55.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.422 ' HG2' ' CE1' ' A' ' 95' ' ' PHE . 62.1 mtt -55.55 -47.02 77.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.527 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.2 t90 -58.01 -35.95 71.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.938 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.77 -18.41 60.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.556 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 81' ' ' VAL . 96.7 t -81.04 -34.3 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.488 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -83.81 -32.85 25.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 6.9 mm-40 -75.53 -40.55 56.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.095 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -102.21 6.12 40.51 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.946 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t 46.08 53.87 8.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 110.746 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.546 HD13 ' HB ' ' A' ' 121' ' ' VAL . 67.5 mt -81.95 169.23 17.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.118 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -152.54 148.88 27.9 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.911 0.386 . . . . 0.0 111.757 -179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.86 -7.4 81.33 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 115.848 -0.615 . . . . 0.0 113.855 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.623 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.5 p -76.74 134.48 28.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.423 0.612 . . . . 0.0 111.073 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.4 131.78 48.83 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.442 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 82' ' ' MET . 40.0 m-85 -85.07 -28.69 25.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.143 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.74 -33.33 72.76 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.5 mptm? -67.23 -34.35 77.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.123 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 51.1 m-85 -99.32 35.81 1.87 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.598 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.99 64.43 7.13 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.045 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.48 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.8 ptp -155.64 167.34 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.046 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.0 p -70.9 158.12 36.97 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.538 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.51 -42.04 93.75 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.83 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.95 64.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.719 0.295 . . . . 0.0 110.876 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.5 -44.93 63.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.571 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.448 HD22 HG13 ' A' ' 77' ' ' VAL . 18.9 tp -55.15 -44.28 75.01 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.264 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 70.8 m -66.93 -40.61 87.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.713 0.292 . . . . 0.0 110.763 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.16 67.55 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.642 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.9 mt -68.01 -38.46 82.63 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.88 176.42 51.49 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.331 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.2 ttpt -61.6 -51.22 69.4 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.76 -51.75 36.84 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.3 m -66.73 -40.93 88.54 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.445 0.164 . . . . 0.0 111.356 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 125' ' ' LEU . 32.2 t80 -62.31 -43.59 98.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.95 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.8 -25.06 66.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.831 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -76.15 -22.38 55.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 110.216 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 91.4 mt -89.07 -35.63 16.21 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.37 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' HB1' HG23 ' A' ' 121' ' ' VAL . . . -118.32 148.96 44.97 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.934 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 84.4 Cg_exo -41.89 163.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.752 2.968 . . . . 0.0 114.355 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.5 -21.49 62.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.131 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 121' ' ' VAL . 11.3 p90 -108.1 -48.63 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.374 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.623 HG21 ' HB ' ' A' ' 93' ' ' VAL . 6.2 m -64.15 -37.52 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.48 0.181 . . . . 0.0 111.168 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.02 89.59 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.831 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.96 -49.35 75.07 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.621 0.248 . . . . 0.0 110.957 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.483 HD12 HD21 ' A' ' 90' ' ' LEU . 47.7 mt -58.09 -57.33 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.0 0.428 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 90.4 mt -52.3 -59.21 4.67 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.057 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.583 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -61.74 -32.97 73.25 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.36 -56.35 21.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.236 0.471 . . . . 0.0 110.159 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.43 ' HA ' HD12 ' A' ' 131' ' ' ILE . 12.8 t-80 -68.13 -36.94 80.51 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.097 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 69' ' ' PRO . 32.9 tp -58.71 -46.51 87.18 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.474 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.16 -39.5 86.65 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 128' ' ' HIS . 88.7 mt -60.11 -41.69 87.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.177 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.6 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 85.4 mt -66.52 -37.72 85.63 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.11 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.583 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 -54.52 -41.21 69.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.249 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -57.96 -43.78 86.66 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -84.9 101.9 12.69 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.213 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.68 97.23 7.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.11 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.07 129.86 58.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.916 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.806 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.2 p80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -158.77 -60.41 0.07 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.716 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.57 -55.94 3.45 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.827 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.1 p -149.66 110.86 4.4 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.8 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.33 104.3 0.2 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.343 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -162.21 117.61 1.93 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.764 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.22 89.42 44.96 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.163 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.61 149.93 62.22 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.9 2.4 . . . . 0.0 112.246 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.6 tp -114.09 124.05 51.15 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.024 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.7 tp -161.18 87.71 0.72 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.599 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.86 147.44 74.8 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.788 2.325 . . . . 0.0 112.39 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.1 t -107.25 166.42 10.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.221 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -66.4 -40.39 89.59 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.003 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -66.43 -40.1 89.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.938 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 29.7 ttp -74.21 -38.1 63.68 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.342 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 56.3 ttp -60.39 -45.79 92.31 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.678 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.3 m -77.31 -26.42 52.21 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.254 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -45.21 -49.7 12.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.735 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.01 -44.04 87.05 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.766 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.93 -41.11 91.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.604 0.24 . . . . 0.0 110.896 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -58.51 -34.41 70.93 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.685 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.12 -51.15 25.92 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.7 m -81.25 -43.87 18.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.184 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -46.73 -46.45 20.33 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.4 p -59.43 -40.18 85.95 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -75.7 -11.5 84.46 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.792 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.428 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 9.0 t80 -99.43 -46.5 5.47 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.647 0.223 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.0 m -55.91 -34.9 66.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.626 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 55' ' ' GLY . 56.9 pttt -58.37 -39.11 78.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.129 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -41.08 40.95 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.94 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.8 mt-30 -58.53 -29.19 66.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.677 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.11 -37.6 18.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.211 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -70.18 -30.64 67.81 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.663 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.55 -36.79 6.66 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.07 -2.91 29.98 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.915 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 69.0 mt -56.29 122.9 52.21 Favored Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 116.784 0.292 . . . . 0.0 111.026 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 70.5 Cg_endo -75.27 174.8 12.18 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.461 2.107 . . . . 0.0 112.249 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.502 ' HD2' HG12 ' A' ' 137' ' ' VAL . 30.3 tttp -101.22 42.59 1.11 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.028 0.442 . . . . 0.0 110.729 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -132.7 97.76 16.98 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HG2' ' HB3' ' A' ' 133' ' ' GLN . 27.6 Cg_endo -61.66 -26.94 80.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.36 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -79.64 -37.83 35.15 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -95.21 41.7 1.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.23 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.484 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.3 m0 -111.01 172.31 6.95 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.675 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -131.82 -179.14 5.21 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.99 -43.49 60.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.3 m -63.59 -49.24 74.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.389 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -62.2 -41.16 98.1 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.186 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.527 HG13 HD22 ' A' ' 105' ' ' LEU . 67.1 t -64.06 -52.97 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.39 -46.16 77.59 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.594 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.23 -37.04 85.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.776 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.6 t90 -64.9 -65.64 0.65 Allowed 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.5 p -42.14 -46.54 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.215 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.402 ' N ' HG13 ' A' ' 81' ' ' VAL . 43.8 ttm -60.21 -45.93 91.49 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.393 . . . . 0.0 110.432 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.541 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 11.7 t90 -60.65 -37.53 81.83 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.558 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -17.06 62.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 81' ' ' VAL . 75.4 t -84.28 -32.37 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.164 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -81.55 -35.37 30.35 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.541 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.72 -40.73 55.12 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.63 7.67 43.84 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t 43.34 59.5 2.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 110.883 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.566 HD21 HD12 ' A' ' 124' ' ' ILE . 62.3 mt -89.35 171.63 9.62 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.024 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.99 148.32 23.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.947 0.403 . . . . 0.0 111.547 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.04 -9.1 78.71 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.694 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.6 p -74.23 136.86 24.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 117.39 0.595 . . . . 0.0 110.837 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.77 132.81 50.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.524 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -86.36 -24.18 25.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.371 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.31 -36.57 84.53 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 5.8 mptp? -65.38 -36.18 83.2 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.855 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.4 m-85 -98.54 32.18 2.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.381 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 46.2 t -87.29 67.65 9.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 110.25 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.8 ptp -159.73 171.38 19.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.897 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.4 p -72.33 159.45 34.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.252 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.44 -42.9 94.06 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.636 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.54 -38.74 64.09 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.695 0.283 . . . . 0.0 110.964 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.77 -47.55 58.99 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.697 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.527 HD22 HG13 ' A' ' 77' ' ' VAL . 22.3 tp -55.71 -47.21 77.26 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.389 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.51 -38.53 91.34 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.681 0.277 . . . . 0.0 110.634 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -32.31 73.97 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.409 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 58.4 mt -59.77 -34.72 73.36 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.88 173.42 45.43 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.471 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.536 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 38.9 ttpt -59.98 -45.92 91.15 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.34 0.126 . . . . 0.0 111.34 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -49.75 -65.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.19 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 93.0 m -58.07 -38.7 76.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.435 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.95 -43.43 98.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.748 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.34 -26.19 67.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 12.5 mm-40 -75.39 -22.62 57.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.77 0.319 . . . . 0.0 110.149 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -87.36 -39.61 15.17 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.46 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -111.54 150.92 42.88 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.606 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.3 Cg_exo -44.04 165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.606 2.871 . . . . 0.0 114.111 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.37 -20.14 62.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.938 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -108.53 -55.0 2.44 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.606 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.8 m -59.99 -33.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -55.73 -32.13 58.47 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.208 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -68.59 -52.52 30.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.66 0.23 . . . . 0.0 111.305 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 90' ' ' LEU . 56.3 mt -56.18 -47.11 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.714 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.12 -60.48 3.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.753 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -62.33 -28.78 69.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.622 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -67.33 -54.75 17.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.062 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.404 ' HA ' HD12 ' A' ' 131' ' ' ILE . 12.7 t-160 -66.71 -32.84 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.17 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.6 tp -63.73 -41.32 98.06 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.247 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 32.6 tt0 -70.26 -23.57 62.91 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.395 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 128' ' ' HIS . 78.0 mt -77.21 -37.49 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.887 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 95.4 mt -58.95 -47.9 83.44 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.542 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.524 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 6.7 pt20 -55.01 -37.76 67.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.542 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -76.62 -55.47 5.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.779 0.323 . . . . 0.0 111.043 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.37 100.35 12.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -118.66 126.97 53.1 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.329 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.502 HG12 ' HD2' ' A' ' 67' ' ' LYS . 10.8 p -103.66 -33.74 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.746 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.565 179.919 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.6 p80 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.488 0.185 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 63.83 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.543 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -111.35 -51.68 2.84 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.998 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 24.4 p -147.12 177.55 9.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.503 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.66 -43.74 72.64 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.752 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -131.26 111.15 11.64 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 110.948 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.59 125.69 68.62 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.005 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.67 135.55 12.99 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.754 2.303 . . . . 0.0 112.721 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 36' ' ' LEU . 7.8 mp -83.77 -49.83 8.71 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.79 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.4 mt -85.04 89.97 7.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.672 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.438 HG22 ' O ' ' A' ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.98 156.66 43.08 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.797 2.331 . . . . 0.0 112.326 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.9 p -75.32 85.85 2.49 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.032 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . 0.426 ' HA ' ' HE2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -60.7 -38.79 86.21 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.566 0.209 . . . . 0.0 111.566 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -73.76 -40.54 63.41 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.426 ' HE2' ' HA ' ' A' ' 41' ' ' SEP . 4.6 mpp? -73.25 -41.12 64.05 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.506 0.193 . . . . 0.0 111.204 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.6 ttt -61.07 -39.71 90.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.782 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.563 ' HB3' ' HG2' ' A' ' 134' ' ' LYS . 95.1 p -71.54 -33.25 68.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.702 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -48.45 -44.15 35.18 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.905 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.55 94.5 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.988 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.9 mt -58.85 -39.16 80.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.601 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HG2' ' HE3' ' A' ' 67' ' ' LYS . 26.5 tptp -68.81 -36.5 78.31 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.217 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.14 -38.38 39.0 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.2 p -58.6 -28.81 65.93 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.64 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -99.36 64.17 1.33 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.936 0.398 . . . . 0.0 110.724 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 p -67.9 -26.65 66.1 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.415 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.49 -7.38 82.78 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.761 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.421 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 16.7 t80 -95.39 -45.77 6.98 Favored 'General case' 0 CA--C 1.526 0.043 0 CA-C-N 116.735 0.267 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.2 m -56.52 -39.17 72.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.954 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -62.03 -36.1 80.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.66 0.267 . . . . 0.0 110.479 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.84 -41.13 60.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.4 mt-30 -58.04 -26.69 62.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.331 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -83.31 -31.4 26.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.186 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -71.76 -43.21 66.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 111.188 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HB2' HG13 ' A' ' 65' ' ' ILE . 36.5 mt -94.73 -25.79 16.55 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.198 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.56 1.82 61.95 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.595 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 79' ' ' ASP . 67.4 mt -49.81 126.48 18.76 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 122.525 0.33 . . . . 0.0 111.418 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 37.1 Cg_exo -60.36 170.09 4.51 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.095 2.53 . . . . 0.0 112.956 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.623 ' HE2' ' HG2' ' A' ' 135' ' ' GLU . 74.2 tttt -100.99 38.91 1.46 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 136' ' ' ASP . 38.4 t70 -163.96 122.37 1.24 Allowed Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.326 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.587 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 35.3 Cg_exo -60.25 -44.66 27.11 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.248 2.632 . . . . 0.0 112.601 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 13.5 mtt180 -53.71 -34.24 58.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.611 0.244 . . . . 0.0 110.957 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.85 42.29 1.1 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.491 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 12.9 m0 -120.74 175.94 5.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.636 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 p -137.36 -176.06 4.27 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.029 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' CA ' ' A' ' 100' ' ' MET . 46.2 mt-10 -51.77 -37.76 52.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.572 0.225 . . . . 0.0 111.188 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.4 m -67.62 -56.0 11.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.546 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -59.76 -42.72 93.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.607 0.241 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 81' ' ' VAL . 47.2 t -58.35 -47.69 87.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 5.4 tmm_? -73.24 -42.4 62.6 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.037 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 65' ' ' ILE . 1.3 m-20 -58.51 -36.82 74.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.509 0.195 . . . . 0.0 110.617 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.593 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -71.84 -62.24 1.49 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 85' ' ' VAL . 58.1 t -41.53 -51.86 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.63 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 56.9 tpp -54.06 -49.06 69.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.7 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -57.27 -38.4 73.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.108 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' PHE . . . -76.18 -18.69 58.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.513 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 81' ' ' VAL . 78.8 t -85.88 -30.48 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -86.7 -39.66 15.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.096 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.71 -34.95 62.69 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.528 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 51.3 m-85 -100.79 4.21 42.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.448 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 46.71 55.97 7.11 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 122.611 0.364 . . . . 0.0 111.506 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD13 ' HB ' ' A' ' 121' ' ' VAL . 71.8 mt -86.34 167.32 14.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.588 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.64 154.88 38.29 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 111.724 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -8.24 66.58 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.69 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.574 ' HB ' HG21 ' A' ' 121' ' ' VAL . 14.1 p -74.84 130.54 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 117.403 0.601 . . . . 0.0 111.029 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.87 130.68 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.339 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.0 -20.85 29.89 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.43 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -65.49 -33.5 76.07 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 34.9 mmtp -66.48 -35.76 81.06 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.697 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 28.8 m-85 -100.08 29.75 4.11 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.325 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.5 t -82.4 67.93 8.63 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.175 0.512 . . . . 0.0 110.328 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.406 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.2 ptp -160.75 172.2 17.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.697 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.7 p -73.28 158.65 34.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.173 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 69' ' ' PRO . . . -60.81 -37.62 93.94 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.804 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.41 72.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.684 0.278 . . . . 0.0 110.694 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -43.2 63.5 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.387 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.32 -43.76 75.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.113 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 71.2 m -67.31 -42.42 83.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.815 0.341 . . . . 0.0 110.575 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.09 67.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.669 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 64.8 mt -68.53 -31.95 71.55 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.71 174.98 49.0 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.326 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.0 ttpt -63.59 -42.52 98.25 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.571 0.185 . . . . 0.0 111.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.82 -63.37 1.17 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.511 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.8 m -59.06 -40.68 85.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.357 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.98 -43.35 99.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.02 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.49 HD12 ' HA3' ' A' ' 122' ' ' GLY . 12.0 tp -66.48 -27.15 67.57 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.632 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -75.05 -22.48 58.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.695 0.284 . . . . 0.0 110.653 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.1 mt -84.98 -32.22 23.1 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.451 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -113.04 154.2 45.11 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.608 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 77.2 Cg_exo -44.32 164.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.502 2.802 . . . . 0.0 113.901 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.1 -19.45 62.99 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.031 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.458 ' CE2' HG13 ' A' ' 121' ' ' VAL . 13.4 p90 -108.75 -51.72 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.608 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 5.8 m -62.93 -34.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.49 ' HA3' HD12 ' A' ' 114' ' ' LEU . . . -52.41 -39.74 52.79 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.95 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.54 -47.6 75.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.611 0.244 . . . . 0.0 110.967 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.78 -55.1 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.372 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.85 -57.2 13.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.505 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 5.9 t90 -60.78 -28.27 68.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.04 -57.72 11.39 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -71.99 -35.24 69.42 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.459 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.593 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.8 tp -56.78 -49.87 74.0 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.788 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.36 -36.71 84.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 70.2 mt -61.47 -45.71 98.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.177 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.8 mt -55.48 -36.84 67.05 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.052 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 68.4 mt-30 -62.9 -42.77 99.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.014 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.563 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 71.2 tttt -63.53 -34.72 78.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.716 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.623 ' HG2' ' HE2' ' A' ' 67' ' ' LYS . 0.6 OUTLIER -50.23 -48.83 54.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.724 0.297 . . . . 0.0 111.292 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 68' ' ' ASP . 8.9 m-20 -132.53 83.67 2.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.496 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.67 97.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.122 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.725 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 50.9 m80 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.733 0.301 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 51.0 tpp 64.19 -80.16 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.177 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.73 -39.14 13.34 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.835 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -69.32 147.9 50.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.703 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.55 66.38 8.12 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -144.17 172.18 13.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.976 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.17 120.7 82.43 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.613 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -56.97 106.01 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.757 2.305 . . . . 0.0 112.531 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 tp -155.52 -56.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.697 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.4 tp -96.27 84.97 3.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.768 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.5 -179.81 5.19 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.681 2.254 . . . . 0.0 112.512 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.5 t -54.61 -41.38 69.9 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.905 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -66.65 -39.84 88.42 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.656 0.265 . . . . 0.0 110.907 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -69.19 -40.39 78.09 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.684 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 41' ' ' SEP . 25.5 ptt? -74.65 -28.92 61.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.464 0.173 . . . . 0.0 111.199 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.63 -39.88 81.78 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.49 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.494 ' HA ' HD12 ' A' ' 49' ' ' LEU . 80.6 p -85.62 -27.86 25.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -51.63 -51.99 51.31 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.727 0.299 . . . . 0.0 111.205 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.28 80.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.768 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 46' ' ' SER . 74.8 mt -59.34 -38.61 80.8 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.563 0.22 . . . . 0.0 111.498 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -68.99 -36.86 78.33 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.16 -31.2 21.94 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.5 HG23 ' CD2' ' A' ' 53' ' ' PHE . 11.8 t -67.63 -29.38 68.68 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.5 ' CD2' HG23 ' A' ' 52' ' ' THR . 66.8 m-85 -102.76 55.4 0.77 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.968 0.413 . . . . 0.0 110.808 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -75.66 -24.43 56.35 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.199 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.82 -19.44 77.67 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.304 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 13.1 t80 -81.03 -49.23 11.17 Favored 'General case' 0 C--N 1.338 0.072 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.7 m -55.54 -34.0 64.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.051 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -63.97 -31.78 73.09 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.831 0.348 . . . . 0.0 110.485 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -81.18 -41.75 21.89 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.132 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 47.6 mt-30 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.791 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -83.04 -13.61 55.49 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 48.8 mtp180 -85.1 -37.38 20.34 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.66 0.267 . . . . 0.0 111.143 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 mp -105.19 -27.42 11.57 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.69 5.26 42.16 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.129 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 86.9 mt -57.14 125.23 69.85 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 116.891 0.346 . . . . 0.0 111.027 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 64.4 Cg_endo -74.65 170.45 20.29 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.375 2.05 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -75.84 -36.93 59.45 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.617 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.19 125.22 90.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-O 120.59 0.233 . . . . 0.0 111.075 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 132' ' ' LEU . 63.5 Cg_endo -74.51 -32.98 5.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.015 2.477 . . . . 0.0 113.183 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -29.06 70.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.593 0.235 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -96.56 40.48 1.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.885 0.374 . . . . 0.0 110.95 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.648 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 11.0 m0 -112.12 169.56 8.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -128.62 -178.4 4.57 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.76 -39.31 62.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.444 0.164 . . . . 0.0 111.373 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.5 m -66.81 -49.34 66.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.597 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CD2' HG12 ' A' ' 65' ' ' ILE . 47.3 m170 -61.45 -42.66 99.11 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.654 0.264 . . . . 0.0 110.965 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 81' ' ' VAL . 54.0 t -60.71 -52.64 59.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.8 ttm105 -66.92 -46.71 73.98 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.708 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.69 -40.72 88.82 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.838 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 14.3 t90 -63.43 -62.69 1.51 Allowed 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 85' ' ' VAL . 73.5 t -41.17 -49.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 55.2 tpp -55.68 -50.73 69.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.832 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -55.19 -39.9 70.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.85 -48.47 53.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.874 0.369 . . . . 0.0 110.27 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.568 ' CG2' HG11 ' A' ' 93' ' ' VAL . 79.4 t -52.85 -30.46 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.445 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -82.38 -46.92 12.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.356 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -66.39 -32.19 73.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.56 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.34 2.5 28.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.4 m 45.02 59.69 3.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.078 0.466 . . . . 0.0 110.63 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.605 HD13 ' HB ' ' A' ' 121' ' ' VAL . 71.3 mt -86.96 153.08 21.85 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.464 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 155.52 49.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.712 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.83 -7.35 59.28 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.721 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.579 ' HB ' HG21 ' A' ' 121' ' ' VAL . 13.0 p -74.62 132.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 117.315 0.557 . . . . 0.0 111.044 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -105.01 132.26 51.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.375 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.07 -25.52 24.13 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -62.0 -34.05 75.47 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.5 mmtt -66.54 -34.94 79.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.713 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 30.3 m-85 -97.97 32.94 2.24 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.43 65.13 9.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 110.209 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.7 ptp -158.9 169.81 23.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.86 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -75.43 161.59 29.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.332 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.648 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.47 -38.37 90.75 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.825 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.01 70.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.773 0.321 . . . . 0.0 110.634 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.48 -44.98 56.72 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.421 HD22 HG13 ' A' ' 77' ' ' VAL . 15.1 tp -56.06 -46.88 78.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.195 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 95.1 m -66.71 -38.75 87.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.813 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.57 69.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.436 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 57.3 mt -65.72 -32.96 74.81 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 175.39 48.75 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.459 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -62.71 -42.12 99.49 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -53.36 -63.28 1.2 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.353 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.8 m -60.85 -38.01 84.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.394 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -63.27 -45.26 92.33 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.488 0.185 . . . . 0.0 110.828 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.04 -25.86 68.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.704 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.2 -21.81 58.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.613 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 72.7 mt -87.21 -35.22 18.67 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.599 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -115.84 151.25 46.17 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.8 Cg_exo -43.05 163.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.61 2.873 . . . . 0.0 114.065 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.56 -21.3 62.4 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.193 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.81 -52.8 2.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.179 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.605 ' HB ' HD13 ' A' ' 90' ' ' LEU . 3.8 m -61.26 -37.22 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.434 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.2 74.74 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.658 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.64 -50.0 72.94 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.468 0.175 . . . . 0.0 110.884 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.547 HD12 HD21 ' A' ' 90' ' ' LEU . 64.2 mt -56.8 -55.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.431 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.28 -56.36 17.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.274 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 21.4 t90 -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.234 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.66 -54.59 43.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -73.0 -36.05 66.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.312 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.532 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.1 tp -59.08 -43.42 91.8 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.596 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -68.24 -32.84 73.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.192 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.493 HG23 HD13 ' A' ' 49' ' ' LEU . 52.9 mt -65.04 -37.71 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.502 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.8 mt -61.55 -53.6 54.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.103 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.407 ' HB3' ' HG2' ' A' ' 69' ' ' PRO . 8.8 pt20 -60.11 -38.52 83.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.855 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -72.83 -27.66 62.08 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.645 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -99.15 23.84 8.62 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.671 0.272 . . . . 0.0 111.445 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -154.22 154.84 34.17 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.727 0.298 . . . . 0.0 110.957 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 27.1 m -112.81 167.47 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 86.0 tttt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.172 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.41 ' O ' ' HD2' ' A' ' 35' ' ' PRO . 55.2 m80 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.495 0.188 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.4 mmt 57.58 90.94 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.235 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -101.71 76.54 1.66 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.957 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.6 m -138.3 -62.21 0.58 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.648 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.55 -56.09 1.9 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.708 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.65 144.07 51.03 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.569 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 56.7 t -106.44 90.65 5.05 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.51 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 34' ' ' VAL . 11.8 Cg_endo -55.03 115.78 2.67 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.952 2.435 . . . . 0.0 112.581 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.1 tp -146.77 -54.35 0.24 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.8 tt -143.99 80.78 1.66 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.57 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.91 141.32 94.26 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.884 2.39 . . . . 0.0 112.353 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.3 m -81.93 96.04 7.55 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.116 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.96 -40.13 95.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.866 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -70.96 -38.77 72.8 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.637 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 35.5 ttp -67.15 -38.2 85.1 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.692 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.7 tpt -62.4 -43.54 98.57 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.123 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.0 p -78.04 -26.34 48.33 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.188 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -48.21 -52.06 22.59 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.438 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.34 -46.23 89.65 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.403 HD22 HD13 ' A' ' 131' ' ' ILE . 95.1 mt -60.1 -44.77 94.6 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.199 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.515 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 68.4 mttm -65.01 -34.11 77.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.187 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.9 -38.29 70.01 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.735 0.302 . . . . 0.0 110.876 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.5 m -79.31 -43.93 22.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.899 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 22.9 m-30 -47.74 -45.06 28.56 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.5 p -60.36 -37.8 81.84 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.45 0.166 . . . . 0.0 111.382 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.49 -8.6 85.95 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.669 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 15.3 t80 -98.89 -47.33 5.31 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 116.598 0.199 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -55.51 -32.81 63.2 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.33 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -60.36 -32.34 71.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.415 ' N ' ' HD3' ' A' ' 58' ' ' LYS . 43.1 tt0 -82.6 -40.08 21.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 56' ' ' PHE . 11.8 mm100 -58.63 -30.99 67.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.284 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -84.93 -38.45 19.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.238 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -67.19 -40.22 86.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.678 0.275 . . . . 0.0 111.264 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 mt -96.42 -31.17 12.97 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.187 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -2.41 55.98 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.685 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.6 mt -53.62 129.26 54.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 122.291 0.236 . . . . 0.0 111.178 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.0 166.69 26.36 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.447 2.098 . . . . 0.0 112.149 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 58.7 mttp -97.06 52.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.96 0.41 . . . . 0.0 110.437 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.23 98.82 5.04 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.145 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.585 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 32.0 Cg_exo -58.38 -38.83 88.63 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.857 2.371 . . . . 0.0 112.32 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 12.1 mtt180 -66.44 -35.63 80.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -98.15 43.55 1.06 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 69' ' ' PRO . 2.0 m0 -115.02 174.75 5.82 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.267 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.7 t -133.51 -179.31 5.44 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -50.36 -44.41 54.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.5 m -63.39 -49.09 75.17 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.422 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -62.31 -41.9 98.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.234 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.508 HG13 HD22 ' A' ' 105' ' ' LEU . 56.1 t -60.37 -49.91 82.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.358 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HA ' HG12 ' A' ' 81' ' ' VAL . 70.9 ttt180 -71.43 -41.86 68.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.518 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.27 -35.57 79.4 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.485 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 19.6 t90 -69.36 -65.49 0.7 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.7 p -42.39 -46.88 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.174 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.415 ' N ' HG13 ' A' ' 81' ' ' VAL . 43.8 ttm -60.82 -47.78 84.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.407 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 17.6 t90 -55.94 -37.95 69.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.87 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.98 60.42 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.627 ' CG2' HG11 ' A' ' 93' ' ' VAL . 88.8 t -49.59 -34.0 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.244 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -79.47 -42.22 25.8 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.255 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 7.2 mm-40 -68.27 -36.28 79.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.564 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -105.63 6.6 32.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.7 m 44.36 53.36 6.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.915 0.388 . . . . 0.0 110.948 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.522 ' HB3' HG12 ' A' ' 121' ' ' VAL . 68.1 mt -80.32 166.85 20.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.513 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.87 157.83 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.63 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.98 -5.74 69.76 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.677 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' A' ' 85' ' ' VAL . 13.6 p -81.92 142.71 13.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.238 0.519 . . . . 0.0 111.338 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.5 m-20 -116.58 141.96 47.51 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -90.34 -23.58 21.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.938 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -60.6 -36.25 78.1 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.9 mptt -67.09 -35.12 79.1 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.281 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.634 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 43.1 m-85 -96.26 32.28 2.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.565 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.2 t -89.84 67.67 7.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.12 0.486 . . . . 0.0 110.193 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.5 ptp -156.56 166.59 32.96 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.5 t -69.68 157.58 36.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.49 74.36 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.634 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.17 61.42 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.669 0.271 . . . . 0.0 111.182 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.58 -48.1 61.36 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.789 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.508 HD22 HG13 ' A' ' 77' ' ' VAL . 18.8 tp -57.25 -46.29 83.16 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.162 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.9 m -64.04 -38.9 92.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.796 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.53 76.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.368 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -58.56 -36.05 73.32 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.51 176.76 49.41 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.473 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HD2' ' CZ2' ' A' ' 126' ' ' TRP . 57.5 tttp -59.67 -47.45 85.58 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 1.0 OUTLIER -50.75 -66.94 0.3 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.4 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.7 m -57.48 -37.58 73.15 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -62.41 -42.93 99.81 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.738 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -65.72 -24.49 66.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 10.5 mm-40 -74.55 -22.89 58.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.5 mt -84.11 -40.11 18.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.629 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -105.77 157.43 34.65 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.265 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.752 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.2 Cg_endo -56.71 174.26 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.685 2.257 . . . . 0.0 112.958 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -63.07 -14.39 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -107.93 -59.79 1.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.755 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.752 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -58.52 -31.25 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.04 -32.43 42.38 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.115 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.81 -46.35 53.62 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.68 0.24 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.424 HD12 HD21 ' A' ' 90' ' ' LEU . 57.0 mt -62.64 -58.64 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.743 0.306 . . . . 0.0 111.658 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.403 HD13 HG23 ' A' ' 81' ' ' VAL . 66.5 mt -51.19 -58.77 5.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.793 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.517 ' CZ2' ' HD2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.42 -31.59 71.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.288 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.1 -57.09 14.58 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.54 -29.69 66.23 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.63 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.438 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.5 tp -57.83 -49.72 75.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.783 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 13.5 mm-40 -67.78 -34.87 77.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.767 0.318 . . . . 0.0 110.316 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.403 HD13 HD22 ' A' ' 49' ' ' LEU . 80.5 mt -62.59 -37.55 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.629 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.9 -36.7 82.88 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.521 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.585 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 79.1 mt-30 -60.68 -55.68 30.37 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.316 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -55.48 -36.76 66.99 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.008 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.95 74.34 9.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.201 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -75.03 98.6 3.67 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.326 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 46.5 t -134.96 100.25 2.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.075 -179.73 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.598 0.237 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.6 mtm 61.68 75.72 0.4 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.365 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -68.31 118.96 12.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.7 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -96.93 67.96 2.29 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.984 0.421 . . . . 0.0 110.599 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.53 -54.85 0.1 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.398 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -124.71 -65.64 1.02 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 15.7 m -147.66 136.63 11.59 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.088 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 32.1 Cg_exo -58.96 140.15 94.05 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.803 2.335 . . . . 0.0 112.474 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.3 mt -138.0 104.34 5.22 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.856 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.6 mp -100.22 133.74 44.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.755 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.472 HG22 ' O ' ' A' ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.584 ' HD2' ' HD3' ' A' ' 42' ' ' LYS . 32.8 Cg_endo -64.8 179.9 1.21 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.776 2.318 . . . . 0.0 112.173 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.4 m -50.4 -48.82 55.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.525 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.584 ' HD3' ' HD2' ' A' ' 39' ' ' PRO . 37.0 mtpt -69.03 -31.48 70.31 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.368 -0.133 . . . . 0.0 111.274 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -61.81 -28.53 69.53 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.39 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.8 mtm -66.38 -30.08 70.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.027 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -57.44 -45.2 84.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.916 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.4 m -66.25 -40.35 90.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.51 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -51.95 -52.93 46.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.66 70.49 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.549 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.436 HD21 ' CD1' ' A' ' 131' ' ' ILE . 42.3 tp -56.29 -47.54 78.43 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.867 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -63.51 -40.06 96.07 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.994 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.07 -30.21 64.9 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 m -59.32 -29.03 67.33 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -97.18 37.63 1.31 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.7 t -71.11 -23.5 62.11 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.214 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . -77.28 -0.96 73.23 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.127 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.465 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 16.9 t80 -99.16 -47.06 5.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.721 0.26 . . . . 0.0 110.657 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.2 m -57.1 -37.28 71.7 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 19.9 pttp -63.21 -36.1 82.53 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.346 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -40.49 61.19 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 55.3 mt-30 -59.4 -28.09 66.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.408 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -82.87 -40.88 19.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -65.86 -41.85 91.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -89.16 -31.12 18.11 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.924 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.89 -5.87 51.04 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.617 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' A' ' 76' ' ' HIS . 85.2 mt -51.43 124.13 23.71 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-O 120.61 0.243 . . . . 0.0 110.889 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.62 171.74 16.6 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.675 2.25 . . . . 0.0 112.714 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -100.3 45.57 0.98 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -140.05 102.76 6.83 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.406 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 32.1 Cg_exo -59.06 -31.33 95.42 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.865 2.377 . . . . 0.0 112.555 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -75.98 -36.03 59.38 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -95.73 38.45 1.17 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.743 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.465 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.0 OUTLIER -108.43 170.78 7.81 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.322 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.5 p -133.24 -179.01 5.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.464 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -52.18 -40.45 61.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.8 m -64.25 -50.63 67.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.324 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CD2' HG12 ' A' ' 65' ' ' ILE . 25.4 m170 -63.42 -41.3 98.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.81 -54.83 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.109 0.48 . . . . 0.0 111.002 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -63.31 -49.52 73.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.385 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -56.77 -41.03 76.91 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.3 t90 -63.88 -61.88 2.0 Allowed 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.491 HG13 HD21 ' A' ' 125' ' ' LEU . 53.5 t -41.08 -55.36 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.775 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 30.0 ttm -57.68 -45.65 85.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.711 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.535 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 14.4 t90 -56.59 -35.84 68.68 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.933 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.2 -19.72 61.03 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.209 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 81' ' ' VAL . 58.2 t -81.37 -33.47 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.041 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -84.76 -40.26 17.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.61 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 12.2 mm-40 -72.15 -38.7 69.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.496 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -102.62 9.22 39.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t 44.71 52.87 7.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.818 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.833 HD13 HG13 ' A' ' 121' ' ' VAL . 69.4 mt -86.85 176.23 7.8 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.314 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.438 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -162.82 152.97 16.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.004 0.431 . . . . 0.0 111.745 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.49 -14.21 65.37 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.9 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.499 ' HB ' HG11 ' A' ' 121' ' ' VAL . 13.0 p -75.54 130.55 36.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.39 0.595 . . . . 0.0 110.879 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 9.4 m-20 -98.71 134.68 41.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -86.37 -26.99 24.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.474 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 15.8 mm100 -60.52 -37.58 81.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.973 0.415 . . . . 0.0 109.91 177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HD2' ' HB2' ' A' ' 94' ' ' ASP . 99.5 mttt -66.88 -29.57 69.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.51 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.465 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 50.9 m-85 -101.84 33.07 3.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.474 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 59.3 m -86.24 65.24 8.98 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.113 0.482 . . . . 0.0 110.32 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.518 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.7 ptp -153.48 165.46 35.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -74.73 164.68 26.3 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.341 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.13 -42.67 95.3 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.717 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.03 -38.33 62.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.97 55.62 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.71 -47.55 73.58 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.152 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.7 m -65.85 -38.8 89.8 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.99 -21.25 66.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.8 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 43.4 mt -71.31 -34.91 71.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.18 179.77 46.87 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.45 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.416 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 40.1 ttpt -60.92 -47.81 84.7 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -50.56 -65.15 0.61 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 94.9 m -60.53 -42.27 96.15 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 52.8 t80 -61.61 -46.35 90.21 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.281 -0.168 . . . . 0.0 111.119 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.3 mt -62.44 -31.35 72.05 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.598 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.98 -25.65 64.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.748 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 97' ' ' LYS . 65.2 mt -87.47 -31.23 20.1 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.214 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.514 ' CB ' ' HA2' ' A' ' 122' ' ' GLY . . . -99.13 166.42 13.04 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.82 0.343 . . . . 0.0 111.6 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 21.0 Cg_exo -66.59 173.5 7.75 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.095 2.53 . . . . 0.0 113.225 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.42 -28.21 69.82 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.088 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.2 -53.06 2.68 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.475 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.833 HG13 HD13 ' A' ' 90' ' ' LEU . 81.8 t -57.18 -39.55 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 117' ' ' ALA . . . -50.99 -43.48 49.43 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.15 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 12.6 m-20 -63.04 -46.09 89.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.675 0.274 . . . . 0.0 111.148 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.0 mt -57.94 -50.31 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.631 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.491 HD21 HG13 ' A' ' 81' ' ' VAL . 10.5 mp -63.95 -57.81 8.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.258 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.416 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.06 -31.73 71.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.632 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 123' ' ' ASP . 8.2 tp10 -62.75 -52.45 63.18 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.01 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.568 ' HA ' HD12 ' A' ' 131' ' ' ILE . 18.6 t-160 -71.98 -30.66 65.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.508 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.424 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 40.4 tp -62.39 -46.2 89.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.605 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 64.6 mm-40 -67.07 -33.62 75.89 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.9 mt -59.89 -42.89 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.38 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.23 -38.4 89.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.544 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.478 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 75.5 mt-30 -65.89 -49.35 68.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.158 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -66.63 -47.46 72.53 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.05 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.85 -39.77 82.28 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -126.92 77.46 1.73 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.367 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.2 m -72.69 80.3 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.246 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 mttp . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.404 -0.808 . . . . 0.0 110.724 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 48.9 t60 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.304 0.097 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.476 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 24.7 mmt 62.71 84.91 0.14 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.933 0.396 . . . . 0.0 110.652 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -74.84 -41.0 60.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.209 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.8 m -67.56 -41.36 84.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.036 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 29' ' ' MET . . . -68.0 -45.41 74.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.082 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -137.31 131.26 31.97 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.909 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.3 t -112.08 91.91 17.0 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.06 -174.94 2.4 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.577 2.185 . . . . 0.0 112.454 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.4 tp -52.3 -47.09 66.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.92 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.449 ' C ' HD12 ' A' ' 37' ' ' LEU . 3.6 pp -98.52 168.81 9.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.065 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.44 168.23 18.41 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.97 2.447 . . . . 0.0 112.806 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.6 m -96.31 98.55 10.37 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.747 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . 0.488 ' HA ' ' HE2' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -69.55 -39.98 77.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.678 0.275 . . . . 0.0 110.967 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -69.86 -40.91 75.49 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.155 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.488 ' HE2' ' HA ' ' A' ' 41' ' ' SEP . 70.9 mtm -66.87 -40.76 87.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.434 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 84.1 mmm -60.06 -41.85 93.25 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.676 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -81.79 -29.22 32.81 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.226 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -53.56 -52.04 61.01 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.156 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.5 81.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.479 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.5 mt -58.77 -43.87 90.5 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.404 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -77.07 -42.3 38.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.597 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.47 -44.69 90.26 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 m -71.46 -50.13 34.7 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 135' ' ' GLU . 9.3 m-85 -55.25 -39.34 69.64 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 74.3 m -58.12 -44.57 87.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 121.304 -0.158 . . . . 0.0 111.079 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.22 -20.74 74.82 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.36 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.446 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 11.7 t80 -77.62 -49.76 13.91 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.0 m -55.31 -32.54 62.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.399 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 54' ' ' SER . 34.7 mmtp -59.42 -33.65 71.51 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.809 0.338 . . . . 0.0 110.57 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -83.21 -41.61 18.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.865 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 43.6 mt-30 -57.66 -29.45 64.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.736 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 28.2 pt20 -83.25 -32.21 26.56 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -71.25 -40.16 71.19 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.77 -26.81 13.02 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.75 11.69 39.85 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.916 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 75.5 mt -56.94 121.22 44.24 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 120.62 0.248 . . . . 0.0 111.4 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.8 Cg_exo -68.07 170.32 14.68 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.747 2.298 . . . . 0.0 112.241 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -94.05 -4.09 50.07 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.606 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 6.5 t70 -98.5 108.24 46.77 Favored Pre-proline 0 C--O 1.232 0.175 0 CA-C-O 120.715 0.293 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.571 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 33.2 Cg_endo -63.59 -26.96 69.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.001 2.467 . . . . 0.0 112.973 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -76.53 -35.22 58.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -94.7 40.48 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.078 0.466 . . . . 0.0 110.558 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.55 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 1.2 m0 -108.51 170.35 8.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.375 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.9 p -130.96 179.69 5.84 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -39.49 58.81 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.0 m -64.24 -53.3 51.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -61.56 -39.38 90.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.009 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 81' ' ' VAL . 50.5 t -64.18 -52.13 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.136 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -66.01 -48.17 72.06 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.911 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.81 -32.13 72.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.035 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.533 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 25.7 t90 -72.58 -65.86 0.73 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.2 p -40.99 -47.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.506 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.429 ' N ' HG13 ' A' ' 81' ' ' VAL . 38.5 ttm -59.3 -48.43 81.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.819 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.423 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 87.2 t90 -61.55 -40.22 93.91 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.3 62.76 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.264 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.61 ' CG2' HG11 ' A' ' 93' ' ' VAL . 40.2 t -82.49 -31.4 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.363 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.9 -38.43 37.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 83' ' ' TRP . 11.6 mm-40 -70.27 -36.68 74.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.21 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -104.28 5.67 34.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 m 44.64 55.59 5.75 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.998 0.427 . . . . 0.0 110.779 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.557 HD21 HG13 ' A' ' 124' ' ' ILE . 83.0 mt -78.2 127.34 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.088 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -108.47 142.34 39.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.464 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 -5.72 84.42 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.756 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.61 HG11 ' CG2' ' A' ' 85' ' ' VAL . 12.5 p -76.34 137.57 22.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.298 0.549 . . . . 0.0 110.926 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -112.93 138.82 49.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.437 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -89.46 -26.02 21.17 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.598 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -60.61 -34.15 73.81 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.006 0.431 . . . . 0.0 109.916 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.8 mmmm -68.02 -34.33 76.3 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.847 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.2 m-85 -99.34 35.45 1.94 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.443 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 42.4 t -86.91 69.08 10.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.21 169.15 24.75 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.778 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -76.9 165.18 25.03 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.55 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.27 -43.19 95.66 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.103 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.11 -39.23 66.2 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.989 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.21 53.61 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.841 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.427 HD22 HG13 ' A' ' 77' ' ' VAL . 14.7 tp -56.73 -46.59 81.24 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.345 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 80.5 m -66.52 -40.66 89.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.71 0.291 . . . . 0.0 110.68 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.57 76.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.215 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.2 mt -58.82 -32.51 69.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.997 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.23 177.18 45.57 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.662 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.521 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -60.66 -45.51 93.85 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.367 0.136 . . . . 0.0 111.367 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 35.2 tt0 -50.88 -66.73 0.34 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.77 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 84.0 m -57.98 -40.16 79.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.767 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.98 -45.42 93.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.554 0.216 . . . . 0.0 111.018 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.46 -26.19 68.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.745 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 18.5 mm-40 -73.92 -24.03 59.62 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.568 0.223 . . . . 0.0 110.771 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 82.1 mt -82.39 -35.47 27.67 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.508 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -109.69 160.23 28.71 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-O 120.716 0.293 . . . . 0.0 111.62 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.674 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 50.4 Cg_exo -52.91 171.89 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.116 2.544 . . . . 0.0 113.651 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.73 -22.77 66.05 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.774 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -107.76 -58.75 1.93 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.674 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 10.9 m -62.39 -32.83 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.0 -38.51 38.77 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.599 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.49 -46.35 88.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.653 0.264 . . . . 0.0 111.007 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.557 HG13 HD21 ' A' ' 90' ' ' LEU . 50.5 mm -51.29 -51.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.132 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 69.1 mt -63.65 -57.09 11.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.418 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.521 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -61.32 -26.95 68.14 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.08 -57.27 12.2 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.473 ' HA ' HD12 ' A' ' 131' ' ' ILE . 20.8 t-160 -73.28 -35.15 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.688 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.533 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 29.7 tp -57.8 -45.63 85.79 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 1.7 tm-20 -68.29 -38.93 82.15 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 128' ' ' HIS . 66.5 mt -55.15 -45.24 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.627 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.479 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 96.2 mt -53.25 -36.31 60.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.318 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.571 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 63.5 mt-30 -61.94 -48.17 81.63 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.926 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -66.14 -35.67 81.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.563 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 131' ' ' ILE . 20.2 mm-40 -52.27 -37.33 55.18 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.622 0.248 . . . . 0.0 111.33 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.09 76.86 1.53 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.038 0.447 . . . . 0.0 110.909 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.8 m -75.8 168.03 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.352 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.865 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 111.414 0.154 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 90.4 mtp 58.9 66.66 1.02 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.035 0.445 . . . . 0.0 110.711 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.44 -45.36 13.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.957 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.9 p -112.52 124.8 53.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.624 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.07 -57.44 2.22 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.575 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -103.89 -56.91 2.12 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.268 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.43 124.43 28.55 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.203 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.32 154.68 56.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.622 2.214 . . . . 0.0 112.039 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.436 ' HB3' ' HD3' ' A' ' 134' ' ' LYS . 28.4 tp -144.76 141.73 29.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.23 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.543 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 6.5 mp -95.54 159.84 14.8 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.852 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.469 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 37' ' ' LEU . 43.8 Cg_endo -67.88 177.82 3.93 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.554 2.17 . . . . 0.0 112.446 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.2 p -50.84 -64.48 0.8 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.41 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . 0.437 ' HA ' ' HE1' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 38' ' ' TPO . 21.2 tptm -65.4 -25.73 67.68 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -38.08 74.66 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.429 0.104 . . . . 0.0 111.131 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.437 ' HE1' ' HA ' ' A' ' 41' ' ' SEP . 2.9 mpp? -56.66 -41.49 77.33 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.673 0.273 . . . . 0.0 110.552 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.7 mtp -67.76 -42.67 81.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.406 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.4 m -60.77 -34.4 74.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.696 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -49.41 -52.71 26.86 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.071 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.75 -49.86 76.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.572 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -59.44 -44.85 92.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.525 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -57.17 -39.65 75.75 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.897 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.63 -30.31 29.5 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.3 m -70.06 -33.57 72.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.439 0.162 . . . . 0.0 111.267 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -93.06 41.01 1.07 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.861 0.363 . . . . 0.0 111.389 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.3 p -76.09 -16.53 59.9 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.237 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' HA2' ' HE2' ' A' ' 58' ' ' LYS . . . -78.23 -14.11 82.58 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.803 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HB2' ' CH2' ' A' ' 83' ' ' TRP . 9.5 t80 -88.77 -51.08 5.84 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 116.745 0.273 . . . . 0.0 110.628 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 91.0 m -56.11 -42.24 76.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.112 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HE2' ' HA2' ' A' ' 55' ' ' GLY . 56.4 pttt -60.01 -33.85 72.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.734 0.302 . . . . 0.0 110.419 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -77.27 -42.89 35.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.66 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.3 mt-30 -60.66 -27.34 67.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.832 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 57' ' ' THR . 87.1 mm-40 -80.45 -14.34 58.37 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 78.6 mtt180 -85.01 -34.41 22.34 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.109 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.79 -24.56 12.89 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.72 9.94 48.25 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.073 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.451 HG12 ' CD2' ' A' ' 76' ' ' HIS . 25.9 mt -56.53 126.01 68.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.742 0.271 . . . . 0.0 111.281 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 63.6 Cg_endo -73.89 175.51 10.71 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.617 2.211 . . . . 0.0 112.361 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -98.99 39.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.517 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -148.02 110.48 3.78 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 120.543 0.211 . . . . 0.0 111.439 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 133' ' ' GLN . 34.4 Cg_exo -57.32 -37.96 96.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.181 2.587 . . . . 0.0 112.597 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -63.34 -32.94 74.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.668 0.27 . . . . 0.0 110.494 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -96.47 38.7 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.526 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -114.82 169.32 9.16 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.681 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.4 t -132.25 -177.77 4.61 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -49.31 -42.0 40.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.2 m -67.01 -50.08 63.25 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.451 ' CD2' HG12 ' A' ' 65' ' ' ILE . 37.1 m170 -61.66 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.631 0.253 . . . . 0.0 111.176 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.473 HG13 HD22 ' A' ' 105' ' ' LEU . 54.6 t -59.7 -51.73 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -71.03 -43.37 68.04 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.785 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.03 -39.45 74.82 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.58 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.541 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 20.4 t90 -68.35 -60.57 2.35 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.2 t -41.61 -55.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.647 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 38.6 ttm -55.8 -46.15 78.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.69 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CH2' ' HB2' ' A' ' 56' ' ' PHE . 14.5 t90 -57.2 -37.13 71.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.686 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.58 -18.68 62.22 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.273 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 HG11 ' A' ' 93' ' ' VAL . 24.4 t -81.9 -35.91 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.853 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -90.9 -30.36 16.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.051 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -76.67 -38.81 53.89 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.836 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -108.2 11.15 27.65 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.746 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t 45.72 57.11 5.28 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.905 0.383 . . . . 0.0 111.624 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HB3' HG12 ' A' ' 121' ' ' VAL . 70.8 mt -89.16 172.74 8.86 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -155.37 153.89 31.16 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 111.643 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.12 -6.23 80.13 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.74 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG22 ' A' ' 85' ' ' VAL . 13.2 p -78.07 133.7 29.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 117.348 0.574 . . . . 0.0 111.087 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -104.66 135.98 45.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.74 -28.33 21.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.528 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.15 -34.58 75.25 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 75.0 mmtt -66.72 -34.98 79.05 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.026 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.605 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 42.3 m-85 -100.62 34.21 2.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.386 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 37.8 t -86.94 66.51 9.46 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.119 0.485 . . . . 0.0 110.077 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.6 ptp -159.0 170.76 21.37 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.871 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.9 m -74.24 157.11 36.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -60.27 -36.36 90.62 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.925 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.2 -39.46 72.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.806 0.336 . . . . 0.0 110.645 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.28 -43.16 61.5 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.425 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.473 HD22 HG13 ' A' ' 77' ' ' VAL . 14.4 tp -56.48 -44.89 81.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.074 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.2 t -66.6 -40.22 88.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.723 0.297 . . . . 0.0 110.676 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.08 -24.28 66.68 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.749 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 39.9 mt -68.49 -35.09 77.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.79 172.11 48.56 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.329 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.491 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.8 ttpt -61.47 -48.75 79.7 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -51.47 -51.81 51.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 89.8 m -66.69 -39.65 88.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.558 0.218 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 125' ' ' LEU . 64.1 t80 -63.0 -43.72 98.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.796 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.27 -25.95 66.31 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.68 -23.53 59.84 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.639 0.257 . . . . 0.0 110.617 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 78.1 mt -85.84 -35.04 20.88 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.302 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -104.89 161.5 22.59 Favored Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.501 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.795 ' HG2' HG22 ' A' ' 121' ' ' VAL . 18.9 Cg_endo -59.42 176.12 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.748 2.298 . . . . 0.0 112.888 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.35 -12.91 59.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -108.67 -56.44 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.773 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.795 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.6 m -62.98 -31.59 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.72 -43.96 38.47 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.782 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.29 -49.36 43.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.647 0.26 . . . . 0.0 110.846 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.86 -55.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.517 HD21 HG13 ' A' ' 81' ' ' VAL . 10.3 mp -56.81 -53.08 61.96 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.753 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.491 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 17.4 t90 -61.43 -28.18 69.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -63.95 -54.84 28.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.147 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.451 ' HA ' HD12 ' A' ' 131' ' ' ILE . 22.7 t-160 -72.37 -34.33 67.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.613 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.541 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.7 tp -61.93 -45.29 94.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.623 ' HG2' ' HE2' ' A' ' 134' ' ' LYS . 31.9 tt0 -67.58 -27.73 67.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.48 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 128' ' ' HIS . 62.2 mt -68.28 -37.57 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.44 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.414 ' HB2' ' HG3' ' A' ' 69' ' ' PRO . 96.2 mt -64.67 -48.52 74.43 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.68 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.65 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 8.4 pt20 -57.13 -38.18 73.09 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.623 ' HE2' ' HG2' ' A' ' 130' ' ' GLU . 64.5 mttm -68.67 -38.46 80.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.914 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.64 130.28 36.64 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.86 90.58 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.881 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.9 m -122.02 147.15 26.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.16 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.698 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.0 m80 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 51.7 ttm -157.79 -59.7 0.08 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.749 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -139.29 96.57 3.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.57 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.5 m 59.18 44.26 16.0 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.145 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.25 100.96 5.19 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -128.36 140.81 51.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.033 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.458 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.2 m -93.36 135.15 25.79 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 23.4 Cg_exo -64.67 146.4 88.65 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.943 2.429 . . . . 0.0 112.497 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.91 100.86 1.01 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.4 mt -127.57 156.95 41.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.397 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 42' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.84 -178.97 3.81 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.811 2.341 . . . . 0.0 112.388 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.8 t -49.97 -47.79 52.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.948 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . 0.418 ' HA ' ' CE ' ' A' ' 44' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 38' ' ' TPO . 59.4 tptt -69.94 -40.02 75.75 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.784 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.86 -39.23 93.71 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.948 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.418 ' CE ' ' HA ' ' A' ' 41' ' ' SEP . 66.3 mtm -74.27 -26.71 60.37 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.142 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.4 ttt -56.71 -38.09 71.82 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.339 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 136' ' ' ASP . 24.8 t -69.37 -36.76 77.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.905 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -47.46 -52.23 17.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.565 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.34 -45.93 71.56 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.64 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.86 -45.76 82.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.776 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 21.7 ptmt -74.6 -30.52 61.71 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.629 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.94 73.34 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.4 p -56.63 -33.41 66.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.378 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -96.74 68.13 2.39 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 110.73 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -72.68 -26.42 61.61 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.442 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.8 -17.14 80.22 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.698 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.496 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.3 t80 -96.43 -49.67 5.07 Favored 'General case' 0 C--O 1.23 0.045 0 CA-C-N 116.646 0.223 . . . . 0.0 110.9 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.7 m -54.52 -33.23 59.59 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.248 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.93 -35.38 78.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 110.115 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.03 -38.89 35.43 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.952 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 25.0 mt-30 -58.98 -31.72 69.01 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.608 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -85.75 -37.06 19.74 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -71.98 -31.98 66.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 mt -105.54 -32.14 8.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.0 0.49 41.75 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.157 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 60' ' ' GLN . 48.9 mt -55.83 122.66 47.92 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.762 0.281 . . . . 0.0 110.917 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 74.4 Cg_endo -76.35 171.77 17.47 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.455 2.103 . . . . 0.0 112.648 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HE3' ' HG2' ' A' ' 135' ' ' GLU . 30.9 mtpp -98.75 45.91 1.0 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.927 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -146.17 103.31 4.09 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.068 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.6 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 51.0 Cg_exo -57.08 -46.88 25.7 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.921 2.414 . . . . 0.0 112.238 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HG2' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -57.71 -33.09 68.05 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.555 0.217 . . . . 0.0 110.805 178.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG3' ' HG2' ' A' ' 70' ' ' ARG . 46.0 mt-30 -99.98 42.04 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.186 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.635 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 2.9 m0 -115.33 170.21 8.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.363 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -130.66 -179.46 5.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.23 -43.04 52.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.5 m -62.52 -50.39 71.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.301 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -61.57 -40.74 95.83 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.159 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.49 -52.4 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.9 tmm_? -66.34 -48.74 69.29 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.482 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -60.25 -36.22 77.26 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.008 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 33.5 t90 -69.56 -65.17 0.75 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 85' ' ' VAL . 11.6 p -41.7 -47.53 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.227 0.329 . . . . 0.0 111.378 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.427 ' N ' HG13 ' A' ' 81' ' ' VAL . 60.4 tpp -59.84 -47.64 84.89 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.101 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.516 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 10.3 t90 -61.22 -38.17 85.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.988 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.45 61.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.43 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 81' ' ' VAL . 54.1 t -83.17 -32.84 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.161 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -81.16 -33.84 32.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.2 mm-40 -73.59 -39.9 64.28 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.989 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -102.19 7.49 40.87 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m 44.67 55.22 6.03 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.944 0.402 . . . . 0.0 110.976 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.626 HD13 ' HB ' ' A' ' 121' ' ' VAL . 53.4 mt -83.12 168.75 16.57 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.36 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -150.99 153.77 35.81 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.733 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.1 -7.61 63.02 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.008 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 85' ' ' VAL . 12.3 p -73.81 131.97 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 117.547 0.673 . . . . 0.0 111.167 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -99.66 131.1 45.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.105 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -86.29 -23.09 26.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.754 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -61.95 -35.7 79.24 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 6.1 mptp? -65.56 -34.27 77.86 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.32 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 36.6 m-85 -101.1 29.95 4.39 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.693 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 49.3 t -84.86 66.55 9.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.1 0.476 . . . . 0.0 110.241 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.1 ptp -158.43 171.66 19.74 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.657 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.7 m -75.92 158.26 32.23 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.175 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.635 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.57 -37.95 90.11 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.872 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.42 -39.51 67.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 110.64 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 108' ' ' LEU . . . -73.49 -46.76 46.05 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.2 tp -52.89 -47.5 67.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.323 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.71 -38.52 86.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.785 0.326 . . . . 0.0 110.492 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.85 -18.46 64.16 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.932 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 112' ' ' CYS . 41.9 mt -74.36 -28.49 61.14 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.18 169.8 42.44 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.673 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -60.58 -44.92 95.67 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -52.95 -60.79 2.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.734 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 49.8 t -59.61 -44.21 93.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.395 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -59.78 -43.34 94.42 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.973 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.48 -30.15 70.89 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.723 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.04 -21.85 60.73 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.778 0.323 . . . . 0.0 110.733 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 89.0 mt -83.65 -32.21 25.77 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.586 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . . . -112.02 154.62 44.16 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.724 0.297 . . . . 0.0 111.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.639 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 82.0 Cg_exo -45.77 167.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.398 2.732 . . . . 0.0 113.796 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.21 -21.88 66.74 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.892 -1.049 . . . . 0.0 113.087 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.422 ' CE2' HG13 ' A' ' 121' ' ' VAL . 18.9 p90 -108.63 -51.51 2.88 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.639 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 9.9 m -61.69 -35.76 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.39 -35.1 49.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.238 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -63.11 -49.91 72.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.706 0.253 . . . . 0.0 111.202 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.535 HD12 HD21 ' A' ' 90' ' ' LEU . 74.1 mt -60.16 -53.33 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.565 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -52.62 -58.1 7.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.278 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 1.4 t90 -64.74 -25.45 67.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.427 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.51 -56.69 17.29 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.423 ' HA ' HD12 ' A' ' 131' ' ' ILE . 21.9 t-160 -73.17 -36.63 66.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.523 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.55 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 37.9 tp -57.23 -45.16 84.14 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.22 -36.42 79.48 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.56 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 128' ' ' HIS . 64.8 mt -58.31 -41.51 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.698 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.507 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 86.7 mt -57.22 -37.37 72.14 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.683 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.6 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 45.4 mt-30 -68.31 -46.84 69.19 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.164 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -90.04 31.54 0.97 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.732 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.468 ' HG2' ' HE3' ' A' ' 67' ' ' LYS . 19.0 tp10 -63.54 -56.97 11.83 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.519 0.199 . . . . 0.0 111.002 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 46' ' ' SER . 3.7 t70 -176.84 111.54 0.09 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.985 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.8 m -131.53 150.88 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.387 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.421 ' HA ' ' HB ' ' A' ' 38' ' ' TPO . 65.6 tttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.161 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.461 ' CD2' ' HB2' ' A' ' 32' ' ' ALA . 14.4 p80 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.721 0.296 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.416 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 53.9 ttm -93.04 -63.02 1.27 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.091 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 29' ' ' MET . 41.6 mt-10 -121.7 -57.43 1.81 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.234 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.2 t -105.94 128.57 53.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.006 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' HB2' ' CD2' ' A' ' 28' ' ' HIS . . . -91.97 -49.85 6.01 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.152 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.17 139.69 39.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 26.9 m -85.83 133.69 40.98 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.152 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 24.5 Cg_exo -63.57 139.18 68.69 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.852 2.368 . . . . 0.0 112.33 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.0 mt -139.41 142.73 37.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.186 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.8 tp -91.34 125.22 36.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.592 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.97 166.97 26.07 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.785 2.323 . . . . 0.0 112.237 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.8 p -66.72 129.39 39.7 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.164 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.488 ' O ' ' HE2' ' A' ' 45' ' ' MET . 39.2 mmtm -80.26 -21.16 43.02 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.629 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 31.9 mt-10 -75.31 -32.72 61.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.434 0.159 . . . . 0.0 110.952 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 73.1 mtm -64.62 -26.77 68.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.54 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.488 ' HE2' ' O ' ' A' ' 42' ' ' LYS . 69.5 mtm -56.22 -32.1 64.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 49' ' ' LEU . 66.5 m -52.24 -37.79 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.574 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.401 ' HA ' ' CE ' ' A' ' 50' ' ' LYS . 48.9 mt-30 -51.35 -52.31 46.67 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.463 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.57 -28.84 41.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.444 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.588 HD13 ' CG2' ' A' ' 131' ' ' ILE . 62.4 mt -61.67 -32.44 72.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.565 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' CE ' ' HA ' ' A' ' 47' ' ' GLN . 49.5 mtmt -64.54 -27.44 68.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.613 0.244 . . . . 0.0 111.094 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.33 -30.65 16.45 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.474 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.1 p -71.14 -32.04 68.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.396 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -88.9 74.41 8.22 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.019 0.438 . . . . 0.0 110.775 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -72.77 -24.17 60.91 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.116 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.69 -16.61 72.67 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.735 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 15.1 t80 -96.42 -53.73 3.5 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 116.697 0.249 . . . . 0.0 110.864 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.6 m -54.7 -33.66 61.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.402 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 14.7 ptmm? -62.15 -31.27 71.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.856 0.36 . . . . 0.0 110.569 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -83.3 -39.3 20.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.087 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 28.4 mt-30 -58.29 -28.32 64.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.455 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 29.1 pt20 -84.78 -37.03 21.3 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.564 0.221 . . . . 0.0 110.962 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -65.06 -42.95 93.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 33.7 mt -99.14 -29.33 12.92 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.29 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.66 6.66 54.51 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.564 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.56 119.21 14.8 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 122.31 0.244 . . . . 0.0 111.283 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.14 166.93 13.43 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.739 2.293 . . . . 0.0 112.386 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -98.92 41.07 1.16 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.725 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -156.28 125.15 3.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 132' ' ' LEU . 38.2 Cg_endo -67.59 -37.73 16.04 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.089 2.526 . . . . 0.0 113.02 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.442 ' HD3' ' HG2' ' A' ' 69' ' ' PRO . 1.5 mpp_? -61.91 -33.06 73.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.519 0.199 . . . . 0.0 110.763 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.37 41.92 1.13 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.932 0.396 . . . . 0.0 110.843 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.595 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 4.9 m0 -119.8 170.05 9.58 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.509 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -133.59 -178.86 5.19 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -49.87 -43.31 49.11 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -63.1 -49.64 73.65 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.335 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -61.67 -41.6 97.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.156 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.605 HG13 HD22 ' A' ' 105' ' ' LEU . 64.8 t -62.35 -56.14 19.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.19 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 7.0 tmm_? -64.08 -46.97 81.94 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.347 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.1 -43.21 99.24 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.724 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 22.0 t90 -61.13 -62.93 1.49 Allowed 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 85' ' ' VAL . 55.8 t -40.91 -49.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.791 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.403 ' HE3' ' HB2' ' A' ' 82' ' ' MET . 29.9 ttm -58.17 -45.02 88.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.788 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.595 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 17.3 t90 -59.26 -37.82 78.56 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.68 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.52 -20.28 61.37 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.173 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 81' ' ' VAL . 69.7 t -81.35 -32.07 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.188 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -83.7 -35.48 24.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.134 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.595 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.1 mm-40 -73.04 -40.13 65.37 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.84 10.78 36.33 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.916 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p 41.83 51.72 4.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.978 0.418 . . . . 0.0 111.183 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.432 ' HB3' HG12 ' A' ' 121' ' ' VAL . 79.5 mt -80.11 171.25 15.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.6 OUTLIER -155.08 160.35 40.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.199 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.06 -7.88 58.85 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.783 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.549 ' HB ' HG21 ' A' ' 121' ' ' VAL . 11.4 p -79.9 131.61 33.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 117.497 0.648 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -103.53 139.47 38.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.3 -25.33 21.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -61.59 -30.65 70.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 29.9 mmmt -68.41 -34.59 76.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.872 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 40.6 m-85 -101.52 32.4 3.35 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.189 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.1 t -84.07 67.51 9.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.127 0.489 . . . . 0.0 110.232 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.428 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.6 ptp -157.42 168.56 26.98 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.804 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -73.3 161.02 30.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.336 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -56.37 -44.79 89.78 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.866 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.8 63.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.656 0.265 . . . . 0.0 110.836 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.55 61.77 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.681 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.605 HD22 HG13 ' A' ' 77' ' ' VAL . 16.2 tp -55.95 -47.51 77.45 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.182 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.41 -38.77 85.15 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.799 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.66 67.64 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.794 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 30.6 mt -67.67 -30.53 70.09 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 77.86 173.48 40.82 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.628 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.6 ttpt -59.18 -46.81 87.44 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.087 0.155 . . . . 0.0 111.263 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.49 -64.74 0.71 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.894 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 97.7 m -61.02 -40.78 94.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -60.19 -46.83 88.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.459 0.171 . . . . 0.0 111.23 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.83 -28.51 69.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.838 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.28 -20.69 60.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.89 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 69.2 mt -87.24 -35.49 18.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.791 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.604 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -111.93 159.52 33.24 Favored Pre-proline 0 N--CA 1.465 0.287 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.741 ' HG2' HG22 ' A' ' 121' ' ' VAL . 10.2 Cg_endo -56.3 172.59 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.673 2.249 . . . . 0.0 113.213 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.04 -19.03 60.89 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -108.66 -50.63 2.99 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.741 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -63.02 -34.2 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.532 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -54.36 -39.43 65.13 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.801 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -68.53 -48.18 65.0 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 120.628 0.251 . . . . 0.0 110.93 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.33 -55.52 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.41 ' HB3' ' CH2' ' A' ' 80' ' ' TRP . 92.7 mt -57.73 -59.93 4.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.188 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.517 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -61.47 -28.58 69.39 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.36 -52.54 26.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.298 0.499 . . . . 0.0 110.088 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.404 ' HA ' HD12 ' A' ' 131' ' ' ILE . 18.4 t-160 -67.61 -34.42 76.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.508 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 28.7 tp -64.28 -39.39 93.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.972 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' A' ' 133' ' ' GLN . 34.9 tt0 -67.21 -29.12 68.7 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.182 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.588 ' CG2' HD13 ' A' ' 49' ' ' LEU . 51.6 mt -67.86 -35.65 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.571 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.593 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 99.1 mt -68.63 -40.87 80.11 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.563 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.503 ' HB3' ' CG ' ' A' ' 69' ' ' PRO . 9.4 pt20 -68.5 -47.44 67.0 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 43' ' ' GLU . 19.8 ptpt -58.58 -21.7 53.79 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.75 -42.09 67.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.622 0.249 . . . . 0.0 111.317 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -133.23 -171.41 2.68 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.082 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.33 -55.82 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.292 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.947 -179.658 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.6 p80 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mpp? 67.69 -80.6 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.756 0.422 . . . . 0.0 111.184 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -115.57 -57.6 2.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.642 0.258 . . . . 0.0 110.55 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 77.0 m -94.39 132.71 38.73 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.509 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.73 145.31 24.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.532 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -61.88 111.75 2.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.9 t -70.39 113.47 18.43 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.212 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -91.42 135.67 1.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.054 2.503 . . . . 0.0 112.565 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.77 HD22 ' HG3' ' A' ' 130' ' ' GLU . 21.8 tp -158.49 -67.78 0.09 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.924 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.9 tp -161.88 81.72 0.57 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.716 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.596 HG22 ' O ' ' A' ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 71.2 Cg_endo -73.59 -178.64 3.86 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.915 2.41 . . . . 0.0 112.699 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.9 t -98.12 -75.48 0.55 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.768 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 39' ' ' PRO . 59.4 mtpt -76.36 -17.86 59.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.746 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 39' ' ' PRO . 4.9 tp10 -57.44 -22.85 46.04 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -30.55 62.57 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -72.91 -39.91 65.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.951 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.4 t -69.8 -26.63 64.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.281 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -45.25 -52.3 9.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.786 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.68 -45.22 85.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.429 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.07 -40.46 94.71 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.96 -40.47 97.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.066 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.39 -36.14 66.09 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.69 0.281 . . . . 0.0 111.268 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.6 m -62.83 -34.1 76.62 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.341 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -83.67 11.92 6.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.6 m -66.69 -19.85 65.85 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.372 0.129 . . . . 0.0 111.006 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.423 ' CA ' ' HE3' ' A' ' 58' ' ' LYS . . . -76.08 -0.71 66.2 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.814 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.9 t80 -95.21 -45.42 7.19 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m -57.61 -37.27 72.96 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 20.6 pttp -63.35 -32.79 74.3 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.747 0.308 . . . . 0.0 110.625 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -82.84 -38.98 22.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 56.6 mt-30 -57.7 -27.43 62.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.82 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 30.1 pt20 -85.11 -34.64 22.15 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 110.959 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -73.05 -33.67 65.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.581 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 50.3 mt -101.53 -30.84 11.17 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.701 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.18 -1.99 56.38 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.701 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.645 HD11 ' HB3' ' A' ' 79' ' ' ASP . 54.7 mt -55.55 122.05 42.43 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.73 0.265 . . . . 0.0 111.203 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 16.4 Cg_exo -68.13 177.83 4.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.834 2.356 . . . . 0.0 112.252 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -108.47 31.57 5.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.73 98.85 27.27 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.273 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.55 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 32.9 Cg_exo -61.35 -27.03 82.42 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.919 2.413 . . . . 0.0 112.907 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -78.65 -38.38 39.66 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -96.57 39.32 1.17 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.667 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -107.18 175.61 5.44 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.351 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -135.66 -179.56 5.72 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -50.55 -43.79 56.28 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -62.43 -53.39 55.55 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -58.49 -40.71 83.52 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.24 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 81' ' ' VAL . 60.3 t -62.7 -51.52 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.659 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -64.12 -53.86 42.95 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.352 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.645 ' HB3' HD11 ' A' ' 65' ' ' ILE . 1.2 m-20 -55.99 -35.21 66.51 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.375 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.519 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 29.9 t90 -70.34 -63.24 1.12 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 85' ' ' VAL . 79.3 t -40.51 -54.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.435 ' HG2' ' CE1' ' A' ' 95' ' ' PHE . 63.5 mtt -55.53 -47.41 76.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.564 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 7.0 t90 -55.8 -37.83 69.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 -18.56 61.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.523 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.603 HG22 HG11 ' A' ' 93' ' ' VAL . 47.5 t -79.26 -35.12 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.575 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.54 -31.71 24.26 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.386 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.564 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.9 mm-40 -75.78 -40.66 54.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.66 0.267 . . . . 0.0 111.102 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -103.09 6.22 38.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t 45.67 55.58 6.65 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.013 0.435 . . . . 0.0 110.452 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.578 ' HB3' HG12 ' A' ' 121' ' ' VAL . 64.4 mt -81.92 174.28 11.43 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.457 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.446 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -155.07 146.92 23.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.457 -179.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.07 81.3 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.739 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG22 ' A' ' 85' ' ' VAL . 14.7 p -71.98 128.19 34.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 117.472 0.636 . . . . 0.0 110.917 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.463 ' CB ' ' HD3' ' A' ' 97' ' ' LYS . 11.1 m-20 -98.8 128.68 45.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' ' HG2' ' A' ' 82' ' ' MET . 39.4 m-85 -86.31 -25.97 25.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.463 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.466 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 30.1 mm-40 -63.9 -34.33 77.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 14.1 mptt -67.05 -33.5 75.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.189 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 48.6 m-85 -98.28 33.14 2.27 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 37.2 m -88.49 67.19 8.5 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.041 0.448 . . . . 0.0 110.346 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.524 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.8 ptp -157.08 168.41 27.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.855 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -73.29 158.69 34.64 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.98 -43.93 87.91 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.743 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.23 62.79 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.718 0.294 . . . . 0.0 110.872 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.98 62.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.562 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.3 tp -55.95 -46.75 78.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.264 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.4 t -65.21 -40.85 94.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.716 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -26.17 67.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.654 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.588 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 38.6 mt -65.27 -37.61 87.74 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.09 172.95 49.47 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.331 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 39.0 ttpt -60.76 -47.2 87.38 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -53.38 -51.69 61.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 96.8 m -67.19 -39.51 86.38 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.442 0.163 . . . . 0.0 111.23 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -63.42 -43.1 98.44 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.687 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.93 -24.15 66.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.823 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.87 -23.62 48.75 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.454 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 95.9 mt -83.62 -36.68 23.69 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.35 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.607 ' HB1' ' CG2' ' A' ' 121' ' ' VAL . . . -108.29 157.79 35.46 Favored Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.782 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.0 Cg_endo -56.7 176.82 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.787 2.325 . . . . 0.0 112.978 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.51 -15.63 61.18 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.29 -57.47 2.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.706 -0.798 . . . . 0.0 112.949 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.782 HG22 ' HG2' ' A' ' 118' ' ' PRO . 2.5 m -59.17 -33.69 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.75 -34.51 50.85 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.776 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.07 -50.05 21.35 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.419 0.152 . . . . 0.0 110.987 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -57.12 -57.65 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.1 mt -51.68 -58.97 4.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.905 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -61.33 -31.03 70.89 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.559 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.19 -55.5 27.96 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.056 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -70.89 -32.41 69.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.441 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.519 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 45.1 tp -59.11 -49.59 77.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.77 ' HG3' HD22 ' A' ' 36' ' ' LEU . 12.6 tp10 -65.65 -33.91 76.98 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.485 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.519 ' HA ' ' HE2' ' A' ' 134' ' ' LYS . 67.5 mt -61.69 -39.03 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.425 ' HB2' ' HG3' ' A' ' 69' ' ' PRO . 86.2 mt -64.4 -35.69 81.72 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.777 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.55 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 66.7 mt-30 -64.82 -54.38 32.1 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.418 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.721 ' HD3' HD23 ' A' ' 36' ' ' LEU . 55.6 pttt -57.94 -38.19 75.51 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.435 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.14 -52.91 56.8 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.459 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -82.76 113.06 20.16 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.91 0.386 . . . . 0.0 111.066 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.8 m -120.68 39.92 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.119 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 138' ' ' LYS . 2.7 mptp? . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.177 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' A' ' 29' ' ' MET . 66.8 t60 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.338 0.113 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.422 ' HB3' ' O ' ' A' ' 28' ' ' HIS . 28.1 ttt 73.34 -68.8 0.21 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.487 0.492 . . . . 0.0 111.095 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.46 165.17 31.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.5 t -84.65 63.23 7.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.113 0.483 . . . . 0.0 110.45 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.47 -49.26 0.02 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.848 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -139.89 140.11 36.38 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.021 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' A' ' 35' ' ' PRO . 34.5 m -78.83 156.15 77.56 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.956 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 34' ' ' VAL . 23.8 Cg_endo -61.56 103.94 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.566 2.177 . . . . 0.0 112.092 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.4 tp 177.81 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.603 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 37' ' ' LEU . 6.6 mp -81.87 178.2 8.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.439 HG22 ' O ' ' A' ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.81 147.92 22.03 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.533 2.155 . . . . 0.0 112.225 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.9 m -103.52 68.77 0.96 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 111.285 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -62.01 -40.07 94.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.863 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -73.26 -37.43 66.31 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.08 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.2 ttp -67.48 -44.24 79.04 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.112 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 92.3 mtp -61.02 -43.89 98.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.373 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.3 p -75.89 -26.92 57.46 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -47.86 -49.41 29.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.339 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.34 -44.62 95.37 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.486 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.6 mp -61.58 -44.0 97.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.971 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.408 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 90.3 mttt -62.75 -41.48 99.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.41 80.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.416 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.8 m -67.12 -44.19 80.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.421 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 21.8 m-85 -45.95 -61.33 1.79 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.9 t -60.38 -39.72 88.29 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.05 -9.85 76.91 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.222 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.589 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 8.5 t80 -101.52 -38.11 8.11 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.823 0.312 . . . . 0.0 110.986 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.0 m -65.25 -24.56 67.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.194 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -74.66 -36.21 62.82 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.786 -0.188 . . . . 0.0 111.003 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -83.6 -31.68 26.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.667 179.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 54.9 mt-30 -61.32 -29.16 69.71 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.5 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 58' ' ' LYS . 29.8 pt20 -85.68 -39.5 17.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.521 0.2 . . . . 0.0 111.132 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -71.49 -33.23 69.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.443 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.441 HD13 ' OD1' ' A' ' 79' ' ' ASP . 12.5 mt -99.3 -34.7 10.21 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.638 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.67 -5.0 53.97 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.569 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 85.4 mt -50.74 122.92 17.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 122.522 0.329 . . . . 0.0 111.483 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 22.9 Cg_exo -64.79 172.23 7.33 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.093 2.528 . . . . 0.0 112.719 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' HD3' ' HG2' ' A' ' 135' ' ' GLU . 40.0 ttmt -93.08 -12.17 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.339 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 14.5 t70 -104.12 122.77 43.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.884 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.547 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 41.8 Cg_endo -67.51 -24.99 41.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.05 2.5 . . . . 0.0 113.405 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 5.9 mpt_? -70.27 -32.27 70.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.145 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 27.3 pt20 -93.78 24.7 3.98 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.654 0.264 . . . . 0.0 111.213 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.466 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 10.3 m0 -97.69 169.96 9.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.211 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.6 p -136.9 -174.55 3.76 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.55 -36.73 62.16 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.473 0.178 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.2 m -68.17 -52.85 29.88 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.349 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -60.79 -39.72 89.95 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.678 0.275 . . . . 0.0 111.12 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.95 -52.47 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -67.5 -47.75 69.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.376 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD1' HD13 ' A' ' 63' ' ' LEU . 10.1 t70 -61.41 -34.65 75.73 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.678 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -66.87 -65.16 0.72 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.3 p -42.87 -45.41 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.097 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 51.8 tpp -58.54 -48.13 81.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -59.18 -38.84 80.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.638 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.5 -20.89 62.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.335 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 81' ' ' VAL . 62.5 t -82.16 -32.39 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.469 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -82.03 -36.92 27.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.096 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.82 -38.45 67.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.262 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.61 6.31 39.67 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m 44.97 56.4 5.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.092 0.472 . . . . 0.0 110.768 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.544 ' HB3' HG12 ' A' ' 121' ' ' VAL . 77.0 mt -85.19 172.78 10.91 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 153.59 29.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.323 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.26 77.32 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.828 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.619 ' HB ' HG21 ' A' ' 121' ' ' VAL . 11.1 p -77.97 132.58 32.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 117.416 0.608 . . . . 0.0 111.118 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 97' ' ' LYS . 29.0 t70 -102.56 136.53 42.23 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.737 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -89.22 -23.45 22.36 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.446 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.75 -31.45 72.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 74.5 mmtt -68.11 -35.46 78.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.876 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.543 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 33.7 m-85 -100.17 34.59 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 t -90.26 68.9 7.06 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.024 0.44 . . . . 0.0 110.285 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.466 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.7 ptp -157.78 170.9 21.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.239 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 t -72.12 160.5 32.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.278 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.06 -48.5 79.04 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.62 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.76 -37.48 51.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.647 0.261 . . . . 0.0 111.181 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.46 -45.79 65.07 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 tp -56.72 -44.67 81.84 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 81.3 m -66.48 -39.49 88.8 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.825 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.9 73.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.479 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 48.2 mt -60.46 -37.92 82.54 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.807 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.72 175.92 50.69 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.662 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HD3' ' CZ2' ' A' ' 126' ' ' TRP . 26.2 ttpp -59.85 -53.86 52.95 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 10.6 pt-20 -48.84 -51.87 27.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.1 m -67.51 -41.77 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.436 ' HE1' ' HB2' ' A' ' 125' ' ' LEU . 50.4 t80 -62.53 -44.91 95.18 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.06 -28.95 70.13 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.941 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 19.3 mm-40 -73.08 -23.68 60.58 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.638 0.256 . . . . 0.0 110.807 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 76.9 mt -83.29 -34.73 25.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.52 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.598 ' HB1' HG23 ' A' ' 121' ' ' VAL . . . -104.99 158.12 32.73 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.471 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.798 ' HG2' HG22 ' A' ' 121' ' ' VAL . 12.5 Cg_endo -57.43 176.88 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.778 2.318 . . . . 0.0 112.927 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.75 -14.77 60.06 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.16 -59.01 1.95 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.913 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 118' ' ' PRO . 3.0 m -58.76 -32.33 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.34 -33.48 46.55 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.1 -45.86 46.41 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.497 0.189 . . . . 0.0 111.27 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.401 HD12 HD21 ' A' ' 90' ' ' LEU . 50.3 mt -63.64 -60.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.539 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.436 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . 71.6 mt -49.74 -56.82 8.8 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.085 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.474 ' CZ2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -63.7 -34.28 77.52 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.16 -55.51 32.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.579 ' HA ' HD12 ' A' ' 131' ' ' ILE . 17.9 t-160 -71.14 -31.35 67.61 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 34.3 tp -57.93 -46.07 85.59 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 126' ' ' TRP . 14.0 mm-40 -70.32 -32.4 70.12 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.377 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 128' ' ' HIS . 76.8 mt -60.96 -39.42 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.491 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 93.7 mt -60.77 -33.62 73.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.76 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.534 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 76.3 mt-30 -65.98 -57.43 7.83 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.032 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -65.06 -32.69 74.53 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.681 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.477 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 42.8 tt0 -71.63 -38.0 70.8 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.397 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -151.77 112.53 4.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.793 0.33 . . . . 0.0 110.704 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.39 -27.61 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.772 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.042 -179.752 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 32' ' ' ALA . 40.9 t60 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.46 0.172 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.5 mmt 64.59 -82.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.37 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -145.5 110.02 5.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.641 0.257 . . . . 0.0 111.098 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.3 m 58.14 88.97 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.697 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 28' ' ' HIS . . . -107.33 87.48 2.51 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.77 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -152.25 151.94 31.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.319 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.02 93.56 22.68 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.96 126.17 18.19 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.742 2.294 . . . . 0.0 112.13 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.1 mt -144.24 144.3 31.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.281 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 38' ' ' TPO . 6.4 tt -80.64 125.79 30.46 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.425 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.465 ' N ' HD23 ' A' ' 37' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.08 162.44 32.78 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.786 2.324 . . . . 0.0 112.282 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.0 m -138.88 163.13 33.09 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.428 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' C ' ' HD3' ' A' ' 42' ' ' LYS . 1.1 tmtp? -70.15 -40.51 74.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.502 0.191 . . . . 0.0 110.87 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -60.3 -38.85 84.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.051 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 39.6 mtm -85.88 -26.42 25.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.546 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 46.5 ttm -55.91 -39.13 71.18 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 75.8 m -71.26 -38.49 71.88 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -52.88 -49.75 65.24 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.749 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.69 -38.09 62.47 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.681 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.01 -44.66 94.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.658 0.266 . . . . 0.0 111.079 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HE3' ' HD3' ' A' ' 67' ' ' LYS . 4.6 mptp? -73.3 -30.01 63.1 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.102 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.72 -32.91 64.12 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.93 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.0 p -78.73 -37.7 40.75 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.521 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -98.43 65.63 1.66 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.088 0.47 . . . . 0.0 109.999 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -68.17 -25.31 65.19 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.666 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.56 -18.2 77.98 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.602 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -97.79 -48.84 5.04 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.694 0.247 . . . . 0.0 111.085 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 m -59.42 -35.98 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.191 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.01 -31.96 73.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.66 0.267 . . . . 0.0 110.295 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 39.8 tt0 -68.6 -37.62 79.96 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.061 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -59.77 -24.81 64.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.207 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -84.17 -18.19 37.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.764 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 51.7 mtt180 -87.99 -42.67 12.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.601 0.239 . . . . 0.0 111.379 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mp -106.6 -25.56 11.75 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.29 10.59 50.91 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.84 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 81.4 mt -50.43 125.21 19.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.667 0.233 . . . . 0.0 111.484 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 27.0 Cg_exo -61.69 170.11 6.15 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.876 2.384 . . . . 0.0 112.361 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HD3' ' HE3' ' A' ' 50' ' ' LYS . 57.6 mttp -98.69 39.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.575 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . 12.5 t70 -172.75 126.45 0.51 Allowed Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 111.453 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.663 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 22.2 Cg_endo -60.4 -40.7 55.65 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.397 2.731 . . . . 0.0 113.01 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -52.85 -36.23 58.58 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.13 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 29.4 pt20 -99.06 36.73 1.65 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.931 0.396 . . . . 0.0 111.373 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.517 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 17.1 m0 -113.03 174.85 5.7 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.625 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -134.86 -175.42 3.9 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' MET . 42.0 mt-10 -52.42 -37.9 57.82 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.9 m -68.72 -52.76 27.22 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.641 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.64 -42.24 96.52 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.668 0.27 . . . . 0.0 111.163 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.558 HG13 HD22 ' A' ' 105' ' ' LEU . 42.6 t -59.72 -52.95 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.226 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -69.98 -45.14 67.98 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.599 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.36 -37.45 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.484 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -68.82 -60.69 2.21 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.9 t -41.26 -55.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.538 177.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.4 ttm -54.5 -45.66 73.32 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -59.23 -35.62 73.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.998 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.18 -18.85 58.89 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.304 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.811 ' CG2' HG11 ' A' ' 93' ' ' VAL . 96.3 t -83.18 -33.39 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.659 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.41 -35.06 17.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -41.15 63.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.135 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -100.61 7.68 43.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.817 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.7 m 45.52 56.74 5.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.977 0.418 . . . . 0.0 111.172 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.656 ' HB3' HG12 ' A' ' 121' ' ' VAL . 71.3 mt -85.14 173.11 10.69 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.321 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.31 152.27 32.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.673 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.95 -2.75 87.17 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.699 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.811 HG11 ' CG2' ' A' ' 85' ' ' VAL . 13.2 p -78.86 135.03 26.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 117.201 0.5 . . . . 0.0 111.318 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 9.8 m-20 -112.41 137.69 50.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.024 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.98 -24.54 23.51 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.929 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -61.21 -33.69 73.88 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 13.2 mptt -70.41 -34.01 72.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.721 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 47.9 m-85 -98.26 33.33 2.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.5 66.16 8.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.123 0.487 . . . . 0.0 110.32 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 108' ' ' LEU . 15.5 ptp -157.74 167.01 31.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.791 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 m -72.88 160.57 31.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -58.45 -42.34 95.76 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.871 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.93 68.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.706 0.289 . . . . 0.0 110.841 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.76 68.48 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.529 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.558 HD22 HG13 ' A' ' 77' ' ' VAL . 15.4 tp -56.08 -43.62 78.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.085 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 69' ' ' PRO . 75.8 m -67.17 -41.74 85.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.842 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -27.98 69.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.556 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 26.3 mt -63.69 -36.19 83.05 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.746 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.7 178.21 50.0 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.725 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -59.96 -53.28 59.69 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -46.66 -52.2 14.26 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.3 m -70.27 -41.37 73.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.443 ' HE2' HD21 ' A' ' 105' ' ' LEU . 36.6 t80 -61.79 -45.53 93.46 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.41 0.148 . . . . 0.0 111.232 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.45 -25.73 67.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.884 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -76.58 -21.6 55.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.669 0.271 . . . . 0.0 110.48 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 96.0 mt -86.51 -39.74 15.95 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.721 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -104.2 158.37 32.08 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.21 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.677 ' HG2' HG22 ' A' ' 121' ' ' VAL . 19.2 Cg_endo -58.16 175.11 0.53 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.864 2.376 . . . . 0.0 113.17 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -62.66 -15.94 54.55 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.28 -55.08 2.42 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.631 -0.827 . . . . 0.0 112.902 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.705 ' CG2' ' HB1' ' A' ' 117' ' ' ALA . 2.2 m -62.19 -33.64 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.83 -35.87 54.05 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.781 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.59 -43.86 53.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.74 0.305 . . . . 0.0 111.139 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.33 -56.48 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 111.568 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.523 HD23 HG22 ' A' ' 81' ' ' VAL . 11.0 mp -58.44 -58.9 6.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -30.94 70.81 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.49 -53.44 48.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.316 0.507 . . . . 0.0 109.921 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.488 ' HA ' HD12 ' A' ' 131' ' ' ILE . 19.9 t-80 -68.79 -31.56 70.67 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.241 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.456 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 29.3 tp -58.3 -45.9 87.14 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.288 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.58 -41.81 99.17 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.035 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 128' ' ' HIS . 95.8 mt -55.68 -43.3 72.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.284 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.581 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 88.3 mt -63.36 -41.68 98.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.867 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.663 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 71.3 mt-30 -56.14 -45.32 79.64 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.068 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -60.74 -40.37 92.14 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.455 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -102.66 82.89 2.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.417 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' A' ' 68' ' ' ASP . 12.3 t70 -75.84 -48.02 23.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.235 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.72 -179.37 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.538 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 mptt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.85 179.865 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.2 p80 . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.632 0.254 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.3 mmt 54.33 67.46 1.01 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.962 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -95.28 139.71 31.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.186 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.401 ' HA ' ' H ' ' A' ' 110' ' ' LYS . 50.1 t -148.0 -67.33 0.24 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.68 102.87 13.09 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.835 0.35 . . . . 0.0 111.109 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -137.43 80.95 1.84 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.528 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.47 126.87 27.05 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.159 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.94 170.99 18.77 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.908 2.406 . . . . 0.0 112.487 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 36' ' ' LEU . 3.2 mm? -91.15 84.88 5.74 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.821 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.59 ' HG ' ' HD3' ' A' ' 39' ' ' PRO . 14.8 tp -167.99 139.44 2.9 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.618 ' HG2' ' HD3' ' A' ' 42' ' ' LYS . 74.4 Cg_endo -74.39 -179.83 5.16 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.539 2.16 . . . . 0.0 112.072 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.2 t -55.92 -50.54 70.42 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.411 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.618 ' HD3' ' HG2' ' A' ' 39' ' ' PRO . 12.8 mptt -73.4 -39.45 65.07 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.535 0.207 . . . . 0.0 111.25 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -61.53 -40.08 93.37 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.235 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -81.5 -28.87 33.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.315 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.454 ' HE3' ' HA ' ' A' ' 45' ' ' MET . 4.2 tpt -59.89 -48.85 80.03 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.23 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.6 m -79.1 -26.79 42.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.051 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -49.05 -49.88 39.2 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.117 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.28 -44.13 84.44 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.666 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.577 HD12 ' HB2' ' A' ' 128' ' ' HIS . 4.6 mm? -60.86 -42.09 97.18 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.619 0.247 . . . . 0.0 111.289 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -64.56 -29.26 70.28 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.145 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.58 -30.55 59.67 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.85 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.8 p -54.57 -28.54 46.64 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -43.58 -57.09 3.32 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 m -60.26 -39.95 88.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.432 0.158 . . . . 0.0 111.414 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' HA2' ' HE3' ' A' ' 58' ' ' LYS . . . -76.58 -8.83 86.23 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.901 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.441 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 8.0 t80 -95.39 -46.72 6.59 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 116.621 0.211 . . . . 0.0 110.473 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.8 m -57.05 -35.87 69.82 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.232 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HE3' ' HA2' ' A' ' 55' ' ' GLY . 20.4 pttp -63.32 -32.88 74.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.811 0.339 . . . . 0.0 110.31 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -41.3 21.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.349 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 56' ' ' PHE . 53.3 mt-30 -59.85 -27.08 66.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.719 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -85.85 -38.34 18.22 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.505 0.193 . . . . 0.0 111.106 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -70.25 -33.59 71.81 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.475 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.9 mt -100.17 -33.79 10.3 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.725 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.32 -1.68 50.34 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.705 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 79' ' ' ASP . 56.3 mt -53.52 125.68 45.37 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 111.316 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 65' ' ' ILE . 20.2 Cg_exo -65.23 173.81 5.75 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.828 2.352 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.404 ' CG ' ' HB2' ' A' ' 136' ' ' ASP . 56.4 tptt -93.02 -18.67 22.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.485 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.462 ' HB2' ' N ' ' A' ' 138' ' ' LYS . 38.7 t70 -94.1 121.44 63.96 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.73 0.3 . . . . 0.0 111.295 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.561 ' HG2' ' HG2' ' A' ' 133' ' ' GLN . 38.5 Cg_endo -66.93 -26.99 43.52 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.075 2.517 . . . . 0.0 113.151 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 133' ' ' GLN . 3.7 mpt_? -72.88 -33.58 66.15 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.601 0.239 . . . . 0.0 110.399 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.23 40.98 1.07 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.505 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 6.7 m0 -113.38 171.47 7.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.661 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.2 p -134.12 -178.38 5.01 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -50.62 -38.99 48.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.489 0.185 . . . . 0.0 111.214 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.5 m -66.61 -55.82 13.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.345 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -58.45 -39.07 78.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.161 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 81' ' ' VAL . 44.7 t -61.87 -49.52 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.554 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -74.62 -40.4 61.55 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.326 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -60.14 -36.25 77.11 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.506 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.505 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 15.3 t90 -71.96 -60.99 1.95 Allowed 'General case' 0 C--N 1.339 0.124 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 85' ' ' VAL . 46.8 t -40.77 -53.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 123.421 0.451 . . . . 0.0 110.842 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 36.4 ttm -56.03 -46.33 78.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.445 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 19.1 t90 -60.93 -39.7 90.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.776 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.87 -21.67 64.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.993 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 81' ' ' VAL . 77.6 t -80.22 -29.56 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.954 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -82.25 -34.41 28.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.49 -40.41 70.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -103.27 6.55 38.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.808 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.2 m 43.99 54.58 5.77 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.617 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.522 HD13 ' HB ' ' A' ' 121' ' ' VAL . 72.8 mt -81.23 174.12 11.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.472 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.4 OUTLIER -156.52 151.52 26.2 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.501 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 -8.01 78.55 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.901 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.628 ' HB ' HG21 ' A' ' 121' ' ' VAL . 12.6 p -76.77 135.35 26.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 117.53 0.665 . . . . 0.0 110.911 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -104.79 138.34 41.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.05 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.75 -27.11 20.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.285 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.518 ' HA ' ' SG ' ' A' ' 99' ' ' CYS . 14.7 tt0 -60.48 -31.52 70.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 35.5 mmtp -65.32 -36.88 85.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.867 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 33.3 m-85 -99.82 34.28 2.32 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.643 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 96' ' ' GLN . 9.6 m -87.3 69.16 9.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.194 0.521 . . . . 0.0 110.208 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.433 ' SD ' HD11 ' A' ' 108' ' ' LEU . 16.4 ptp -158.97 171.03 20.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.824 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.9 p -72.18 159.85 33.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -57.37 -43.5 93.81 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.54 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.39 63.99 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.48 -46.18 60.56 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.6 -46.18 84.39 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.146 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 72.6 m -64.18 -38.78 92.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 110.516 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.69 74.44 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.218 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 54.3 mt -61.54 -34.97 76.46 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.808 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 177.49 41.19 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.609 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.506 ' HD3' ' CE2' ' A' ' 126' ' ' TRP . 37.5 ttpt -62.89 -40.96 99.16 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.565 0.221 . . . . 0.0 110.986 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.35 -64.06 0.93 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.301 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 88.4 m -64.52 -37.54 87.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -62.06 -46.2 90.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.541 0.21 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.1 -30.29 71.36 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.673 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.4 -22.96 61.04 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.734 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 88.5 mt -85.01 -41.4 15.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.543 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.478 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -102.74 157.62 33.36 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.849 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.639 ' HD2' ' CG2' ' A' ' 121' ' ' VAL . 74.1 Cg_exo -47.14 166.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.309 2.672 . . . . 0.0 113.662 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.44 -15.01 63.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.719 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -108.25 -60.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.98 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.639 ' CG2' ' HD2' ' A' ' 118' ' ' PRO . 11.8 m -59.24 -34.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -52.85 -36.65 50.82 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.934 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.47 -49.22 67.36 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.447 0.165 . . . . 0.0 111.188 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.0 mt -58.92 -57.34 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.722 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -50.35 -53.94 25.24 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.335 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 4.7 t90 -66.18 -28.74 69.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.178 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -58.31 -51.8 68.29 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.577 ' HB2' HD12 ' A' ' 49' ' ' LEU . 20.6 t-160 -76.45 -37.26 57.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 126' ' ' TRP . 41.5 tp -54.22 -48.58 70.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -65.85 -40.73 91.97 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.619 ' HA ' ' HE2' ' A' ' 134' ' ' LYS . 64.0 mt -54.72 -46.33 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.641 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.1 mt -51.63 -36.9 47.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.126 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.561 ' HG2' ' HG2' ' A' ' 69' ' ' PRO . 64.4 mt-30 -63.0 -56.48 16.69 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.393 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.619 ' HE2' ' HA ' ' A' ' 131' ' ' ILE . 60.6 pttt -69.58 -30.59 68.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.449 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 131' ' ' ILE . 40.1 mm-40 -62.42 -69.39 0.26 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.404 ' HB2' ' CG ' ' A' ' 67' ' ' LYS . 12.1 m-20 -143.79 160.61 40.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.084 0.469 . . . . 0.0 111.685 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 68' ' ' ASP . 17.3 m -121.86 52.19 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.652 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' N ' ' HB2' ' A' ' 68' ' ' ASP . 90.6 mttt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.999 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.5 p80 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.5 mmt 73.1 -73.1 0.1 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.773 0.429 . . . . 0.0 111.177 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -174.45 -49.66 0.01 OUTLIER 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.578 0.228 . . . . 0.0 111.041 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.2 t -93.11 -42.73 9.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.33 97.89 0.59 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.808 0.337 . . . . 0.0 111.215 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -143.73 121.9 12.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 38' ' ' TPO . 47.0 t -118.69 103.8 48.09 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HG2' ' HB ' ' A' ' 38' ' ' TPO . 82.0 Cg_endo -77.42 -177.37 3.79 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.791 2.327 . . . . 0.0 112.685 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.0 mt -61.07 -53.83 52.24 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.175 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.3 mt -108.62 103.1 12.13 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TPO . . . . . 0.479 ' HB ' ' HG2' ' A' ' 35' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.93 153.68 72.21 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.721 2.281 . . . . 0.0 112.417 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.3 t -71.21 107.83 4.41 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.933 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -60.57 -41.08 93.9 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.692 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -79.47 -38.88 33.5 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.608 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.2 ttm -54.91 -46.38 74.86 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.16 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.6 mtp -58.88 -33.78 70.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.722 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -85.56 -28.4 24.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 121.291 -0.163 . . . . 0.0 111.195 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -54.97 -52.24 63.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.725 0.297 . . . . 0.0 110.954 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.99 -34.76 50.67 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.563 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.581 HD11 HD13 ' A' ' 131' ' ' ILE . 40.6 tp -61.45 -45.74 93.02 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.535 0.207 . . . . 0.0 111.113 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 53' ' ' PHE . 43.4 mmtm -70.29 -34.85 73.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.432 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.96 -35.31 80.75 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.729 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 m -67.48 -46.57 72.59 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.483 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' A' ' 50' ' ' LYS . 22.7 m-85 -48.46 -44.17 35.34 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.311 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.469 ' O ' ' HD3' ' A' ' 58' ' ' LYS . 42.9 m -58.83 -44.43 90.91 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.814 -0.175 . . . . 0.0 111.129 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.57 -14.57 79.55 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.546 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -89.31 -48.3 7.45 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.3 m -55.04 -38.86 68.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 54' ' ' SER . 6.1 mptp? -57.99 -35.96 71.96 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.753 0.311 . . . . 0.0 110.461 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -77.97 -41.38 36.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.847 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -58.58 -29.32 66.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.477 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -78.84 -19.27 52.43 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.416 ' HB2' HD12 ' A' ' 63' ' ' LEU . 81.6 mtt180 -77.46 -42.9 34.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.526 0.203 . . . . 0.0 111.31 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 62' ' ' ARG . 5.7 mp -101.34 -24.73 14.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.2 11.03 53.67 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.495 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.43 HG12 ' CD2' ' A' ' 76' ' ' HIS . 64.5 mt -60.51 129.44 89.33 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.312 0.245 . . . . 0.0 111.249 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' A' ' 72' ' ' TRP . 61.8 Cg_endo -74.29 167.72 26.49 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.394 2.063 . . . . 0.0 112.112 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -93.52 55.61 2.25 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 111.194 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 25.1 t70 -168.14 124.84 0.86 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.18 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.602 ' HG2' ' HG3' ' A' ' 133' ' ' GLN . 22.8 Cg_exo -65.12 -44.06 10.24 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.523 2.815 . . . . 0.0 113.517 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.47 -37.19 37.2 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.252 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.471 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 10.5 pt20 -100.56 44.36 1.02 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.901 0.381 . . . . 0.0 111.377 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.595 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . 7.0 m0 -119.88 169.51 10.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -132.53 179.67 5.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.99 -42.6 49.35 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.6 m -63.47 -49.44 73.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.527 0.203 . . . . 0.0 111.357 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.43 ' CD2' HG12 ' A' ' 65' ' ' ILE . 44.0 m170 -61.2 -41.26 96.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.009 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.75 -53.59 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -65.64 -47.96 73.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.513 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.15 -37.7 72.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 121.149 -0.22 . . . . 0.0 110.776 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.544 ' CH2' ' HB2' ' A' ' 129' ' ' LEU . 17.4 t90 -69.2 -62.02 1.55 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 85' ' ' VAL . 54.5 t -41.47 -53.1 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.4 ttm -55.22 -46.73 75.94 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.493 ' CE2' ' HG3' ' A' ' 87' ' ' GLU . 16.0 t90 -60.37 -38.1 82.85 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.17 -19.91 61.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.571 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 81' ' ' VAL . 78.6 t -83.16 -33.71 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 120.67 0.271 . . . . 0.0 110.295 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -82.1 -37.66 26.0 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HG3' ' CE2' ' A' ' 83' ' ' TRP . 8.0 mm-40 -71.5 -39.04 71.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.097 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -100.48 4.81 43.94 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 m 45.38 53.8 7.9 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.125 0.488 . . . . 0.0 110.657 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 121' ' ' VAL . 63.3 mt -85.34 166.55 16.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.498 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -151.37 152.82 33.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.82 -10.97 71.94 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.605 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.644 ' HB ' HG11 ' A' ' 121' ' ' VAL . 14.7 p -79.74 135.86 24.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 117.361 0.581 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.71 138.97 41.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.293 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.18 -27.18 23.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.755 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -61.59 -29.69 70.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 49.6 mmtm -67.02 -33.14 74.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.292 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.62 ' HZ ' ' HB2' ' A' ' 117' ' ' ALA . 28.3 m-85 -100.13 32.25 3.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.709 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.35 65.63 8.42 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.218 0.532 . . . . 0.0 110.533 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.448 ' SD ' HD11 ' A' ' 108' ' ' LEU . 14.9 ptp -158.77 167.73 28.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.7 p -74.04 161.7 29.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 72' ' ' TRP . . . -59.45 -40.28 95.96 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.701 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.38 76.87 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 110.743 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.03 -44.95 64.77 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.553 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.98 -42.24 84.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.01 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.56 -42.12 92.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.76 0.314 . . . . 0.0 110.539 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.65 72.62 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 112' ' ' CYS . 50.0 mt -59.95 -33.57 72.1 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.39 177.72 48.77 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.36 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.72 -47.11 86.74 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.386 0.143 . . . . 0.0 111.386 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 10.0 tp10 -50.1 -67.35 0.27 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.701 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.574 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 91.6 m -55.75 -40.99 73.31 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.704 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -62.54 -43.78 97.97 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.785 -0.189 . . . . 0.0 111.0 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.88 -30.84 71.85 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.679 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 14.4 mm-40 -70.33 -25.08 63.13 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 83.4 mt -86.92 -36.74 18.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.119 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.62 ' HB2' ' HZ ' ' A' ' 98' ' ' PHE . . . -97.14 167.44 11.97 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.827 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 121' ' ' VAL . 18.1 Cg_exo -67.65 174.39 7.58 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.054 2.503 . . . . 0.0 113.178 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.78 -29.92 71.07 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.324 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.4 -49.91 3.11 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.885 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 90' ' ' LEU . 98.9 t -59.44 -39.45 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.399 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 117' ' ' ALA . . . -52.5 -38.77 51.89 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.909 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.31 -49.22 70.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.523 0.202 . . . . 0.0 111.054 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mt -56.95 -47.87 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.713 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.7 -59.21 4.87 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.87 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -63.34 -27.16 69.13 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.18 -54.97 25.2 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.945 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -71.25 -35.55 71.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.177 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.544 ' HB2' ' CH2' ' A' ' 80' ' ' TRP . 39.0 tp -61.02 -46.54 90.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.72 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.21 -35.63 81.45 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.126 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.591 ' HA ' ' HE2' ' A' ' 134' ' ' LYS . 70.4 mt -62.67 -44.33 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 91.6 mt -57.22 -35.83 70.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.974 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.602 ' HG3' ' HG2' ' A' ' 69' ' ' PRO . 70.1 mt-30 -60.48 -53.44 57.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.976 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 131' ' ' ILE . 53.5 mtmt -51.99 -43.23 63.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.255 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.94 81.17 6.93 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.935 0.398 . . . . 0.0 110.402 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -81.06 84.98 6.37 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.593 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.68 128.04 41.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.986 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.835 179.843 . . . . . . . . 0 0 . 1 stop_ save_